Genes in Region
329839778 | LOC129995700 | ATAC-STARR-seq lymphoblastoid active region 23932 | 6 | 6918802 | 6918851 | Human |
10398873 | RN7SL554P | RNA, 7SL, cytoplasmic 554, pseudogene | 6 | 6938606 | 6938897 | Human |
38614705 | LOC113175009 | Sharpr-MPRA regulatory region 4402 | 6 | 6968696 | 6968990 | Human |
38664607 | LOC105374904 | uncharacterized LOC105374904 | 6 | 6994096 | 6995825 | Human |
38656202 | LOC113175013 | Sharpr-MPRA regulatory region 13455 | 6 | 7001376 | 7001670 | Human |
155662854 | LOC127405257 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7042699-7043587 | 6 | 7042466 | 7043354 | Human |
155659873 | LOC127405258 | H3K27ac hESC enhancer GRCh37_chr6:7051539-7052040 | 6 | 7051306 | 7051807 | Human |
329844266 | LOC129995701 | ATAC-STARR-seq lymphoblastoid silent region 16880 | 6 | 7051789 | 7052238 | Human |
329844825 | LOC129995702 | ATAC-STARR-seq lymphoblastoid active region 23933 | 6 | 7073660 | 7073899 | Human |
329837038 | LOC129995703 | ATAC-STARR-seq lymphoblastoid active region 23934 | 6 | 7086063 | 7086152 | Human |
329827628 | LOC129995704 | ATAC-STARR-seq lymphoblastoid silent region 16881 | 6 | 7087930 | 7087999 | Human |
329830670 | LOC129995705 | ATAC-STARR-seq lymphoblastoid active region 23935 | 6 | 7106770 | 7106829 | Human |
329835290 | LOC129995706 | ATAC-STARR-seq lymphoblastoid silent region 16882 | 6 | 7107180 | 7107659 | Human |
329816356 | LOC129995707 | ATAC-STARR-seq lymphoblastoid silent region 16883 | 6 | 7107720 | 7107939 | Human |
1322078 | RREB1 | ras responsive element binding protein 1 | 6 | 7107743 | 7251980 | Human |
329835668 | LOC129995708 | ATAC-STARR-seq lymphoblastoid silent region 16884 | 6 | 7108730 | 7109219 | Human |
329842429 | LOC129995709 | ATAC-STARR-seq lymphoblastoid silent region 16885 | 6 | 7109240 | 7109329 | Human |
150530532 | LOC123575662 | Sharpr-MPRA regulatory region 12169 | 6 | 7115456 | 7115750 | Human |
155660950 | LOC127405259 | H3K27ac hESC enhancer GRCh37_chr6:7119221-7119796 | 6 | 7118988 | 7119563 | Human |
155653739 | LOC127405260 | NANOG hESC enhancer GRCh37_chr6:7124594-7125112 | 6 | 7124361 | 7124879 | Human |
329821577 | LOC129995710 | ATAC-STARR-seq lymphoblastoid active region 23936 | 6 | 7137012 | 7137081 | Human |
155650136 | LOC127405261 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7140608-7141135 | 6 | 7140375 | 7140902 | Human |
329840212 | LOC129995711 | ATAC-STARR-seq lymphoblastoid silent region 16886 | 6 | 7140913 | 7141292 | Human |
329841533 | LOC129995712 | ATAC-STARR-seq lymphoblastoid active region 23937 | 6 | 7141373 | 7141502 | Human |
155659962 | LOC127405262 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7145752-7146422 | 6 | 7145519 | 7146189 | Human |
329818050 | LOC129995713 | ATAC-STARR-seq lymphoblastoid active region 23938 | 6 | 7146448 | 7146597 | Human |
329340144 | LOC129661630 | ReSE screen-validated silencer GRCh37_chr6:7151030-7151195 | 6 | 7150797 | 7150962 | Human |
155650484 | LOC127405263 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7156680-7157346 | 6 | 7156447 | 7157113 | Human |
38674143 | LOC113175014 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7160729-7161690 | 6 | 7160496 | 7161457 | Human |
38627635 | LOC110121247 | VISTA enhancer hs2061 | 6 | 7163717 | 7165821 | Human |
126779692 | LOC121099724 | Sharpr-MPRA regulatory region 4659 | 6 | 7166456 | 7166750 | Human |
155657026 | LOC127405264 | H3K27ac hESC enhancer GRCh37_chr6:7169201-7169702 | 6 | 7168968 | 7169469 | Human |
155661524 | LOC127405265 | H3K27ac hESC enhancer GRCh37_chr6:7169703-7170202 | 6 | 7169470 | 7169969 | Human |
38659622 | LOC111721709 | skeletal muscle cis-regulatory module in RREB1 intron | 6 | 7182132 | 7182585 | Human |
38630580 | LOC113175015 | Sharpr-MPRA regulatory region 2698 | 6 | 7201036 | 7201330 | Human |
329827607 | LOC129995714 | ATAC-STARR-seq lymphoblastoid active region 23939 | 6 | 7202095 | 7202244 | Human |
329815158 | LOC129995715 | ATAC-STARR-seq lymphoblastoid active region 23940 | 6 | 7202295 | 7202344 | Human |
329827373 | LOC129995716 | ATAC-STARR-seq lymphoblastoid active region 23941 | 6 | 7236124 | 7236223 | Human |
329835835 | LOC129995717 | ATAC-STARR-seq lymphoblastoid active region 23942 | 6 | 7236504 | 7236603 | Human |
155662421 | LOC127405266 | H3K4me1 hESC enhancer GRCh37_chr6:7258615-7259114 | 6 | 7258382 | 7258881 | Human |
155654991 | LOC127405267 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7261311-7262102 | 6 | 7261078 | 7261869 | Human |
155650979 | LOC127405268 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7262103-7262894 | 6 | 7261870 | 7262661 | Human |
150530576 | LOC123575663 | H3K4me1 hESC enhancer GRCh37_chr6:7267569-7268070 | 6 | 7267336 | 7267837 | Human |
155661416 | LOC127405269 | H3K4me1 hESC enhancer GRCh37_chr6:7273665-7274166 | 6 | 7273432 | 7273933 | Human |
401826821 | LOC132089447 | Neanderthal introgressed variant-containing enhancer experimental_94357 | 6 | 7276177 | 7276346 | Human |
1322158 | SSR1 | signal sequence receptor subunit 1 | 6 | 7281143 | 7313199 | Human |
329342365 | LOC129389435 | MPRA-validated peak5642 silencer | 6 | 7281742 | 7281942 | Human |
155652001 | LOC127405270 | H3K27ac hESC enhancer GRCh37_chr6:7312596-7313464 | 6 | 7312363 | 7313231 | Human |
155662889 | LOC127405271 | H3K27ac hESC enhancer GRCh37_chr6:7313465-7314331 | 6 | 7313232 | 7314098 | Human |
329821210 | LOC129995718 | ATAC-STARR-seq lymphoblastoid silent region 16890 | 6 | 7324597 | 7324706 | Human |
1604175 | CAGE1 | cancer antigen 1 | 6 | 7326659 | 7389742 | Human |
2305417 | RPS3P4 | ribosomal protein S3 pseudogene 4 | 6 | 7338831 | 7339598 | Human |
38639226 | ACCSLP1 | ACCSL pseudogene 1 | 6 | 7340744 | 7342555 | Human |
329338004 | LOC129661631 | ReSE screen-validated silencer GRCh37_chr6:7342644-7342806 | 6 | 7342411 | 7342573 | Human |
155661337 | LOC127405272 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:7346982-7347886 | 6 | 7346749 | 7347653 | Human |
329341218 | LOC129389436 | MPRA-validated peak5644 silencer | 6 | 7373862 | 7374062 | Human |
329815512 | LOC129995719 | ATAC-STARR-seq lymphoblastoid active region 23947 | 6 | 7389421 | 7389480 | Human |
329834472 | LOC129995720 | ATAC-STARR-seq lymphoblastoid active region 23948 | 6 | 7389491 | 7389540 | Human |
155658989 | LOC127405273 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7389927-7390713 | 6 | 7389671 | 7390480 | Human |
1314499 | RIOK1 | RIO kinase 1 | 6 | 7389808 | 7418037 | Human |
155650112 | LOC127405274 | NANOG hESC enhancer GRCh37_chr6:7413126-7413896 | 6 | 7412893 | 7413663 | Human |
155657826 | LOC127405275 | H3K4me1 hESC enhancer GRCh37_chr6:7425815-7426316 | 6 | 7425582 | 7426083 | Human |
38634079 | LOC102724234 | uncharacterized LOC102724234 | 6 | 7426872 | 7452793 | Human |
155658987 | LOC127405276 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7456191-7456810 | 6 | 7455958 | 7456577 | Human |
155656613 | LOC127405277 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:7464142-7465134 | 6 | 7463909 | 7464901 | Human |
7246013 | HNRNPLP1 | heterogeneous nuclear ribonucleoprotein L pseudogene 1 | 6 | 7480864 | 7482595 | Human |
155227746 | LOC126859576 | MED14-independent group 3 enhancer GRCh37_chr6:7505263-7506462 | 6 | 7505030 | 7506229 | Human |
2305732 | RPS26P29 | ribosomal protein S26 pseudogene 29 | 6 | 7506176 | 7506618 | Human |
38599987 | IDH1P1 | IDH1 pseudogene 1 | 6 | 7516094 | 7517878 | Human |
155661471 | LOC127405278 | H3K4me1 hESC enhancer GRCh37_chr6:7526687-7527188 | 6 | 7526454 | 7526955 | Human |
155651059 | LOC127405279 | OCT4-NANOG hESC enhancer GRCh37_chr6:7532914-7533459 | 6 | 7532681 | 7533226 | Human |
38602884 | LOC114827828 | VISTA enhancer hs2285 | 6 | 7536881 | 7539659 | Human |
38667824 | DSP-AS1 | DSP antisense RNA 1 | 6 | 7540451 | 7543083 | Human |
1314043 | DSP | desmoplakin | 6 | 7541671 | 7586714 | Human |
38620580 | LOC110121274 | VISTA enhancer hs2191 | 6 | 7560927 | 7562502 | Human |
155660504 | LOC127405280 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7590188-7590927 | 6 | 7589955 | 7590694 | Human |
1319128 | SNRNP48 | small nuclear ribonucleoprotein U11/U12 subunit 48 | 6 | 7590198 | 7611967 | Human |
150530545 | LOC123575664 | Sharpr-MPRA regulatory region 13737 | 6 | 7615996 | 7616290 | Human |
1353029 | RPL29P1 | ribosomal protein L29 pseudogene 1 | 6 | 7620423 | 7620885 | Human |
329343171 | LOC129389437 | MPRA-validated peak5647 silencer | 6 | 7631422 | 7631622 | Human |
38624979 | LOC105374906 | uncharacterized LOC105374906 | 6 | 7672649 | 7699982 | Human |
155659823 | LOC127405281 | NANOG hESC enhancer GRCh37_chr6:7685011-7685581 | 6 | 7684778 | 7685348 | Human |
329341604 | LOC129661632 | ReSE screen-validated silencer GRCh37_chr6:7696296-7696460 | 6 | 7696063 | 7696227 | Human |
38668040 | LOC113175016 | Sharpr-MPRA regulatory region 4297 | 6 | 7698276 | 7698570 | Human |
329818479 | LOC129995721 | ATAC-STARR-seq lymphoblastoid active region 23951 | 6 | 7723275 | 7723334 | Human |
1353193 | BMP6 | bone morphogenetic protein 6 | 6 | 7726099 | 7881728 | Human |
155661226 | LOC127405282 | H3K4me1 hESC enhancer GRCh37_chr6:7734858-7735358 | 6 | 7734625 | 7735125 | Human |
155662589 | LOC127405283 | H3K4me1 hESC enhancer GRCh37_chr6:7735359-7735859 | 6 | 7735126 | 7735626 | Human |
155230140 | LOC126859577 | BRD4-independent group 4 enhancer GRCh37_chr6:7763783-7764982 | 6 | 7763550 | 7764749 | Human |
5133076 | BLOC1S5-TXNDC5 | BLOC1S5-TXNDC5 readthrough (NMD candidate) | 6 | 7881250 | 8064414 | Human |
1313292 | TXNDC5 | thioredoxin domain containing 5 | 6 | 7881517 | 7910788 | Human |
155229002 | LOC126859578 | MED14-independent group 3 enhancer GRCh37_chr6:7882299-7883498 | 6 | 7882066 | 7883265 | Human |
329837816 | LOC129995722 | ATAC-STARR-seq lymphoblastoid silent region 16891 | 6 | 7909863 | 7909952 | Human |
329843587 | LOC129995723 | ATAC-STARR-seq lymphoblastoid silent region 16892 | 6 | 7910153 | 7910272 | Human |
329830507 | LOC129995724 | ATAC-STARR-seq lymphoblastoid silent region 16893 | 6 | 7910643 | 7911072 | Human |
329832064 | LOC129995725 | ATAC-STARR-seq lymphoblastoid active region 23952 | 6 | 7912913 | 7913062 | Human |
155227321 | LOC126859579 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:7919793-7920992 | 6 | 7919560 | 7920759 | Human |
329816380 | LOC129995726 | ATAC-STARR-seq lymphoblastoid active region 23953 | 6 | 7938864 | 7938933 | Human |
329838893 | LOC129995727 | ATAC-STARR-seq lymphoblastoid active region 23954 | 6 | 7963682 | 7963731 | Human |
329817849 | LOC129995728 | ATAC-STARR-seq lymphoblastoid silent region 16894 | 6 | 7975917 | 7976046 | Human |
155650148 | LOC127405284 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:7986177-7986678 | 6 | 7985944 | 7986445 | Human |
2804371 | PIP5K1P1 | phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 1 | 6 | 7986102 | 7990344 | Human |
329340367 | LOC129661633 | ReSE screen-validated silencer GRCh37_chr6:8012284-8012492 | 6 | 8012051 | 8012259 | Human |
1315693 | BLOC1S5 | biogenesis of lysosomal organelles complex 1 subunit 5 | 6 | 8013567 | 8064414 | Human |
7383336 | EEF1E1-BLOC1S5 | EEF1E1-BLOC1S5 readthrough (NMD candidate) | 6 | 8013567 | 8102595 | Human |
329338685 | LOC129389438 | MPRA-validated peak5648 silencer | 6 | 8031103 | 8031303 | Human |
155659458 | LOC127405285 | H3K27ac hESC enhancer GRCh37_chr6:8063830-8064456 | 6 | 8063597 | 8064223 | Human |
329814285 | LOC129995729 | ATAC-STARR-seq lymphoblastoid active region 23956 | 6 | 8065713 | 8065812 | Human |
329827276 | LOC129995730 | ATAC-STARR-seq lymphoblastoid active region 23957 | 6 | 8065823 | 8065972 | Human |
1322308 | EEF1E1 | eukaryotic translation elongation factor 1 epsilon 1 | 6 | 8073360 | 8102548 | Human |
1642104 | SCARNA27 | small Cajal body-specific RNA 27 | 6 | 8086408 | 8086533 | Human |
329338443 | LOC129661634 | ReSE screen-validated silencer GRCh37_chr6:8102180-8102365 | 6 | 8101947 | 8102132 | Human |
329823773 | LOC129995731 | ATAC-STARR-seq lymphoblastoid silent region 16895 | 6 | 8102341 | 8102460 | Human |
329840499 | LOC129995732 | ATAC-STARR-seq lymphoblastoid silent region 16896 | 6 | 8102601 | 8102800 | Human |
329337852 | LOC129661635 | ReSE screen-validated silencer GRCh37_chr6:8109366-8109558 | 6 | 8109133 | 8109325 | Human |
329840492 | LOC129995733 | ATAC-STARR-seq lymphoblastoid active region 23958 | 6 | 8131342 | 8131391 | Human |
38662759 | LOC105374910 | uncharacterized LOC105374910 | 6 | 8158181 | 8260982 | Human |
155661192 | LOC127405286 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:8180101-8180646 | 6 | 8179868 | 8180413 | Human |
155648393 | LOC127405287 | OCT4-NANOG hESC enhancer GRCh37_chr6:8230067-8230588 | 6 | 8229834 | 8230355 | Human |
38662441 | LOC105374911 | uncharacterized LOC105374911 | 6 | 8283225 | 8326315 | Human |
401825264 | LOC132089483 | Neanderthal introgressed variant-containing enhancer experimental_96039 | 6 | 8380017 | 8380186 | Human |
155648766 | LOC127405288 | OCT4-NANOG hESC enhancer GRCh37_chr6:8383593-8384467 | 6 | 8383360 | 8384234 | Human |
155228963 | LOC126859580 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:8387849-8389048 | 6 | 8387616 | 8388815 | Human |
329337901 | LOC129389439 | MPRA-validated peak5649 silencer | 6 | 8392663 | 8392863 | Human |
401826820 | LOC132090749 | Neanderthal introgressed variant-containing enhancer experimental_96052 | 6 | 8394509 | 8394678 | Human |
401826931 | LOC132089484 | Neanderthal introgressed variant-containing enhancer experimental_96058 | 6 | 8397466 | 8397635 | Human |
401826643 | LOC132090750 | Neanderthal introgressed variant-containing enhancer experimental_96067 | 6 | 8404439 | 8404608 | Human |
401825784 | LOC132089485 | Neanderthal introgressed variant-containing enhancer experimental_96069 | 6 | 8405129 | 8405298 | Human |
401825066 | LOC132089486 | Neanderthal introgressed variant-containing enhancer experimental_96073 | 6 | 8406395 | 8406564 | Human |
401825358 | LOC132090751 | Neanderthal introgressed variant-containing enhancer experimental_96077 | 6 | 8407741 | 8407910 | Human |
1316221 | SLC35B3 | solute carrier family 35 member B3 | 6 | 8411435 | 8435567 | Human |
401825670 | LOC132089487 | Neanderthal introgressed variant-containing enhancer experimental_96094 | 6 | 8432553 | 8432722 | Human |
155653501 | LOC127405289 | H3K27ac hESC enhancer GRCh37_chr6:8435518-8436059 | 6 | 8435173 | 8435826 | Human |
2293810 | HULC | hepatocellular carcinoma up-regulated long non-coding RNA | 6 | 8435623 | 8785445 | Human |
329822550 | LOC129995734 | ATAC-STARR-seq lymphoblastoid active region 23962 | 6 | 8435853 | 8435942 | Human |
401827074 | LOC132089488 | Neanderthal introgressed variant-containing enhancer experimental_96121 | 6 | 8455762 | 8455931 | Human |
401825106 | LOC132089489 | Neanderthal introgressed variant-containing enhancer experimental_96126 | 6 | 8456072 | 8456241 | Human |
401826413 | LOC132089490 | Neanderthal introgressed variant-containing enhancer experimental_96137 | 6 | 8457250 | 8457419 | Human |
401825728 | LOC132089491 | Neanderthal introgressed variant-containing enhancer experimental_96153 | 6 | 8469285 | 8469454 | Human |
401824884 | LOC132089492 | Neanderthal introgressed variant-containing enhancer experimental_96161 | 6 | 8475861 | 8476030 | Human |
401826792 | LOC132089493 | Neanderthal introgressed variant-containing enhancer experimental_96186 | 6 | 8492203 | 8492372 | Human |
401824901 | LOC132089494 | Neanderthal introgressed variant-containing enhancer experimental_96299 | 6 | 8533466 | 8533635 | Human |
401825528 | LOC132089495 | Neanderthal introgressed variant-containing enhancer experimental_96383 | 6 | 8555915 | 8556084 | Human |
401825148 | LOC132089496 | Neanderthal introgressed variant-containing enhancer experimental_96450 | 6 | 8572129 | 8572298 | Human |
401826755 | LOC132089497 | Neanderthal introgressed variant-containing enhancer experimental_96469 | 6 | 8590073 | 8590242 | Human |
401826678 | LOC132089498 | Neanderthal introgressed variant-containing enhancer experimental_96472 | 6 | 8590252 | 8590421 | Human |
155647644 | LOC127405290 | H3K27ac hESC enhancer GRCh37_chr6:8619731-8620403 | 6 | 8619498 | 8620170 | Human |
155229132 | LOC126859581 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:8627414-8628613 | 6 | 8627181 | 8628380 | Human |
30307096 | HULC | hepatocellular carcinoma up-regulated long non-coding RNA | 6 | 8652269 | 8653856 | Human |
401825910 | LOC132089499 | Neanderthal introgressed variant-containing enhancer experimental_96605 | 6 | 8659920 | 8660089 | Human |
401825481 | LOC132089500 | Neanderthal introgressed variant-containing enhancer experimental_96748 | 6 | 8721831 | 8722000 | Human |
401825875 | LOC132090752 | Neanderthal introgressed variant-containing enhancer experimental_96779 | 6 | 8762028 | 8762197 | Human |
38630656 | LOC112267952 | uncharacterized LOC112267952 | 6 | 8906074 | 8940358 | Human |
38667571 | LOC105374914 | uncharacterized LOC105374914 | 6 | 8959908 | 9051662 | Human |
126779683 | LOC121106426 | Sharpr-MPRA regulatory region 5599 | 6 | 8983176 | 8983470 | Human |
38628167 | LOC110121052 | VISTA enhancer hs1315 | 6 | 9095101 | 9096752 | Human |
38620963 | LOC107986562 | uncharacterized LOC107986562 | 6 | 9124221 | 9140398 | Human |
155658764 | LOC127405291 | NANOG hESC enhancer GRCh37_chr6:9199635-9200136 | 6 | 9199402 | 9199903 | Human |
151672023 | LOC124901255 | uncharacterized LOC124901255 | 6 | 9224857 | 9226417 | Human |
155230256 | LOC126859582 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:9405051-9406250 | 6 | 9404818 | 9406017 | Human |
155655727 | LOC127405292 | OCT4-NANOG hESC enhancer GRCh37_chr6:9456335-9456986 | 6 | 9456102 | 9456753 | Human |
329820204 | LOC129995735 | ATAC-STARR-seq lymphoblastoid active region 23963 | 6 | 9520352 | 9520431 | Human |
329832842 | LOC129995736 | ATAC-STARR-seq lymphoblastoid active region 23964 | 6 | 9520838 | 9520887 | Human |
155228854 | LOC126859583 | MED14-independent group 3 enhancer GRCh37_chr6:9614589-9615788 | 6 | 9614356 | 9615555 | Human |
329833628 | LOC129995737 | ATAC-STARR-seq lymphoblastoid active region 23965 | 6 | 9623319 | 9623398 | Human |
155230021 | LOC126859584 | BRD4-independent group 4 enhancer GRCh37_chr6:9648237-9649436 | 6 | 9648004 | 9649203 | Human |
151672568 | LOC124901484 | uncharacterized LOC124901484 | 6 | 9697235 | 9698141 | Human |
1352821 | OFCC1 | orofacial cleft 1 candidate 1 (pseudogene) | 6 | 9704978 | 10211608 | Human |
329841099 | LOC129995738 | ATAC-STARR-seq lymphoblastoid silent region 16898 | 6 | 9783617 | 9783696 | Human |
155659600 | LOC127405293 | H3K27ac hESC enhancer GRCh37_chr6:9810687-9811203 | 6 | 9810454 | 9810970 | Human |
155658715 | LOC127405294 | H3K27ac hESC enhancer GRCh37_chr6:9811204-9811719 | 6 | 9810971 | 9811486 | Human |
155648355 | LOC127405295 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:9971388-9971998 | 6 | 9971155 | 9971765 | Human |
155653365 | LOC127405296 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:9971999-9972609 | 6 | 9971766 | 9972376 | Human |
38611483 | LOC105374919 | uncharacterized LOC105374919 | 6 | 10041199 | 10062357 | Human |
329329326 | LOC129389440 | MPRA-validated peak5651 silencer | 6 | 10082472 | 10082672 | Human |
151671832 | LOC124900218 | uncharacterized LOC124900218 | 6 | 10095417 | 10140684 | Human |
2305571 | RPL7AP36 | ribosomal protein L7a pseudogene 36 | 6 | 10118434 | 10119312 | Human |
155656183 | LOC127405297 | H3K4me1 hESC enhancer GRCh37_chr6:10134047-10134548 | 6 | 10133814 | 10134315 | Human |
38613596 | LOC105374918 | uncharacterized LOC105374918 | 6 | 10140786 | 10145145 | Human |
2305731 | RPL21P62 | ribosomal protein L21 pseudogene 62 | 6 | 10213850 | 10214402 | Human |
10399705 | RNU6ATAC21P | RNA, U6atac small nuclear 21, pseudogene | 6 | 10222036 | 10222161 | Human |
155647036 | LOC127405298 | OCT4-NANOG hESC enhancer GRCh37_chr6:10315195-10315916 | 6 | 10314962 | 10315683 | Human |
38617354 | LOC105374920 | uncharacterized LOC105374920 | 6 | 10325210 | 10330104 | Human |
155229203 | LOC126859585 | MED14-independent group 3 enhancer GRCh37_chr6:10347421-10348620 | 6 | 10347188 | 10348387 | Human |
38609118 | LOC105374921 | uncharacterized LOC105374921 | 6 | 10347963 | 10352094 | Human |
38629346 | RPL7L1P20 | RPL7L1 pseudogene 20 | 6 | 10365313 | 10366592 | Human |
155663115 | LOC127405299 | H3K4me1 hESC enhancer GRCh37_chr6:10390646-10391250 | 6 | 10390413 | 10391017 | Human |
151670686 | LOC124901485 | uncharacterized LOC124901485 | 6 | 10393181 | 10396668 | Human |
1321067 | TFAP2A | transcription factor AP-2 alpha | 6 | 10396677 | 10419659 | Human |
155662886 | LOC127405300 | H3K4me1 hESC enhancer GRCh37_chr6:10399255-10399797 | 6 | 10399022 | 10399564 | Human |
155647057 | LOC127405301 | H3K4me1 hESC enhancer GRCh37_chr6:10399798-10400339 | 6 | 10399565 | 10400106 | Human |
127338299 | LOC121740638 | BRD4-independent group 4 enhancer GRCh37_chr6:10403277-10404476 | 6 | 10403044 | 10404863 | Human |
12790783 | TFAP2A-AS2 | TFAP2A antisense RNA 2 | 6 | 10404502 | 10407927 | Human |
7247789 | TFAP2A-AS1 | TFAP2A antisense RNA 1 | 6 | 10412318 | 10416169 | Human |
329842928 | LOC129995739 | ATAC-STARR-seq lymphoblastoid silent region 16900 | 6 | 10412558 | 10412917 | Human |
155647590 | LOC127405302 | H3K4me1 hESC enhancer GRCh37_chr6:10414531-10415188 | 6 | 10414298 | 10414955 | Human |
155662403 | LOC127405303 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:10415189-10415848 | 6 | 10414956 | 10415615 | Human |
155652396 | LOC127405304 | H3K4me1 hESC enhancer GRCh37_chr6:10416507-10417164 | 6 | 10416274 | 10416931 | Human |
155659859 | LOC127405305 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:10417165-10417822 | 6 | 10416932 | 10417589 | Human |
155660641 | LOC127405306 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10419141-10419798 | 6 | 10418908 | 10419565 | Human |
329823521 | LOC129995740 | ATAC-STARR-seq lymphoblastoid silent region 16901 | 6 | 10426144 | 10426413 | Human |
38618237 | LOC107986564 | uncharacterized LOC107986564 | 6 | 10426428 | 10428281 | Human |
1602284 | LINC00518 | long intergenic non-protein coding RNA 518 | 6 | 10427785 | 10434822 | Human |
155230452 | LOC126859586 | MED14-independent group 3 enhancer GRCh37_chr6:10433906-10435105 | 6 | 10433673 | 10434872 | Human |
10402712 | MIR5689HG | MIR5689 host gene | 6 | 10434329 | 10456781 | Human |
6483943 | MIR5689 | microRNA 5689 | 6 | 10439717 | 10439794 | Human |
155659877 | LOC127405307 | H3K4me1 hESC enhancer GRCh37_chr6:10440968-10441468 | 6 | 10440735 | 10441235 | Human |
155652197 | LOC127405308 | H3K4me1 hESC enhancer GRCh37_chr6:10441469-10441969 | 6 | 10441236 | 10441736 | Human |
1344176 | MRPL48P1 | mitochondrial ribosomal protein L48 pseudogene 1 | 6 | 10459677 | 10460589 | Human |
12904842 | LINC02522 | long intergenic non-protein coding RNA 2522 | 6 | 10465912 | 10481966 | Human |
155653720 | LOC127405309 | H3K4me1 hESC enhancer GRCh37_chr6:10466572-10467078 | 6 | 10466339 | 10466845 | Human |
38666043 | LOC101928146 | uncharacterized LOC101928146 | 6 | 10508660 | 10521406 | Human |
16552236 | AL139039.1 | glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase) (GCNT1) pseudogene | 6 | 10514185 | 10514946 | Human |
155648605 | LOC127405310 | H3K27ac hESC enhancer GRCh37_chr6:10518715-10519215 | 6 | 10518482 | 10518982 | Human |
38648397 | LOC111591500 | NFE2L2 motif-containing MPRA enhancer 266 | 6 | 10518998 | 10519142 | Human |
155662595 | LOC127405311 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10519455-10520150 | 6 | 10519222 | 10519917 | Human |
1607088 | GCNT2 | glucosaminyl (N-acetyl) transferase 2 (I blood group) | 6 | 10521351 | 10629368 | Human |
329836841 | LOC129995741 | ATAC-STARR-seq lymphoblastoid active region 23967 | 6 | 10521638 | 10521697 | Human |
329840835 | LOC129995742 | ATAC-STARR-seq lymphoblastoid active region 23968 | 6 | 10534002 | 10534251 | Human |
329828474 | LOC129995743 | ATAC-STARR-seq lymphoblastoid active region 23969 | 6 | 10534372 | 10534701 | Human |
155646316 | LOC127405312 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10555959-10556854 | 6 | 10555726 | 10556621 | Human |
155659605 | LOC127405313 | OCT4-NANOG hESC enhancer GRCh37_chr6:10558788-10559335 | 6 | 10558555 | 10559102 | Human |
155651814 | LOC127405314 | H3K27ac hESC enhancer GRCh37_chr6:10559462-10560216 | 6 | 10559229 | 10559983 | Human |
155655113 | LOC127405315 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10564953-10565514 | 6 | 10564720 | 10565281 | Human |
2305016 | RPL21P63 | ribosomal protein L21 pseudogene 63 | 6 | 10574712 | 10575239 | Human |
155655753 | LOC127405316 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:10575275-10575920 | 6 | 10575042 | 10575687 | Human |
155648971 | LOC127405317 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:10575921-10576566 | 6 | 10575688 | 10576333 | Human |
155656697 | LOC127405318 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10576567-10577212 | 6 | 10576334 | 10576979 | Human |
150530516 | LOC123575665 | Sharpr-MPRA regulatory region 5327 | 6 | 10578736 | 10579030 | Human |
155658970 | LOC127405319 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10582905-10583878 | 6 | 10582672 | 10583645 | Human |
155647185 | LOC127405320 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10585827-10586799 | 6 | 10585594 | 10586566 | Human |
155662482 | LOC127405321 | H3K27ac hESC enhancer GRCh37_chr6:10589255-10589802 | 6 | 10589022 | 10589569 | Human |
155651587 | LOC127405322 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:10596165-10597152 | 6 | 10595932 | 10596919 | Human |
1342918 | GCNT2P1 | GCNT2 pseudogene 1 | 6 | 10633760 | 10634830 | Human |
329329401 | LOC129389441 | MPRA-validated peak5653 silencer | 6 | 10662067 | 10662267 | Human |
1348700 | C6orf52 | chromosome 6 open reading frame 52 | 6 | 10671422 | 10694891 | Human |
1353310 | PAK1IP1 | PAK1 interacting protein 1 | 6 | 10690865 | 10709782 | Human |
329813250 | LOC129995744 | ATAC-STARR-seq lymphoblastoid active region 23970 | 6 | 10694530 | 10694579 | Human |
155652059 | LOC127405323 | H3K27ac hESC enhancer GRCh37_chr6:10694821-10695423 | 6 | 10694588 | 10695190 | Human |
329823654 | LOC129995745 | ATAC-STARR-seq lymphoblastoid silent region 16902 | 6 | 10720127 | 10720286 | Human |
329829445 | LOC129995746 | ATAC-STARR-seq lymphoblastoid silent region 16903 | 6 | 10720617 | 10720756 | Human |
155658202 | LOC127405324 | H3K27ac hESC enhancer GRCh37_chr6:10723303-10724199 | 6 | 10723001 | 10723966 | Human |
1313920 | TMEM14C | transmembrane protein 14C | 6 | 10723070 | 10731127 | Human |
127338438 | LOC121740639 | Sharpr-MPRA regulatory region 12108 | 6 | 10725059 | 10725410 | Human |
39128306 | TMEM14B-DT | TMEM14B divergent transcript | 6 | 10743324 | 10747584 | Human |
329841320 | LOC129995747 | ATAC-STARR-seq lymphoblastoid active region 23972 | 6 | 10747365 | 10747414 | Human |
329339072 | LOC129661636 | ReSE screen-validated silencer GRCh37_chr6:10747832-10748052 | 6 | 10747535 | 10747834 | Human |
1344544 | TMEM14B | transmembrane protein 14B | 6 | 10747759 | 10759774 | Human |
6481827 | RNA5SP203 | RNA, 5S ribosomal pseudogene 203 | 6 | 10752791 | 10752926 | Human |
733464 | MAK | male germ cell associated kinase | 6 | 10762723 | 10838539 | Human |
329342064 | LOC129661637 | ReSE screen-validated silencer GRCh37_chr6:10814688-10814873 | 6 | 10814455 | 10814640 | Human |
329818912 | LOC129995748 | ATAC-STARR-seq lymphoblastoid silent region 16907 | 6 | 10838602 | 10838731 | Human |
329843616 | LOC129995749 | ATAC-STARR-seq lymphoblastoid active region 23973 | 6 | 10838952 | 10839011 | Human |
329833585 | LOC129995750 | ATAC-STARR-seq lymphoblastoid active region 23974 | 6 | 10839062 | 10839221 | Human |
1322420 | GCM2 | glial cells missing transcription factor 2 | 6 | 10873223 | 10882041 | Human |
150530509 | LOC123575666 | Sharpr-MPRA regulatory region 8043 | 6 | 10881936 | 10882230 | Human |
155657152 | LOC127405325 | H3K27ac hESC enhancer GRCh37_chr6:10886452-10887220 | 6 | 10886219 | 10886987 | Human |
1604969 | SYCP2L | synaptonemal complex protein 2 like | 6 | 10887052 | 10974309 | Human |
38663504 | LOC101928191 | uncharacterized LOC101928191 | 6 | 10932317 | 10954089 | Human |
38642679 | LOC113121298 | Sharpr-MPRA regulatory region 7443 | 6 | 10954536 | 10954830 | Human |
155653595 | LOC127405326 | OCT4-NANOG hESC enhancer GRCh37_chr6:10963174-10963734 | 6 | 10962941 | 10963501 | Human |
155652306 | LOC127405327 | H3K4me1 hESC enhancer GRCh37_chr6:10976416-10976916 | 6 | 10976183 | 10976683 | Human |
1318475 | ELOVL2 | ELOVL fatty acid elongase 2 | 6 | 10980759 | 11044305 | Human |
38599406 | LOC100421248 | siah E3 ubiquitin protein ligase family member 3 pseudogene | 6 | 11015446 | 11015983 | Human |
6770589 | ELOVL2-AS1 | ELOVL2 antisense RNA 1 | 6 | 11043758 | 11079144 | Human |
329833025 | LOC129995751 | ATAC-STARR-seq lymphoblastoid silent region 16908 | 6 | 11044201 | 11044400 | Human |
155648089 | LOC127405328 | H3K4me1 hESC enhancer GRCh37_chr6:11045068-11045568 | 6 | 11044835 | 11045335 | Human |
155657993 | LOC127405329 | H3K4me1 hESC enhancer GRCh37_chr6:11045569-11046069 | 6 | 11045336 | 11045836 | Human |
155650755 | LOC127405330 | H3K27ac hESC enhancer GRCh37_chr6:11093674-11094214 | 6 | 11093441 | 11093981 | Human |
5508051 | SMIM13 | small integral membrane protein 13 | 6 | 11093834 | 11138733 | Human |
155651358 | LOC127405331 | H3K27ac hESC enhancer GRCh37_chr6:11094215-11094756 | 6 | 11093982 | 11094523 | Human |
329824915 | LOC129995752 | ATAC-STARR-seq lymphoblastoid silent region 16910 | 6 | 11096381 | 11096460 | Human |
1606632 | ERVFRD-1 | endogenous retrovirus group FRD member 1, envelope | 6 | 11102489 | 11111725 | Human |
150530529 | LOC123575667 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:11126939-11127440 | 6 | 11126706 | 11127232 | Human |
329840659 | LOC129995753 | ATAC-STARR-seq lymphoblastoid active region 23978 | 6 | 11144425 | 11144474 | Human |
401846763 | PAGE4P1 | PAGE4 pseudogene 1 | 6 | 11154929 | 11155150 | Human |
127338295 | LOC121740640 | Sharpr-MPRA regulatory region 2452 | 6 | 11172556 | 11172850 | Human |
1314803 | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 6 | 11183298 | 11382348 | Human |
155229032 | LOC126859587 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:11185257-11186456 | 6 | 11185024 | 11186223 | Human |
155660819 | LOC127405332 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11189930-11190701 | 6 | 11189697 | 11190468 | Human |
155660087 | LOC127405333 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11190702-11191472 | 6 | 11190469 | 11191239 | Human |
155657514 | LOC127405334 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11195391-11196257 | 6 | 11195158 | 11196024 | Human |
155663286 | LOC127405335 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11196258-11197123 | 6 | 11196025 | 11196890 | Human |
329816347 | LOC129995754 | ATAC-STARR-seq lymphoblastoid active region 23979 | 6 | 11199230 | 11199279 | Human |
151671371 | LOC124901256 | uncharacterized LOC124901256 | 6 | 11219861 | 11230710 | Human |
329838235 | LOC129995755 | ATAC-STARR-seq lymphoblastoid silent region 16911 | 6 | 11232176 | 11232225 | Human |
329825204 | LOC129995756 | ATAC-STARR-seq lymphoblastoid silent region 16912 | 6 | 11232706 | 11232755 | Human |
329821961 | LOC129995757 | ATAC-STARR-seq lymphoblastoid active region 23980 | 6 | 11258612 | 11258791 | Human |
150530570 | LOC123575668 | Sharpr-MPRA regulatory region 1219 | 6 | 11277396 | 11277690 | Human |
329843654 | LOC129995758 | ATAC-STARR-seq lymphoblastoid active region 23982 | 6 | 11277758 | 11277807 | Human |
329840486 | LOC129995759 | ATAC-STARR-seq lymphoblastoid active region 23983 | 6 | 11277818 | 11277917 | Human |
38630075 | LOC105374925 | uncharacterized LOC105374925 | 6 | 11291722 | 11335790 | Human |
155652758 | LOC127405336 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11298822-11299579 | 6 | 11298589 | 11299346 | Human |
329820213 | LOC129995760 | ATAC-STARR-seq lymphoblastoid active region 23984 | 6 | 11318243 | 11318462 | Human |
155227246 | LOC126859588 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:11344190-11345389 | 6 | 11343957 | 11345156 | Human |
150530558 | LOC123575669 | Sharpr-MPRA regulatory region 10259 | 6 | 11365116 | 11365410 | Human |
155661502 | LOC127405337 | H3K4me1 hESC enhancer GRCh37_chr6:11370467-11370968 | 6 | 11370234 | 11370735 | Human |
155646930 | LOC127405338 | H3K4me1 hESC enhancer GRCh37_chr6:11370969-11371468 | 6 | 11370736 | 11371235 | Human |
329838144 | LOC129995761 | ATAC-STARR-seq lymphoblastoid active region 23985 | 6 | 11382020 | 11382219 | Human |
38619610 | LOC105374927 | uncharacterized LOC105374927 | 6 | 11391875 | 11394862 | Human |
329341957 | LOC129661638 | ReSE screen-validated silencer GRCh37_chr6:11395146-11395358 | 6 | 11394913 | 11395125 | Human |
38613929 | LOC105374928 | uncharacterized LOC105374928 | 6 | 11417363 | 11524124 | Human |
38667518 | LOC105374929 | uncharacterized LOC105374929 | 6 | 11417619 | 11429560 | Human |
329815502 | LOC129995762 | ATAC-STARR-seq lymphoblastoid active region 23986 | 6 | 11444660 | 11444779 | Human |
329818742 | LOC129995763 | ATAC-STARR-seq lymphoblastoid active region 23987 | 6 | 11460222 | 11460411 | Human |
329841529 | LOC129995764 | ATAC-STARR-seq lymphoblastoid active region 23988 | 6 | 11492005 | 11492124 | Human |
10400095 | RNU1-64P | RNA, U1 small nuclear 64, pseudogene | 6 | 11503509 | 11503671 | Human |
5128997 | THAP12P5 | THAP domain containing 12 pseudogene 5 | 6 | 11514192 | 11516389 | Human |
329833053 | LOC129995765 | ATAC-STARR-seq lymphoblastoid active region 23989 | 6 | 11515053 | 11515102 | Human |
329830956 | LOC129995766 | ATAC-STARR-seq lymphoblastoid silent region 16913 | 6 | 11537213 | 11538042 | Human |
2293893 | TMEM170B | transmembrane protein 170B | 6 | 11537749 | 11583524 | Human |
155658729 | LOC127405339 | H3K4me1 hESC enhancer GRCh37_chr6:11538275-11538776 | 6 | 11538042 | 11538702 | Human |
155646616 | LOC127405340 | NANOG-H3K4me1 hESC enhancer GRCh37_chr6:11609547-11610088 | 6 | 11609314 | 11609855 | Human |
155646743 | LOC127405341 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:11650363-11650968 | 6 | 11650130 | 11650735 | Human |
155655945 | LOC127405342 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:11650969-11651574 | 6 | 11650736 | 11651341 | Human |
329819248 | LOC129995767 | ATAC-STARR-seq lymphoblastoid silent region 16917 | 6 | 11655674 | 11655843 | Human |
38631260 | LOC340184 | uncharacterized LOC340184 | 6 | 11690257 | 11710399 | Human |
16551820 | LOC124900221 | small nucleolar RNA SNORA67 | 6 | 11709819 | 11709960 | Human |
329836806 | LOC129995768 | ATAC-STARR-seq lymphoblastoid active region 23990 | 6 | 11711640 | 11711689 | Human |
1313849 | ADTRP | androgen dependent TFPI regulating protein | 6 | 11713523 | 11778803 | Human |
329825155 | LOC129995769 | ATAC-STARR-seq lymphoblastoid active region 23991 | 6 | 11714376 | 11714525 | Human |
155228631 | LOC126859589 | BRD4-independent group 4 enhancer GRCh37_chr6:11722447-11723646 | 6 | 11722214 | 11723413 | Human |
151672316 | LOC124901258 | uncharacterized LOC124901258 | 6 | 11727165 | 11731247 | Human |
401825783 | LOC132090753 | Neanderthal introgressed variant-containing enhancer experimental_88259 | 6 | 11729534 | 11729703 | Human |
329841234 | LOC129995770 | ATAC-STARR-seq lymphoblastoid active region 23992 | 6 | 11732088 | 11732387 | Human |
329841913 | LOC129995771 | ATAC-STARR-seq lymphoblastoid active region 23993 | 6 | 11732668 | 11732757 | Human |
329343588 | LOC129661639 | ReSE screen-validated silencer GRCh37_chr6:11763549-11763791 | 6 | 11763316 | 11763558 | Human |
155658842 | LOC127405343 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11770197-11770720 | 6 | 11769964 | 11770487 | Human |
127338422 | LOC121740641 | H3K27ac-H3K4me1 hESC enhancers GRCh37_chr6:11770721-11771242 and GRCh37_chr6:11771243-11771766 | 6 | 11770488 | 11771533 | Human |
155655146 | LOC127405344 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11794232-11794800 | 6 | 11793999 | 11794567 | Human |
155662042 | LOC127405345 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:11794801-11795369 | 6 | 11794568 | 11795136 | Human |
38635422 | LOC107986567 | uncharacterized LOC107986567 | 6 | 11806640 | 11811266 | Human |
151671860 | LOC124901257 | uncharacterized LOC124901257 | 6 | 11810084 | 11811063 | Human |
329343771 | LOC129661640 | ReSE screen-validated silencer GRCh37_chr6:11834142-11834332 | 6 | 11833832 | 11834099 | Human |
329834823 | LOC129995772 | ATAC-STARR-seq lymphoblastoid active region 23994 | 6 | 11834322 | 11834621 | Human |
329339015 | LOC129661641 | ReSE screen-validated silencer GRCh37_chr6:11838380-11838562 | 6 | 11838147 | 11838329 | Human |
329822582 | LOC129995773 | ATAC-STARR-seq lymphoblastoid active region 23995 | 6 | 11852716 | 11852775 | Human |
329834770 | LOC129995774 | ATAC-STARR-seq lymphoblastoid active region 23996 | 6 | 11854739 | 11854818 | Human |
329830393 | LOC129995775 | ATAC-STARR-seq lymphoblastoid active region 23997 | 6 | 11854899 | 11854968 | Human |
38638260 | LOC102724379 | uncharacterized LOC102724379 | 6 | 11858472 | 11868600 | Human |
9846229 | AMD1P4 | adenosylmethionine decarboxylase 1 pseudogene 4 | 6 | 11861426 | 11862699 | Human |
329824720 | LOC129995776 | ATAC-STARR-seq lymphoblastoid active region 23998 | 6 | 11876965 | 11877184 | Human |
150530589 | LOC123575670 | Sharpr-MPRA regulatory region 316 | 6 | 11900736 | 11901030 | Human |
38660054 | LOC107986570 | uncharacterized LOC107986570 | 6 | 11934030 | 11961002 | Human |
329338953 | LOC129661642 | ReSE screen-validated silencer GRCh37_chr6:11935862-11936084 | 6 | 11935629 | 11935851 | Human |
329820772 | LOC129995777 | ATAC-STARR-seq lymphoblastoid active region 23999 | 6 | 11938553 | 11938612 | Human |
329830839 | LOC129995778 | ATAC-STARR-seq lymphoblastoid active region 24000 | 6 | 11978454 | 11978683 | Human |
16553087 | AL157373.1 | novel transcript | 6 | 11990343 | 12001244 | Human |
736425 | HIVEP1 | HIVEP zinc finger 1 | 6 | 12007693 | 12212048 | Human |
329818132 | LOC129995779 | ATAC-STARR-seq lymphoblastoid silent region 16919 | 6 | 12009170 | 12009289 | Human |
155651479 | LOC127405346 | H3K27ac hESC enhancer GRCh37_chr6:12010596-12011140 | 6 | 12010363 | 12010907 | Human |
329817245 | LOC129995780 | ATAC-STARR-seq lymphoblastoid silent region 16920 | 6 | 12011237 | 12012146 | Human |
329840233 | LOC129995781 | ATAC-STARR-seq lymphoblastoid silent region 16921 | 6 | 12012327 | 12012466 | Human |
150530599 | LOC123575671 | Sharpr-MPRA regulatory region 4667 | 6 | 12034396 | 12034690 | Human |
155659122 | LOC127405347 | H3K27ac hESC enhancer GRCh37_chr6:12036533-12037034 | 6 | 12036300 | 12036801 | Human |
155651372 | LOC127405348 | H3K27ac hESC enhancer GRCh37_chr6:12037035-12037534 | 6 | 12036802 | 12037301 | Human |
329844783 | LOC129995782 | ATAC-STARR-seq lymphoblastoid active region 24001 | 6 | 12047280 | 12047349 | Human |
329822955 | LOC129995783 | ATAC-STARR-seq lymphoblastoid active region 24002 | 6 | 12047990 | 12048099 | Human |
329829187 | LOC129995784 | ATAC-STARR-seq lymphoblastoid active region 24003 | 6 | 12049502 | 12049561 | Human |
329818640 | LOC129995785 | ATAC-STARR-seq lymphoblastoid active region 24004 | 6 | 12051826 | 12052095 | Human |
329837717 | LOC129995786 | ATAC-STARR-seq lymphoblastoid active region 24005 | 6 | 12052126 | 12052175 | Human |
329830622 | LOC129995787 | ATAC-STARR-seq lymphoblastoid active region 24006 | 6 | 12052196 | 12052275 | Human |
155656470 | LOC127405349 | H3K4me1 hESC enhancer GRCh37_chr6:12099563-12100062 | 6 | 12099330 | 12099829 | Human |
329839974 | LOC129995788 | ATAC-STARR-seq lymphoblastoid active region 24007 | 6 | 12114330 | 12114379 | Human |
329841986 | LOC129995789 | ATAC-STARR-seq lymphoblastoid active region 24008 | 6 | 12119089 | 12119138 | Human |
126779656 | LOC121113497 | Sharpr-MPRA regulatory region 8641 | 6 | 12119156 | 12119450 | Human |
329825659 | LOC129995790 | ATAC-STARR-seq lymphoblastoid active region 24011 | 6 | 12138607 | 12138686 | Human |
329815744 | LOC129995791 | ATAC-STARR-seq lymphoblastoid active region 24012 | 6 | 12163297 | 12163356 | Human |
329825997 | LOC129995792 | ATAC-STARR-seq lymphoblastoid active region 24013 | 6 | 12163417 | 12163466 | Human |
155661741 | LOC127405350 | H3K4me1 hESC enhancer GRCh37_chr6:12164419-12164919 | 6 | 12164186 | 12164686 | Human |
730848 | EDN1 | endothelin 1 | 6 | 12230516 | 12297194 | Human |
151673570 | LOC124901260 | uncharacterized LOC124901260 | 6 | 12241447 | 12265376 | Human |
329831872 | LOC129995793 | ATAC-STARR-seq lymphoblastoid silent region 16922 | 6 | 12275178 | 12275297 | Human |
155657227 | LOC127405351 | H3K4me1 hESC enhancer GRCh37_chr6:12288202-12288702 | 6 | 12287969 | 12288469 | Human |
155661957 | LOC127405352 | H3K4me1 hESC enhancer GRCh37_chr6:12288703-12289203 | 6 | 12288470 | 12288970 | Human |
329815940 | LOC129995794 | ATAC-STARR-seq lymphoblastoid active region 24014 | 6 | 12290114 | 12290213 | Human |
329818622 | LOC129995795 | ATAC-STARR-seq lymphoblastoid active region 24015 | 6 | 12290224 | 12290293 | Human |
10399801 | SUMO2P12 | SUMO2 pseudogene 12 | 6 | 12319453 | 12319592 | Human |
329827172 | LOC129995796 | ATAC-STARR-seq lymphoblastoid active region 24016 | 6 | 12363616 | 12363935 | Human |
329338235 | LOC129389442 | MPRA-validated peak5660 silencer | 6 | 12365723 | 12365923 | Human |
155646402 | LOC127405353 | H3K27ac hESC enhancer GRCh37_chr6:12366181-12366852 | 6 | 12365949 | 12366620 | Human |
329841058 | LOC129995797 | ATAC-STARR-seq lymphoblastoid active region 24017 | 6 | 12383623 | 12383702 | Human |
38639731 | LOC105374931 | uncharacterized LOC105374931 | 6 | 12395474 | 12407928 | Human |
10399089 | RN7SKP293 | RN7SK pseudogene 293 | 6 | 12406486 | 12406781 | Human |
38657365 | LOC113146407 | Sharpr-MPRA regulatory region 4078 | 6 | 12456317 | 12456611 | Human |
155229680 | LOC126859590 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:12483687-12484886 | 6 | 12483455 | 12484654 | Human |
155653473 | LOC127405354 | H3K4me1 hESC enhancer GRCh37_chr6:12494607-12495106 | 6 | 12494375 | 12494874 | Human |
1346139 | RPL15P3 | ribosomal protein L15 pseudogene 3 | 6 | 12514070 | 12514775 | Human |
12904997 | LINC02530 | long intergenic non-protein coding RNA 2530 | 6 | 12582768 | 12585404 | Human |
150530609 | LOC123575672 | Sharpr-MPRA regulatory region 7011 | 6 | 12605797 | 12606091 | Human |
329842733 | LOC129995798 | ATAC-STARR-seq lymphoblastoid active region 24019 | 6 | 12608490 | 12608609 | Human |
329840881 | LOC129995799 | ATAC-STARR-seq lymphoblastoid silent region 16923 | 6 | 12638247 | 12638306 | Human |
155648209 | LOC127405355 | NANOG hESC enhancer GRCh37_chr6:12672164-12672665 | 6 | 12671932 | 12672433 | Human |
155649295 | LOC127405356 | H3K4me1 hESC enhancer GRCh37_chr6:12673381-12673882 | 6 | 12673149 | 12673650 | Human |
38644993 | LOC107984015 | uncharacterized LOC107984015 | 6 | 12695217 | 12744282 | Human |
1353173 | PHACTR1 | phosphatase and actin regulator 1 | 6 | 12716767 | 13287837 | Human |
151674857 | LOC124901503 | uncharacterized LOC124901503 | 6 | 12736800 | 12736949 | Human |
38628515 | LOC105374935 | uncharacterized LOC105374935 | 6 | 12744905 | 12747458 | Human |
155653032 | LOC127405357 | H3K4me1 hESC enhancer GRCh37_chr6:12749187-12749871 | 6 | 12748955 | 12749639 | Human |
155649617 | LOC127405358 | H3K4me1 hESC enhancer GRCh37_chr6:12749997-12750498 | 6 | 12749765 | 12750266 | Human |
38625364 | LOC105374934 | uncharacterized LOC105374934 | 6 | 12828595 | 12834753 | Human |
155660889 | LOC127405359 | OCT4-NANOG hESC enhancer GRCh37_chr6:12851299-12851828 | 6 | 12851067 | 12851596 | Human |
155662649 | LOC127405360 | OCT4-NANOG hESC enhancer GRCh37_chr6:12887216-12887819 | 6 | 12886984 | 12887587 | Human |
155647417 | LOC127405361 | OCT4-NANOG hESC enhancer GRCh37_chr6:12956003-12956794 | 6 | 12955771 | 12956562 | Human |
151671772 | LOC124901262 | uncharacterized LOC124901262 | 6 | 12958810 | 12963778 | Human |
329828361 | LOC129995800 | ATAC-STARR-seq lymphoblastoid silent region 16924 | 6 | 13195070 | 13195159 | Human |
1347098 | RNU1-11P | RNA, U1 small nuclear 11, pseudogene | 6 | 13214040 | 13214255 | Human |
329329815 | LOC129389443 | MPRA-validated peak5664 silencer | 6 | 13217583 | 13217783 | Human |
38603158 | LOC105374933 | uncharacterized LOC105374933 | 6 | 13222961 | 13229973 | Human |
329839045 | LOC129995801 | ATAC-STARR-seq lymphoblastoid active region 24020 | 6 | 13229272 | 13229331 | Human |
329820985 | LOC129995802 | ATAC-STARR-seq lymphoblastoid silent region 16925 | 6 | 13229502 | 13229591 | Human |
38659790 | LOC113146411 | Sharpr-MPRA regulatory region 805 | 6 | 13248077 | 13248371 | Human |
155658092 | LOC127405362 | H3K27ac hESC enhancer GRCh37_chr6:13257894-13258394 | 6 | 13257662 | 13258162 | Human |
155652704 | LOC127405363 | H3K27ac hESC enhancer GRCh37_chr6:13258395-13258895 | 6 | 13258163 | 13258663 | Human |
1316981 | TBC1D7 | TBC1 domain family member 7 | 6 | 13266536 | 13328537 | Human |
329845249 | LOC129995803 | ATAC-STARR-seq lymphoblastoid active region 24021 | 6 | 13272480 | 13272579 | Human |
16552177 | AL008729.1 | novel transcript, antisense to PHACTR1 | 6 | 13273094 | 13295586 | Human |
155229932 | LOC126859591 | BRD4-independent group 4 enhancer GRCh37_chr6:13273523-13274722 | 6 | 13273291 | 13274490 | Human |
329843229 | LOC129995804 | ATAC-STARR-seq lymphoblastoid active region 24022 | 6 | 13278169 | 13278338 | Human |
329815297 | LOC129995805 | ATAC-STARR-seq lymphoblastoid active region 24023 | 6 | 13303101 | 13303150 | Human |
36174094 | TBC1D7 | TBC1 domain family member 7 | 6 | 13304951 | 13328537 | Human |
155230346 | LOC126859592 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:13307473-13308672 | 6 | 13307241 | 13308440 | Human |
155661124 | LOC127405364 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:13328608-13329114 | 6 | 13328353 | 13328882 | Human |
151669171 | LOC124901261 | uncharacterized LOC124901261 | 6 | 13328615 | 13329857 | Human |
329821593 | LOC129995806 | ATAC-STARR-seq lymphoblastoid silent region 16927 | 6 | 13338087 | 13338196 | Human |
38650391 | LOC105374936 | uncharacterized LOC105374936 | 6 | 13351157 | 13353740 | Human |
329825111 | LOC129995807 | ATAC-STARR-seq lymphoblastoid silent region 16928 | 6 | 13355616 | 13355705 | Human |
1323002 | GFOD1 | Gfo/Idh/MocA-like oxidoreductase domain containing 1 | 6 | 13357830 | 13487600 | Human |
329839553 | LOC129995808 | ATAC-STARR-seq lymphoblastoid active region 24024 | 6 | 13383553 | 13383872 | Human |
329821573 | LOC129995809 | ATAC-STARR-seq lymphoblastoid silent region 16929 | 6 | 13400750 | 13400799 | Human |
329329519 | LOC129389444 | MPRA-validated peak5665 silencer | 6 | 13405953 | 13406153 | Human |
329829836 | LOC129995810 | ATAC-STARR-seq lymphoblastoid active region 24025 | 6 | 13419964 | 13420053 | Human |
155662298 | LOC127405365 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:13422205-13422994 | 6 | 13421973 | 13422762 | Human |
329825822 | LOC129995811 | ATAC-STARR-seq lymphoblastoid active region 24026 | 6 | 13427829 | 13428258 | Human |
329821481 | LOC129995812 | ATAC-STARR-seq lymphoblastoid active region 24027 | 6 | 13429269 | 13429338 | Human |
329840116 | LOC129995813 | ATAC-STARR-seq lymphoblastoid active region 24028 | 6 | 13431058 | 13431157 | Human |
329823235 | LOC129995814 | ATAC-STARR-seq lymphoblastoid active region 24029 | 6 | 13431248 | 13431307 | Human |
329818916 | LOC129995815 | ATAC-STARR-seq lymphoblastoid active region 24030 | 6 | 13432146 | 13432195 | Human |
329840802 | LOC129995816 | ATAC-STARR-seq lymphoblastoid active region 24031 | 6 | 13432937 | 13432986 | Human |
155661698 | LOC127405366 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:13461923-13462595 | 6 | 13461691 | 13462363 | Human |
155655438 | LOC127405367 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:13462671-13463323 | 6 | 13462439 | 13463091 | Human |
155650891 | LOC127405368 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:13463324-13463975 | 6 | 13463092 | 13463743 | Human |
155227603 | LOC126859593 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:13466168-13467367 | 6 | 13465936 | 13467135 | Human |
127338285 | LOC121740642 | Sharpr-MPRA regulatory region 12646 | 6 | 13471917 | 13472211 | Human |
155228098 | LOC126859594 | BRD4-independent group 4 enhancer GRCh37_chr6:13479720-13480919 | 6 | 13479488 | 13480687 | Human |
329823022 | LOC129995817 | ATAC-STARR-seq lymphoblastoid active region 24032 | 6 | 13484147 | 13484216 | Human |
6481371 | GFOD1-AS1 | GFOD1 antisense RNA 1 | 6 | 13486261 | 13486771 | Human |
329339948 | LOC129661643 | ReSE screen-validated silencer GRCh37_chr6:13487020-13487183 | 6 | 13486788 | 13486961 | Human |
329829959 | LOC129995818 | ATAC-STARR-seq lymphoblastoid silent region 16930 | 6 | 13487092 | 13487571 | Human |
329816420 | LOC129995819 | ATAC-STARR-seq lymphoblastoid silent region 16931 | 6 | 13487592 | 13487971 | Human |
329836218 | LOC129995820 | ATAC-STARR-seq lymphoblastoid silent region 16932 | 6 | 13488352 | 13488461 | Human |
329839945 | LOC129995821 | ATAC-STARR-seq lymphoblastoid active region 24034 | 6 | 13488522 | 13488651 | Human |
329821590 | LOC129995822 | ATAC-STARR-seq lymphoblastoid active region 24035 | 6 | 13514166 | 13514235 | Human |
2305730 | RPS4XP7 | ribosomal protein S4X pseudogene 7 | 6 | 13521213 | 13522116 | Human |
329839228 | LOC129995823 | ATAC-STARR-seq lymphoblastoid active region 24036 | 6 | 13526815 | 13526934 | Human |
10412568 | RN7SKP204 | RN7SK pseudogene 204 | 6 | 13547704 | 13547956 | Human |
38645682 | LOC105374937 | uncharacterized LOC105374937 | 6 | 13572072 | 13574434 | Human |
155656489 | LOC127405369 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:13574598-13575184 | 6 | 13574154 | 13574952 | Human |
1351920 | SIRT5 | sirtuin 5 | 6 | 13574274 | 13615158 | Human |
155659505 | LOC127405370 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:13575185-13575770 | 6 | 13574884 | 13575538 | Human |
38641690 | LOC105374938 | uncharacterized LOC105374938 | 6 | 13599030 | 13608594 | Human |
151674114 | LOC124901263 | uncharacterized LOC124901263 | 6 | 13609266 | 13615202 | Human |
329841760 | LOC129995824 | ATAC-STARR-seq lymphoblastoid active region 24038 | 6 | 13614548 | 13614717 | Human |
1343047 | NOL7 | nucleolar protein 7 | 6 | 13615335 | 13632470 | Human |
1344686 | RANBP9 | RAN binding protein 9 | 6 | 13621498 | 13711835 | Human |
151676371 | LOC124901523 | U7 small nuclear RNA | 6 | 13680080 | 13680141 | Human |
126779653 | LOC121113498 | Sharpr-MPRA regulatory region 12249 | 6 | 13702817 | 13703111 | Human |
329835408 | LOC129995825 | ATAC-STARR-seq lymphoblastoid silent region 16934 | 6 | 13710780 | 13710899 | Human |
329838858 | LOC129995826 | ATAC-STARR-seq lymphoblastoid silent region 16935 | 6 | 13711160 | 13711209 | Human |
329834311 | LOC129995827 | ATAC-STARR-seq lymphoblastoid silent region 16936 | 6 | 13711290 | 13711409 | Human |
329830166 | LOC129995828 | ATAC-STARR-seq lymphoblastoid silent region 16937 | 6 | 13711570 | 13712339 | Human |
151675714 | LOC124901264 | uncharacterized LOC124901264 | 6 | 13712352 | 13712754 | Human |
38615946 | LOC113146412 | Sharpr-MPRA regulatory region 2979 | 6 | 13715597 | 13715891 | Human |
329338755 | LOC129661644 | ReSE screen-validated silencer GRCh37_chr6:13755870-13756079 | 6 | 13755638 | 13755847 | Human |
329832451 | LOC129995829 | ATAC-STARR-seq lymphoblastoid silent region 16938 | 6 | 13765188 | 13765287 | Human |
329830553 | LOC129995830 | ATAC-STARR-seq lymphoblastoid active region 24039 | 6 | 13767693 | 13767752 | Human |
155659307 | LOC127405371 | H3K27ac hESC enhancer GRCh37_chr6:13769328-13769828 | 6 | 13769096 | 13769596 | Human |
1349094 | MCUR1 | mitochondrial calcium uniporter regulator 1 | 6 | 13786557 | 13814557 | Human |
155663030 | LOC127405372 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:13787884-13788716 | 6 | 13787652 | 13788484 | Human |
329343026 | LOC129661645 | ReSE screen-validated silencer GRCh37_chr6:13789385-13789553 | 6 | 13789153 | 13789321 | Human |
329831157 | LOC129995831 | ATAC-STARR-seq lymphoblastoid silent region 16939 | 6 | 13813745 | 13814414 | Human |
38668082 | LOC107986571 | uncharacterized LOC107986571 | 6 | 13813810 | 13826568 | Human |
329842370 | LOC129995832 | ATAC-STARR-seq lymphoblastoid silent region 16940 | 6 | 13814495 | 13814764 | Human |
329844745 | LOC129995833 | ATAC-STARR-seq lymphoblastoid active region 24040 | 6 | 13814925 | 13815024 | Human |
155656035 | LOC127405373 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:13872467-13873049 | 6 | 13872236 | 13872818 | Human |
329824655 | LOC129995834 | ATAC-STARR-seq lymphoblastoid silent region 16941 | 6 | 13873932 | 13874071 | Human |
38671545 | LOC116158540 | CRISPRi-validated cis-regulatory element chr6.697 | 6 | 13912965 | 13913326 | Human |
155648492 | LOC127405374 | H3K27ac hESC enhancer GRCh37_chr6:13924078-13924578 | 6 | 13923847 | 13924347 | Human |
1351673 | RNF182 | ring finger protein 182 | 6 | 13924446 | 13980310 | Human |
155647574 | LOC127405375 | NANOG hESC enhancer GRCh37_chr6:13944174-13944689 | 6 | 13943943 | 13944458 | Human |
4144489 | MRPL35P1 | mitochondrial ribosomal protein L35 pseudogene 1 | 6 | 13949092 | 13949610 | Human |
38654311 | LOC116158541 | CRISPRi-validated cis-regulatory element chr6.702 | 6 | 13987283 | 13987905 | Human |
38667392 | LOC116158542 | CRISPRi-validated cis-regulatory element chr6.703 | 6 | 13989666 | 13989766 | Human |
38603837 | LOC116158543 | CRISPRi-validated cis-regulatory element chr6.704 | 6 | 13992618 | 13993055 | Human |
155228886 | LOC126859595 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:14001334-14002533 | 6 | 14001103 | 14002302 | Human |
155230503 | LOC126859596 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:14035147-14036346 | 6 | 14034916 | 14036115 | Human |
329344426 | LOC129661646 | ReSE screen-validated silencer GRCh37_chr6:14069795-14069896 | 6 | 14069564 | 14069665 | Human |
329813203 | LOC129995835 | ATAC-STARR-seq lymphoblastoid active region 24041 | 6 | 14085489 | 14085588 | Human |
329820127 | LOC129995836 | ATAC-STARR-seq lymphoblastoid active region 24042 | 6 | 14088642 | 14088691 | Human |
155654000 | LOC127405376 | NANOG hESC enhancer GRCh37_chr6:14088959-14089460 | 6 | 14088728 | 14089229 | Human |
329816729 | LOC129995837 | ATAC-STARR-seq lymphoblastoid active region 24043 | 6 | 14094335 | 14094464 | Human |
155888538 | LOC128462396 | CRISPRi-FlowFISH-validated CD83 regulatory element GRCh37_chr6:14095567-14096067 | 6 | 14095336 | 14095836 | Human |
38647794 | LOC105374939 | uncharacterized LOC105374939 | 6 | 14098634 | 14107284 | Human |
38636988 | LOC116158544 | CRISPRi-validated cis-regulatory element chr6.709 | 6 | 14108628 | 14109415 | Human |
151668213 | LOC124901265 | uncharacterized LOC124901265 | 6 | 14108763 | 14111808 | Human |
150530551 | LOC123575673 | CRISPRi-FlowFISH-validated CD83 regulatory elements GRCh37_chr6:14117366-14118274 to GRCh37_chr6:14117614-14118430 | 6 | 14117098 | 14118199 | Human |
1320150 | CD83 | CD83 molecule | 6 | 14117256 | 14136918 | Human |
156420122 | LOC128462417 | CRISPRi-FlowFISH-validated CD83 regulatory elements GRCh37_chr6:14118435-14118935 to GRCh37_chr6:14118800-14119300 | 6 | 14118204 | 14119101 | Human |
329841895 | LOC129995838 | ATAC-STARR-seq lymphoblastoid active region 24046 | 6 | 14121865 | 14121924 | Human |
329814107 | LOC129995839 | ATAC-STARR-seq lymphoblastoid active region 24047 | 6 | 14121945 | 14122274 | Human |
155657642 | LOC127405377 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:14128774-14129372 | 6 | 14128543 | 14129141 | Human |
329839878 | LOC129995840 | ATAC-STARR-seq lymphoblastoid active region 24048 | 6 | 14129772 | 14129821 | Human |
10398948 | RNU7-133P | RNA, U7 small nuclear 133 pseudogene | 6 | 14156462 | 14156523 | Human |
329342795 | LOC129389445 | MPRA-validated peak5669 silencer | 6 | 14187484 | 14187684 | Human |
38663521 | LOC105374940 | uncharacterized LOC105374940 | 6 | 14194449 | 14202294 | Human |
329816790 | LOC129995841 | ATAC-STARR-seq lymphoblastoid silent region 16943 | 6 | 14209835 | 14209884 | Human |
329821308 | LOC129995842 | ATAC-STARR-seq lymphoblastoid silent region 16944 | 6 | 14210975 | 14211414 | Human |
329822636 | LOC129995843 | ATAC-STARR-seq lymphoblastoid active region 24049 | 6 | 14211665 | 14211724 | Human |
329342638 | LOC129389446 | MPRA-validated peak5670 silencer | 6 | 14234584 | 14234784 | Human |
155656412 | LOC127405378 | H3K4me1 hESC enhancer GRCh37_chr6:14235700-14236200 | 6 | 14235469 | 14235969 | Human |
155650940 | LOC127405379 | H3K4me1 hESC enhancer GRCh37_chr6:14236201-14236701 | 6 | 14235970 | 14236470 | Human |
329839869 | LOC129995844 | ATAC-STARR-seq lymphoblastoid active region 24050 | 6 | 14241487 | 14241556 | Human |
155654118 | LOC127405380 | NANOG hESC enhancer GRCh37_chr6:14265410-14265941 | 6 | 14265179 | 14265710 | Human |
38649717 | LOC111556163 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:14270712-14271911 | 6 | 14270481 | 14271680 | Human |
155656189 | LOC127405381 | OCT4-NANOG hESC enhancer GRCh37_chr6:14273182-14274095 | 6 | 14272951 | 14273864 | Human |
7382811 | LINC01108 | long intergenic non-protein coding RNA 1108 | 6 | 14280127 | 14285454 | Human |
151672586 | LOC124901266 | uncharacterized LOC124901266 | 6 | 14285821 | 14292366 | Human |
155648319 | LOC127405382 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:14297089-14297757 | 6 | 14296858 | 14297526 | Human |
155651528 | LOC127405383 | H3K27ac hESC enhancer GRCh37_chr6:14298956-14299481 | 6 | 14298725 | 14299250 | Human |
155655782 | LOC127405384 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:14301988-14302627 | 6 | 14301757 | 14302396 | Human |
155662822 | LOC127405385 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:14302628-14303268 | 6 | 14302397 | 14303037 | Human |
155646149 | LOC127405386 | H3K4me1 hESC enhancer GRCh37_chr6:14330461-14330962 | 6 | 14330230 | 14330731 | Human |
150530606 | LOC123575674 | Sharpr-MPRA regulatory region 8710 | 6 | 14380438 | 14380732 | Human |
155653559 | LOC127405387 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:14381289-14381830 | 6 | 14381058 | 14381599 | Human |
155648165 | LOC127405388 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:14381831-14382374 | 6 | 14381600 | 14382143 | Human |
38625397 | LOC105374943 | uncharacterized LOC105374943 | 6 | 14391091 | 14393861 | Human |
38625784 | LOC105374942 | uncharacterized LOC105374942 | 6 | 14420674 | 14461936 | Human |
38656851 | LOC101928331 | uncharacterized LOC101928331 | 6 | 14431780 | 14516097 | Human |
155661693 | LOC127405389 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:14441647-14442345 | 6 | 14441416 | 14442114 | Human |
155651294 | LOC127405390 | NANOG hESC enhancer GRCh37_chr6:14450188-14450778 | 6 | 14449957 | 14450547 | Human |
155652982 | LOC127405391 | H3K27ac hESC enhancer GRCh37_chr6:14472912-14473412 | 6 | 14472681 | 14473181 | Human |
155660575 | LOC127405392 | H3K27ac hESC enhancer GRCh37_chr6:14473413-14473913 | 6 | 14473182 | 14473682 | Human |
329341671 | LOC129661647 | ReSE screen-validated silencer GRCh37_chr6:14474901-14475125 | 6 | 14474670 | 14474894 | Human |
155227675 | LOC126859597 | BRD4-independent group 4 enhancer GRCh37_chr6:14508670-14509869 | 6 | 14508439 | 14509638 | Human |
155654990 | LOC127405393 | H3K4me1 hESC enhancer GRCh37_chr6:14540385-14540955 | 6 | 14540154 | 14540724 | Human |
38616669 | LOC101928354 | uncharacterized LOC101928354 | 6 | 14586304 | 14717489 | Human |
150530603 | LOC123575675 | Sharpr-MPRA regulatory region 399 | 6 | 14625498 | 14625792 | Human |
329825528 | LOC129995845 | ATAC-STARR-seq lymphoblastoid active region 24051 | 6 | 14636539 | 14636638 | Human |
150530562 | LOC123575676 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:14639937-14640920 | 6 | 14639706 | 14640689 | Human |
10399152 | RNU6-793P | RNA, U6 small nuclear 793, pseudogene | 6 | 14646535 | 14646638 | Human |
38665267 | LOC102724463 | uncharacterized LOC102724463 | 6 | 14659151 | 14665263 | Human |
329837734 | LOC129995846 | ATAC-STARR-seq lymphoblastoid active region 24052 | 6 | 14661195 | 14661274 | Human |
329838725 | LOC129995847 | ATAC-STARR-seq lymphoblastoid active region 24053 | 6 | 14661365 | 14661484 | Human |
155658876 | LOC127405394 | H3K4me1 hESC enhancer GRCh37_chr6:14676877-14677412 | 6 | 14676646 | 14677181 | Human |
155229214 | LOC126859598 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:14706129-14707328 | 6 | 14705898 | 14707097 | Human |
329816819 | LOC129995848 | ATAC-STARR-seq lymphoblastoid active region 24054 | 6 | 14717576 | 14717635 | Human |
155227722 | LOC126859599 | BRD4-independent group 4 enhancer GRCh37_chr6:14730658-14731857 | 6 | 14730427 | 14731626 | Human |
155227000 | LOC126859600 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:14733080-14734279 | 6 | 14732849 | 14734048 | Human |
329842488 | LOC129995849 | ATAC-STARR-seq lymphoblastoid silent region 16945 | 6 | 14736322 | 14736401 | Human |
155230036 | LOC126859601 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:14743342-14744541 | 6 | 14743111 | 14744310 | Human |
155647652 | LOC127405395 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:14784175-14784726 | 6 | 14783944 | 14784495 | Human |
126779660 | LOC121113499 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancers GRCh37_chr6:14784727-14785278 and GRCh37_chr6:14785279-14785830 | 6 | 14784496 | 14785599 | Human |
150530540 | LOC123575677 | H3K4me1 hESC enhancer GRCh37_chr6:14804615-14805450 | 6 | 14804384 | 14805219 | Human |
150530590 | LOC123575678 | Sharpr-MPRA regulatory region 9195 | 6 | 14819038 | 14819332 | Human |
329835194 | LOC129995850 | ATAC-STARR-seq lymphoblastoid active region 24056 | 6 | 14820847 | 14820926 | Human |
155663311 | LOC127405396 | NANOG hESC enhancer GRCh37_chr6:14822305-14822806 | 6 | 14822074 | 14822575 | Human |
155653471 | LOC127405397 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:14823177-14823964 | 6 | 14822946 | 14823733 | Human |
155654429 | LOC127405398 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:14824752-14825538 | 6 | 14824521 | 14825307 | Human |
155650897 | LOC127405399 | NANOG hESC enhancer GRCh37_chr6:14832080-14832596 | 6 | 14831849 | 14832365 | Human |
150530521 | LOC123575679 | Sharpr-MPRA regulatory region 9180 | 6 | 14844538 | 14844832 | Human |
329839000 | LOC129995851 | ATAC-STARR-seq lymphoblastoid active region 24057 | 6 | 14857653 | 14857782 | Human |
38622835 | LOC105374945 | uncharacterized LOC105374945 | 6 | 14860416 | 15009084 | Human |
329842795 | LOC129995852 | ATAC-STARR-seq lymphoblastoid active region 24058 | 6 | 14875773 | 14875842 | Human |
329840134 | LOC129995853 | ATAC-STARR-seq lymphoblastoid active region 24059 | 6 | 14875863 | 14875922 | Human |
155656745 | LOC127405400 | H3K4me1 hESC enhancer GRCh37_chr6:14876936-14877436 | 6 | 14876705 | 14877205 | Human |
155651435 | LOC127405401 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:14879976-14880486 | 6 | 14879745 | 14880255 | Human |
155657588 | LOC127405402 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:14880487-14880996 | 6 | 14880256 | 14880765 | Human |
155658185 | LOC127405403 | H3K4me1 hESC enhancer GRCh37_chr6:14883452-14884163 | 6 | 14883221 | 14883932 | Human |
329343880 | LOC129389447 | MPRA-validated peak5674 silencer | 6 | 14892084 | 14892284 | Human |
329819946 | LOC129995854 | ATAC-STARR-seq lymphoblastoid active region 24061 | 6 | 14910623 | 14910682 | Human |
329841449 | LOC129995855 | ATAC-STARR-seq lymphoblastoid active region 24062 | 6 | 14911373 | 14911432 | Human |
329338994 | LOC129389448 | MPRA-validated peak5675 silencer | 6 | 14930624 | 14930824 | Human |
329339076 | LOC129661648 | ReSE screen-validated silencer GRCh37_chr6:14958411-14958600 | 6 | 14958180 | 14958369 | Human |
155649992 | LOC127405404 | H3K27ac hESC enhancer GRCh37_chr6:14997283-14997782 | 6 | 14997052 | 14997551 | Human |
329342649 | LOC129661649 | ReSE screen-validated silencer GRCh37_chr6:15013597-15013834 | 6 | 15013366 | 15013603 | Human |
155650524 | LOC127405405 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15017607-15018302 | 6 | 15017376 | 15018071 | Human |
155652418 | LOC127405406 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15021466-15022336 | 6 | 15021235 | 15022105 | Human |
155657946 | LOC127405407 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15022337-15023206 | 6 | 15022106 | 15022975 | Human |
329842922 | LOC129995856 | ATAC-STARR-seq lymphoblastoid active region 24063 | 6 | 15048433 | 15048482 | Human |
155228905 | LOC126859602 | MED14-independent group 3 enhancer GRCh37_chr6:15066479-15067678 | 6 | 15066248 | 15067447 | Human |
155650563 | LOC127405408 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15077925-15078456 | 6 | 15077694 | 15078225 | Human |
329339987 | LOC129661650 | ReSE screen-validated silencer GRCh37_chr6:15096502-15096739 | 6 | 15096271 | 15096508 | Human |
2305602 | RPL6P17 | ribosomal protein L6 pseudogene 17 | 6 | 15102946 | 15104211 | Human |
329337773 | LOC129661651 | ReSE screen-validated silencer GRCh37_chr6:15104898-15105100 | 6 | 15104667 | 15104869 | Human |
10400414 | RN7SL332P | RNA, 7SL, cytoplasmic 332, pseudogene | 6 | 15112968 | 15113221 | Human |
155229769 | LOC126859603 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:15132654-15133853 | 6 | 15132423 | 15133622 | Human |
38642580 | LOC105374946 | uncharacterized LOC105374946 | 6 | 15143785 | 15176913 | Human |
329338033 | LOC129389449 | MPRA-validated peak5677 silencer | 6 | 15176245 | 15176445 | Human |
329344653 | LOC129389450 | MPRA-validated peak5678 silencer | 6 | 15193945 | 15194145 | Human |
155653021 | LOC127405409 | H3K4me1 hESC enhancer GRCh37_chr6:15203770-15204322 | 6 | 15203539 | 15204091 | Human |
155655893 | LOC127405410 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15207084-15207636 | 6 | 15206853 | 15207405 | Human |
329339103 | LOC129661652 | ReSE screen-validated silencer GRCh37_chr6:15212336-15212500 | 6 | 15212105 | 15212269 | Human |
155656986 | LOC127405411 | H3K4me1 hESC enhancer GRCh37_chr6:15239058-15239558 | 6 | 15238827 | 15239327 | Human |
155660664 | LOC127405412 | H3K4me1 hESC enhancer GRCh37_chr6:15239559-15240059 | 6 | 15239328 | 15239828 | Human |
39128298 | JARID2-DT | JARID2 divergent transcript | 6 | 15243923 | 15245374 | Human |
155657611 | LOC127405413 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15244415-15244928 | 6 | 15244184 | 15244697 | Human |
329836464 | LOC129995857 | ATAC-STARR-seq lymphoblastoid silent region 16946 | 6 | 15244697 | 15245006 | Human |
329845183 | LOC129995858 | ATAC-STARR-seq lymphoblastoid silent region 16947 | 6 | 15245017 | 15245276 | Human |
329834561 | LOC129995859 | ATAC-STARR-seq lymphoblastoid active region 24064 | 6 | 15245887 | 15245936 | Human |
329818090 | LOC129995860 | ATAC-STARR-seq lymphoblastoid active region 24065 | 6 | 15246047 | 15246146 | Human |
1354253 | JARID2 | jumonji and AT-rich interaction domain containing 2 | 6 | 15246069 | 15522042 | Human |
5684146 | JARID2-AS1 | JARID2 antisense RNA 1 | 6 | 15247815 | 15248696 | Human |
329827940 | LOC129995861 | ATAC-STARR-seq lymphoblastoid silent region 16948 | 6 | 15248262 | 15248321 | Human |
329820126 | LOC129995862 | ATAC-STARR-seq lymphoblastoid silent region 16949 | 6 | 15248442 | 15248921 | Human |
38661677 | LOC106799837 | nonconserved acetylation island sequence 83 enhancer | 6 | 15249110 | 15249951 | Human |
155662178 | LOC127405414 | H3K4me1 hESC enhancer GRCh37_chr6:15251871-15252646 | 6 | 15251640 | 15252415 | Human |
329833405 | LOC129995863 | ATAC-STARR-seq lymphoblastoid active region 24066 | 6 | 15254448 | 15254517 | Human |
155655430 | LOC127405415 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:15264949-15265458 | 6 | 15264718 | 15265227 | Human |
329831002 | LOC129995864 | ATAC-STARR-seq lymphoblastoid active region 24067 | 6 | 15265233 | 15265372 | Human |
155649607 | LOC127405416 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15267598-15268156 | 6 | 15267367 | 15267925 | Human |
155653100 | LOC127405417 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15268157-15268714 | 6 | 15267926 | 15268483 | Human |
155659692 | LOC127405418 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:15268715-15269273 | 6 | 15268484 | 15269042 | Human |
155663068 | LOC127405419 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:15269274-15269831 | 6 | 15269043 | 15269600 | Human |
155647089 | LOC127405420 | H3K4me1 hESC enhancer GRCh37_chr6:15280804-15281784 | 6 | 15280573 | 15281553 | Human |
329833633 | LOC129995865 | ATAC-STARR-seq lymphoblastoid active region 24068 | 6 | 15287746 | 15287795 | Human |
329842078 | LOC129995866 | ATAC-STARR-seq lymphoblastoid active region 24069 | 6 | 15287816 | 15287865 | Human |
155662023 | LOC127405421 | H3K4me1 hESC enhancer GRCh37_chr6:15291865-15292366 | 6 | 15291634 | 15292135 | Human |
329827322 | LOC129995867 | ATAC-STARR-seq lymphoblastoid active region 24070 | 6 | 15296861 | 15296950 | Human |
329831114 | LOC129995868 | ATAC-STARR-seq lymphoblastoid active region 24071 | 6 | 15296981 | 15297030 | Human |
329830254 | LOC129995869 | ATAC-STARR-seq lymphoblastoid silent region 16950 | 6 | 15307922 | 15307981 | Human |
150530579 | LOC123575680 | Sharpr-MPRA regulatory region 4383 | 6 | 15308818 | 15309112 | Human |
329816229 | LOC129995870 | ATAC-STARR-seq lymphoblastoid active region 24072 | 6 | 15312527 | 15312596 | Human |
10413527 | RNU6-522P | RNA, U6 small nuclear 522, pseudogene | 6 | 15314920 | 15315026 | Human |
329833501 | LOC129995871 | ATAC-STARR-seq lymphoblastoid active region 24073 | 6 | 15317808 | 15317897 | Human |
329830727 | LOC129995872 | ATAC-STARR-seq lymphoblastoid active region 24074 | 6 | 15323419 | 15323468 | Human |
10399589 | RNU6-645P | RNA, U6 small nuclear 645, pseudogene | 6 | 15324367 | 15324472 | Human |
329816250 | LOC129995873 | ATAC-STARR-seq lymphoblastoid silent region 16951 | 6 | 15327265 | 15327314 | Human |
329839768 | LOC129995874 | ATAC-STARR-seq lymphoblastoid active region 24075 | 6 | 15335785 | 15335834 | Human |
329816886 | LOC129995875 | ATAC-STARR-seq lymphoblastoid active region 24076 | 6 | 15335955 | 15336104 | Human |
155654624 | LOC127405422 | H3K4me1 hESC enhancer GRCh37_chr6:15337209-15337728 | 6 | 15336978 | 15337497 | Human |
329813948 | LOC129995876 | ATAC-STARR-seq lymphoblastoid active region 24077 | 6 | 15363936 | 15364095 | Human |
155656329 | LOC127405423 | H3K4me1 hESC enhancer GRCh37_chr6:15385480-15386240 | 6 | 15385249 | 15386009 | Human |
329826708 | LOC129995877 | ATAC-STARR-seq lymphoblastoid active region 24078 | 6 | 15387401 | 15387480 | Human |
329841569 | LOC129995878 | ATAC-STARR-seq lymphoblastoid active region 24079 | 6 | 15387491 | 15387600 | Human |
329815052 | LOC129995879 | ATAC-STARR-seq lymphoblastoid active region 24080 | 6 | 15390223 | 15390582 | Human |
155653987 | LOC127405424 | H3K4me1 hESC enhancer GRCh37_chr6:15402869-15403369 | 6 | 15402638 | 15403138 | Human |
126781815 | LOC121132669 | Sharpr-MPRA regulatory region 1760 | 6 | 15403998 | 15404292 | Human |
155646715 | LOC127405425 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15404593-15405283 | 6 | 15404362 | 15405052 | Human |
329342402 | LOC129661653 | ReSE screen-validated silencer GRCh37_chr6:15413673-15413840 | 6 | 15413442 | 15413609 | Human |
329819674 | LOC129995880 | ATAC-STARR-seq lymphoblastoid active region 24081 | 6 | 15422500 | 15422559 | Human |
329822027 | LOC129995881 | ATAC-STARR-seq lymphoblastoid silent region 16952 | 6 | 15432946 | 15432995 | Human |
329832867 | LOC129995882 | ATAC-STARR-seq lymphoblastoid active region 24082 | 6 | 15438890 | 15438959 | Human |
155652645 | LOC127405426 | H3K4me1 hESC enhancer GRCh37_chr6:15444755-15445255 | 6 | 15444524 | 15445024 | Human |
155650020 | LOC127405427 | H3K4me1 hESC enhancer GRCh37_chr6:15447999-15448499 | 6 | 15447768 | 15448268 | Human |
155649674 | LOC127405428 | NANOG hESC enhancer GRCh37_chr6:15461204-15461861 | 6 | 15460973 | 15461630 | Human |
329339267 | LOC129661654 | ReSE screen-validated silencer GRCh37_chr6:15469722-15469904 | 6 | 15469491 | 15469673 | Human |
155227742 | LOC126859604 | BRD4-independent group 4 enhancer GRCh37_chr6:15473668-15474867 | 6 | 15473437 | 15474636 | Human |
155655824 | LOC127405429 | NANOG-H3K4me1 hESC enhancer GRCh37_chr6:15491921-15492422 | 6 | 15491690 | 15492191 | Human |
155659811 | LOC127405430 | H3K4me1 hESC enhancer GRCh37_chr6:15507577-15508118 | 6 | 15507346 | 15507887 | Human |
155658784 | LOC127405431 | H3K4me1 hESC enhancer GRCh37_chr6:15508119-15508660 | 6 | 15507888 | 15508429 | Human |
155647044 | LOC127405432 | NANOG-H3K4me1 hESC enhancer GRCh37_chr6:15508661-15509202 | 6 | 15508430 | 15508971 | Human |
155661789 | LOC127405433 | H3K4me1 hESC enhancer GRCh37_chr6:15513022-15514000 | 6 | 15512791 | 15513769 | Human |
155657846 | LOC127405434 | H3K4me1 hESC enhancer GRCh37_chr6:15517558-15518058 | 6 | 15517327 | 15517827 | Human |
1342501 | DTNBP1 | dystrobrevin binding protein 1 | 6 | 15522807 | 15663058 | Human |
329341474 | LOC129661655 | ReSE screen-validated silencer GRCh37_chr6:15523265-15523451 | 6 | 15523034 | 15523220 | Human |
38642388 | LOC105374947 | uncharacterized LOC105374947 | 6 | 15526334 | 15544371 | Human |
329342082 | LOC129389451 | MPRA-validated peak5680 silencer | 6 | 15535044 | 15535244 | Human |
151673218 | DTNBP1-AS1 | DTNBP1 antisense RNA 1 | 6 | 15546070 | 15562203 | Human |
150537063 | LOC123620059 | Sharpr-MPRA regulatory region 14615 | 6 | 15550998 | 15551292 | Human |
155648568 | LOC127405435 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15551965-15552513 | 6 | 15551734 | 15552282 | Human |
329343078 | LOC129389452 | MPRA-validated peak5681 silencer | 6 | 15572204 | 15572404 | Human |
329343797 | LOC129389453 | MPRA-validated peak5682 silencer | 6 | 15583284 | 15583484 | Human |
329834281 | LOC129995883 | ATAC-STARR-seq lymphoblastoid active region 24083 | 6 | 15612859 | 15612968 | Human |
329838998 | LOC129995884 | ATAC-STARR-seq lymphoblastoid active region 24084 | 6 | 15613009 | 15613078 | Human |
329827705 | LOC129995885 | ATAC-STARR-seq lymphoblastoid active region 24085 | 6 | 15616064 | 15616153 | Human |
329814267 | LOC129995886 | ATAC-STARR-seq lymphoblastoid active region 24086 | 6 | 15621755 | 15621854 | Human |
329343425 | LOC129389454 | MPRA-validated peak5684 silencer | 6 | 15631634 | 15631834 | Human |
329338071 | LOC129661656 | ReSE screen-validated silencer GRCh37_chr6:15641694-15641884 | 6 | 15641463 | 15641653 | Human |
329845204 | LOC129995887 | ATAC-STARR-seq lymphoblastoid active region 24087 | 6 | 15662235 | 15662284 | Human |
329825359 | LOC129995888 | ATAC-STARR-seq lymphoblastoid silent region 16953 | 6 | 15662515 | 15663024 | Human |
329341978 | LOC129389455 | MPRA-validated peak5686 silencer | 6 | 15701324 | 15701524 | Human |
155663035 | LOC127405436 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:15725723-15726536 | 6 | 15725492 | 15726305 | Human |
38630987 | LOC102724520 | uncharacterized LOC102724520 | 6 | 15730040 | 15758205 | Human |
155661229 | LOC127405437 | OCT4-NANOG hESC enhancer GRCh37_chr6:15745025-15745698 | 6 | 15744794 | 15745467 | Human |
155653397 | LOC127405438 | OCT4-NANOG hESC enhancer GRCh37_chr6:15745699-15746372 | 6 | 15745468 | 15746141 | Human |
329342865 | LOC129389456 | MPRA-validated peak5688 silencer | 6 | 15757704 | 15757904 | Human |
329342279 | LOC129389457 | MPRA-validated peak5689 silencer | 6 | 15761124 | 15761324 | Human |
38648122 | LOC105374948 | uncharacterized LOC105374948 | 6 | 15830293 | 15834463 | Human |
329340923 | LOC129389458 | MPRA-validated peak5691 silencer | 6 | 15842384 | 15842584 | Human |
155660196 | LOC127405439 | OCT4-NANOG hESC enhancer GRCh37_chr6:15855489-15856036 | 6 | 15855258 | 15855805 | Human |
329338682 | LOC129389459 | MPRA-validated peak5692 silencer | 6 | 15860174 | 15860374 | Human |
329830053 | LOC129995889 | ATAC-STARR-seq lymphoblastoid active region 24088 | 6 | 15880258 | 15880307 | Human |
127338354 | LOC121740643 | Sharpr-MPRA regulatory region 4250 | 6 | 15896258 | 15896552 | Human |
329822284 | LOC129995890 | ATAC-STARR-seq lymphoblastoid active region 24089 | 6 | 15897219 | 15897268 | Human |
329827943 | LOC129995891 | ATAC-STARR-seq lymphoblastoid active region 24090 | 6 | 15901310 | 15901399 | Human |
329829136 | LOC129995892 | ATAC-STARR-seq lymphoblastoid active region 24091 | 6 | 15901580 | 15901859 | Human |
329845340 | LOC129995893 | ATAC-STARR-seq lymphoblastoid active region 24092 | 6 | 15902360 | 15902419 | Human |
329844927 | LOC129995894 | ATAC-STARR-seq lymphoblastoid active region 24093 | 6 | 15905172 | 15905321 | Human |
329814026 | LOC129995895 | ATAC-STARR-seq lymphoblastoid active region 24094 | 6 | 15906032 | 15906211 | Human |
38606368 | LOC113146424 | Sharpr-MPRA regulatory region 12068 | 6 | 15908178 | 15908472 | Human |
155661899 | LOC127405440 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:15912456-15913115 | 6 | 15912225 | 15912884 | Human |
4890724 | ARPC3P5 | actin related protein 2/3 complex subunit 3 pseudogene 5 | 6 | 15934743 | 15935514 | Human |
38647916 | LOC105374949 | uncharacterized LOC105374949 | 6 | 15956495 | 15980936 | Human |
38673358 | LOC113146425 | Sharpr-MPRA regulatory region 8871 | 6 | 15961338 | 15961632 | Human |
329835473 | LOC129995896 | ATAC-STARR-seq lymphoblastoid active region 24095 | 6 | 15962697 | 15962766 | Human |
150537079 | LOC123620060 | Sharpr-MPRA regulatory region 12955 | 6 | 15987578 | 15987872 | Human |
12910394 | LINC02543 | long intergenic non-protein coding RNA 2543 | 6 | 15994944 | 16000491 | Human |
329828304 | LOC129995897 | ATAC-STARR-seq lymphoblastoid silent region 16954 | 6 | 16043254 | 16043313 | Human |
38603411 | LOC116158545 | CRISPRi-validated cis-regulatory element chr6.836 | 6 | 16047546 | 16047736 | Human |
155653289 | LOC127405441 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:16064773-16065514 | 6 | 16064542 | 16065283 | Human |
155651316 | LOC127405442 | NANOG-H3K4me1 hESC enhancer GRCh37_chr6:16065515-16066255 | 6 | 16065284 | 16066024 | Human |
150537049 | LOC123620061 | Sharpr-MPRA regulatory region 5392 | 6 | 16071798 | 16072092 | Human |
27096028 | MDH1P2 | MDH1 pseudogene 2 | 6 | 16107793 | 16108791 | Human |
329817429 | LOC129995898 | ATAC-STARR-seq lymphoblastoid silent region 16955 | 6 | 16128768 | 16129767 | Human |
1313988 | MYLIP | myosin regulatory light chain interacting protein | 6 | 16129086 | 16163887 | Human |
329825696 | LOC129995899 | ATAC-STARR-seq lymphoblastoid active region 24096 | 6 | 16133043 | 16133202 | Human |
5134130 | MIR4639 | microRNA 4639 | 6 | 16141556 | 16141624 | Human |
151669078 | LOC124901514 | uncharacterized LOC124901514 | 6 | 16148365 | 16148445 | Human |
38623276 | PERPP3 | PERP pseudogene 3 | 6 | 16160934 | 16162667 | Human |
4144688 | MRPL42P2 | mitochondrial ribosomal protein L42 pseudogene 2 | 6 | 16171467 | 16172159 | Human |
10399537 | RNU6-1114P | RNA, U6 small nuclear 1114, pseudogene | 6 | 16205014 | 16205120 | Human |
329845025 | LOC129995900 | ATAC-STARR-seq lymphoblastoid active region 24097 | 6 | 16205525 | 16205614 | Human |
329831972 | LOC129995901 | ATAC-STARR-seq lymphoblastoid active region 24098 | 6 | 16205825 | 16206034 | Human |
329337657 | LOC129661657 | ReSE screen-validated silencer GRCh37_chr6:16215087-16215263 | 6 | 16214856 | 16215032 | Human |
38635952 | LOC116158546 | CRISPRi-validated cis-regulatory element chr6.847 | 6 | 16215257 | 16215943 | Human |
329340433 | LOC129661658 | ReSE screen-validated silencer GRCh37_chr6:16217722-16217944 | 6 | 16217491 | 16217713 | Human |
38643314 | LOC116158547 | CRISPRi-validated cis-regulatory element chr6.848 | 6 | 16224437 | 16224805 | Human |
329821128 | LOC129995902 | ATAC-STARR-seq lymphoblastoid silent region 16956 | 6 | 16238370 | 16238469 | Human |
733310 | GMPR | guanosine monophosphate reductase | 6 | 16238587 | 16295549 | Human |
329841863 | LOC129995903 | ATAC-STARR-seq lymphoblastoid silent region 16957 | 6 | 16238590 | 16238689 | Human |
155661671 | LOC127405443 | NANOG hESC enhancer GRCh37_chr6:16259269-16259823 | 6 | 16259038 | 16259592 | Human |
155656156 | LOC127405444 | H3K4me1 hESC enhancer GRCh37_chr6:16262581-16263080 | 6 | 16262350 | 16262849 | Human |
155655219 | LOC127405445 | H3K27ac hESC enhancer GRCh37_chr6:16264120-16264690 | 6 | 16263889 | 16264459 | Human |
155646461 | LOC127405446 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:16264691-16265260 | 6 | 16264460 | 16265029 | Human |
127338333 | LOC121740644 | Sharpr-MPRA regulatory region 9524 | 6 | 16277318 | 16277612 | Human |
329840160 | LOC129995904 | ATAC-STARR-seq lymphoblastoid active region 24099 | 6 | 16286043 | 16286172 | Human |
1344585 | ATXN1 | ataxin 1 | 6 | 16299112 | 16761460 | Human |
155660089 | LOC127405447 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:16303323-16303902 | 6 | 16303092 | 16303671 | Human |
329836787 | LOC129995905 | ATAC-STARR-seq lymphoblastoid active region 24100 | 6 | 16305580 | 16305699 | Human |
329338815 | LOC129661659 | ReSE screen-validated silencer GRCh37_chr6:16310151-16310359 | 6 | 16309920 | 16310128 | Human |
155657950 | LOC127405448 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:16320601-16321434 | 6 | 16320338 | 16321203 | Human |
329825382 | LOC129995906 | ATAC-STARR-seq lymphoblastoid active region 24102 | 6 | 16322681 | 16322740 | Human |
155751078 | LOC127882481 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:16327606-16328166 | 6 | 16327375 | 16327935 | Human |
38674492 | LOC108663993 | ataxin 1 repeat instability region | 6 | 16327634 | 16327724 | Human |
155783006 | LOC127903862 | uncharacterized LOC127903862 | 6 | 16328342 | 16328431 | Human |
127338320 | LOC121740645 | Sharpr-MPRA regulatory region 3581 | 6 | 16332098 | 16332392 | Human |
329340412 | LOC129661660 | ReSE screen-validated silencer GRCh37_chr6:16387334-16387547 | 6 | 16387103 | 16387316 | Human |
329823412 | LOC129995907 | ATAC-STARR-seq lymphoblastoid active region 24103 | 6 | 16414114 | 16414303 | Human |
329824905 | LOC129995908 | ATAC-STARR-seq lymphoblastoid active region 24104 | 6 | 16421204 | 16421253 | Human |
329834821 | LOC129995909 | ATAC-STARR-seq lymphoblastoid active region 24105 | 6 | 16432570 | 16432629 | Human |
329841763 | LOC129995910 | ATAC-STARR-seq lymphoblastoid active region 24106 | 6 | 16473176 | 16473255 | Human |
329829213 | LOC129995911 | ATAC-STARR-seq lymphoblastoid active region 24107 | 6 | 16474926 | 16474975 | Human |
329826496 | LOC129995912 | ATAC-STARR-seq lymphoblastoid active region 24108 | 6 | 16474996 | 16475165 | Human |
329818676 | LOC129995913 | ATAC-STARR-seq lymphoblastoid active region 24109 | 6 | 16493260 | 16493369 | Human |
329813540 | LOC129995914 | ATAC-STARR-seq lymphoblastoid active region 24110 | 6 | 16494028 | 16494087 | Human |
329830326 | LOC129995915 | ATAC-STARR-seq lymphoblastoid active region 24111 | 6 | 16508684 | 16508733 | Human |
329339758 | LOC129661661 | ReSE screen-validated silencer GRCh37_chr6:16603501-16603686 | 6 | 16603270 | 16603455 | Human |
329816343 | LOC129995916 | ATAC-STARR-seq lymphoblastoid active region 24112 | 6 | 16636208 | 16636377 | Human |
329818024 | LOC129995917 | ATAC-STARR-seq lymphoblastoid active region 24113 | 6 | 16654997 | 16655086 | Human |
329830573 | LOC129995918 | ATAC-STARR-seq lymphoblastoid silent region 16958 | 6 | 16670696 | 16670775 | Human |
155661973 | LOC127405449 | H3K4me1 hESC enhancer GRCh37_chr6:16672541-16673042 | 6 | 16672310 | 16672811 | Human |
155656837 | LOC127405450 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:16723974-16724586 | 6 | 16723743 | 16724355 | Human |
38645739 | LOC111429610 | HNF1 motif-containing MPRA enhancer 207 | 6 | 16747171 | 16747315 | Human |
329819447 | LOC129995919 | ATAC-STARR-seq lymphoblastoid silent region 16959 | 6 | 16759868 | 16760227 | Human |
329838344 | LOC129995920 | ATAC-STARR-seq lymphoblastoid silent region 16960 | 6 | 16760238 | 16760717 | Human |
329822140 | LOC129995921 | ATAC-STARR-seq lymphoblastoid silent region 16961 | 6 | 16760788 | 16760917 | Human |
14700640 | ATXN1-AS1 | ATXN1 antisense RNA 1 | 6 | 16761138 | 16766883 | Human |
329824537 | LOC129995922 | ATAC-STARR-seq lymphoblastoid silent region 16962 | 6 | 16761394 | 16761553 | Human |
329338554 | LOC129661662 | ReSE screen-validated silencer GRCh37_chr6:16761792-16762007 | 6 | 16761561 | 16761913 | Human |
155230089 | LOC126859605 | BRD4-independent group 4 enhancer GRCh37_chr6:16762145-16763344 | 6 | 16761914 | 16763113 | Human |
151673148 | LOC124901268 | uncharacterized LOC124901268 | 6 | 16767144 | 16774988 | Human |
38656983 | LOC113174970 | Sharpr-MPRA regulatory region 6173 | 6 | 16769118 | 16769412 | Human |
126781804 | LOC121132670 | Sharpr-MPRA regulatory regions 2171 and 6041 | 6 | 16803298 | 16803632 | Human |
329329386 | LOC129389460 | MPRA-validated peak5695 silencer | 6 | 16890204 | 16890404 | Human |
155650293 | LOC127405451 | OCT4-NANOG hESC enhancer GRCh37_chr6:16891317-16891884 | 6 | 16891086 | 16891653 | Human |
38654615 | LOC107986573 | uncharacterized LOC107986573 | 6 | 16948515 | 16958351 | Human |
38611328 | LOC105374951 | uncharacterized LOC105374951 | 6 | 17015817 | 17034225 | Human |
151669084 | LOC124901269 | uncharacterized LOC124901269 | 6 | 17060287 | 17074203 | Human |
38613124 | LOC101928463 | uncharacterized LOC101928463 | 6 | 17092716 | 17108146 | Human |
7205150 | STMND1 | stathmin domain containing 1 | 6 | 17102050 | 17131378 | Human |
155230403 | LOC126859606 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:17179073-17180272 | 6 | 17178842 | 17180041 | Human |
329329482 | LOC129389461 | MPRA-validated peak5698 silencer | 6 | 17193305 | 17193505 | Human |
1317276 | RBM24 | RNA binding motif protein 24 | 6 | 17281361 | 17293871 | Human |
38600764 | LOC111365167 | MED14-independent group 3 enhancer GRCh37_chr6:17311541-17312740 | 6 | 17311310 | 17312509 | Human |
155229291 | LOC126859607 | BRD4-independent group 4 enhancer GRCh37_chr6:17341060-17342259 | 6 | 17340829 | 17342028 | Human |
38652746 | ESDP1 | ESD pseudogene 1 | 6 | 17381487 | 17382027 | Human |
733378 | CAP2 | cyclase associated actin cytoskeleton regulatory protein 2 | 6 | 17393595 | 17557780 | Human |
150537056 | LOC123620062 | Sharpr-MPRA regulatory region 1209 | 6 | 17417818 | 17418112 | Human |
38627588 | LOC101928491 | uncharacterized LOC101928491 | 6 | 17501360 | 17511265 | Human |
2305500 | RPL7P26 | ribosomal protein L7 pseudogene 26 | 6 | 17530828 | 17531457 | Human |
10400717 | SUMO2P13 | SUMO2 pseudogene 13 | 6 | 17582034 | 17582305 | Human |
38618132 | LOC102724591 | uncharacterized LOC102724591 | 6 | 17585791 | 17598976 | Human |
329836831 | LOC129995923 | ATAC-STARR-seq lymphoblastoid silent region 16964 | 6 | 17600161 | 17600640 | Human |
1351875 | FAM8A1 | family with sequence similarity 8 member A1 | 6 | 17600302 | 17611715 | Human |
155647540 | LOC127405452 | H3K4me1 hESC enhancer GRCh37_chr6:17601938-17602438 | 6 | 17601707 | 17602207 | Human |
155654732 | LOC127405453 | H3K4me1 hESC enhancer GRCh37_chr6:17602439-17602939 | 6 | 17602208 | 17602708 | Human |
329342934 | LOC129389462 | MPRA-validated peak5701 silencer | 6 | 17610624 | 17610824 | Human |
329342247 | LOC129389463 | MPRA-validated peak5703 silencer | 6 | 17611984 | 17612184 | Human |
731840 | NUP153 | nucleoporin 153 | 6 | 17615037 | 17706925 | Human |
10398977 | RNU6-190P | RNA, U6 small nuclear 190, pseudogene | 6 | 17619533 | 17619634 | Human |
329340814 | LOC129389464 | MPRA-validated peak5705 silencer | 6 | 17633384 | 17633584 | Human |
329342963 | LOC129389465 | MPRA-validated peak5706 silencer | 6 | 17638744 | 17638944 | Human |
150537090 | LOC123620063 | Sharpr-MPRA regulatory region 5716 | 6 | 17665138 | 17665432 | Human |
155652143 | LOC127405454 | H3K4me1 hESC enhancer GRCh37_chr6:17685707-17686206 | 6 | 17685476 | 17685975 | Human |
329827079 | LOC129995924 | ATAC-STARR-seq lymphoblastoid active region 24114 | 6 | 17701756 | 17701875 | Human |
329339081 | LOC129661663 | ReSE screen-validated silencer GRCh37_chr6:17704301-17704470 | 6 | 17704070 | 17704239 | Human |
329822449 | LOC129995925 | ATAC-STARR-seq lymphoblastoid silent region 16965 | 6 | 17704756 | 17704915 | Human |
16566327 | NUP153-AS1 | NUP153 antisense RNA 1 | 6 | 17706130 | 17711027 | Human |
155654271 | LOC127405455 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:17706574-17707268 | 6 | 17706247 | 17707116 | Human |
6481830 | RNA5SP204 | RNA, 5S ribosomal pseudogene 204 | 6 | 17721786 | 17721903 | Human |
126781826 | LOC121132671 | Sharpr-MPRA regulatory region 4388 | 6 | 17724836 | 17725472 | Human |
151670615 | LOC124901554 | uncharacterized LOC124901554 | 6 | 17730839 | 17730922 | Human |
155657109 | LOC127405456 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:17741805-17742364 | 6 | 17741574 | 17742133 | Human |
329341306 | LOC129661664 | ReSE screen-validated silencer GRCh37_chr6:17742982-17743213 | 6 | 17742751 | 17742982 | Human |
329337457 | LOC129389466 | MPRA-validated peak5708 silencer | 6 | 17744004 | 17744204 | Human |
155647650 | LOC127405457 | H3K27ac hESC enhancer GRCh37_chr6:17745783-17746283 | 6 | 17745552 | 17746052 | Human |
329342612 | LOC129661665 | ReSE screen-validated silencer GRCh37_chr6:17756633-17756835 | 6 | 17756402 | 17756604 | Human |
1317245 | KIF13A | kinesin family member 13A | 6 | 17759126 | 17987635 | Human |
127338348 | LOC121740646 | Sharpr-MPRA regulatory region 4440 | 6 | 17815378 | 17815672 | Human |
38662437 | LOC105374953 | uncharacterized LOC105374953 | 6 | 17850434 | 17853539 | Human |
150537065 | LOC123620064 | Sharpr-MPRA regulatory region 4275 | 6 | 17884618 | 17884912 | Human |
329339882 | LOC129661666 | ReSE screen-validated silencer GRCh37_chr6:17934402-17934586 | 6 | 17934171 | 17934355 | Human |
155657439 | LOC127405458 | H3K4me1 hESC enhancer GRCh37_chr6:17940169-17940668 | 6 | 17939938 | 17940437 | Human |
2305331 | RPS12P12 | ribosomal protein S12 pseudogene 12 | 6 | 17953569 | 17953942 | Human |
155656923 | LOC127405459 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:17976631-17977191 | 6 | 17976400 | 17976960 | Human |
329843969 | LOC129995926 | ATAC-STARR-seq lymphoblastoid silent region 16967 | 6 | 17987221 | 17987340 | Human |
329826489 | LOC129995927 | ATAC-STARR-seq lymphoblastoid silent region 16968 | 6 | 17987711 | 17988210 | Human |
329824253 | LOC129995928 | ATAC-STARR-seq lymphoblastoid active region 24116 | 6 | 17993536 | 17993585 | Human |
155653305 | LOC127405460 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:18022491-18023444 | 6 | 18022260 | 18023213 | Human |
155656313 | LOC127405461 | H3K27ac hESC enhancer GRCh37_chr6:18089369-18090086 | 6 | 18089138 | 18089855 | Human |
1350688 | NHLRC1 | NHL repeat containing E3 ubiquitin protein ligase 1 | 6 | 18120440 | 18122677 | Human |
1350168 | TPMT | thiopurine S-methyltransferase | 6 | 18128311 | 18155169 | Human |
155227245 | LOC126859608 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:18146951-18148150 | 6 | 18146720 | 18147919 | Human |
329815152 | LOC129995929 | ATAC-STARR-seq lymphoblastoid silent region 16969 | 6 | 18155123 | 18155682 | Human |
1321760 | KDM1B | lysine demethylase 1B | 6 | 18155422 | 18223854 | Human |
329832239 | LOC129995930 | ATAC-STARR-seq lymphoblastoid active region 24117 | 6 | 18156123 | 18156362 | Human |
329344670 | LOC129389467 | MPRA-validated peak5710 silencer | 6 | 18176275 | 18176475 | Human |
329832598 | LOC129995931 | ATAC-STARR-seq lymphoblastoid active region 24118 | 6 | 18211666 | 18211715 | Human |
329828775 | LOC129995932 | ATAC-STARR-seq lymphoblastoid silent region 16970 | 6 | 18215063 | 18215112 | Human |
329840115 | LOC129995933 | ATAC-STARR-seq lymphoblastoid active region 24119 | 6 | 18215323 | 18215442 | Human |
1349075 | DEK | DEK proto-oncogene | 6 | 18223860 | 18264530 | Human |
155650135 | LOC127405462 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:18227006-18227518 | 6 | 18226775 | 18227287 | Human |
155648559 | LOC127405463 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:18227519-18228032 | 6 | 18227288 | 18227801 | Human |
38648260 | LOC113174974 | Sharpr-MPRA regulatory region 13525 | 6 | 18242438 | 18242732 | Human |
329837278 | LOC129995934 | ATAC-STARR-seq lymphoblastoid silent region 16971 | 6 | 18245630 | 18245689 | Human |
329824731 | LOC129995935 | ATAC-STARR-seq lymphoblastoid active region 24120 | 6 | 18260417 | 18260536 | Human |
155655947 | LOC127405464 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:18263885-18264436 | 6 | 18263654 | 18264205 | Human |
329821033 | LOC129995936 | ATAC-STARR-seq lymphoblastoid silent region 16973 | 6 | 18264211 | 18264570 | Human |
151672311 | LOC124901270 | uncharacterized LOC124901270 | 6 | 18264532 | 18269220 | Human |
329813542 | LOC129995937 | ATAC-STARR-seq lymphoblastoid silent region 16974 | 6 | 18264611 | 18264890 | Human |
10400758 | RNU6-263P | RNA, U6 small nuclear 263, pseudogene | 6 | 18306975 | 18307078 | Human |
329343391 | LOC129661667 | ReSE screen-validated silencer GRCh37_chr6:18313696-18313869 | 6 | 18313465 | 18313638 | Human |
329844111 | LOC129995938 | ATAC-STARR-seq lymphoblastoid silent region 16975 | 6 | 18330929 | 18330978 | Human |
2289767 | DDX18P3 | DEAD-box helicase 18 pseudogene 3 | 6 | 18363096 | 18365461 | Human |
2289745 | IMPDH1P9 | inosine monophosphate dehydrogenase 1 pseudogene 9 | 6 | 18366016 | 18368719 | Human |
1318869 | RNF144B | ring finger protein 144B | 6 | 18387350 | 18468870 | Human |
329821914 | LOC129995939 | ATAC-STARR-seq lymphoblastoid active region 24121 | 6 | 18400770 | 18400869 | Human |
329826524 | LOC129995940 | ATAC-STARR-seq lymphoblastoid active region 24122 | 6 | 18400980 | 18401029 | Human |
151673322 | LOC124901544 | small nucleolar RNA U13 | 6 | 18401951 | 18402052 | Human |
155227088 | LOC126859609 | MED14-independent group 3 enhancer GRCh37_chr6:18414863-18416062 | 6 | 18414632 | 18415831 | Human |
151670945 | LOC124901271 | uncharacterized LOC124901271 | 6 | 18421291 | 18423992 | Human |
38614847 | LOC105374955 | uncharacterized LOC105374955 | 6 | 18496860 | 18517420 | Human |
12904805 | MIR548A1HG | MIR548A1 host gene | 6 | 18522747 | 18722898 | Human |
155647091 | LOC127405465 | OCT4-NANOG hESC enhancer GRCh37_chr6:18527823-18528458 | 6 | 18527592 | 18528227 | Human |
38637018 | LOC110120976 | VISTA enhancer hs1052 | 6 | 18536397 | 18538036 | Human |
1603131 | MIR548A1 | microRNA 548a-1 | 6 | 18571784 | 18571880 | Human |
155227114 | LOC126859610 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:18584790-18585989 | 6 | 18584559 | 18585758 | Human |
155657953 | LOC127405466 | H3K4me1 hESC enhancer GRCh37_chr6:18656829-18657328 | 6 | 18656598 | 18657097 | Human |
155227756 | LOC126859611 | BRD4-independent group 4 enhancer GRCh37_chr6:18693220-18694419 | 6 | 18692989 | 18694188 | Human |
38652736 | LOC105374957 | uncharacterized LOC105374957 | 6 | 18746688 | 18757284 | Human |
38635153 | LOC113174975 | Sharpr-MPRA regulatory region 7591 | 6 | 18749418 | 18749712 | Human |
155655930 | LOC127405467 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:18759725-18760225 | 6 | 18759494 | 18759994 | Human |
2300690 | TRQ-CTG1-1 | tRNA-Gln (anticodon CTG) 1-1 | 6 | 18836171 | 18836242 | Human |
38604420 | LOC105374958 | uncharacterized LOC105374958 | 6 | 18977113 | 19096273 | Human |
38634624 | LOC101928519 | uncharacterized LOC101928519 | 6 | 19068543 | 19180480 | Human |
2304631 | RPL21P61 | ribosomal protein L21 pseudogene 61 | 6 | 19143653 | 19144195 | Human |
155654934 | LOC127405468 | OCT4-NANOG hESC enhancer GRCh37_chr6:19247492-19248075 | 6 | 19247261 | 19247844 | Human |
155660893 | LOC127405469 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:19311742-19312526 | 6 | 19311511 | 19312295 | Human |
155660829 | LOC127405470 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:19312527-19313312 | 6 | 19312296 | 19313081 | Human |
38647190 | LOC105374961 | uncharacterized LOC105374961 | 6 | 19317052 | 19322285 | Human |
38644222 | LOC107986575 | uncharacterized LOC107986575 | 6 | 19323063 | 19330903 | Human |
2305096 | RPL5P20 | ribosomal protein L5 pseudogene 20 | 6 | 19348114 | 19349133 | Human |
6481831 | RNA5SP205 | RNA, 5S ribosomal pseudogene 205 | 6 | 19438283 | 19438418 | Human |
38619110 | LOC105374960 | uncharacterized LOC105374960 | 6 | 19449821 | 19459348 | Human |
329341674 | LOC129661668 | ReSE screen-validated silencer GRCh37_chr6:19507481-19507645 | 6 | 19507250 | 19507414 | Human |
38628166 | LOC107403164 | meiotic recombination hotspot C | 6 | 19555937 | 19560930 | Human |
1605774 | KRT18P38 | keratin 18 pseudogene 38 | 6 | 19612688 | 19614090 | Human |
4772784 | UQCRFS1P3 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 pseudogene 3 | 6 | 19637843 | 19639197 | Human |
10398915 | RNU6-801P | RNA, U6 small nuclear 801, pseudogene | 6 | 19642425 | 19642529 | Human |
155647186 | LOC127405471 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:19691659-19692162 | 6 | 19691428 | 19691931 | Human |
155661600 | LOC127405472 | OCT4-NANOG hESC enhancer GRCh37_chr6:19715338-19715863 | 6 | 19715107 | 19715632 | Human |
38659714 | LOC110121134 | VISTA enhancer hs1533 | 6 | 19718991 | 19722679 | Human |
14700851 | LNC-LBCS | lncRNA bladder and prostate cancer suppressor, hnRNPK interacting | 6 | 19729421 | 19804759 | Human |
155227091 | LOC126859612 | MED14-independent group 3 enhancer GRCh37_chr6:19730720-19731919 | 6 | 19730489 | 19731688 | Human |
155654175 | LOC127405473 | H3K27ac hESC enhancer GRCh37_chr6:19734675-19735175 | 6 | 19734444 | 19734944 | Human |
155230391 | LOC126859613 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:19749583-19750782 | 6 | 19749352 | 19750551 | Human |
155659979 | LOC127405474 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:19764761-19765373 | 6 | 19764530 | 19765142 | Human |
155646863 | LOC127405475 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:19765374-19765985 | 6 | 19765143 | 19765754 | Human |
329827349 | LOC129995941 | ATAC-STARR-seq lymphoblastoid silent region 16976 | 6 | 19804678 | 19804727 | Human |
38675089 | LOC105374963 | uncharacterized LOC105374963 | 6 | 19807922 | 19814200 | Human |
155652245 | LOC127405476 | NANOG hESC enhancer GRCh37_chr6:19811543-19812108 | 6 | 19811312 | 19811877 | Human |
736051 | ID4 | inhibitor of DNA binding 4 | 6 | 19837370 | 19842197 | Human |
155656057 | LOC127405477 | H3K27ac hESC enhancer GRCh37_chr6:19940204-19940832 | 6 | 19939973 | 19940601 | Human |
38599249 | LOC110121016 | VISTA enhancer hs1175 | 6 | 19975926 | 19977282 | Human |
155647925 | LOC127405478 | H3K4me1 hESC enhancer GRCh37_chr6:20028521-20029021 | 6 | 20028290 | 20028790 | Human |
2304502 | RPL29P17 | ribosomal protein L29 pseudogene 17 | 6 | 20042336 | 20042985 | Human |
38641250 | LOC105374965 | uncharacterized LOC105374965 | 6 | 20066851 | 20075371 | Human |
155650552 | LOC127405479 | OCT4-NANOG hESC enhancer GRCh37_chr6:20092424-20092927 | 6 | 20092193 | 20092696 | Human |
1322766 | MBOAT1 | membrane bound O-acyltransferase domain containing 1 | 6 | 20099684 | 20212469 | Human |
329341444 | LOC129661669 | ReSE screen-validated silencer GRCh37_chr6:20127115-20127242 | 6 | 20126884 | 20127011 | Human |
155662694 | LOC127405480 | NANOG hESC enhancer GRCh37_chr6:20188894-20189395 | 6 | 20188663 | 20189164 | Human |
329822811 | LOC129995942 | ATAC-STARR-seq lymphoblastoid active region 24123 | 6 | 20197581 | 20197630 | Human |
155652205 | LOC127405481 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:20206230-20206981 | 6 | 20205999 | 20206750 | Human |
329822410 | LOC129995943 | ATAC-STARR-seq lymphoblastoid silent region 16977 | 6 | 20212275 | 20212814 | Human |
155648929 | LOC127405482 | H3K4me1 hESC enhancer GRCh37_chr6:20213228-20213728 | 6 | 20212997 | 20213497 | Human |
38613744 | LOC101928573 | uncharacterized LOC101928573 | 6 | 20265627 | 20333357 | Human |
155229988 | LOC126859614 | MED14-independent group 3 enhancer GRCh37_chr6:20266729-20267928 | 6 | 20266498 | 20267697 | Human |
329338321 | LOC129661670 | ReSE screen-validated silencer GRCh37_chr6:20291927-20292228 | 6 | 20291696 | 20291997 | Human |
329816201 | LOC129995944 | ATAC-STARR-seq lymphoblastoid active region 24126 | 6 | 20319734 | 20319813 | Human |
329822191 | LOC129995945 | ATAC-STARR-seq lymphoblastoid active region 24127 | 6 | 20320554 | 20320603 | Human |
151669916 | LOC124901272 | uncharacterized LOC124901272 | 6 | 20331235 | 20334909 | Human |
151673851 | LOC124901482 | uncharacterized LOC124901482 | 6 | 20400741 | 20402772 | Human |
329836629 | LOC129995946 | ATAC-STARR-seq lymphoblastoid silent region 16978 | 6 | 20401454 | 20401693 | Human |
155652279 | LOC127405483 | H3K27ac hESC enhancer GRCh37_chr6:20402023-20402547 | 6 | 20401792 | 20402316 | Human |
1320122 | E2F3 | E2F transcription factor 3 | 6 | 20401879 | 20493714 | Human |
329826174 | LOC129995947 | ATAC-STARR-seq lymphoblastoid silent region 16979 | 6 | 20402544 | 20403013 | Human |
329845024 | LOC129995948 | ATAC-STARR-seq lymphoblastoid silent region 16980 | 6 | 20403214 | 20403833 | Human |
155658723 | LOC127405484 | H3K4me1 hESC enhancer GRCh37_chr6:20411388-20411888 | 6 | 20411157 | 20411657 | Human |
155653653 | LOC127405485 | H3K4me1 hESC enhancer GRCh37_chr6:20411889-20412389 | 6 | 20411658 | 20412158 | Human |
329838976 | LOC129995949 | ATAC-STARR-seq lymphoblastoid active region 24128 | 6 | 20418045 | 20418114 | Human |
10400842 | RN7SL128P | RNA, 7SL, cytoplasmic 128, pseudogene | 6 | 20421657 | 20421887 | Human |
329841267 | LOC129995950 | ATAC-STARR-seq lymphoblastoid active region 24129 | 6 | 20427809 | 20427878 | Human |
6481103 | E2F3-IT1 | E2F3 intronic transcript 1 | 6 | 20437821 | 20440178 | Human |
10400139 | RNU6-141P | RNA, U6 small nuclear 141, pseudogene | 6 | 20452369 | 20452473 | Human |
155652757 | LOC127405486 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:20467153-20467794 | 6 | 20466922 | 20467563 | Human |
329828127 | LOC129995951 | ATAC-STARR-seq lymphoblastoid active region 24130 | 6 | 20534386 | 20534545 | Human |
1321035 | CDKAL1 | CDK5 regulatory subunit associated protein 1 like 1 | 6 | 20534457 | 21232404 | Human |
329836367 | LOC129995952 | ATAC-STARR-seq lymphoblastoid active region 24131 | 6 | 20534576 | 20534655 | Human |
151674760 | LOC124901273 | uncharacterized LOC124901273 | 6 | 20573804 | 20576510 | Human |
329343214 | LOC129389468 | MPRA-validated peak5719 silencer | 6 | 20586585 | 20586785 | Human |
38631694 | LOC105374968 | uncharacterized LOC105374968 | 6 | 20597690 | 20600617 | Human |
155660440 | LOC127405487 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:20629440-20630213 | 6 | 20629209 | 20629982 | Human |
155656441 | LOC127405488 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:20630214-20630986 | 6 | 20629983 | 20630755 | Human |
155648511 | LOC127405489 | NANOG hESC enhancer GRCh37_chr6:20686272-20686773 | 6 | 20686041 | 20686542 | Human |
329831575 | LOC129995953 | ATAC-STARR-seq lymphoblastoid active region 24132 | 6 | 20708696 | 20708745 | Human |
2304814 | RPL36AP25 | ribosomal protein L36a pseudogene 25 | 6 | 20722281 | 20722570 | Human |
329842110 | LOC129995954 | ATAC-STARR-seq lymphoblastoid silent region 16981 | 6 | 20722534 | 20722603 | Human |
329343400 | LOC129389469 | MPRA-validated peak5720 silencer | 6 | 20729155 | 20729355 | Human |
329339681 | LOC129661671 | ReSE screen-validated silencer GRCh37_chr6:20798064-20798254 | 6 | 20797833 | 20798023 | Human |
155651078 | LOC127405490 | H3K27ac hESC enhancer GRCh37_chr6:20810592-20811186 | 6 | 20810361 | 20810955 | Human |
329339565 | LOC129389470 | MPRA-validated peak5721 silencer | 6 | 20825345 | 20825545 | Human |
155650365 | LOC127405491 | NANOG hESC enhancer GRCh37_chr6:20834311-20834850 | 6 | 20833985 | 20834619 | Human |
38627239 | LOC110121068 | VISTA enhancer hs1340 | 6 | 20866869 | 20870298 | Human |
155229436 | LOC126859615 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:20877312-20878511 | 6 | 20877081 | 20878280 | Human |
126781779 | LOC121132672 | Sharpr-MPRA regulatory region 659 | 6 | 20882078 | 20882372 | Human |
329828525 | LOC129995955 | ATAC-STARR-seq lymphoblastoid active region 24134 | 6 | 20919761 | 20919810 | Human |
329338159 | LOC129389471 | MPRA-validated peak5723 silencer | 6 | 20932425 | 20932625 | Human |
10399224 | RNU6-150P | RNA, U6 small nuclear 150, pseudogene | 6 | 20993474 | 20993568 | Human |
38606458 | LOC105374966 | uncharacterized LOC105374966 | 6 | 21135979 | 21140935 | Human |
156451584 | LOC128772275 | melanoma risk locus-associated MPRA allelic enhancer 6:21150224 | 6 | 21149921 | 21150065 | Human |
156451545 | LOC128772276 | melanoma risk locus-associated MPRA allelic enhancer 6:21163919 | 6 | 21163616 | 21163760 | Human |
242994926 | LOC128781586 | melanoma risk locus-associated MPRA allelic enhancers 6:21164131 and 6:21164145 | 6 | 21163828 | 21163986 | Human |
156451567 | LOC128772277 | melanoma risk locus-associated MPRA allelic enhancer 6:21166705 | 6 | 21166402 | 21166546 | Human |
329839421 | LOC129995956 | ATAC-STARR-seq lymphoblastoid active region 24135 | 6 | 21182148 | 21182207 | Human |
155653803 | LOC127405492 | OCT4-NANOG hESC enhancer GRCh37_chr6:21186041-21186767 | 6 | 21185810 | 21186536 | Human |
155652343 | LOC127405493 | NANOG hESC enhancer GRCh37_chr6:21223372-21223889 | 6 | 21223141 | 21223658 | Human |
38621859 | LOC107986578 | uncharacterized LOC107986578 | 6 | 21227804 | 21231059 | Human |
155227094 | LOC126859616 | MED14-independent group 3 enhancer GRCh37_chr6:21230452-21231651 | 6 | 21230221 | 21231420 | Human |
150537045 | LOC123620065 | Sharpr-MPRA regulatory region 5810 | 6 | 21245998 | 21246292 | Human |
155661553 | LOC127405494 | H3K4me1 hESC enhancer GRCh37_chr6:21263602-21264102 | 6 | 21263371 | 21263871 | Human |
329834735 | LOC129995957 | ATAC-STARR-seq lymphoblastoid active region 24136 | 6 | 21264048 | 21264097 | Human |
329825100 | LOC129995958 | ATAC-STARR-seq lymphoblastoid active region 24137 | 6 | 21264118 | 21264177 | Human |
329834626 | LOC129995959 | ATAC-STARR-seq lymphoblastoid active region 24138 | 6 | 21264188 | 21264307 | Human |
155660874 | LOC127405495 | H3K4me1 hESC enhancer GRCh37_chr6:21275814-21276318 | 6 | 21275583 | 21276087 | Human |
155654798 | LOC127405496 | H3K4me1 hESC enhancer GRCh37_chr6:21276319-21276823 | 6 | 21276088 | 21276592 | Human |
155654111 | LOC127405497 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21327213-21328056 | 6 | 21326982 | 21327825 | Human |
155662410 | LOC127405498 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21361231-21362046 | 6 | 21361000 | 21361815 | Human |
155647198 | LOC127405499 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:21362047-21362861 | 6 | 21361816 | 21362630 | Human |
155646562 | LOC127405501 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21367138-21367689 | 6 | 21366907 | 21367458 | Human |
155660831 | LOC127405502 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21367690-21368242 | 6 | 21367459 | 21368011 | Human |
155654596 | LOC127405503 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21368243-21368793 | 6 | 21368012 | 21368562 | Human |
155651688 | LOC127405504 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21393485-21394340 | 6 | 21393254 | 21394109 | Human |
6480858 | LINC00581 | long intergenic non-protein coding RNA 581 | 6 | 21486061 | 21511892 | Human |
329337860 | LOC129389472 | MPRA-validated peak5728 silencer | 6 | 21509824 | 21510024 | Human |
38649874 | LOC107986579 | uncharacterized LOC107986579 | 6 | 21537364 | 21541085 | Human |
155656099 | LOC127405505 | H3K4me1 hESC enhancer GRCh37_chr6:21586838-21587370 | 6 | 21586607 | 21587139 | Human |
329837024 | LOC129995960 | ATAC-STARR-seq lymphoblastoid silent region 16982 | 6 | 21587135 | 21587194 | Human |
329835378 | LOC129995961 | ATAC-STARR-seq lymphoblastoid silent region 16983 | 6 | 21587335 | 21587414 | Human |
155646883 | LOC127405506 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21588011-21588668 | 6 | 21587780 | 21588437 | Human |
329826594 | LOC129995962 | ATAC-STARR-seq lymphoblastoid active region 24139 | 6 | 21589205 | 21589304 | Human |
329813603 | LOC129995963 | ATAC-STARR-seq lymphoblastoid active region 24140 | 6 | 21589315 | 21589364 | Human |
1319854 | SOX4 | SRY-box transcription factor 4 | 6 | 21593751 | 21598619 | Human |
329823189 | LOC129995964 | ATAC-STARR-seq lymphoblastoid silent region 16984 | 6 | 21594362 | 21594541 | Human |
329819791 | LOC129995965 | ATAC-STARR-seq lymphoblastoid silent region 16985 | 6 | 21595312 | 21595401 | Human |
329823507 | LOC129995966 | ATAC-STARR-seq lymphoblastoid silent region 16986 | 6 | 21595452 | 21595501 | Human |
329815706 | LOC129995967 | ATAC-STARR-seq lymphoblastoid active region 24141 | 6 | 21596312 | 21596511 | Human |
10400595 | BOLA2P3 | bolA family member 2 pseudogene 3 | 6 | 21602128 | 21602383 | Human |
329844509 | LOC129995968 | ATAC-STARR-seq lymphoblastoid active region 24142 | 6 | 21628312 | 21628381 | Human |
329342320 | LOC129389473 | MPRA-validated peak5729 silencer | 6 | 21648585 | 21648785 | Human |
155661348 | LOC127405507 | H3K27ac hESC enhancer GRCh37_chr6:21649156-21649656 | 6 | 21648925 | 21649425 | Human |
151673509 | LOC124901483 | uncharacterized LOC124901483 | 6 | 21664541 | 21666060 | Human |
150537052 | LOC123620066 | Sharpr-MPRA regulatory region 7931 | 6 | 21665678 | 21665972 | Human |
5467112 | CASC15 | cancer susceptibility 15 | 6 | 21666413 | 22195820 | Human |
155653411 | LOC127405508 | H3K27ac hESC enhancer GRCh37_chr6:21721085-21721584 | 6 | 21720854 | 21721353 | Human |
155648091 | LOC127405509 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21739035-21739957 | 6 | 21738804 | 21739726 | Human |
155661184 | LOC127405510 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:21740882-21741804 | 6 | 21740651 | 21741573 | Human |
155646917 | LOC127405511 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:21741805-21742728 | 6 | 21741574 | 21742497 | Human |
151671221 | LOC124901274 | uncharacterized LOC124901274 | 6 | 21754700 | 21755639 | Human |
155647722 | LOC127405512 | H3K27ac hESC enhancer GRCh37_chr6:21769680-21770293 | 6 | 21769449 | 21770062 | Human |
155650716 | LOC127405513 | H3K27ac hESC enhancer GRCh37_chr6:21770817-21771316 | 6 | 21770586 | 21771085 | Human |
155658510 | LOC127405514 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21773448-21774170 | 6 | 21773217 | 21773939 | Human |
155652081 | LOC127405515 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:21798093-21798690 | 6 | 21797862 | 21798459 | Human |
38666627 | LOC105374970 | uncharacterized LOC105374970 | 6 | 21825780 | 21828383 | Human |
329840652 | LOC129995969 | ATAC-STARR-seq lymphoblastoid active region 24143 | 6 | 21847057 | 21847106 | Human |
329832121 | LOC129995970 | ATAC-STARR-seq lymphoblastoid active region 24144 | 6 | 21847137 | 21847266 | Human |
150537062 | LOC123620067 | Sharpr-MPRA regulatory region 6328 | 6 | 21856418 | 21856712 | Human |
329830004 | LOC129995971 | ATAC-STARR-seq lymphoblastoid silent region 16987 | 6 | 21871958 | 21872007 | Human |
155227102 | LOC126859617 | MED14-independent group 3 enhancer GRCh37_chr6:21873881-21875080 | 6 | 21873650 | 21874849 | Human |
150537086 | LOC123620068 | Sharpr-MPRA regulatory region 8833 | 6 | 21891118 | 21891412 | Human |
329817172 | LOC129995972 | ATAC-STARR-seq lymphoblastoid active region 24145 | 6 | 21914207 | 21914256 | Human |
329814069 | LOC129995973 | ATAC-STARR-seq lymphoblastoid active region 24146 | 6 | 21925845 | 21925954 | Human |
329832110 | LOC129995974 | ATAC-STARR-seq lymphoblastoid active region 24147 | 6 | 22025941 | 22026110 | Human |
155655936 | LOC127405516 | H3K27ac hESC enhancer GRCh37_chr6:22027355-22028066 | 6 | 22027126 | 22027837 | Human |
329833972 | LOC129995975 | ATAC-STARR-seq lymphoblastoid active region 24148 | 6 | 22037620 | 22037729 | Human |
10413570 | RN7SKP240 | RN7SK pseudogene 240 | 6 | 22085545 | 22085791 | Human |
7287306 | NBAT1 | neuroblastoma associated transcript 1 | 6 | 22134602 | 22147193 | Human |
155662321 | LOC127405517 | NANOG hESC enhancer GRCh37_chr6:22145447-22145948 | 6 | 22145218 | 22145719 | Human |
38607776 | LOC110121065 | VISTA enhancer hs1335 | 6 | 22148345 | 22151158 | Human |
155229544 | LOC126859618 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:22198729-22199928 | 6 | 22198500 | 22199699 | Human |
151673234 | LOC124901275 | uncharacterized LOC124901275 | 6 | 22200989 | 22205065 | Human |
401827248 | NGRNP4 | NGRN pseudogene 4 | 6 | 22213306 | 22214237 | Human |
155649809 | LOC127405518 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:22221433-22222281 | 6 | 22221204 | 22222052 | Human |
155658410 | LOC127405519 | H3K4me1 hESC enhancer GRCh37_chr6:22223143-22223644 | 6 | 22222914 | 22223415 | Human |
736187 | PRL | prolactin | 6 | 22287246 | 22302835 | Human |
155649400 | LOC127405520 | OCT4-NANOG hESC enhancer GRCh37_chr6:22313984-22314538 | 6 | 22313755 | 22314309 | Human |
38648826 | LOC105374971 | uncharacterized LOC105374971 | 6 | 22349218 | 22590314 | Human |
155230198 | LOC126859619 | MED14-independent group 3 enhancer GRCh37_chr6:22441843-22443042 | 6 | 22441614 | 22443097 | Human |
155662826 | LOC127405521 | H3K27ac hESC enhancer GRCh37_chr6:22443327-22443827 | 6 | 22443098 | 22443598 | Human |
1344578 | HDGFL1 | HDGF like 1 | 6 | 22569566 | 22571666 | Human |
329340545 | LOC129389474 | MPRA-validated peak5731 silencer | 6 | 22584007 | 22584207 | Human |
38666287 | LINC03005 | long intergenic non-protein coding RNA 3005 | 6 | 22643510 | 22717924 | Human |
38662457 | LOC105374973 | uncharacterized LOC105374973 | 6 | 22644020 | 22660022 | Human |
38671059 | LOC102724736 | uncharacterized LOC102724736 | 6 | 22662394 | 22674065 | Human |
155656831 | LOC127405522 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:22878206-22879013 | 6 | 22877977 | 22878784 | Human |
155648758 | LOC127405523 | OCT4-NANOG hESC enhancer GRCh37_chr6:22896808-22897410 | 6 | 22896579 | 22897181 | Human |
38622296 | LOC105374974 | uncharacterized LOC105374974 | 6 | 23056297 | 23177045 | Human |
2305218 | RPL6P18 | ribosomal protein L6 pseudogene 18 | 6 | 23102659 | 23103577 | Human |
10398880 | RNU6-1060P | RNA, U6 small nuclear 1060, pseudogene | 6 | 23124982 | 23125087 | Human |
155229588 | LOC126859620 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:23175123-23176322 | 6 | 23174895 | 23176094 | Human |
38652789 | LOC110121074 | VISTA enhancer hs1352 | 6 | 23179784 | 23181958 | Human |
155647506 | LOC127405524 | OCT4-NANOG hESC enhancer GRCh37_chr6:23218776-23219447 | 6 | 23218548 | 23219219 | Human |
38675718 | LOC105374976 | uncharacterized LOC105374976 | 6 | 23336746 | 23626334 | Human |
38639378 | LOC102724749 | uncharacterized LOC102724749 | 6 | 23337691 | 23404141 | Human |
329816780 | LOC129995976 | ATAC-STARR-seq lymphoblastoid active region 24149 | 6 | 23414245 | 23414474 | Human |
38672117 | LOC105374975 | uncharacterized LOC105374975 | 6 | 23416075 | 23452922 | Human |
151668545 | LOC124901276 | uncharacterized LOC124901276 | 6 | 23453000 | 23455137 | Human |
38640751 | LOC113174981 | Sharpr-MPRA regulatory region 10928 | 6 | 23560001 | 23560295 | Human |
155661747 | LOC127405525 | NANOG hESC enhancer GRCh37_chr6:23716734-23717235 | 6 | 23716506 | 23717007 | Human |
155653522 | LOC127405526 | H3K4me1 hESC enhancer GRCh37_chr6:23804320-23804820 | 6 | 23804092 | 23804592 | Human |
155653707 | LOC127405527 | H3K4me1 hESC enhancer GRCh37_chr6:23804821-23805321 | 6 | 23804593 | 23805093 | Human |
38605982 | LOC100129616 | putative UPF0607 protein ENSP00000332738-like | 6 | 23854437 | 23855457 | Human |
6480938 | SPTLC1P2 | serine palmitoyltransferase long chain base subunit 1 pseudogene 2 | 6 | 23856564 | 23856836 | Human |
38604763 | ISG20L2P1 | ISG20L2 pseudogene 1 | 6 | 23971766 | 23973351 | Human |
7246622 | HNRNPA1P58 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 58 | 6 | 24001822 | 24002626 | Human |
329827903 | LOC129995977 | ATAC-STARR-seq lymphoblastoid active region 24150 | 6 | 24061017 | 24061226 | Human |
1317257 | NRSN1 | neurensin 1 | 6 | 24126215 | 24147530 | Human |
329344400 | LOC129389475 | MPRA-validated peak5732 silencer | 6 | 24126848 | 24127048 | Human |
16559372 | LOC124900220 | small nucleolar RNA SNORD46 | 6 | 24166273 | 24166374 | Human |
1321007 | DCDC2 | doublecortin domain containing 2 | 6 | 24171755 | 24383292 | Human |
155658192 | LOC127405528 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:24323956-24324653 | 6 | 24323728 | 24324425 | Human |
1350579 | KAAG1 | kidney associated DCDC2 antisense RNA 1 | 6 | 24356903 | 24358285 | Human |
155647092 | LOC127405529 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24360012-24360600 | 6 | 24359784 | 24360372 | Human |
10399918 | RNU6-391P | RNA, U6 small nuclear 391, pseudogene | 6 | 24365651 | 24365754 | Human |
150537075 | LOC123620069 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24400121-24400856 | 6 | 24399893 | 24400635 | Human |
155631431 | LOC127276564 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24400857-24401592 | 6 | 24400629 | 24401364 | Human |
150537072 | LOC123620070 | Sharpr-MPRA regulatory region 326 | 6 | 24401521 | 24401815 | Human |
732788 | MRS2 | magnesium transporter MRS2 | 6 | 24402936 | 24426190 | Human |
155651385 | LOC127405530 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24403801-24404535 | 6 | 24403573 | 24404307 | Human |
1606585 | GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 6 | 24423969 | 24495287 | Human |
329340797 | LOC129389476 | MPRA-validated peak5733 silencer | 6 | 24462872 | 24463072 | Human |
735245 | ALDH5A1 | aldehyde dehydrogenase 5 family member A1 | 6 | 24494969 | 24537207 | Human |
329830052 | LOC129995978 | ATAC-STARR-seq lymphoblastoid silent region 16989 | 6 | 24494975 | 24495364 | Human |
329843045 | LOC129995979 | ATAC-STARR-seq lymphoblastoid silent region 16990 | 6 | 24513742 | 24513831 | Human |
329833214 | LOC129995980 | ATAC-STARR-seq lymphoblastoid active region 24152 | 6 | 24517477 | 24517526 | Human |
329827960 | LOC129995981 | ATAC-STARR-seq lymphoblastoid active region 24153 | 6 | 24518037 | 24518236 | Human |
329837849 | LOC129995982 | ATAC-STARR-seq lymphoblastoid silent region 16991 | 6 | 24521035 | 24521084 | Human |
329841056 | LOC129995983 | ATAC-STARR-seq lymphoblastoid silent region 16992 | 6 | 24522454 | 24522503 | Human |
151675997 | LOC124901277 | uncharacterized LOC124901277 | 6 | 24535415 | 24540052 | Human |
155228564 | LOC126859621 | BRD4-independent group 4 enhancer GRCh37_chr6:24538795-24539994 | 6 | 24538567 | 24539766 | Human |
1348294 | KIAA0319 | KIAA0319 | 6 | 24540141 | 24646191 | Human |
155656646 | LOC127405531 | NANOG hESC enhancer GRCh37_chr6:24547459-24547981 | 6 | 24547231 | 24547753 | Human |
329339315 | LOC129389477 | MPRA-validated peak5735 silencer | 6 | 24589488 | 24589688 | Human |
5130833 | KRT8P43 | keratin 8 pseudogene 43 | 6 | 24597952 | 24599986 | Human |
329816742 | LOC129995984 | ATAC-STARR-seq lymphoblastoid silent region 16993 | 6 | 24646036 | 24646245 | Human |
1348894 | TDP2 | tyrosyl-DNA phosphodiesterase 2 | 6 | 24649979 | 24666899 | Human |
155654495 | LOC127405532 | H3K27ac hESC enhancer GRCh37_chr6:24666173-24666845 | 6 | 24665945 | 24666617 | Human |
38653989 | LOC113174982 | H3K27ac hESC enhancer GRCh37_chr6:24666846-24667517 | 6 | 24666618 | 24667289 | Human |
1315172 | ACOT13 | acyl-CoA thioesterase 13 | 6 | 24667077 | 24705046 | Human |
151668391 | LOC124901279 | uncharacterized LOC124901279 | 6 | 24669117 | 24683275 | Human |
155654165 | LOC127405533 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24682160-24682927 | 6 | 24681932 | 24682699 | Human |
155647653 | LOC127405534 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24682928-24683696 | 6 | 24682700 | 24683468 | Human |
155651239 | LOC127405535 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:24683697-24684463 | 6 | 24683469 | 24684235 | Human |
151672395 | LOC124901278 | uncharacterized LOC124901278 | 6 | 24689707 | 24695771 | Human |
329342636 | LOC129661672 | ReSE screen-validated silencer GRCh37_chr6:24699525-24699689 | 6 | 24699297 | 24699461 | Human |
1347069 | C6orf62 | chromosome 6 open reading frame 62 | 6 | 24704861 | 24720836 | Human |
155649960 | LOC127405536 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24720063-24720856 | 6 | 24719835 | 24720628 | Human |
155653569 | LOC127405537 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24721651-24722444 | 6 | 24720928 | 24722216 | Human |
14402192 | LINC02828 | long intergenic non-protein coding RNA 2828 | 6 | 24742305 | 24751960 | Human |
329819562 | LOC129995985 | ATAC-STARR-seq lymphoblastoid active region 24157 | 6 | 24743525 | 24743614 | Human |
38607946 | AP3S1P1 | AP3S1 pseudogene 1 | 6 | 24750477 | 24751631 | Human |
329343499 | LOC129661673 | ReSE screen-validated silencer GRCh37_chr6:24754099-24754309 | 6 | 24753871 | 24754081 | Human |
329344042 | LOC129661674 | ReSE screen-validated silencer GRCh37_chr6:24758062-24758263 | 6 | 24757834 | 24758035 | Human |
1317736 | GMNN | geminin DNA replication inhibitor | 6 | 24774937 | 24786099 | Human |
329822781 | LOC129995986 | ATAC-STARR-seq lymphoblastoid active region 24158 | 6 | 24775852 | 24775931 | Human |
151676036 | LOC124901280 | uncharacterized LOC124901280 | 6 | 24792799 | 24795836 | Human |
7779583 | ARMH2 | armadillo like helical domain containing 2 | 6 | 24797335 | 24798917 | Human |
1315839 | RIPOR2 | RHO family interacting cell polarization regulator 2 | 6 | 24804284 | 25042168 | Human |
329340958 | LOC129661675 | ReSE screen-validated silencer GRCh37_chr6:24821142-24821270 | 6 | 24820914 | 24821042 | Human |
155663039 | LOC127405538 | H3K27ac hESC enhancer GRCh37_chr6:24827169-24827670 | 6 | 24826941 | 24827442 | Human |
155662352 | LOC127405539 | H3K27ac hESC enhancer GRCh37_chr6:24827671-24828170 | 6 | 24827443 | 24827942 | Human |
126781816 | LOC121132673 | Sharpr-MPRA regulatory region 11328 | 6 | 24856001 | 24856295 | Human |
329837714 | LOC129995987 | ATAC-STARR-seq lymphoblastoid active region 24159 | 6 | 24862182 | 24862291 | Human |
155647994 | LOC127405540 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24875839-24876775 | 6 | 24875611 | 24876547 | Human |
155658350 | LOC127405541 | H3K27ac hESC enhancer GRCh37_chr6:24918137-24918636 | 6 | 24917909 | 24918408 | Human |
329839455 | LOC129995988 | ATAC-STARR-seq lymphoblastoid active region 24160 | 6 | 24929456 | 24929575 | Human |
38611987 | LOC105374981 | uncharacterized LOC105374981 | 6 | 24933975 | 24950491 | Human |
329821244 | LOC129995989 | ATAC-STARR-seq lymphoblastoid active region 24161 | 6 | 24936673 | 24936842 | Human |
10450340 | MTCO2P33 | MT-CO2 pseudogene 33 | 6 | 24947880 | 24948344 | Human |
5508292 | PPIAP29 | peptidylprolyl isomerase A pseudogene 29 | 6 | 24976377 | 24977187 | Human |
155659371 | LOC127405542 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:24980966-24981536 | 6 | 24980738 | 24981308 | Human |
155654900 | LOC127405543 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:24985321-24985939 | 6 | 24985093 | 24985711 | Human |
329339136 | LOC129661676 | ReSE screen-validated silencer GRCh37_chr6:25009294-25009446 | 6 | 25009066 | 25009218 | Human |
38665409 | LOC102724765 | uncharacterized LOC102724765 | 6 | 25014952 | 25036141 | Human |
1350105 | ASS1P1 | argininosuccinate synthetase 1 pseudogene 1 | 6 | 25023009 | 25024584 | Human |
329815740 | LOC129995990 | ATAC-STARR-seq lymphoblastoid active region 24162 | 6 | 25027452 | 25027691 | Human |
10399842 | RN7SL334P | RNA, 7SL, cytoplasmic 334, pseudogene | 6 | 25031009 | 25031287 | Human |
329836532 | LOC129995991 | ATAC-STARR-seq lymphoblastoid active region 24163 | 6 | 25054106 | 25054275 | Human |
329817072 | LOC129995992 | ATAC-STARR-seq lymphoblastoid active region 24164 | 6 | 25056256 | 25056385 | Human |
329819323 | LOC129995993 | ATAC-STARR-seq lymphoblastoid active region 24165 | 6 | 25056526 | 25056585 | Human |
329344416 | LOC129661677 | ReSE screen-validated silencer GRCh37_chr6:25059321-25059634 | 6 | 25059093 | 25059406 | Human |
155648959 | LOC127405544 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:25061721-25062289 | 6 | 25061493 | 25062061 | Human |
1352628 | CMAHP | cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene | 6 | 25081067 | 25138392 | Human |
151669237 | LOC124901282 | uncharacterized LOC124901282 | 6 | 25121689 | 25135191 | Human |
329826868 | LOC129995994 | ATAC-STARR-seq lymphoblastoid active region 24166 | 6 | 25138256 | 25138305 | Human |
329843285 | LOC129995995 | ATAC-STARR-seq lymphoblastoid active region 24167 | 6 | 25138346 | 25138575 | Human |
329817386 | LOC129995996 | ATAC-STARR-seq lymphoblastoid active region 24168 | 6 | 25138686 | 25138805 | Human |
1606410 | NUP50P2 | nucleoporin 50 pseudogene 2 | 6 | 25139664 | 25141641 | Human |
38602594 | CANT1P1 | CANT1 pseudogene 1 | 6 | 25152525 | 25155420 | Human |
155647879 | LOC127405545 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:25153639-25154343 | 6 | 25153411 | 25154115 | Human |
155654124 | LOC127405546 | H3K27ac hESC enhancer GRCh37_chr6:25174961-25175461 | 6 | 25174733 | 25175233 | Human |
38632802 | UBE2D3P5 | UBE2D3 pseudogene 5 | 6 | 25181025 | 25181795 | Human |
2859128 | RNY5P5 | RNY5 pseudogene 5 | 6 | 25192413 | 25192486 | Human |
38602210 | LOC113174983 | Sharpr-MPRA regulatory region 4970 | 6 | 25207561 | 25207855 | Human |
38623587 | LOC100533655 | aryl hydrocarbon receptor pseudogene | 6 | 25218709 | 25221168 | Human |
151675986 | LOC124901283 | uncharacterized LOC124901283 | 6 | 25230235 | 25232616 | Human |
38643721 | LOC101928663 | uncharacterized LOC101928663 | 6 | 25244916 | 25261407 | Human |
7257627 | KATNBL1P5 | katanin regulatory subunit B1 like 1 pseudogene 5 | 6 | 25248189 | 25248780 | Human |
2304390 | RPL21P68 | ribosomal protein L21 pseudogene 68 | 6 | 25261199 | 25261758 | Human |
401844944 | HNRNPA3P17 | HNRNPA3 pseudogene 17 | 6 | 25272200 | 25273751 | Human |
329815783 | LOC129995997 | ATAC-STARR-seq lymphoblastoid silent region 16995 | 6 | 25279102 | 25279571 | Human |
1315346 | CARMIL1 | capping protein regulator and myosin 1 linker 1 | 6 | 25279374 | 25620530 | Human |
155652090 | LOC127405547 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:25292659-25293159 | 6 | 25292431 | 25292931 | Human |
155648204 | LOC127405548 | H3K4me1 hESC enhancer GRCh37_chr6:25311331-25311831 | 6 | 25311103 | 25311603 | Human |
155659182 | LOC127405549 | H3K4me1 hESC enhancer GRCh37_chr6:25315887-25316577 | 6 | 25315659 | 25316349 | Human |
151675334 | LOC124901281 | uncharacterized LOC124901281 | 6 | 25327706 | 25452190 | Human |
155649711 | LOC127405550 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:25342051-25342783 | 6 | 25341823 | 25342555 | Human |
10413732 | RNU6-987P | RNA, U6 small nuclear 987, pseudogene | 6 | 25383599 | 25383702 | Human |
329837926 | LOC129995998 | ATAC-STARR-seq lymphoblastoid active region 24169 | 6 | 25404748 | 25404957 | Human |
151675545 | LOC124901546 | uncharacterized LOC124901546 | 6 | 25435280 | 25435401 | Human |
155646979 | LOC127405551 | NANOG hESC enhancer GRCh37_chr6:25462672-25463208 | 6 | 25462444 | 25462980 | Human |
329339665 | LOC129389478 | MPRA-validated peak5738 silencer | 6 | 25463448 | 25463648 | Human |
155227716 | LOC126859622 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:25504114-25505313 | 6 | 25503886 | 25505085 | Human |
329343686 | LOC129389479 | MPRA-validated peak5739 silencer | 6 | 25533227 | 25533427 | Human |
155661845 | LOC127405552 | OCT4-NANOG hESC enhancer GRCh37_chr6:25627151-25627701 | 6 | 25626923 | 25627473 | Human |
155647304 | LOC127405553 | NANOG hESC enhancer GRCh37_chr6:25635867-25636368 | 6 | 25635639 | 25636140 | Human |
1347901 | SCGN | secretagogin, EF-hand calcium binding protein | 6 | 25652215 | 25701783 | Human |
155229799 | LOC126859623 | MED14-independent group 3 enhancer GRCh37_chr6:25660432-25661631 | 6 | 25660204 | 25661403 | Human |
6482765 | PRELID1P2 | PRELID1 pseudogene 2 | 6 | 25678779 | 25679423 | Human |
151672878 | LOC124901284 | uncharacterized LOC124901284 | 6 | 25681873 | 25698974 | Human |
1350724 | SLC17A1 | solute carrier family 17 member 1 | 6 | 25723743 | 25832052 | Human |
1349225 | H2AC1 | H2A clustered histone 1 | 6 | 25726063 | 25726562 | Human |
1352004 | H2BC1 | H2B clustered histone 1 | 6 | 25726777 | 25727345 | Human |
1344705 | H2BC2P | H2B clustered histone 2, pseudogene | 6 | 25731728 | 25732166 | Human |
1343258 | H2AC2P | H2A clustered histone 2, pseudogene | 6 | 25732381 | 25737705 | Human |
1314119 | SLC17A4 | solute carrier family 17 member 4 | 6 | 25754699 | 25781199 | Human |
151669822 | LOC124901285 | uncharacterized LOC124901285 | 6 | 25836154 | 25860194 | Human |
329842870 | LOC129995999 | ATAC-STARR-seq lymphoblastoid silent region 16996 | 6 | 25842786 | 25842845 | Human |
1344101 | SLC17A3 | solute carrier family 17 member 3 | 6 | 25844856 | 25874243 | Human |
1344934 | H2AC3P | H2A clustered histone 3, pseudogene | 6 | 25881926 | 25882416 | Human |
155661279 | LOC127405554 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:25882461-25882975 | 6 | 25882233 | 25882747 | Human |
14700714 | H2BP5 | H2B histone pseudogene 5 | 6 | 25885419 | 25885751 | Human |
155656616 | LOC127405555 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:25898344-25898933 | 6 | 25898116 | 25898705 | Human |
1318813 | SLC17A2 | solute carrier family 17 member 2 | 6 | 25912754 | 25930691 | Human |
329827488 | LOC129996000 | ATAC-STARR-seq lymphoblastoid active region 24170 | 6 | 25945610 | 25945669 | Human |
38639891 | LOC116158548 | CRISPRi-validated cis-regulatory element chr6.1077 | 6 | 25958670 | 25958974 | Human |
1349740 | TRIM38 | tripartite motif containing 38 | 6 | 25962802 | 25991231 | Human |
155227777 | LOC126859624 | MED14-independent group 3 enhancer GRCh37_chr6:25971247-25972446 | 6 | 25971019 | 25972218 | Human |
329842251 | LOC129996001 | ATAC-STARR-seq lymphoblastoid silent region 16997 | 6 | 25992476 | 25992785 | Human |
150573780 | LINC02980 | long intergenic non-protein coding RNA 2980 | 6 | 25992667 | 26001775 | Human |
329825812 | LOC129996002 | ATAC-STARR-seq lymphoblastoid active region 24171 | 6 | 25992776 | 25992985 | Human |
155647842 | LOC127405556 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:25999111-25999745 | 6 | 25998883 | 25999517 | Human |
155651215 | LOC127405557 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:25999746-26000381 | 6 | 25999518 | 26000153 | Human |
155647220 | LOC127405558 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26016208-26017207 | 6 | 26015980 | 26016979 | Human |
1346974 | H3P26 | H3 histone pseudogene 26 | 6 | 26016107 | 26016841 | Human |
1313894 | H1-1 | H1.1 linker histone, cluster member | 6 | 26017032 | 26017787 | Human |
155648610 | LOC127405559 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26020191-26021007 | 6 | 26019963 | 26020779 | Human |
1345402 | H3C1 | H3 clustered histone 1 | 6 | 26020451 | 26020958 | Human |
155660743 | LOC127405560 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26021008-26021824 | 6 | 26020780 | 26021596 | Human |
155655493 | LOC127405561 | H3K27ac hESC enhancer GRCh37_chr6:26021825-26022640 | 6 | 26021597 | 26022412 | Human |
1315697 | H4C1 | H4 clustered histone 1 | 6 | 26021649 | 26022050 | Human |
127338260 | LOC121740647 | Sharpr-MPRA regulatory region 4264 | 6 | 26025661 | 26025955 | Human |
329819488 | LOC129996003 | ATAC-STARR-seq lymphoblastoid active region 24176 | 6 | 26026896 | 26026945 | Human |
1342856 | H4C2 | H4 clustered histone 2 | 6 | 26026896 | 26027283 | Human |
329827399 | LOC129996004 | ATAC-STARR-seq lymphoblastoid active region 24177 | 6 | 26026976 | 26027035 | Human |
329841217 | LOC129996005 | ATAC-STARR-seq lymphoblastoid active region 24178 | 6 | 26027056 | 26027375 | Human |
155649751 | LOC127405562 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26027580-26028165 | 6 | 26027352 | 26027937 | Human |
155651062 | LOC127405563 | H3K27ac hESC enhancer GRCh37_chr6:26028166-26028750 | 6 | 26027938 | 26028522 | Human |
155657446 | LOC127405564 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:26028751-26029336 | 6 | 26028523 | 26029108 | Human |
1347747 | H3C2 | H3 clustered histone 2 | 6 | 26031589 | 26032099 | Human |
329813631 | LOC129996006 | ATAC-STARR-seq lymphoblastoid active region 24179 | 6 | 26031736 | 26031965 | Human |
329844011 | LOC129996007 | ATAC-STARR-seq lymphoblastoid active region 24180 | 6 | 26032006 | 26032125 | Human |
155660762 | LOC127405565 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26033291-26033920 | 6 | 26033063 | 26033692 | Human |
1345991 | H2AC4 | H2A clustered histone 4 | 6 | 26033092 | 26033618 | Human |
329843423 | LOC129996008 | ATAC-STARR-seq lymphoblastoid active region 24181 | 6 | 26033996 | 26034055 | Human |
329817430 | LOC129996009 | ATAC-STARR-seq lymphoblastoid active region 24182 | 6 | 26034096 | 26034145 | Human |
329823900 | LOC129996010 | ATAC-STARR-seq lymphoblastoid active region 24183 | 6 | 26034476 | 26034535 | Human |
1343461 | H2BC3 | H2B clustered histone 3 | 6 | 26043227 | 26043713 | Human |
1344950 | H2AC5P | H2A clustered histone 5, pseudogene | 6 | 26043900 | 26044550 | Human |
329838009 | LOC129996011 | ATAC-STARR-seq lymphoblastoid active region 24184 | 6 | 26043957 | 26044196 | Human |
1348947 | H3C3 | H3 clustered histone 3 | 6 | 26045384 | 26045869 | Human |
329831421 | LOC129996012 | ATAC-STARR-seq lymphoblastoid active region 24185 | 6 | 26045427 | 26045746 | Human |
329339331 | LOC129661678 | ReSE screen-validated silencer GRCh37_chr6:26053365-26053538 | 6 | 26053137 | 26053310 | Human |
155658260 | LOC127405566 | H3K27ac hESC enhancer GRCh37_chr6:26053937-26054558 | 6 | 26053709 | 26054330 | Human |
155653527 | LOC127405567 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26055179-26055800 | 6 | 26054951 | 26055572 | Human |
1343160 | H1-2 | H1.2 linker histone, cluster member | 6 | 26055740 | 26056470 | Human |
329838652 | LOC129996013 | ATAC-STARR-seq lymphoblastoid active region 24186 | 6 | 26055983 | 26056032 | Human |
329832501 | LOC129996014 | ATAC-STARR-seq lymphoblastoid active region 24187 | 6 | 26056123 | 26056522 | Human |
329830665 | LOC129996015 | ATAC-STARR-seq lymphoblastoid silent region 17000 | 6 | 26064627 | 26064766 | Human |
155647521 | LOC127405568 | H3K27ac hESC enhancer GRCh37_chr6:26066841-26067340 | 6 | 26066613 | 26067112 | Human |
155654608 | LOC127405569 | H3K4me1 hESC enhancer GRCh37_chr6:26075238-26075738 | 6 | 26075010 | 26075510 | Human |
155661246 | LOC127405570 | H3K4me1 hESC enhancer GRCh37_chr6:26075739-26076239 | 6 | 26075511 | 26076011 | Human |
36947460 | HFE-AS1 | HFE antisense RNA 1 | 6 | 26086290 | 26091034 | Human |
1345296 | HFE | homeostatic iron regulator | 6 | 26087429 | 26098343 | Human |
329813887 | LOC129996016 | ATAC-STARR-seq lymphoblastoid active region 24188 | 6 | 26103471 | 26103580 | Human |
155652688 | LOC127405571 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:26103833-26104523 | 6 | 26103605 | 26104295 | Human |
1352928 | H4C3 | H4 clustered histone 3 | 6 | 26103933 | 26104337 | Human |
737047 | H1-6 | H1.6 linker histone, cluster member | 6 | 26107412 | 26108135 | Human |
1344863 | H2BC4 | H2B clustered histone 4 | 6 | 26113170 | 26123926 | Human |
155657301 | LOC127405572 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26121574-26122260 | 6 | 26121346 | 26122032 | Human |
155651924 | LOC127405573 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26122261-26122945 | 6 | 26122033 | 26122717 | Human |
155230241 | LOC126859625 | BRD4-independent group 4 enhancer GRCh37_chr6:26123079-26124278 | 6 | 26122718 | 26124075 | Human |
155228438 | LOC126859626 | BRD4-independent group 4 enhancer GRCh37_chr6:26124310-26125509 | 6 | 26124082 | 26125281 | Human |
1345959 | H2AC6 | H2A clustered histone 6 | 6 | 26124172 | 26124690 | Human |
329816130 | LOC129996017 | ATAC-STARR-seq lymphoblastoid active region 24192 | 6 | 26125289 | 26125378 | Human |
155653004 | LOC127405574 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26156285-26157036 | 6 | 26156057 | 26156832 | Human |
1345558 | H1-4 | H1.4 linker histone, cluster member | 6 | 26156329 | 26157115 | Human |
329839399 | LOC129996018 | ATAC-STARR-seq lymphoblastoid silent region 17001 | 6 | 26157123 | 26157172 | Human |
155657462 | LOC127405575 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26157790-26158541 | 6 | 26157562 | 26158313 | Human |
1316135 | H2BC5 | H2B clustered histone 5 | 6 | 26158121 | 26171349 | Human |
329819823 | LOC129996019 | ATAC-STARR-seq lymphoblastoid active region 24195 | 6 | 26158453 | 26158502 | Human |
150537088 | LOC123620071 | Sharpr-MPRA regulatory region 13869 | 6 | 26159501 | 26159795 | Human |
155882470 | H2BC6-AS1 | H2BC6 antisense RNA 1 | 6 | 26160274 | 26172773 | Human |
155652921 | LOC127405576 | H3K27ac hESC enhancer GRCh37_chr6:26160799-26161550 | 6 | 26160571 | 26161322 | Human |
1354379 | LARP1P1 | LARP1 pseudogene 1 | 6 | 26164033 | 26168176 | Human |
155663025 | LOC127405577 | H3K27ac hESC enhancer GRCh37_chr6:26172075-26172967 | 6 | 26171847 | 26172739 | Human |
329843955 | LOC129996020 | ATAC-STARR-seq lymphoblastoid active region 24196 | 6 | 26175720 | 26175769 | Human |
155663008 | LOC127405578 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26183023-26183752 | 6 | 26182795 | 26183573 | Human |
1350317 | H2BC6 | H2B clustered histone 6 | 6 | 26183761 | 26184230 | Human |
329820305 | LOC129996021 | ATAC-STARR-seq lymphoblastoid active region 24198 | 6 | 26184024 | 26184083 | Human |
155648293 | LOC127405579 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26187941-26188566 | 6 | 26187713 | 26188338 | Human |
1347367 | H4C4 | H4 clustered histone 4 | 6 | 26188710 | 26189112 | Human |
329814394 | LOC129996022 | ATAC-STARR-seq lymphoblastoid active region 24199 | 6 | 26189121 | 26189300 | Human |
1348498 | H1-12P | H1.12 linker histone, cluster member, pseudogene | 6 | 26195566 | 26195771 | Human |
329825857 | LOC129996023 | ATAC-STARR-seq lymphoblastoid active region 24200 | 6 | 26195617 | 26195666 | Human |
155647141 | LOC127405580 | H3K27ac hESC enhancer GRCh37_chr6:26196641-26197242 | 6 | 26196413 | 26197014 | Human |
1349026 | H3C4 | H3 clustered histone 4 | 6 | 26196784 | 26199293 | Human |
155656046 | LOC127405581 | H3K27ac hESC enhancer GRCh37_chr6:26197243-26197843 | 6 | 26197015 | 26197615 | Human |
329813714 | LOC129996024 | ATAC-STARR-seq lymphoblastoid active region 24202 | 6 | 26198358 | 26198417 | Human |
329823167 | LOC129996025 | ATAC-STARR-seq lymphoblastoid active region 24203 | 6 | 26198448 | 26198507 | Human |
155229123 | LOC126859627 | BRD4-independent group 4 enhancer GRCh37_chr6:26199013-26200212 | 6 | 26198639 | 26199984 | Human |
1342566 | H2AC7 | H2A clustered histone 7 | 6 | 26198784 | 26199293 | Human |
1346859 | H2BC7 | H2B clustered histone 7 | 6 | 26199516 | 26199988 | Human |
1348476 | RPS10P1 | ribosomal protein S10 pseudogene 1 | 6 | 26202123 | 26202705 | Human |
329839968 | LOC129996026 | ATAC-STARR-seq lymphoblastoid active region 24207 | 6 | 26204398 | 26204647 | Human |
1316645 | H4C5 | H4 clustered histone 5 | 6 | 26204610 | 26205021 | Human |
329825444 | LOC129996027 | ATAC-STARR-seq lymphoblastoid active region 24208 | 6 | 26204658 | 26204797 | Human |
329825807 | LOC129996028 | ATAC-STARR-seq lymphoblastoid active region 24209 | 6 | 26206118 | 26206197 | Human |
329842044 | LOC129996029 | ATAC-STARR-seq lymphoblastoid active region 24210 | 6 | 26206248 | 26206347 | Human |
329830824 | LOC129996030 | ATAC-STARR-seq lymphoblastoid active region 24211 | 6 | 26215802 | 26215931 | Human |
329835913 | LOC129996031 | ATAC-STARR-seq lymphoblastoid active region 24212 | 6 | 26215982 | 26216071 | Human |
155655620 | LOC127405582 | NANOG-H3K27ac-H3K4me1 hESC enhancers GRCh37_chr6:26216641-26217292 and GRCh37_chr6:26217293-26217944 | 6 | 26216152 | 26217741 | Human |
1346575 | H2BC8 | H2B clustered histone 8 | 6 | 26216200 | 26216688 | Human |
1353821 | H2AC8 | H2A clustered histone 8 | 6 | 26216921 | 26217437 | Human |
14700717 | H3C5P | H3 clustered histone 5, pseudogene | 6 | 26219045 | 26219240 | Human |
1351707 | H3C6 | H3 clustered histone 6 | 6 | 26224178 | 26227473 | Human |
155649510 | LOC127405584 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:26225373-26225989 | 6 | 26225145 | 26225761 | Human |
155650622 | LOC127405585 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:26225990-26226605 | 6 | 26225762 | 26226377 | Human |
1348318 | H2AC9P | H2A clustered histone 9, pseudogene | 6 | 26233122 | 26233255 | Human |
329837097 | LOC129996032 | ATAC-STARR-seq lymphoblastoid active region 24216 | 6 | 26233310 | 26233359 | Human |
155655862 | LOC127405586 | H3K27ac hESC enhancer GRCh37_chr6:26234741-26235728 | 6 | 26234190 | 26235500 | Human |
1343145 | H1-3 | H1.3 linker histone, cluster member | 6 | 26234212 | 26234987 | Human |
329839242 | LOC129996033 | ATAC-STARR-seq lymphoblastoid active region 24218 | 6 | 26240020 | 26240119 | Human |
1354264 | H4C6 | H4 clustered histone 6 | 6 | 26240393 | 26240793 | Human |
329817939 | LOC129996034 | ATAC-STARR-seq lymphoblastoid active region 24219 | 6 | 26240580 | 26240629 | Human |
1350829 | H4C7 | H4 clustered histone 7 | 6 | 26246611 | 26246996 | Human |
329833320 | LOC129996035 | ATAC-STARR-seq lymphoblastoid active region 24220 | 6 | 26249468 | 26249547 | Human |
329836995 | LOC129996036 | ATAC-STARR-seq lymphoblastoid active region 24221 | 6 | 26249688 | 26250057 | Human |
1343932 | H3C7 | H3 clustered histone 7 | 6 | 26250142 | 26250635 | Human |
329824196 | LOC129996037 | ATAC-STARR-seq lymphoblastoid active region 24222 | 6 | 26250358 | 26250517 | Human |
155646401 | LOC127405587 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:26251592-26252322 | 6 | 26251364 | 26252094 | Human |
1343164 | H2BC9 | H2B clustered histone 9 | 6 | 26251614 | 26252075 | Human |
329821472 | LOC129996038 | ATAC-STARR-seq lymphoblastoid active region 24224 | 6 | 26252180 | 26252279 | Human |
329814662 | LOC129996039 | ATAC-STARR-seq lymphoblastoid active region 24225 | 6 | 26253280 | 26253369 | Human |
155660068 | LOC127405588 | H3K4me1 hESC enhancer GRCh37_chr6:26253831-26254332 | 6 | 26253603 | 26254104 | Human |
155659208 | LOC127405589 | H3K4me1 hESC enhancer GRCh37_chr6:26254333-26254832 | 6 | 26254105 | 26254604 | Human |
329836638 | LOC129996040 | ATAC-STARR-seq lymphoblastoid active region 24226 | 6 | 26254667 | 26254716 | Human |
38637410 | LOC105374986 | uncharacterized LOC105374986 | 6 | 26257500 | 26261928 | Human |
329826319 | LOC129996041 | ATAC-STARR-seq lymphoblastoid silent region 17002 | 6 | 26258461 | 26258550 | Human |
155649582 | LOC127405590 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:26269173-26269769 | 6 | 26268945 | 26269541 | Human |
329815006 | LOC129996042 | ATAC-STARR-seq lymphoblastoid active region 24227 | 6 | 26270315 | 26270454 | Human |
1346430 | H3C8 | H3 clustered histone 8 | 6 | 26270918 | 26271413 | Human |
329839078 | LOC129996043 | ATAC-STARR-seq lymphoblastoid active region 24228 | 6 | 26272182 | 26272521 | Human |
1348354 | H2AC10P | H2A clustered histone 10, pseudogene | 6 | 26272193 | 26272540 | Human |
329833043 | LOC129996044 | ATAC-STARR-seq lymphoblastoid active region 24229 | 6 | 26272852 | 26273191 | Human |
1312785 | H2BC10 | H2B clustered histone 10 | 6 | 26272931 | 26273412 | Human |
329843023 | LOC129996045 | ATAC-STARR-seq lymphoblastoid active region 24230 | 6 | 26273262 | 26273391 | Human |
329822138 | LOC129996046 | ATAC-STARR-seq lymphoblastoid active region 24231 | 6 | 26273402 | 26273451 | Human |
329824597 | LOC129996047 | ATAC-STARR-seq lymphoblastoid active region 24232 | 6 | 26273862 | 26274021 | Human |
155230347 | LOC126859628 | BRD4-independent group 4 enhancer GRCh37_chr6:26285047-26286246 | 6 | 26284375 | 26286018 | Human |
1314497 | H4C8 | H4 clustered histone 8 | 6 | 26285126 | 26285534 | Human |
151675653 | LOC124901287 | uncharacterized LOC124901287 | 6 | 26285680 | 26298964 | Human |
329824001 | LOC129996048 | ATAC-STARR-seq lymphoblastoid silent region 17003 | 6 | 26286265 | 26286314 | Human |
1345406 | TRX-CAT1-2 | tRNA-iMet (anticodon CAT) 1-2 | 6 | 26286526 | 26286597 | Human |
38618000 | LOC113174984 | Sharpr-MPRA regulatory region 6564 | 6 | 26295756 | 26296415 | Human |
38642590 | LOC116158549 | CRISPRi-validated cis-regulatory element chr6.1130 | 6 | 26296920 | 26297447 | Human |
1347212 | TRR-TCG4-1 | tRNA-Arg (anticodon TCG) 4-1 | 6 | 26299677 | 26299749 | Human |
329840536 | LOC129996049 | ATAC-STARR-seq lymphoblastoid active region 24236 | 6 | 26304996 | 26305315 | Human |
329826815 | LOC129996050 | ATAC-STARR-seq lymphoblastoid silent region 17004 | 6 | 26305396 | 26305585 | Human |
2300759 | TRS-GCT6-1 | tRNA-Ser (anticodon GCT) 6-1 | 6 | 26305490 | 26305573 | Human |
38606868 | LOC116158550 | CRISPRi-validated cis-regulatory element chr6.1133 | 6 | 26309856 | 26309970 | Human |
38639759 | LOC116158551 | CRISPRi-validated cis-regulatory element chr6.1134 | 6 | 26311059 | 26311278 | Human |
2300656 | TRQ-TTG3-1 | tRNA-Gln (anticodon TTG) 3-1 | 6 | 26311196 | 26311267 | Human |
329822013 | LOC129996051 | ATAC-STARR-seq lymphoblastoid silent region 17005 | 6 | 26311265 | 26311314 | Human |
329814568 | LOC129996052 | ATAC-STARR-seq lymphoblastoid silent region 17006 | 6 | 26311745 | 26311794 | Human |
2300792 | TRQ-TTG3-2 | tRNA-Gln (anticodon TTG) 3-2 | 6 | 26311747 | 26311818 | Human |
329842320 | LOC129996053 | ATAC-STARR-seq lymphoblastoid silent region 17007 | 6 | 26312496 | 26312735 | Human |
2300547 | TRS-TGA3-1 | tRNA-Ser (anticodon TGA) 3-1 | 6 | 26312596 | 26312677 | Human |
2300883 | TRX-CAT1-3 | tRNA-iMet (anticodon CAT) 1-3 | 6 | 26313124 | 26313195 | Human |
2300541 | TRW-CCA3-1 | tRNA-Trp (anticodon CCA) 3-1 | 6 | 26319102 | 26319173 | Human |
1348994 | H3C9P | H3 clustered histone 9, pseudogene | 6 | 26321876 | 26322292 | Human |
329841361 | LOC129996054 | ATAC-STARR-seq lymphoblastoid active region 24237 | 6 | 26322248 | 26322437 | Human |
2300567 | TRR-TCG2-1 | tRNA-Arg (anticodon TCG) 2-1 | 6 | 26322818 | 26322890 | Human |
16572145 | AL021917.1 | novel transcript | 6 | 26324873 | 26331958 | Human |
2300595 | TRS-AGA2-1 | tRNA-Ser (anticodon AGA) 2-1 | 6 | 26327589 | 26327670 | Human |
2300581 | TRR-ACG1-1 | tRNA-Arg (anticodon ACG) 1-1 | 6 | 26328140 | 26328212 | Human |
2300937 | TRX-CAT1-4 | tRNA-iMet (anticodon CAT) 1-4 | 6 | 26330301 | 26330372 | Human |
2300929 | TRW-CCA3-2 | tRNA-Trp (anticodon CCA) 3-2 | 6 | 26331444 | 26331515 | Human |
151668745 | LOC124901288 | uncharacterized LOC124901288 | 6 | 26331818 | 26340285 | Human |
329341549 | LOC129661679 | ReSE screen-validated silencer GRCh37_chr6:26332100-26332281 | 6 | 26331872 | 26332053 | Human |
38654609 | LOC116158552 | CRISPRi-validated cis-regulatory element chr6.1147 | 6 | 26336278 | 26337156 | Human |
329815563 | LOC129996055 | ATAC-STARR-seq lymphoblastoid active region 24238 | 6 | 26342510 | 26342649 | Human |
151674169 | LOC124901520 | uncharacterized LOC124901520 | 6 | 26352947 | 26353032 | Human |
329833173 | LOC129996056 | ATAC-STARR-seq lymphoblastoid active region 24239 | 6 | 26361026 | 26361075 | Human |
329817711 | LOC129996057 | ATAC-STARR-seq lymphoblastoid active region 24240 | 6 | 26365156 | 26365205 | Human |
1346267 | BTN3A2 | butyrophilin subfamily 3 member A2 | 6 | 26365169 | 26378320 | Human |
329843451 | LOC129996058 | ATAC-STARR-seq lymphoblastoid silent region 17008 | 6 | 26382957 | 26383046 | Human |
1315891 | BTN2A2 | butyrophilin subfamily 2 member A2 | 6 | 26383108 | 26394874 | Human |
329839066 | LOC129996059 | ATAC-STARR-seq lymphoblastoid silent region 17009 | 6 | 26398294 | 26398383 | Human |
329816929 | LOC129996060 | ATAC-STARR-seq lymphoblastoid active region 24241 | 6 | 26402183 | 26402242 | Human |
1346965 | BTN3A1 | butyrophilin subfamily 3 member A1 | 6 | 26402275 | 26415208 | Human |
155649910 | LOC127405591 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26420693-26421656 | 6 | 26420465 | 26421428 | Human |
1346357 | BTN2A3P | butyrophilin subfamily 2 member A3, pseudogene | 6 | 26421391 | 26430588 | Human |
1349753 | BTN3A3 | butyrophilin subfamily 3 member A3 | 6 | 26440504 | 26453415 | Human |
329814718 | LOC129996061 | ATAC-STARR-seq lymphoblastoid active region 24242 | 6 | 26457566 | 26457825 | Human |
1353022 | BTN2A1 | butyrophilin subfamily 2 member A1 | 6 | 26457955 | 26476622 | Human |
329844441 | LOC129996062 | ATAC-STARR-seq lymphoblastoid active region 24243 | 6 | 26457986 | 26458145 | Human |
155229553 | LOC126859629 | BRD4-independent group 4 enhancer GRCh37_chr6:26465895-26467094 | 6 | 26465667 | 26466866 | Human |
38603057 | LOC285819 | uncharacterized LOC285819 | 6 | 26471944 | 26482509 | Human |
329833383 | LOC129996063 | ATAC-STARR-seq lymphoblastoid active region 24244 | 6 | 26473835 | 26473884 | Human |
155230200 | LOC126859630 | BRD4-independent group 4 enhancer GRCh37_chr6:26477169-26478368 | 6 | 26476941 | 26478140 | Human |
9831370 | BTN1A1P1 | butyrophilin subfamily 1 member A1 pseudogene 1 | 6 | 26477865 | 26478521 | Human |
38658425 | LOC116183041 | CRISPRi-validated cis-regulatory element chr6.1165 | 6 | 26478142 | 26478577 | Human |
38633398 | LOC107986583 | uncharacterized LOC107986583 | 6 | 26486649 | 26527398 | Human |
1315909 | BTN1A1 | butyrophilin subfamily 1 member A1 | 6 | 26500303 | 26510425 | Human |
329825698 | LOC129996064 | ATAC-STARR-seq lymphoblastoid active region 24245 | 6 | 26501592 | 26501721 | Human |
10399950 | RNU6-502P | RNA, U6 small nuclear 502, pseudogene | 6 | 26519351 | 26519458 | Human |
329839063 | LOC129996065 | ATAC-STARR-seq lymphoblastoid silent region 17010 | 6 | 26520812 | 26521411 | Human |
2300689 | TRL-CAG1-7 | tRNA-Leu (anticodon CAG) 1-7 | 6 | 26521208 | 26521290 | Human |
329823313 | LOC129996066 | ATAC-STARR-seq lymphoblastoid silent region 17011 | 6 | 26521642 | 26522161 | Human |
1344561 | HCG11 | HLA complex group 11 | 6 | 26521706 | 26527393 | Human |
38663592 | LOC116183042 | CRISPRi-validated cis-regulatory element chr6.1172 | 6 | 26532704 | 26533457 | Human |
2300658 | TRT-AGT2-1 | tRNA-Thr (anticodon AGT) 2-1 | 6 | 26532917 | 26532990 | Human |
155650836 | LOC127405592 | H3K4me1 hESC enhancer GRCh37_chr6:26536291-26536790 | 6 | 26536063 | 26536562 | Human |
155649053 | LOC127405593 | H3K27ac hESC enhancer GRCh37_chr6:26536880-26537544 | 6 | 26536652 | 26537316 | Human |
329338031 | LOC129661680 | ReSE screen-validated silencer GRCh37_chr6:26537578-26537871 | 6 | 26537350 | 26537643 | Human |
1343866 | TRR-ACG1-2 | tRNA-Arg (anticodon ACG) 1-2 | 6 | 26537498 | 26537570 | Human |
329843605 | LOC129996067 | ATAC-STARR-seq lymphoblastoid silent region 17013 | 6 | 26538037 | 26538086 | Human |
2300750 | TRV-CAC1-6 | tRNA-Val (anticodon CAC) 1-6 | 6 | 26538054 | 26538126 | Human |
1344098 | HMGN4 | high mobility group nucleosomal binding domain 4 | 6 | 26538366 | 26546933 | Human |
329837908 | LOC129996068 | ATAC-STARR-seq lymphoblastoid active region 24246 | 6 | 26538577 | 26538986 | Human |
155659295 | LOC127405594 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:26549364-26550318 | 6 | 26549136 | 26550090 | Human |
38665566 | LOC108281120 | HMGN4-LOC105374988 intergenic CAGE-defined low expression enhancer | 6 | 26550350 | 26550884 | Human |
329832284 | LOC129996069 | ATAC-STARR-seq lymphoblastoid active region 24247 | 6 | 26550869 | 26550918 | Human |
38656221 | LOC116183043 | CRISPRi-validated cis-regulatory element chr6.1175 | 6 | 26553186 | 26554396 | Human |
2300669 | TRA-CGC1-1 | tRNA-Ala (anticodon CGC) 1-1 | 6 | 26553503 | 26553574 | Human |
2300824 | TRI-AAT5-1 | tRNA-Ile (anticodon AAT) 5-1 | 6 | 26554122 | 26554195 | Human |
2300754 | TRP-AGG2-2 | tRNA-Pro (anticodon AGG) 2-2 | 6 | 26555270 | 26555341 | Human |
2300867 | TRK-CTT2-4 | tRNA-Lys (anticodon CTT) 2-4 | 6 | 26556546 | 26556618 | Human |
2300705 | TRY-GTA1-1 | tRNA-Tyr (anticodon GTA) 1-1 | 6 | 26568858 | 26568948 | Human |
16570443 | AL121936.1 | novel transcript | 6 | 26569324 | 26574698 | Human |
329836041 | LOC129996070 | ATAC-STARR-seq lymphoblastoid active region 24248 | 6 | 26569400 | 26569529 | Human |
1605135 | TRA-AGC11-1 | tRNA-Ala (anticodon AGC) 11-1 | 6 | 26571864 | 26571936 | Human |
2300640 | TRY-GTA8-1 | tRNA-Tyr (anticodon GTA) 8-1 | 6 | 26575570 | 26575659 | Human |
2300815 | TRY-GTA3-1 | tRNA-Tyr (anticodon GTA) 3-1 | 6 | 26577104 | 26577192 | Human |
38657615 | LOC116183044 | CRISPRi-validated cis-regulatory element chr6.1185 | 6 | 26592812 | 26592916 | Human |
150537068 | LOC123620072 | Sharpr-MPRA regulatory region 4089 | 6 | 26593581 | 26593875 | Human |
2300758 | TRY-GTA6-1 | tRNA-Tyr (anticodon GTA) 6-1 | 6 | 26594874 | 26594962 | Human |
329813768 | LOC129996071 | ATAC-STARR-seq lymphoblastoid active region 24249 | 6 | 26595835 | 26595984 | Human |
329814623 | LOC129996072 | ATAC-STARR-seq lymphoblastoid active region 24250 | 6 | 26596085 | 26596244 | Human |
329841833 | LOC129996073 | ATAC-STARR-seq lymphoblastoid active region 24251 | 6 | 26596802 | 26597241 | Human |
1321888 | ABT1 | activator of basal transcription 1 | 6 | 26596953 | 26600739 | Human |
16567689 | AL513548.3 | novel transcript | 6 | 26602733 | 26606661 | Human |
1348260 | VN1R14P | vomeronasal 1 receptor 14 pseudogene | 6 | 26631085 | 26631736 | Human |
1347331 | ZNF322 | zinc finger protein 322 | 6 | 26634383 | 26659746 | Human |
155662838 | LOC127405595 | H3K27ac hESC enhancer GRCh37_chr6:26659404-26659904 | 6 | 26659176 | 26659676 | Human |
155662416 | LOC127405596 | H3K27ac hESC enhancer GRCh37_chr6:26659905-26660405 | 6 | 26659677 | 26660177 | Human |
38610234 | LOC102724851 | uncharacterized LOC102724851 | 6 | 26671120 | 26687841 | Human |
2300619 | TRA-AGC14-1 | tRNA-Ala (anticodon AGC) 14-1 | 6 | 26673362 | 26673434 | Human |
2300608 | TRA-AGC12-1 | tRNA-Ala (anticodon AGC) 12-1 | 6 | 26682487 | 26682559 | Human |
153305939 | LOC126088086 | MED14-independent group 3 enhancer GRCh37_chr6:26686676-26687875 duplicate 1 | 6 | 26686448 | 26687771 | Human |
2300849 | TRA-AGC10-1 | tRNA-Ala (anticodon AGC) 10-1 | 6 | 26687257 | 26687329 | Human |
38676214 | LOC105374991 | uncharacterized LOC105374991 | 6 | 26698084 | 26720541 | Human |
2300674 | TRM-CAT5-1 | tRNA-Met (anticodon CAT) 5-1 | 6 | 26701483 | 26701555 | Human |
153305917 | LOC126088088 | MED14-independent group 3 enhancer GRCh37_chr6:26704795-26705994 | 6 | 26704566 | 26705765 | Human |
2300566 | TRA-AGC13-1 | tRNA-Ala (anticodon AGC) 13-1 | 6 | 26705377 | 26705449 | Human |
151675732 | TRNAA-AGC | transfer RNA alanine (anticodon AGC) | 6 | 26705377 | 26705449 | Human |
21076087 | TRI-AAT7-1 | tRNA-Ile (anticodon AAT) 7-1 | 6 | 26720992 | 26721065 | Human |
155654833 | LOC127405597 | H3K4me1 hESC enhancer GRCh37_chr6:26778725-26779226 | 6 | 26722671 | 26723172 | Human |
2300821 | TRA-AGC9-1 | tRNA-Ala (anticodon AGC) 9-1 | 6 | 26730534 | 26730606 | Human |
2300877 | TRM-CAT4-1 | tRNA-Met (anticodon CAT) 4-1 | 6 | 26735370 | 26735442 | Human |
2300623 | TRM-CAT4-2 | tRNA-Met (anticodon CAT) 4-2 | 6 | 26743263 | 26743335 | Human |
8663190 | TRUND-NNN1-1 | tRNA-undetermined (NNN) 1-1 | 6 | 26749199 | 26749272 | Human |
2300605 | TRI-AAT6-1 | tRNA-Ile (anticodon AAT) 6-1 | 6 | 26756552 | 26756625 | Human |
2300586 | TRM-CAT4-3 | tRNA-Met (anticodon CAT) 4-3 | 6 | 26766234 | 26766306 | Human |
151675458 | TRNAA-AGC | transfer RNA alanine (anticodon AGC) | 6 | 26771080 | 26771152 | Human |
2300576 | TRI-AAT7-2 | tRNA-Ile (anticodon AAT) 7-2 | 6 | 26780622 | 26780695 | Human |
38657078 | LOC105374992 | uncharacterized LOC105374992 | 6 | 26781146 | 26803584 | Human |
151668741 | LOC124901289 | uncharacterized LOC124901289 | 6 | 26787593 | 26794826 | Human |
2300566 | TRA-AGC13-1 | tRNA-Ala (anticodon AGC) 13-1 | 6 | 26796209 | 26796281 | Human |
151672577 | TRNAA-AGC | transfer RNA alanine (anticodon AGC) | 6 | 26796209 | 26796281 | Human |
15041155 | TRM-CAT5-2 | tRNA-Met (anticodon CAT) 5-2 | 6 | 26800113 | 26800185 | Human |
153305934 | LOC126088087 | MED14-independent group 3 enhancer GRCh37_chr6:26686676-26687875 duplicate 2 | 6 | 26813897 | 26815220 | Human |
151671974 | TRNAA-AGC | transfer RNA alanine (anticodon AGC) | 6 | 26814339 | 26814411 | Human |
151672203 | LOC124901290 | uncharacterized LOC124901290 | 6 | 26815127 | 26842925 | Human |
151672587 | TRNAA-AGC | transfer RNA alanine (anticodon AGC) | 6 | 26819109 | 26819181 | Human |
19165162 | TRA-AGC14-2 | tRNA-Ala (anticodon AGC) 14-2 | 6 | 26828227 | 26828299 | Human |
1344633 | POM121L6P | POM121 transmembrane nucleoporin like 6, pseudogene | 6 | 26870667 | 26898161 | Human |
1604454 | GUSBP2 | GUSB pseudogene 2 | 6 | 26871487 | 26956554 | Human |
329343244 | LOC129661681 | ReSE screen-validated silencer GRCh37_chr6:26845091-26845270 | 6 | 26877312 | 26877491 | Human |
155650419 | LOC127405598 | H3K27ac hESC enhancer GRCh37_chr6:26853600-26854455 | 6 | 26885821 | 26886676 | Human |
155648639 | LOC127405599 | NANOG hESC enhancer GRCh37_chr6:26876271-26876881 | 6 | 26908492 | 26909102 | Human |
155650296 | LOC127405600 | H3K27ac hESC enhancer GRCh37_chr6:26924432-26925130 | 6 | 26956546 | 26957351 | Human |
1347530 | LINC00240 | long intergenic non-protein coding RNA 240 | 6 | 26956993 | 27023974 | Human |
38620254 | LARRPM | LINC00240 antisense RNA regulating promoter methylation | 6 | 27019366 | 27020306 | Human |
329816503 | LOC129996074 | ATAC-STARR-seq lymphoblastoid active region 24256 | 6 | 27020051 | 27020310 | Human |
2300949 | TRI-TAT2-2 | tRNA-Ile (anticodon TAT) 2-2 | 6 | 27020346 | 27020439 | Human |
1348597 | VN1R12P | vomeronasal 1 receptor 12, pseudogene | 6 | 27033346 | 27034343 | Human |
329829688 | LOC129996075 | ATAC-STARR-seq lymphoblastoid active region 24257 | 6 | 27052418 | 27052467 | Human |
329817102 | LOC129996076 | ATAC-STARR-seq lymphoblastoid active region 24258 | 6 | 27052538 | 27052757 | Human |
1348444 | VN1R13P | vomeronasal 1 receptor 13 pseudogene | 6 | 27060370 | 27061267 | Human |
329841871 | LOC129996077 | ATAC-STARR-seq lymphoblastoid silent region 17017 | 6 | 27078756 | 27078835 | Human |
1342547 | VN1R11P | vomeronasal 1 receptor 11, pseudogene | 6 | 27083292 | 27084216 | Human |
2300805 | TRP-CGG2-1 | tRNA-Pro (anticodon CGG) 2-1 | 6 | 27091742 | 27091813 | Human |
329815802 | LOC129996078 | ATAC-STARR-seq lymphoblastoid silent region 17018 | 6 | 27091890 | 27091939 | Human |
2300820 | TRS-GCT1-1 | tRNA-Ser (anticodon GCT) 1-1 | 6 | 27097306 | 27097387 | Human |
10399891 | RNU2-62P | RNA, U2 small nuclear 62, pseudogene | 6 | 27109790 | 27109980 | Human |
329835573 | LOC129996079 | ATAC-STARR-seq lymphoblastoid active region 24259 | 6 | 27115211 | 27115310 | Human |
329844123 | LOC129996080 | ATAC-STARR-seq lymphoblastoid active region 24260 | 6 | 27127047 | 27127096 | Human |
329832953 | LOC129996081 | ATAC-STARR-seq lymphoblastoid active region 24261 | 6 | 27127307 | 27127376 | Human |
329842461 | LOC129996082 | ATAC-STARR-seq lymphoblastoid active region 24262 | 6 | 27128399 | 27128558 | Human |
329827385 | LOC129996083 | ATAC-STARR-seq lymphoblastoid active region 24263 | 6 | 27132015 | 27132074 | Human |
1348596 | H2BC11 | H2B clustered histone 11 | 6 | 27132316 | 27132795 | Human |
329820482 | LOC129996084 | ATAC-STARR-seq lymphoblastoid active region 24264 | 6 | 27132415 | 27132484 | Human |
329842458 | LOC129996085 | ATAC-STARR-seq lymphoblastoid active region 24265 | 6 | 27132495 | 27132564 | Human |
155653064 | LOC127405601 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27100475-27100988 | 6 | 27132696 | 27133209 | Human |
1344301 | H2AC11 | H2A clustered histone 11 | 6 | 27133043 | 27133535 | Human |
155649137 | LOC127405602 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27100989-27101504 | 6 | 27133175 | 27133725 | Human |
1353528 | H2BC12 | H2B clustered histone 12 | 6 | 27138293 | 27146858 | Human |
155647807 | LOC127405603 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27107017-27107609 | 6 | 27139096 | 27139830 | Human |
1342673 | H4C9 | H4 clustered histone 9 | 6 | 27139282 | 27139678 | Human |
155654428 | LOC127405604 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27107610-27108201 | 6 | 27139831 | 27140422 | Human |
329833727 | LOC129996086 | ATAC-STARR-seq lymphoblastoid active region 24268 | 6 | 27145753 | 27145862 | Human |
155661336 | LOC127405605 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27114061-27114977 | 6 | 27146282 | 27147198 | Human |
1349795 | H2AC12 | H2A clustered histone 12 | 6 | 27147106 | 27147562 | Human |
329836876 | LOC129996087 | ATAC-STARR-seq lymphoblastoid active region 24270 | 6 | 27147243 | 27147492 | Human |
4109918 | MIR3143 | microRNA 3143 | 6 | 27147626 | 27147688 | Human |
329824669 | LOC129996088 | ATAC-STARR-seq lymphoblastoid silent region 17019 | 6 | 27149272 | 27149321 | Human |
2300781 | TRV-CAC9-1 | tRNA-Val (anticodon CAC) 9-1 | 6 | 27150243 | 27150315 | Human |
2300990 | TRH-GTG1-5 | tRNA-His (anticodon GTG) 1-5 | 6 | 27158127 | 27158198 | Human |
329819906 | LOC129996089 | ATAC-STARR-seq lymphoblastoid silent region 17020 | 6 | 27158238 | 27158287 | Human |
2300834 | TRT-AGT6-1 | tRNA-Thr (anticodon AGT) 6-1 | 6 | 27162271 | 27162344 | Human |
38671349 | LOC116183045 | CRISPRi-validated cis-regulatory element chr6.1219 | 6 | 27177127 | 27178204 | Human |
2300641 | TRI-AAT5-2 | tRNA-Ile (anticodon AAT) 5-2 | 6 | 27177215 | 27177288 | Human |
329826340 | LOC129996090 | ATAC-STARR-seq lymphoblastoid active region 24273 | 6 | 27178386 | 27178445 | Human |
38659157 | LOC116183046 | CRISPRi-validated cis-regulatory element chr6.1221 | 6 | 27188342 | 27189228 | Human |
2300609 | TRV-CAC6-1 | tRNA-Val (anticodon CAC) 6-1 | 6 | 27206088 | 27206160 | Human |
2300936 | TRS-CGA2-1 | tRNA-Ser (anticodon CGA) 2-1 | 6 | 27209849 | 27209930 | Human |
1342477 | RPL10P2 | ribosomal protein L10 pseudogene 2 | 6 | 27211203 | 27211941 | Human |
2300810 | TRR-ACG2-2 | tRNA-Arg (anticodon ACG) 2-2 | 6 | 27213844 | 27213916 | Human |
155660803 | LOC127405606 | H3K4me1 hESC enhancer GRCh37_chr6:27182922-27183422 | 6 | 27215143 | 27215643 | Human |
2300878 | TRR-ACG2-3 | tRNA-Arg (anticodon ACG) 2-3 | 6 | 27215173 | 27215245 | Human |
151672500 | LOC124901293 | uncharacterized LOC124901293 | 6 | 27217666 | 27218761 | Human |
329827197 | LOC129996091 | ATAC-STARR-seq lymphoblastoid active region 24274 | 6 | 27224904 | 27224963 | Human |
2300910 | TRL-TAA4-1 | tRNA-Leu (anticodon TAA) 4-1 | 6 | 27230555 | 27230637 | Human |
329821972 | LOC129996092 | ATAC-STARR-seq lymphoblastoid silent region 17022 | 6 | 27235473 | 27235522 | Human |
2300963 | TRV-AAC5-1 | tRNA-Val (anticodon AAC) 5-1 | 6 | 27235509 | 27235581 | Human |
329816003 | LOC129996093 | ATAC-STARR-seq lymphoblastoid silent region 17023 | 6 | 27235533 | 27235582 | Human |
329823801 | LOC129996094 | ATAC-STARR-seq lymphoblastoid active region 24275 | 6 | 27237341 | 27237420 | Human |
2300667 | TRI-AAT5-3 | tRNA-Ile (anticodon AAT) 5-3 | 6 | 27237571 | 27237644 | Human |
155659623 | LOC127405607 | H3K27ac hESC enhancer GRCh37_chr6:27206036-27206536 | 6 | 27238257 | 27238757 | Human |
1315387 | PRSS16 | serine protease 16 | 6 | 27247701 | 27256620 | Human |
329837930 | LOC129996095 | ATAC-STARR-seq lymphoblastoid active region 24277 | 6 | 27250752 | 27250801 | Human |
329819876 | LOC129996096 | ATAC-STARR-seq lymphoblastoid active region 24278 | 6 | 27250932 | 27251001 | Human |
329839885 | LOC129996097 | ATAC-STARR-seq lymphoblastoid active region 24279 | 6 | 27251142 | 27251511 | Human |
155650395 | LOC127405608 | H3K27ac hESC enhancer GRCh37_chr6:27219561-27220081 | 6 | 27251782 | 27252302 | Human |
16565737 | CDCA7P1 | CDCA7 pseudogene 1 | 6 | 27268012 | 27269362 | Human |
1351110 | TRI-AAT9-1 | tRNA-Ile (anticodon AAT) 9-1 | 6 | 27273960 | 27274033 | Human |
2300764 | TRI-AAT3-1 | tRNA-Ile (anticodon AAT) 3-1 | 6 | 27275211 | 27275284 | Human |
329344280 | LOC129661682 | ReSE screen-validated silencer GRCh37_chr6:27244261-27244431 | 6 | 27276482 | 27276652 | Human |
329338810 | LOC129661683 | ReSE screen-validated silencer GRCh37_chr6:27247245-27247471 | 6 | 27279466 | 27279692 | Human |
2300614 | TRV-CAC2-1 | tRNA-Val (anticodon CAC) 2-1 | 6 | 27280270 | 27280342 | Human |
2300515 | TRI-AAT10-1 | tRNA-Ile (anticodon AAT) 10-1 | 6 | 27284085 | 27284158 | Human |
2300569 | TRV-TAC4-1 | tRNA-Val (anticodon TAC) 4-1 | 6 | 27290626 | 27290698 | Human |
155652649 | LOC127405609 | H3K4me1 hESC enhancer GRCh37_chr6:27258990-27259635 | 6 | 27291211 | 27291856 | Human |
2300451 | TRS-ACT1-1 | tRNA-Ser (anticodon ACT) 1-1 | 6 | 27293892 | 27293965 | Human |
2300648 | TRQ-CTG5-1 | tRNA-Gln (anticodon CTG) 5-1 | 6 | 27295433 | 27295504 | Human |
2300975 | TRS-GCT2-1 | tRNA-Ser (anticodon GCT) 2-1 | 6 | 27297996 | 27298077 | Human |
1343533 | POM121L2 | POM121 transmembrane nucleoporin like 2 | 6 | 27308377 | 27312273 | Human |
38632960 | LOC105375107 | uncharacterized LOC105375107 | 6 | 27312169 | 27313736 | Human |
150537091 | LOC123620073 | Sharpr-MPRA regulatory region 151 | 6 | 27312330 | 27312624 | Human |
1352823 | VN1R10P | vomeronasal 1 receptor 10 pseudogene | 6 | 27324761 | 27325963 | Human |
329840968 | LOC129996098 | ATAC-STARR-seq lymphoblastoid silent region 17024 | 6 | 27332981 | 27333060 | Human |
2300632 | TRX-CAT1-5 | tRNA-iMet (anticodon CAT) 1-5 | 6 | 27332985 | 27333056 | Human |
2300795 | TRK-TTT6-1 | tRNA-Lys (anticodon TTT) 6-1 | 6 | 27334990 | 27335062 | Human |
1347057 | ZNF204P | zinc finger protein 204, pseudogene | 6 | 27357823 | 27375374 | Human |
155662060 | LOC127405610 | H3K4me1 hESC enhancer GRCh37_chr6:27335298-27335798 | 6 | 27367519 | 27368019 | Human |
155656515 | LOC127405611 | H3K4me1 hESC enhancer GRCh37_chr6:27335799-27336299 | 6 | 27368020 | 27368520 | Human |
329341278 | LOC129661684 | ReSE screen-validated silencer GRCh37_chr6:27340678-27340840 | 6 | 27372899 | 27373061 | Human |
1606101 | ZNF391 | zinc finger protein 391 | 6 | 27374615 | 27403908 | Human |
329813228 | LOC129996099 | ATAC-STARR-seq lymphoblastoid active region 24282 | 6 | 27375020 | 27375089 | Human |
155651408 | LOC127405612 | OCT4-NANOG hESC enhancer GRCh37_chr6:27346083-27346611 | 6 | 27378304 | 27378832 | Human |
1312451 | ZNF184 | zinc finger protein 184 | 6 | 27404006 | 27473105 | Human |
1346657 | MCFD2P1 | multiple coagulation factor deficiency 2 pseudogene 1 | 6 | 27407697 | 27409691 | Human |
329342259 | LOC129389480 | MPRA-validated peak5742 silencer | 6 | 27451756 | 27451956 | Human |
329338432 | LOC129389481 | MPRA-validated peak5743 silencer | 6 | 27452516 | 27452716 | Human |
329836258 | LOC129996100 | ATAC-STARR-seq lymphoblastoid active region 24283 | 6 | 27472227 | 27472356 | Human |
329844579 | LOC129996101 | ATAC-STARR-seq lymphoblastoid active region 24284 | 6 | 27472687 | 27472776 | Human |
329829028 | LOC129996102 | ATAC-STARR-seq lymphoblastoid active region 24285 | 6 | 27472797 | 27472896 | Human |
329815695 | LOC129996103 | ATAC-STARR-seq lymphoblastoid active region 24286 | 6 | 27472957 | 27473116 | Human |
38669081 | LOC105375001 | uncharacterized LOC105375001 | 6 | 27473124 | 27475980 | Human |
2300900 | TRS-AGA2-2 | tRNA-Ser (anticodon AGA) 2-2 | 6 | 27478812 | 27478893 | Human |
2300819 | TRD-GTC2-6 | tRNA-Asp (anticodon GTC) 2-6 | 6 | 27479674 | 27479745 | Human |
329834908 | LOC129996104 | ATAC-STARR-seq lymphoblastoid silent region 17025 | 6 | 27479727 | 27479786 | Human |
329817710 | LOC129996105 | ATAC-STARR-seq lymphoblastoid silent region 17026 | 6 | 27495785 | 27495984 | Human |
1342551 | TRS-AGA2-3 | tRNA-Ser (anticodon AGA) 2-3 | 6 | 27495814 | 27495895 | Human |
155653913 | LOC127405613 | H3K27ac hESC enhancer GRCh37_chr6:27464009-27464509 | 6 | 27496230 | 27496730 | Human |
329821531 | LOC129996106 | ATAC-STARR-seq lymphoblastoid active region 24287 | 6 | 27502450 | 27502729 | Human |
329823575 | LOC129996107 | ATAC-STARR-seq lymphoblastoid active region 24288 | 6 | 27502910 | 27502959 | Human |
2300730 | TRS-AGA2-4 | tRNA-Ser (anticodon AGA) 2-4 | 6 | 27503039 | 27503120 | Human |
2300685 | TRD-GTC2-7 | tRNA-Asp (anticodon GTC) 2-7 | 6 | 27503744 | 27503815 | Human |
329837256 | LOC129996108 | ATAC-STARR-seq lymphoblastoid silent region 17027 | 6 | 27503760 | 27503879 | Human |
329825018 | LOC129996109 | ATAC-STARR-seq lymphoblastoid active region 24289 | 6 | 27505642 | 27505721 | Human |
1351968 | TRS-TGA4-1 | tRNA-Ser (anticodon TGA) 4-1 | 6 | 27505828 | 27505909 | Human |
329337512 | LOC129661685 | ReSE screen-validated silencer GRCh37_chr6:27473611-27474042 | 6 | 27505832 | 27506263 | Human |
329826861 | LOC129996110 | ATAC-STARR-seq lymphoblastoid active region 24290 | 6 | 27518882 | 27519171 | Human |
2300788 | TRQ-CTG1-2 | tRNA-Gln (anticodon CTG) 1-2 | 6 | 27519529 | 27519600 | Human |
329827524 | LOC129996111 | ATAC-STARR-seq lymphoblastoid silent region 17029 | 6 | 27519562 | 27519611 | Human |
1351717 | HNRNPA1P1 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 1 | 6 | 27523447 | 27524537 | Human |
1605442 | TRS-AGA3-1 | tRNA-Ser (anticodon AGA) 3-1 | 6 | 27532208 | 27532289 | Human |
2300625 | TRS-AGA1-1 | tRNA-Ser (anticodon AGA) 1-1 | 6 | 27541775 | 27541856 | Human |
329833815 | LOC129996112 | ATAC-STARR-seq lymphoblastoid silent region 17030 | 6 | 27541834 | 27541883 | Human |
329823974 | LOC129996113 | ATAC-STARR-seq lymphoblastoid active region 24291 | 6 | 27545397 | 27545536 | Human |
329832987 | LOC129996114 | ATAC-STARR-seq lymphoblastoid active region 24292 | 6 | 27545557 | 27545606 | Human |
1348651 | TRS-TGA2-1 | tRNA-Ser (anticodon TGA) 2-1 | 6 | 27545689 | 27545770 | Human |
329822985 | LOC129996115 | ATAC-STARR-seq lymphoblastoid silent region 17031 | 6 | 27545707 | 27545836 | Human |
2300709 | TRQ-CTG2-1 | tRNA-Gln (anticodon CTG) 2-1 | 6 | 27547752 | 27547823 | Human |
2300907 | TRS-AGA4-1 | tRNA-Ser (anticodon AGA) 4-1 | 6 | 27553413 | 27553494 | Human |
329340254 | LOC129661686 | ReSE screen-validated silencer GRCh37_chr6:27525659-27525858 | 6 | 27557880 | 27558079 | Human |
1352472 | CD83P1 | CD83 molecule pseudogene 1 | 6 | 27560631 | 27561752 | Human |
150537050 | LOC123620074 | Sharpr-MPRA regulatory region 7994 | 6 | 27562070 | 27562364 | Human |
2300965 | TRR-TCT5-1 | tRNA-Arg (anticodon TCT) 5-1 | 6 | 27562184 | 27562270 | Human |
329843743 | LOC129996116 | ATAC-STARR-seq lymphoblastoid active region 24293 | 6 | 27565856 | 27565905 | Human |
329818835 | LOC129996117 | ATAC-STARR-seq lymphoblastoid active region 24294 | 6 | 27565936 | 27566095 | Human |
2300587 | TRK-TTT9-1 | tRNA-Lys (TTT) 9-1 | 6 | 27576067 | 27576139 | Human |
2300777 | TRD-GTC3-1 | tRNA-Asp (anticodon GTC) 3-1 | 6 | 27583457 | 27583528 | Human |
2300924 | TRK-TTT4-1 | tRNA-Lys (anticodon TTT) 4-1 | 6 | 27591814 | 27591886 | Human |
329823720 | LOC129996118 | ATAC-STARR-seq lymphoblastoid active region 24295 | 6 | 27592407 | 27592616 | Human |
150537082 | LOC123620075 | Sharpr-MPRA regulatory region 6095 | 6 | 27592590 | 27592946 | Human |
2300680 | TRX-CAT1-6 | tRNA-iMet (anticodon CAT) 1-6 | 6 | 27592821 | 27592892 | Human |
150537071 | LOC123620076 | Sharpr-MPRA regulatory region 11926 | 6 | 27594350 | 27594644 | Human |
10400256 | RNU6-471P | RNA, U6 small nuclear 471, pseudogene | 6 | 27596412 | 27596517 | Human |
38611226 | LOC116183047 | CRISPRi-validated cis-regulatory element chr6.1269 | 6 | 27600519 | 27600691 | Human |
155647139 | LOC127405614 | NANOG-H3K4me1 hESC enhancer GRCh37_chr6:27569374-27569874 | 6 | 27601595 | 27602095 | Human |
2300939 | TRL-CAA3-1 | tRNA-Leu (anticodon CAA) 3-1 | 6 | 27602569 | 27602675 | Human |
2300676 | TRL-CAA2-1 | tRNA-Leu (anticodon CAA) 2-1 | 6 | 27605638 | 27605745 | Human |
2300677 | TRT-CGT5-1 | tRNA-Thr (anticodon CGT) 5-1 | 6 | 27618356 | 27618429 | Human |
329829555 | LOC129996119 | ATAC-STARR-seq lymphoblastoid active region 24296 | 6 | 27624957 | 27625006 | Human |
2300846 | TRI-TAT2-3 | tRNA-Ile (anticodon TAT) 2-3 | 6 | 27631421 | 27631514 | Human |
329823004 | LOC129996120 | ATAC-STARR-seq lymphoblastoid active region 24297 | 6 | 27631562 | 27631631 | Human |
155655926 | LOC127405615 | H3K4me1 hESC enhancer GRCh37_chr6:27610387-27611160 | 6 | 27642608 | 27643381 | Human |
126781800 | LOC121132674 | Sharpr-MPRA regulatory region 3569 | 6 | 27650790 | 27651084 | Human |
1604661 | TRV-AAC3-1 | tRNA-Val (anticodon AAC) 3-1 | 6 | 27650928 | 27651000 | Human |
1349022 | RPL8P1 | ribosomal protein L8 pseudogene 1 | 6 | 27652591 | 27652733 | Human |
151672026 | LOC124901292 | uncharacterized LOC124901292 | 6 | 27666972 | 27668573 | Human |
38651012 | LOC116183048 | CRISPRi-validated cis-regulatory element chr6.1279 | 6 | 27668441 | 27668959 | Human |
2300882 | TRI-AAT8-1 | tRNA-Ile (anticodon AAT) 8-1 | 6 | 27668583 | 27668656 | Human |
150537054 | LOC123620077 | Sharpr-MPRA regulatory region 12122 | 6 | 27669770 | 27670064 | Human |
2300549 | TRR-ACG2-4 | tRNA-Arg (anticodon ACG) 2-4 | 6 | 27670565 | 27670637 | Human |
2300772 | TRS-CGA3-1 | tRNA-Ser (anticodon CGA) 3-1 | 6 | 27672450 | 27672531 | Human |
155649955 | LOC127405616 | H3K4me1 hESC enhancer GRCh37_chr6:27646365-27646866 | 6 | 27678586 | 27679087 | Human |
2300816 | TRV-AAC4-1 | tRNA-Val (anticodon AAC) 4-1 | 6 | 27681106 | 27681178 | Human |
329838000 | LOC129996121 | ATAC-STARR-seq lymphoblastoid silent region 17035 | 6 | 27681109 | 27681188 | Human |
329830625 | LOC129996122 | ATAC-STARR-seq lymphoblastoid silent region 17036 | 6 | 27684651 | 27684790 | Human |
2300637 | TRT-AGT2-2 | tRNA-Thr (anticodon AGT) 2-2 | 6 | 27684695 | 27684768 | Human |
38647847 | LOC116183049 | CRISPRi-validated cis-regulatory element chr6.1284 | 6 | 27687274 | 27688662 | Human |
2300906 | TRI-AAT2-1 | tRNA-Ile (anticodon AAT) 2-1 | 6 | 27688188 | 27688261 | Human |
7247871 | LINC01012 | long intergenic non-protein coding RNA 1012 | 6 | 27694035 | 27710222 | Human |
151674455 | LOC124901291 | uncharacterized LOC124901291 | 6 | 27703135 | 27710896 | Human |
329830149 | LOC129996123 | ATAC-STARR-seq lymphoblastoid active region 24299 | 6 | 27719251 | 27719330 | Human |
2300813 | TRL-TAA2-1 | tRNA-Leu (anticodon TAA) 2-1 | 6 | 27721119 | 27721201 | Human |
329818336 | LOC129996124 | ATAC-STARR-seq lymphoblastoid active region 24300 | 6 | 27721366 | 27721435 | Human |
2300603 | TRT-AGT4-1 | tRNA-Thr (anticodon AGT) 4-1 | 6 | 27726694 | 27726767 | Human |
2300876 | TRV-CAC7-1 | tRNA-Val (CAC) 7-1 | 6 | 27728548 | 27728620 | Human |
1346240 | GPR89P | G protein-coupled receptor 89 pseudogene | 6 | 27736575 | 27738514 | Human |
155228829 | LOC126859631 | BRD4-independent group 4 enhancer GRCh37_chr6:27705353-27706552 | 6 | 27737574 | 27738773 | Human |
329843812 | LOC129996125 | ATAC-STARR-seq lymphoblastoid active region 24303 | 6 | 27746998 | 27747077 | Human |
329834907 | LOC129996126 | ATAC-STARR-seq lymphoblastoid active region 24304 | 6 | 27752666 | 27752725 | Human |
329839625 | LOC129996127 | ATAC-STARR-seq lymphoblastoid active region 24305 | 6 | 27752896 | 27752985 | Human |
1604662 | TRV-AAC1-5 | tRNA-Val (anticodon AAC) 1-5 | 6 | 27753400 | 27753472 | Human |
329816743 | LOC129996128 | ATAC-STARR-seq lymphoblastoid silent region 17038 | 6 | 27753436 | 27753575 | Human |
38600525 | LOC100131289 | uncharacterized LOC100131289 | 6 | 27761744 | 27763187 | Human |
155659789 | LOC127405617 | OCT4-NANOG hESC enhancer GRCh37_chr6:27738157-27738797 | 6 | 27770378 | 27771018 | Human |
155652968 | LOC127405618 | OCT4-NANOG hESC enhancer GRCh37_chr6:27738798-27739437 | 6 | 27771019 | 27771658 | Human |
329842587 | LOC129996129 | ATAC-STARR-seq lymphoblastoid silent region 17039 | 6 | 27777883 | 27777942 | Human |
1346477 | TRX-CAT2-1 | tRNA-iMet (anticodon CAT) 2-1 | 6 | 27777885 | 27777956 | Human |
1349992 | RSL24D1P1 | ribosomal L24 domain containing 1 pseudogene 1 | 6 | 27780483 | 27781157 | Human |
329813460 | LOC129996130 | ATAC-STARR-seq lymphoblastoid silent region 17040 | 6 | 27791305 | 27791474 | Human |
2300763 | TRQ-CTG6-1 | tRNA-Gln (anticodon CTG) 6-1 | 6 | 27791356 | 27791427 | Human |
329831253 | LOC129996131 | ATAC-STARR-seq lymphoblastoid silent region 17041 | 6 | 27792697 | 27792776 | Human |
329825104 | LOC129996132 | ATAC-STARR-seq lymphoblastoid active region 24306 | 6 | 27793007 | 27793076 | Human |
2300903 | TRQ-TTG3-3 | tRNA-Gln (anticodon TTG) 3-3 | 6 | 27795861 | 27795932 | Human |
155652708 | LOC127405619 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27774412-27775012 | 6 | 27806634 | 27807234 | Human |
1348139 | H4C10P | H4 clustered histone 10, pseudogene | 6 | 27807167 | 27807337 | Human |
155649761 | LOC127405620 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27775013-27775612 | 6 | 27807235 | 27807976 | Human |
1316667 | H2BC13 | H2B clustered histone 13 | 6 | 27807479 | 27807929 | Human |
1346479 | H2AC13 | H2A clustered histone 13 | 6 | 27808173 | 27808667 | Human |
155661298 | LOC127405621 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27776213-27776811 | 6 | 27808317 | 27809033 | Human |
155653162 | LOC127405622 | H3K27ac hESC enhancer GRCh37_chr6:27777495-27778166 | 6 | 27809717 | 27810388 | Human |
1345148 | H3C10 | H3 clustered histone 10 | 6 | 27810051 | 27810536 | Human |
155647513 | LOC127405623 | H3K27ac hESC enhancer GRCh37_chr6:27778167-27778838 | 6 | 27810389 | 27811060 | Human |
1342935 | H2AC14 | H2A clustered histone 14 | 6 | 27814302 | 27814777 | Human |
329839380 | LOC129996133 | ATAC-STARR-seq lymphoblastoid active region 24311 | 6 | 27814411 | 27814560 | Human |
1346747 | H2BC14 | H2B clustered histone 14 | 6 | 27815022 | 27815489 | Human |
329829698 | LOC129996134 | ATAC-STARR-seq lymphoblastoid active region 24312 | 6 | 27815251 | 27815370 | Human |
329833059 | LOC129996135 | ATAC-STARR-seq lymphoblastoid active region 24313 | 6 | 27815481 | 27815540 | Human |
329820815 | LOC129996136 | ATAC-STARR-seq lymphoblastoid active region 24314 | 6 | 27815631 | 27815680 | Human |
329818779 | LOC129996137 | ATAC-STARR-seq lymphoblastoid active region 24315 | 6 | 27823812 | 27823951 | Human |
1315785 | H4C11 | H4 clustered histone 11 | 6 | 27824092 | 27824480 | Human |
155655497 | LOC127405624 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27792023-27792664 | 6 | 27824245 | 27824886 | Human |
155653687 | LOC127405625 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:27793307-27793948 | 6 | 27825529 | 27826170 | Human |
155658674 | LOC127405626 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:27793949-27794592 | 6 | 27826171 | 27826814 | Human |
155654100 | LOC127405627 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27795877-27796518 | 6 | 27828099 | 27828740 | Human |
155657641 | LOC127405628 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27798822-27799647 | 6 | 27831011 | 27831869 | Human |
1349552 | H4C12 | H4 clustered histone 12 | 6 | 27831174 | 27831560 | Human |
155657808 | LOC127405629 | H3K27ac hESC enhancer GRCh37_chr6:27804283-27805220 | 6 | 27836505 | 27837442 | Human |
329833246 | LOC129996138 | ATAC-STARR-seq lymphoblastoid active region 24318 | 6 | 27837531 | 27837620 | Human |
329820554 | LOC129996139 | ATAC-STARR-seq lymphoblastoid active region 24319 | 6 | 27837691 | 27837740 | Human |
1312612 | H2AC15 | H2A clustered histone 15 | 6 | 27837880 | 27838375 | Human |
329821361 | LOC129996140 | ATAC-STARR-seq lymphoblastoid active region 24320 | 6 | 27838011 | 27838120 | Human |
329826959 | LOC129996141 | ATAC-STARR-seq lymphoblastoid active region 24321 | 6 | 27838191 | 27838280 | Human |
1317658 | H2BC15 | H2B clustered histone 15 | 6 | 27838569 | 27839110 | Human |
329817416 | LOC129996142 | ATAC-STARR-seq lymphoblastoid active region 24322 | 6 | 27838611 | 27838820 | Human |
329822141 | LOC129996143 | ATAC-STARR-seq lymphoblastoid active region 24323 | 6 | 27839651 | 27839850 | Human |
1348661 | H2BC16P | H2B clustered histone 16, pseudogene | 6 | 27864062 | 27864401 | Human |
329821006 | LOC129996144 | ATAC-STARR-seq lymphoblastoid active region 24324 | 6 | 27864098 | 27864277 | Human |
329836804 | LOC129996145 | ATAC-STARR-seq lymphoblastoid active region 24325 | 6 | 27864938 | 27865007 | Human |
329815865 | LOC129996146 | ATAC-STARR-seq lymphoblastoid active region 24326 | 6 | 27865068 | 27865137 | Human |
1319217 | H2AC16 | H2A clustered histone 16 | 6 | 27865317 | 27865798 | Human |
155662309 | LOC127405630 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27833113-27833634 | 6 | 27865335 | 27865856 | Human |
1351111 | H1-5 | H1.5 linker histone, cluster member | 6 | 27866792 | 27867588 | Human |
329824426 | LOC129996147 | ATAC-STARR-seq lymphoblastoid active region 24329 | 6 | 27867408 | 27867517 | Human |
329839487 | LOC129996148 | ATAC-STARR-seq lymphoblastoid active region 24330 | 6 | 27867778 | 27867847 | Human |
155646990 | LOC127405631 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27837681-27838320 | 6 | 27869903 | 27870542 | Human |
155648746 | LOC127405632 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27838321-27838958 | 6 | 27870543 | 27871180 | Human |
1322682 | H3C11 | H3 clustered histone 11 | 6 | 27871845 | 27872346 | Human |
155660608 | LOC127405633 | H3K27ac hESC enhancer GRCh37_chr6:27840874-27841511 | 6 | 27873096 | 27873733 | Human |
1318739 | H4C13 | H4 clustered histone 13 | 6 | 27873148 | 27873534 | Human |
329838695 | LOC129996149 | ATAC-STARR-seq lymphoblastoid active region 24333 | 6 | 27873765 | 27873814 | Human |
1344045 | HCG13P | HLA complex group 13 pseudogene | 6 | 27878594 | 27878818 | Human |
155648486 | LOC127405634 | H3K27ac hESC enhancer GRCh37_chr6:27856906-27857550 | 6 | 27889128 | 27889772 | Human |
155652516 | LOC127405635 | H3K27ac hESC enhancer GRCh37_chr6:27857551-27858195 | 6 | 27889773 | 27890417 | Human |
1349112 | H3C12 | H3 clustered histone 12 | 6 | 27890315 | 27890826 | Human |
155654059 | LOC127405636 | H3K27ac hESC enhancer GRCh37_chr6:27858196-27858840 | 6 | 27890418 | 27891062 | Human |
155653282 | LOC127405637 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27860089-27860632 | 6 | 27892311 | 27892854 | Human |
1323073 | H2AC17 | H2A clustered histone 17 | 6 | 27892699 | 27893185 | Human |
155650453 | LOC127405638 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:27860633-27861176 | 6 | 27892855 | 27893398 | Human |
329828218 | LOC129996150 | ATAC-STARR-seq lymphoblastoid active region 24337 | 6 | 27893419 | 27893658 | Human |
1343166 | H2BC17 | H2B clustered histone 17 | 6 | 27893425 | 27893891 | Human |
329827298 | LOC129996151 | ATAC-STARR-seq lymphoblastoid active region 24338 | 6 | 27894049 | 27894188 | Human |
329817173 | LOC129996152 | ATAC-STARR-seq lymphoblastoid active region 24339 | 6 | 27895071 | 27895120 | Human |
38619383 | LOC116183050 | CRISPRi-validated cis-regulatory element chr6.1313 | 6 | 27895524 | 27895808 | Human |
2293274 | RNU7-26P | RNA, U7 small nuclear 26 pseudogene | 6 | 27897506 | 27897565 | Human |
38617682 | LOC116183051 | CRISPRi-validated cis-regulatory element chr6.1314 | 6 | 27901846 | 27902104 | Human |
38636061 | LOC116183052 | CRISPRi-validated cis-regulatory element chr6.1315 | 6 | 27902330 | 27903402 | Human |
2300662 | TRX-CAT1-7 | tRNA-iMet (anticodon CAT) 1-7 | 6 | 27902493 | 27902564 | Human |
2300663 | TRG-GCC2-3 | tRNA-Gly (anticodon GCC) 2-3 | 6 | 27902908 | 27902978 | Human |
733998 | OR2B2 | olfactory receptor family 2 subfamily B member 2 | 6 | 27911185 | 27912396 | Human |
1349332 | OR2W6P | olfactory receptor family 2 subfamily W member 6 pseudogene | 6 | 27937404 | 27938401 | Human |
1346885 | OR2B6 | olfactory receptor family 2 subfamily B member 6 | 6 | 27957241 | 27958182 | Human |
1345554 | RPLP2P1 | ribosomal protein lateral stalk subunit P2 pseudogene 1 | 6 | 27965128 | 27965532 | Human |
329344158 | LOC129661687 | ReSE screen-validated silencer GRCh37_chr6:27934676-27934834 | 6 | 27966898 | 27967056 | Human |
1343741 | OR2W4P | olfactory receptor family 2 subfamily W member 4 pseudogene | 6 | 27977151 | 27978073 | Human |
329840416 | LOC129996153 | ATAC-STARR-seq lymphoblastoid active region 24340 | 6 | 28008274 | 28008343 | Human |
1343299 | IQCB2P | IQ motif containing B2 pseudogene | 6 | 28010551 | 28012902 | Human |
155227838 | LOC126859632 | BRD4-independent group 4 enhancer GRCh37_chr6:27982765-27983964 | 6 | 28014987 | 28016186 | Human |
16551071 | U3 | Small nucleolar RNA U3 | 6 | 28015568 | 28015777 | Human |
1351010 | OR2W2P | olfactory receptor family 2 subfamily W member 2 pseudogene | 6 | 28033915 | 28034862 | Human |
1344530 | OR2B7P | olfactory receptor family 2 subfamily B member 7 pseudogene | 6 | 28046435 | 28047369 | Human |
1346989 | OR2B8 | olfactory receptor family 2 subfamily B member 8 (gene/pseudogene) | 6 | 28053228 | 28054202 | Human |
1606624 | OR1F12P | olfactory receptor family 1 subfamily F member 12, pseudogene | 6 | 28073316 | 28074236 | Human |
329823239 | LOC129996154 | ATAC-STARR-seq lymphoblastoid active region 24341 | 6 | 28080024 | 28080093 | Human |
1342847 | ZNF165 | zinc finger protein 165 | 6 | 28080282 | 28089563 | Human |
329823444 | LOC129996155 | ATAC-STARR-seq lymphoblastoid active region 24342 | 6 | 28080894 | 28081013 | Human |
1345307 | ZSCAN12P1 | zinc finger and SCAN domain containing 12 pseudogene 1 | 6 | 28090807 | 28095715 | Human |
1346158 | ZNF601P | zinc finger protein 601, pseudogene | 6 | 28097111 | 28097369 | Human |
329825961 | LOC129996156 | ATAC-STARR-seq lymphoblastoid active region 24343 | 6 | 28105579 | 28105718 | Human |
329338740 | LOC129389482 | MPRA-validated peak5744 silencer | 6 | 28109177 | 28109377 | Human |
1349597 | ZNF602P | zinc finger protein 602, pseudogene | 6 | 28115649 | 28116220 | Human |
7248007 | ZSCAN16-AS1 | ZSCAN16 antisense RNA 1 | 6 | 28121795 | 28137316 | Human |
155656833 | LOC127405639 | H3K27ac hESC enhancer GRCh37_chr6:28092031-28092532 | 6 | 28124253 | 28124754 | Human |
1345084 | ZSCAN16 | zinc finger and SCAN domain containing 16 | 6 | 28124609 | 28130082 | Human |
329837782 | LOC129996157 | ATAC-STARR-seq lymphoblastoid active region 24344 | 6 | 28137487 | 28137676 | Human |
1319074 | ZKSCAN8 | zinc finger with KRAB and SCAN domains 8 | 6 | 28141635 | 28159460 | Human |
329819288 | LOC129996158 | ATAC-STARR-seq lymphoblastoid active region 24345 | 6 | 28141895 | 28142014 | Human |
329841034 | LOC129996159 | ATAC-STARR-seq lymphoblastoid active region 24346 | 6 | 28142025 | 28142144 | Human |
1347253 | ZKSCAN8P1 | ZKSCAN8 pseudogene 1 | 6 | 28161761 | 28169595 | Human |
329838552 | LOC129996160 | ATAC-STARR-seq lymphoblastoid active region 24347 | 6 | 28161804 | 28161853 | Human |
1346602 | ZNF603P | zinc finger protein 603, pseudogene | 6 | 28176188 | 28176674 | Human |
5490507 | ZKSCAN8P2 | ZKSCAN8 pseudogene 2 | 6 | 28187938 | 28189411 | Human |
155648720 | LOC127405640 | OCT4-NANOG hESC enhancer GRCh37_chr6:28180715-28181391 | 6 | 28212937 | 28213613 | Human |
2300818 | TRS-GCT5-1 | tRNA-Ser (anticodon GCT) 5-1 | 6 | 28213037 | 28213118 | Human |
1347878 | TOB2P1 | transducer of ERBB2, 2 pseudogene 1 | 6 | 28215338 | 28218929 | Human |
329338267 | LOC129661688 | ReSE screen-validated silencer GRCh37_chr6:28184762-28184955 | 6 | 28216984 | 28217177 | Human |
329842662 | LOC129996161 | ATAC-STARR-seq lymphoblastoid active region 24348 | 6 | 28218986 | 28219105 | Human |
329820180 | LOC129996162 | ATAC-STARR-seq lymphoblastoid active region 24349 | 6 | 28225080 | 28225179 | Human |
1347085 | ZSCAN9 | zinc finger and SCAN domain containing 9 | 6 | 28225240 | 28233487 | Human |
155657796 | LOC127405641 | OCT4-NANOG hESC enhancer GRCh37_chr6:28203630-28204444 | 6 | 28235852 | 28236666 | Human |
329814296 | LOC129996163 | ATAC-STARR-seq lymphoblastoid silent region 17042 | 6 | 28239858 | 28239937 | Human |
1319105 | ZKSCAN4 | zinc finger with KRAB and SCAN domains 4 | 6 | 28241697 | 28259211 | Human |
329829882 | LOC129996164 | ATAC-STARR-seq lymphoblastoid active region 24350 | 6 | 28251828 | 28251897 | Human |
329814670 | LOC129996165 | ATAC-STARR-seq lymphoblastoid active region 24351 | 6 | 28252028 | 28252077 | Human |
1323244 | NKAPL | NFKB activating protein like | 6 | 28259297 | 28260958 | Human |
329821987 | LOC129996166 | ATAC-STARR-seq lymphoblastoid silent region 17043 | 6 | 28259305 | 28259384 | Human |
329833801 | LOC129996167 | ATAC-STARR-seq lymphoblastoid active region 24352 | 6 | 28266981 | 28267040 | Human |
1345585 | ZSCAN26 | zinc finger and SCAN domain containing 26 | 6 | 28267143 | 28278204 | Human |
155654561 | LOC127405642 | H3K27ac hESC enhancer GRCh37_chr6:28234963-28235527 | 6 | 28267185 | 28267749 | Human |
1352422 | PGBD1 | piggyBac transposable element derived 1 | 6 | 28281572 | 28302549 | Human |
329816664 | LOC129996168 | ATAC-STARR-seq lymphoblastoid silent region 17044 | 6 | 28281603 | 28281752 | Human |
329341424 | LOC129661689 | ReSE screen-validated silencer GRCh37_chr6:28249721-28249897 | 6 | 28281944 | 28282120 | Human |
329337810 | LOC129661690 | ReSE screen-validated silencer GRCh37_chr6:28251848-28252055 | 6 | 28284071 | 28284278 | Human |
155656618 | LOC127405643 | H3K4me1 hESC enhancer GRCh37_chr6:28278749-28279250 | 6 | 28310972 | 28311473 | Human |
155658287 | LOC127405644 | H3K4me1 hESC enhancer GRCh37_chr6:28279251-28279750 | 6 | 28311474 | 28311973 | Human |
27095973 | SMIM15P2 | SMIM15 pseudogene 2 | 6 | 28319660 | 28319870 | Human |
1605639 | ZSCAN31 | zinc finger and SCAN domain containing 31 | 6 | 28324737 | 28356271 | Human |
329842621 | LOC129996169 | ATAC-STARR-seq lymphoblastoid active region 24353 | 6 | 28335694 | 28335813 | Human |
1313974 | ZKSCAN3 | zinc finger with KRAB and SCAN domains 3 | 6 | 28349878 | 28369172 | Human |
329831116 | LOC129996170 | ATAC-STARR-seq lymphoblastoid active region 24354 | 6 | 28349882 | 28350241 | Human |
155662193 | LOC127405645 | H3K4me1 hESC enhancer GRCh37_chr6:28321865-28322364 | 6 | 28354088 | 28354587 | Human |
329826309 | LOC129996171 | ATAC-STARR-seq lymphoblastoid active region 24355 | 6 | 28356065 | 28356134 | Human |
155650869 | LOC127405646 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28324191-28325095 | 6 | 28356414 | 28357318 | Human |
1346257 | ZSCAN12 | zinc finger and SCAN domain containing 12 | 6 | 28378821 | 28399747 | Human |
329835834 | LOC129996172 | ATAC-STARR-seq lymphoblastoid active region 24356 | 6 | 28383571 | 28383670 | Human |
329838081 | LOC129996173 | ATAC-STARR-seq lymphoblastoid silent region 17045 | 6 | 28398800 | 28398869 | Human |
38674816 | LOC105374998 | uncharacterized LOC105374998 | 6 | 28399819 | 28404283 | Human |
329818324 | LOC129996174 | ATAC-STARR-seq lymphoblastoid active region 24357 | 6 | 28399881 | 28400130 | Human |
6484651 | ZNF968P | zinc finger protein 968, pseudogene | 6 | 28408225 | 28409250 | Human |
10400051 | RNU2-45P | RNA, U2 small nuclear 45, pseudogene | 6 | 28410270 | 28410456 | Human |
155661993 | LOC127405647 | H3K4me1 hESC enhancer GRCh37_chr6:28384184-28384684 | 6 | 28416407 | 28416907 | Human |
155646900 | LOC127405648 | H3K4me1 hESC enhancer GRCh37_chr6:28384685-28385185 | 6 | 28416908 | 28417408 | Human |
1353335 | ZSCAN23 | zinc finger and SCAN domain containing 23 | 6 | 28421400 | 28443491 | Human |
155228761 | LOC126859633 | BRD4-independent group 4 enhancer GRCh37_chr6:28390954-28392153 | 6 | 28423177 | 28424376 | Human |
155647290 | LOC127405649 | H3K27ac hESC enhancer GRCh37_chr6:28411067-28411577 | 6 | 28443290 | 28443800 | Human |
1344168 | COX11P1 | COX11 pseudogene 1 | 6 | 28446920 | 28447630 | Human |
1345854 | OR2E1P | olfactory receptor family 2 subfamily E member 1 pseudogene | 6 | 28455530 | 28456157 | Human |
2300633 | TRT-TGT1-1 | tRNA-Thr (anticodon TGT) 1-1 | 6 | 28474552 | 28474625 | Human |
1354339 | TRNAL47P | transfer RNA leucine 47 (anticodon AAG) pseudogene | 6 | 28478573 | 28478654 | Human |
2300859 | TRL-AAG4-1 | tRNA-Leu (anticodon AAG) 4-1 | 6 | 28478623 | 28478704 | Human |
1346845 | TRMEP1 | tRNA methionine elongator pseudogene 1 | 6 | 28480726 | 28480798 | Human |
16572876 | LOC124901294 | uncharacterized LOC124901294 | 6 | 28485429 | 28489490 | Human |
2300942 | TRT-CGT1-1 | tRNA-Thr (anticodon CGT) 1-1 | 6 | 28488993 | 28489066 | Human |
151668490 | LOC124901295 | uncharacterized LOC124901295 | 6 | 28489730 | 28490987 | Human |
329337859 | LOC129389483 | MPRA-validated peak5745 silencer | 6 | 28502858 | 28503058 | Human |
735998 | GPX6 | glutathione peroxidase 6 | 6 | 28503296 | 28515793 | Human |
1352844 | GPX5 | glutathione peroxidase 5 | 6 | 28525881 | 28534955 | Human |
2300629 | TRI-TAT3-1 | tRNA-Ile (anticodon TAT) 3-1 | 6 | 28537590 | 28537683 | Human |
38637079 | LOC107986586 | uncharacterized LOC107986586 | 6 | 28543061 | 28544997 | Human |
2300943 | TRR-TCG5-1 | tRNA-Arg (anticodon TCG) 5-1 | 6 | 28543114 | 28543186 | Human |
155657927 | LOC127405650 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28511751-28512333 | 6 | 28543974 | 28544556 | Human |
1351610 | SCAND3 | SCAN domain containing 3 | 6 | 28570535 | 28616202 | Human |
155658429 | LOC127405651 | H3K27ac hESC enhancer GRCh37_chr6:28554695-28555571 | 6 | 28586918 | 28587794 | Human |
127284905 | ZBED9-AS1 | ZBED9 antisense RNA 1 | 6 | 28587378 | 28591749 | Human |
155659897 | LOC127405652 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr6:28557063-28557742 | 6 | 28589286 | 28589965 | Human |
2300839 | TRQ-TTG2-1 | tRNA-Gln (anticodon TTG) 2-1 | 6 | 28589379 | 28589450 | Human |
2300752 | TRS-GCT4-1 | tRNA-Ser (anticodon GCT) 4-1 | 6 | 28597340 | 28597421 | Human |
2300678 | TRA-AGC3-1 | tRNA-Ala (anticodon AGC) 3-1 | 6 | 28607156 | 28607227 | Human |
401844597 | COX8CP1 | COX8C pseudogene 1 | 6 | 28633381 | 28633594 | Human |
2300448 | TRA-TGC9-1 | tRNA-Ala (anticodon TGC) 9-1 | 6 | 28634082 | 28634153 | Human |
38628041 | LOC105374996 | uncharacterized LOC105374996 | 6 | 28638584 | 28653234 | Human |
155657303 | LOC127405653 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28607773-28608273 | 6 | 28639996 | 28640496 | Human |
2300863 | TRA-TGC2-1 | tRNA-Ala (anticodon TGC) 2-1 | 6 | 28643445 | 28643516 | Human |
2300617 | TRT-CGT3-1 | tRNA-Thr (anticodon CGT) 3-1 | 6 | 28648207 | 28648280 | Human |
1345357 | LINC00533 | long intergenic non-protein coding RNA 533 | 6 | 28648286 | 28654475 | Human |
2300931 | TRA-AGC4-1 | tRNA-Ala (anticodon AGC) 4-1 | 6 | 28658237 | 28658308 | Human |
2300577 | TRA-CGC2-1 | tRNA-Ala (anticodon CGC) 2-1 | 6 | 28673836 | 28673907 | Human |
2300438 | TRK-TTT13-1 | tRNA-Lys (anticodon TTT) 13-1 | 6 | 28693210 | 28693283 | Human |
2300582 | TRA-CGC5-1 | tRNA-Ala (CGC) 5-1 | 6 | 28695932 | 28696003 | Human |
329344468 | LOC129661691 | ReSE screen-validated silencer GRCh37_chr6:28676876-28677066 | 6 | 28709099 | 28709289 | Human |
2300930 | TRA-AGC5-1 | tRNA-Ala (anticodon AGC) 5-1 | 6 | 28710589 | 28710660 | Human |
38650119 | LOC116183053 | CRISPRi-validated cis-regulatory element chr6.1371 | 6 | 28719663 | 28719931 | Human |
2300885 | TRA-AGC7-1 | tRNA-Ala (anticodon AGC) 7-1 | 6 | 28719704 | 28719775 | Human |
2300544 | TRT-AGT3-1 | trRNA-Thr (anticodon AGT) 3-1 | 6 | 28726018 | 28726091 | Human |
2300505 | TRF-GAA11-1 | tRNA-Phe (anticodon GAA) 11-1 | 6 | 28727078 | 28727150 | Human |
38669177 | LOC116183054 | CRISPRi-validated cis-regulatory element chr6.1373 | 6 | 28729184 | 28729506 | Human |
2300944 | TRA-CGC4-1 | tRNA-Ala (anticodon CGC) 4-1 | 6 | 28729315 | 28729386 | Human |
1348591 | RPSAP2 | ribosomal protein SA pseudogene 2 | 6 | 28731939 | 28732974 | Human |
2300799 | TRV-AAC6-1 | tRNA-Val (anticodon AAC) 6-1 | 6 | 28735429 | 28735500 | Human |
2300612 | TRR-CCG1-1 | tRNA-Arg (anticodon CCG) 1-1 | 6 | 28742952 | 28743024 | Human |
2300645 | TRK-TTT7-1 | tRNA-Lys (anticodon TTT) 7-1 | 6 | 28747744 | 28747816 | Human |
155229238 | LOC126859634 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:28725125-28726324 | 6 | 28757348 | 28758547 | Human |
2300895 | TRA-TGC6-1 | tRNA-Ala (anticodon TGC) 6-1 | 6 | 28758364 | 28758435 | Human |
2300715 | TRF-GAA6-1 | tRNA-Phe (anticodon GAA) 6-1 | 6 | 28763597 | 28763670 | Human |
2300832 | TRF-GAA5-1 | tRNA-Phe (anticodon GAA) 5-1 | 6 | 28764387 | 28764463 | Human |
155652739 | LOC127405654 | H3K4me1 hESC enhancer GRCh37_chr6:28733173-28733725 | 6 | 28765396 | 28765948 | Human |
155654721 | LOC127405655 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:28743727-28744298 | 6 | 28775950 | 28776521 | Human |
2300509 | TRA-AGC23-1 | tRNA-Ala (anticodon AGC) 23-1 | 6 | 28778767 | 28778838 | Human |
1342956 | NOP56P1 | NOP56 ribonucleoprotein pseudogene 1 | 6 | 28783536 | 28784011 | Human |
2300828 | TRA-TGC1-1 | tRNA-Ala (anticodon TGC) 1-1 | 6 | 28789770 | 28789841 | Human |
329344186 | LOC129661692 | ReSE screen-validated silencer GRCh37_chr6:28757743-28757942 | 6 | 28789966 | 28790165 | Human |
2300840 | TRF-GAA1-1 | tRNA-Phe (anticodon GAA) 1-1 | 6 | 28790722 | 28790794 | Human |
2300631 | TRA-AGC1-1 | tRNA-Ala (anticodon AGC) 1-1 | 6 | 28795964 | 28796035 | Human |
151670757 | LOC124901504 | uncharacterized LOC124901504 | 6 | 28796878 | 28797033 | Human |
1350834 | TRA-TGC7-1 | tRNA-Ala (anticodon TGC) 7-1 | 6 | 28802800 | 28802870 | Human |
2300807 | TRF-GAA3-1 | tRNA-Phe (anticodon GAA) 3-1 | 6 | 28807833 | 28807905 | Human |
2300935 | TRA-AGC6-1 | tRNA-Ala (anticodon AGC) 6-1 | 6 | 28812072 | 28812143 | Human |
155649257 | LOC127405656 | H3K4me1 hESC enhancer GRCh37_chr6:28780364-28780864 | 6 | 28812587 | 28813087 | Human |
2300911 | TRA-TGC5-1 | tRNA-Ala (anticodon TGC) 5-1 | 6 | 28817235 | 28817306 | Human |
2300684 | TRF-GAA4-1 | tRNA-Phe (anticodon GAA) 4-1 | 6 | 28823316 | 28823389 | Human |
16553111 | LOC124901296 | uncharacterized LOC124901296 | 6 | 28837241 | 28839023 | Human |
155646427 | LOC127405657 | H3K27ac hESC enhancer GRCh37_chr6:28805097-28806088 | 6 | 28837320 | 28838311 | Human |
155662879 | LOC127405658 | H3K27ac hESC enhancer GRCh37_chr6:28806089-28807080 | 6 | 28838312 | 28839303 | Human |
2300884 | TRA-AGC2-1 | tRNA-Ala (anticodon AGC) 2-1 | 6 | 28838444 | 28838515 | Human |
10402683 | LINC01623 | long intergenic non-protein coding RNA 1623 | 6 | 28859625 | 28863677 | Human |
1344645 | RPL13P | ribosomal protein L13 pseudogene | 6 | 28861387 | 28862069 | Human |
2300682 | TRA-AGC2-2 | tRNA-Ala (anticodon AGC) 2-2 | 6 | 28863685 | 28863756 | Human |
155653055 | LOC127405659 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:28833646-28834318 | 6 | 28865869 | 28866541 | Human |
155647284 | LOC127405660 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28840145-28840668 | 6 | 28872368 | 28872891 | Human |
155660790 | LOC127405661 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28840669-28841190 | 6 | 28872892 | 28873413 | Human |
2300893 | TRR-CCG1-2 | tRNA-Arg (anticodon CCG) 1-2 | 6 | 28881388 | 28881460 | Human |
1354246 | ZNF90P2 | zinc finger protein 90 pseudogene 2 | 6 | 28888981 | 28889634 | Human |
155661177 | LOC127405662 | H3K27ac hESC enhancer GRCh37_chr6:28862712-28863348 | 6 | 28894935 | 28895571 | Human |
329342672 | LOC129661693 | ReSE screen-validated silencer GRCh37_chr6:28863410-28863573 | 6 | 28895633 | 28895796 | Human |
155659266 | LOC127405663 | H3K27ac hESC enhancer GRCh37_chr6:28863984-28864619 | 6 | 28896207 | 28896842 | Human |
8663250 | TRL-CAA1-1 | tRNA-Leu (anticodon CAA) 1-1 | 6 | 28896223 | 28896328 | Human |
1354076 | HCG14 | HLA complex group 14 | 6 | 28896530 | 28897320 | Human |
1320820 | TRIM27 | tripartite motif containing 27 | 6 | 28903002 | 28923985 | Human |
10413724 | RNU6-930P | RNA, U6 small nuclear 930, pseudogene | 6 | 28915645 | 28915744 | Human |
155662145 | LOC127405664 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28890501-28891032 | 6 | 28922724 | 28923255 | Human |
155647926 | LOC127405665 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28891033-28891564 | 6 | 28923256 | 28923787 | Human |
155651984 | LOC127405666 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:28908035-28908604 | 6 | 28940258 | 28940827 | Human |
2300740 | TRL-CAA1-2 | tRNA-Leu (anticodon CAA) 1-2 | 6 | 28941053 | 28941157 | Human |
155649901 | LOC127405667 | H3K27ac hESC enhancer GRCh37_chr6:28909176-28909745 | 6 | 28941399 | 28941968 | Human |
2300856 | TRQ-CTG1-3 | tRNA-Gln (anticodon CTG) 1-3 | 6 | 28941601 | 28941672 | Human |
2300775 | TRL-AAG2-2 | tRNA-Leu (anticodon AAG) 2-2 | 6 | 28943622 | 28943703 | Human |
1351960 | LINC01556 | long intergenic non-protein coding RNA 1556 | 6 | 28943784 | 28944538 | Human |
2300761 | TRM-CAT3-1 | tRNA-Met (anticodon CAT) 3-1 | 6 | 28944575 | 28944647 | Human |
155660933 | LOC127405668 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:28917695-28918254 | 6 | 28949918 | 28950477 | Human |
126781823 | LOC121132675 | Sharpr-MPRA regulatory region 4538 | 6 | 28950892 | 28951186 | Human |
2300743 | TRK-TTT3-3 | tRNA-Lys (anticodon TTT) 3-3 | 6 | 28951029 | 28951101 | Human |
2300866 | TRM-CAT3-2 | tRNA-Met (anticodon CAT) 3-2 | 6 | 28953265 | 28953337 | Human |
155230473 | LOC126859635 | BRD4-independent group 4 enhancer GRCh37_chr6:28928607-28929806 | 6 | 28960830 | 28962029 | Human |
329340557 | LOC129661694 | ReSE screen-validated silencer GRCh37_chr6:28936514-28936698 | 6 | 28968737 | 28968921 | Human |
1349327 | KRT18P1 | keratin 18 pseudogene 1 | 6 | 28969072 | 28970467 | Human |
10400733 | RN7SL471P | RNA, 7SL, cytoplasmic 471, pseudogene | 6 | 28977475 | 28977773 | Human |
38619224 | LOC116183055 | CRISPRi-validated cis-regulatory element chr6.1412 | 6 | 28980631 | 28981453 | Human |
2300723 | TRF-GAA1-2 | tRNA-Phe (anticodon GAA) 1-2 | 6 | 28981672 | 28981744 | Human |
2300953 | TRE-CTC1-6 | tRNA-Glu (anticodon CTC) 1-6 | 6 | 28982199 | 28982270 | Human |
1344551 | HCG15 | HLA complex group 15 | 6 | 28984749 | 28988567 | Human |
2300808 | TRL-AAG3-1 | tRNA-Leu (anticodon AAG) 3-1 | 6 | 28989002 | 28989083 | Human |
38667567 | LOC116183056 | CRISPRi-validated cis-regulatory element chr6.1416 | 6 | 28992601 | 28992912 | Human |
1604963 | ZNF311 | zinc finger protein 311 | 6 | 28994788 | 29005612 | Human |
38626596 | LOC105375002 | uncharacterized LOC105375002 | 6 | 29021983 | 29035992 | Human |
1345178 | OR2AD1P | olfactory receptor family 2 subfamily AD member 1 pseudogene | 6 | 29026680 | 29027607 | Human |
38668457 | OR2W1-AS1 | OR2W1 antisense RNA 1 | 6 | 29036021 | 29076740 | Human |
1348465 | OR2W1 | olfactory receptor family 2 subfamily W member 1 | 6 | 29044213 | 29045175 | Human |
1344769 | OR2P1P | olfactory receptor family 2 subfamily P member 1 pseudogene | 6 | 29071832 | 29072566 | Human |
1352062 | SAR1AP1 | secretion associated Ras related GTPase 1A pseudogene 1 | 6 | 29074407 | 29077241 | Human |
1351242 | OR2B3 | olfactory receptor family 2 subfamily B member 3 | 6 | 29086208 | 29087313 | Human |
1606623 | OR2J1 | olfactory receptor family 2 subfamily J member 1 | 6 | 29099490 | 29102701 | Human |
1351141 | OR2J3 | olfactory receptor family 2 subfamily J member 3 | 6 | 29108058 | 29114770 | Human |
1343159 | OR2N1P | olfactory receptor family 2 subfamily N member 1 pseudogene | 6 | 29137770 | 29138916 | Human |
155229536 | LOC126859636 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:29127190-29128389 | 6 | 29159376 | 29160612 | Human |
1353815 | OR2J2 | olfactory receptor family 2 subfamily J member 2 | 6 | 29170907 | 29175811 | Human |
1349778 | OR2J4P | olfactory receptor family 2 subfamily J member 4 pseudogene | 6 | 29181510 | 29182442 | Human |
151668709 | LOC124901297 | uncharacterized LOC124901297 | 6 | 29195209 | 29200490 | Human |
1350767 | OR2H4P | olfactory receptor family 2 subfamily H member 4 pseudogene | 6 | 29215236 | 29216176 | Human |
16550947 | LINC03003 | long intergenic non-protein coding RNA 3003 | 6 | 29223973 | 29290440 | Human |
1353058 | OR2G1P | olfactory receptor family 2 subfamily G member 1 pseudogene | 6 | 29229230 | 29230220 | Human |
38638293 | LOC105375006 | uncharacterized LOC105375006 | 6 | 29230813 | 29232799 | Human |
155226948 | LOC126859637 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:29219099-29220298 | 6 | 29251322 | 29252521 | Human |
1348617 | OR2U1P | olfactory receptor family 2 subfamily U member 1 pseudogene | 6 | 29262659 | 29264079 | Human |
1350632 | OR2U2P | olfactory receptor family 2 subfamily U member 2 pseudogene | 6 | 29268465 | 29269421 | Human |
38656225 | LOC105375005 | uncharacterized LOC105375005 | 6 | 29284072 | 29334443 | Human |
1348346 | OR2B4P | olfactory receptor family 2 subfamily B member 4 pseudogene | 6 | 29290596 | 29291750 | Human |
1344262 | OR14J1 | olfactory receptor family 14 subfamily J member 1 | 6 | 29301701 | 29313017 | Human |
1350251 | DDX6P1 | DEAD-box helicase 6 pseudogene 1 | 6 | 29329429 | 29331261 | Human |
1348304 | OR5V1 | olfactory receptor family 5 subfamily V member 1 | 6 | 29353749 | 29368865 | Human |
1352207 | OR12D3 | olfactory receptor family 12 subfamily D member 3 | 6 | 29373423 | 29375291 | Human |
1345064 | OR12D2 | olfactory receptor family 12 subfamily D member 2 | 6 | 29395631 | 29398008 | Human |
1354423 | OR12D1 | olfactory receptor family 12 subfamily D member 1 (gene/pseudogene) | 6 | 29417065 | 29418396 | Human |
1346770 | OR11A1 | olfactory receptor family 11 subfamily A member 1 | 6 | 29425504 | 29457071 | Human |
1353336 | OR10C1 | olfactory receptor family 10 subfamily C member 1 | 6 | 29439306 | 29440977 | Human |
155649387 | LOC127405669 | H3K4me1 hESC enhancer GRCh37_chr6:29408251-29408751 | 6 | 29440474 | 29440974 | Human |
38618472 | LOC105379641 | uncharacterized LOC105379641 | 6 | 29442503 | 29458401 | Human |
155663076 | LOC127405670 | NANOG hESC enhancer GRCh37_chr6:29415417-29415953 | 6 | 29447640 | 29448176 | Human |
1353217 | OR2H1 | olfactory receptor family 2 subfamily H member 1 | 6 | 29457155 | 29464328 | Human |
1350880 | UBDP1 | ubiquitin D pseudogene 1 | 6 | 29464675 | 29464945 | Human |
2292062 | MAS1LP1 | MAS1L pseudogene 1 | 6 | 29475025 | 29476071 | Human |
38669419 | LOC105375008 | uncharacterized LOC105375008 | 6 | 29475699 | 29490181 | Human |
1351772 | MAS1L | MAS1 proto-oncogene like, G protein-coupled receptor | 6 | 29486697 | 29487956 | Human |
151670169 | LOC124901486 | uncharacterized LOC124901486 | 6 | 29488516 | 29494142 | Human |
1342727 | RPS17P1 | ribosomal protein S17 pseudogene 1 | 6 | 29489203 | 29489693 | Human |
14402161 | LINC02829 | long intergenic non-protein coding RNA 2829 | 6 | 29497475 | 29510564 | Human |
155650863 | LOC127405671 | OCT4-NANOG hESC enhancer GRCh37_chr6:29492704-29493211 | 6 | 29524927 | 29525434 | Human |
7248225 | LINC01015 | long intergenic non-protein coding RNA 1015 | 6 | 29529406 | 29533568 | Human |
1343401 | GPR53P | G protein-coupled receptor 53, pseudogene | 6 | 29537812 | 29538651 | Human |
1606622 | OR2I1 | olfactory receptor family 2 subfamily I member 1 (gene/pseudogene) | 6 | 29550407 | 29557773 | Human |
69468 | UBD | ubiquitin D | 6 | 29555515 | 29559732 | Human |
155229608 | LOC126859638 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:29530647-29531846 | 6 | 29562870 | 29564069 | Human |
329340238 | LOC129661695 | ReSE screen-validated silencer GRCh37_chr6:29541846-29542105 | 6 | 29574069 | 29574328 | Human |
1349294 | OR2H5P | olfactory receptor family 2 subfamily H member 5 pseudogene | 6 | 29574073 | 29574651 | Human |
5684194 | TMEM183AP1 | TMEM183A pseudogene 1 | 6 | 29577459 | 29577748 | Human |
1602734 | SNORD32B | small nucleolar RNA, C/D box 32B | 6 | 29582252 | 29582328 | Human |
1353873 | RPL13AP | ribosomal protein L13a pseudogene | 6 | 29582508 | 29583055 | Human |
1348875 | OR2H2 | olfactory receptor family 2 subfamily H member 2 | 6 | 29585121 | 29590500 | Human |
155658432 | LOC127405672 | NANOG hESC enhancer GRCh37_chr6:29562576-29563083 | 6 | 29594799 | 29595306 | Human |
734108 | GABBR1 | gamma-aminobutyric acid type B receptor subunit 1 | 6 | 29602238 | 29633183 | Human |
155655139 | LOC127405673 | H3K27ac hESC enhancer GRCh37_chr6:29589456-29590006 | 6 | 29621679 | 29622229 | Human |
155647606 | LOC127405674 | H3K27ac hESC enhancer GRCh37_chr6:29590007-29590556 | 6 | 29622230 | 29622779 | Human |
155652380 | LOC127405675 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:29592149-29592734 | 6 | 29624372 | 29624957 | Human |
155662795 | LOC127405676 | H3K27ac hESC enhancer GRCh37_chr6:29596552-29597357 | 6 | 29628775 | 29629580 | Human |
155648626 | LOC127405677 | H3K4me1 hESC enhancer GRCh37_chr6:29598769-29599270 | 6 | 29630992 | 29631493 | Human |
1350239 | SUMO2P1 | SUMO2 pseudogene 1 | 6 | 29635454 | 29636468 | Human |
155655367 | LOC127405678 | H3K4me1 hESC enhancer GRCh37_chr6:29610193-29610692 | 6 | 29642416 | 29642915 | Human |
155648660 | LOC127405679 | NANOG-H3K4me1 hESC enhancer GRCh37_chr6:29616349-29616969 | 6 | 29648572 | 29649192 | Human |
155659367 | LOC127405680 | H3K27ac hESC enhancer GRCh37_chr6:29622853-29623353 | 6 | 29655076 | 29655576 | Human |
736817 | MOG | myelin oligodendrocyte glycoprotein | 6 | 29657092 | 29672365 | Human |
329338819 | LOC129661696 | ReSE screen-validated silencer GRCh37_chr6:29627633-29628069 | 6 | 29659856 | 29660292 | Human |
155660728 | LOC127405681 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29628451-29629365 | 6 | 29660674 | 29661588 | Human |
155649503 | LOC127405682 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29629366-29630280 | 6 | 29661589 | 29662503 | Human |
155646731 | LOC127405683 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29630281-29631194 | 6 | 29662504 | 29663417 | Human |
155647441 | LOC127405684 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:29634045-29634654 | 6 | 29666268 | 29666877 | Human |
155660275 | LOC127405685 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:29634655-29635264 | 6 | 29666878 | 29667487 | Human |
1344217 | ZFP57 | ZFP57 zinc finger protein | 6 | 29672392 | 29681152 | Human |
155647595 | LOC127405686 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29647510-29648030 | 6 | 29679733 | 29680253 | Human |
155658991 | LOC127405687 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29648031-29648552 | 6 | 29680254 | 29680775 | Human |
329338923 | LOC129661697 | ReSE screen-validated silencer GRCh37_chr6:29671001-29671115 | 6 | 29703224 | 29703338 | Human |
5134875 | ZDHHC20P1 | zinc finger DHHC-type containing 20 pseudogene 1 | 6 | 29708141 | 29708547 | Human |
1348171 | HCG4P11 | HLA complex group 4 pseudogene 11 | 6 | 29721178 | 29722167 | Human |
1345133 | HLA-F | major histocompatibility complex, class I, F | 6 | 29723434 | 29738532 | Human |
155660417 | LOC127405688 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29691770-29692604 | 6 | 29723993 | 29724827 | Human |
1343228 | RPL23AP1 | ribosomal protein L23a pseudogene 1 | 6 | 29726597 | 29727154 | Human |
2303893 | HLA-F-AS1 | HLA-F antisense RNA 1 | 6 | 29726601 | 29749049 | Human |
1346954 | MICE | MHC class I polypeptide-related sequence E (pseudogene) | 6 | 29741556 | 29745784 | Human |
1352356 | HCG9P5 | HLA complex group 9 pseudogene 5 | 6 | 29748254 | 29748648 | Human |
155647039 | LOC127405689 | H3K4me1 hESC enhancer GRCh37_chr6:29716125-29716632 | 6 | 29748348 | 29748855 | Human |
1602166 | IFITM4P | interferon induced transmembrane protein 4 pseudogene | 6 | 29750807 | 29751148 | Human |
155648321 | LOC127405690 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29719894-29720566 | 6 | 29752117 | 29752789 | Human |
329342642 | LOC129661698 | ReSE screen-validated silencer GRCh37_chr6:29724174-29724335 | 6 | 29756397 | 29756558 | Human |
155653780 | LOC127405691 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29726920-29727612 | 6 | 29759143 | 29759835 | Human |
38643525 | LOC353010 | HLA complex group 26 (non-protein coding) pseudogene | 6 | 29765116 | 29766296 | Human |
155657861 | LOC127405692 | H3K4me1 hESC enhancer GRCh37_chr6:29747845-29748345 | 6 | 29780068 | 29780568 | Human |
155227438 | LOC126859639 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:29757998-29759197 | 6 | 29790221 | 29791420 | Human |
1348159 | HCG4 | HLA complex group 4 | 6 | 29791031 | 29793073 | Human |
1349746 | HLA-V | major histocompatibility complex, class I, V (pseudogene) | 6 | 29791906 | 29797807 | Human |
1604944 | HCG4P9 | HLA complex group 4 pseudogene 9 | 6 | 29798424 | 29800126 | Human |
1342820 | HLA-P | major histocompatibility complex, class I, P (pseudogene) | 6 | 29800044 | 29803079 | Human |
155652266 | LOC127405693 | H3K4me1 hESC enhancer GRCh37_chr6:29768209-29768708 | 6 | 29800432 | 29800931 | Human |
1351099 | RPL7AP7 | ribosomal protein L7a pseudogene 7 | 6 | 29803132 | 29804017 | Human |
1352177 | MICG | MHC class I polypeptide-related sequence G (pseudogene) | 6 | 29812390 | 29812692 | Human |
155661582 | LOC127405694 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:29780458-29781338 | 6 | 29812681 | 29813561 | Human |
155661271 | LOC127405695 | H3K4me1 hESC enhancer GRCh37_chr6:29782298-29782798 | 6 | 29814521 | 29815021 | Human |
155653208 | LOC127405696 | H3K4me1 hESC enhancer GRCh37_chr6:29782799-29783299 | 6 | 29815022 | 29815522 | Human |
1352669 | HCG4P8 | HLA complex group 4 pseudogene 8 | 6 | 29826129 | 29827114 | Human |
1347423 | HLA-G | major histocompatibility complex, class I, G | 6 | 29826474 | 29831021 | Human |
38630317 | HCGVIII-2 | HCGVIII-2 pseudogene | 6 | 29833588 | 29835128 | Human |
155229858 | LOC126859640 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:29812738-29813937 | 6 | 29844961 | 29846160 | Human |
38631973 | LOC105375010 | uncharacterized LOC105375010 | 6 | 29848002 | 29857386 | Human |
150537067 | LOC123620078 | Sharpr-MPRA regulatory region 7378 | 6 | 29848112 | 29848406 | Human |
1349529 | MICF | MHC class I polypeptide-related sequence F (pseudogene) | 6 | 29852187 | 29854052 | Human |
38601811 | LOC353009 | HLA complex group 26 (non-protein coding) pseudogene | 6 | 29865915 | 29867087 | Human |
1605218 | HCP5B | HLA complex P5B | 6 | 29871895 | 29873783 | Human |
13208270 | ERVK9-12 | endogenous retrovirus group K9, member 12 | 6 | 29876073 | 29878220 | Human |
1346603 | HCG4P7 | HLA complex group 4 pseudogene 7 | 6 | 29886110 | 29887007 | Human |
1349235 | HLA-H | major histocompatibility complex, class I, H (pseudogene) | 6 | 29887573 | 29891079 | Human |
1347312 | HLA-T | major histocompatibility complex, class I, T (pseudogene) | 6 | 29896443 | 29898947 | Human |
4892545 | DDX39BP1 | DEAD-box helicase 39B pseudogene 1 | 6 | 29906547 | 29907449 | Human |
6482155 | MCCD1P1 | mitochondrial coiled-coil domain 1 pseudogene 1 | 6 | 29907783 | 29908645 | Human |
38610774 | LOC353008 | HLA complex group 26 (non-protein coding) pseudogene | 6 | 29910235 | 29911400 | Human |
1349547 | HCG4B | HLA complex group 4B | 6 | 29924592 | 29927215 | Human |
1350973 | HLA-K | major histocompatibility complex, class I, K (pseudogene) | 6 | 29926659 | 29929825 | Human |
151673698 | LOC124901298 | uncharacterized LOC124901298 | 6 | 29928198 | 29945593 | Human |
1351895 | HLA-U | major histocompatibility complex, class I, U (pseudogene) | 6 | 29933764 | 29934880 | Human |
1353380 | HCG4P5 | HLA complex group 4 pseudogene 5 | 6 | 29940912 | 29941801 | Human |
1349444 | HLA-A | major histocompatibility complex, class I, A | 6 | 29942532 | 29945870 | Human |
1343995 | HCG4P4 | HLA complex group 4 pseudogene 4 | 6 | 29955205 | 29955633 | Human |
1343069 | HLA-W | major histocompatibility complex, class I, W (pseudogene) | 6 | 29955834 | 29959058 | Human |
38633098 | LOC106799842 | nonconserved acetylation island sequence 101 enhancer | 6 | 29964951 | 29965370 | Human |
1344366 | MICD | MHC class I polypeptide-related sequence D (pseudogene) | 6 | 29970372 | 29975745 | Human |
155656799 | LOC127405697 | H3K4me1 hESC enhancer GRCh37_chr6:29942669-29943319 | 6 | 29974892 | 29975542 | Human |
1345986 | HCG9 | HLA complex group 9 | 6 | 29975115 | 29978403 | Human |
155654716 | LOC127405698 | H3K4me1 hESC enhancer GRCh37_chr6:29943320-29943969 | 6 | 29975543 | 29976192 | Human |
4892544 | DDX39BP2 | DEAD-box helicase 39B pseudogene 2 | 6 | 29993209 | 29994133 | Human |
6483488 | MCCD1P2 | mitochondrial coiled-coil domain 1 pseudogene 2 | 6 | 29995142 | 29995314 | Human |
38633849 | LOC353007 | HLA complex group 26 (non-protein coding) pseudogene | 6 | 29995957 | 29996415 | Human |
1351959 | POLR1HASP | POLR1H antisense, pseudogene | 6 | 30001011 | 30061189 | Human |
1344229 | HCG4P3 | HLA complex group 4 pseudogene 3 | 6 | 30004845 | 30005828 | Human |
1342604 | HLA-J | major histocompatibility complex, class I, J (pseudogene) | 6 | 30005971 | 30009956 | Human |
1351224 | ETF1P1 | eukaryotic translation termination factor 1 pseudogene 1 | 6 | 30031713 | 30033877 | Human |
1351679 | POLR1H | RNA polymerase I subunit H | 6 | 30060062 | 30064907 | Human |
155653379 | LOC127405699 | H3K27ac hESC enhancer GRCh37_chr6:30028069-30028935 | 6 | 30060292 | 30061158 | Human |
155661399 | LOC127405700 | H3K27ac hESC enhancer GRCh37_chr6:30028936-30029801 | 6 | 30061159 | 30062024 | Human |
1350582 | PPP1R11 | protein phosphatase 1 regulatory inhibitor subunit 11 | 6 | 30061265 | 30070333 | Human |
1604283 | RNF39 | ring finger protein 39 | 6 | 30070270 | 30075769 | Human |
155661239 | LOC127405701 | H3K4me1 hESC enhancer GRCh37_chr6:30041647-30042322 | 6 | 30073870 | 30074545 | Human |
155656597 | LOC127405702 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30042323-30042996 | 6 | 30074546 | 30075219 | Human |
155652674 | LOC127405703 | H3K4me1 hESC enhancer GRCh37_chr6:30068196-30068705 | 6 | 30100419 | 30100928 | Human |
155647936 | LOC127405704 | H3K4me1 hESC enhancer GRCh37_chr6:30070193-30070692 | 6 | 30102416 | 30102915 | Human |
1318479 | TRIM31 | tripartite motif containing 31 | 6 | 30102897 | 30113090 | Human |
9589865 | TRIM31-AS1 | TRIM31 antisense RNA 1 | 6 | 30105240 | 30114724 | Human |
155227314 | LOC126859641 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:30080310-30081509 | 6 | 30112533 | 30113732 | Human |
16559438 | LOC124900227 | small nucleolar RNA SNORA48 | 6 | 30132805 | 30132942 | Human |
1346356 | TRIM40 | tripartite motif containing 40 | 6 | 30136140 | 30148735 | Human |
1349784 | TRIM10 | tripartite motif containing 10 | 6 | 30151943 | 30164009 | Human |
1322537 | TRIM15 | tripartite motif containing 15 | 6 | 30163546 | 30172693 | Human |
155650813 | LOC127405705 | H3K4me1 hESC enhancer GRCh37_chr6:30139523-30140072 | 6 | 30171746 | 30172295 | Human |
1346405 | TRIM26 | tripartite motif containing 26 | 6 | 30184455 | 30213406 | Human |
1354158 | PAIP1P1 | PAIP1 pseudogene 1 | 6 | 30186610 | 30188643 | Human |
329329436 | LOC129389484 | MPRA-validated peak5749 silencer | 6 | 30194978 | 30195178 | Human |
155656063 | LOC127405706 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:30168993-30169678 | 6 | 30201216 | 30201901 | Human |
155646198 | LOC127405707 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:30169679-30170363 | 6 | 30201902 | 30202586 | Human |
155654857 | LOC127405708 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30175183-30176130 | 6 | 30207406 | 30208353 | Human |
155656493 | LOC127405709 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30181514-30182402 | 6 | 30213737 | 30214625 | Human |
1352352 | HCG17 | HLA complex group 17 | 6 | 30234039 | 30326134 | Human |
1348872 | TRIM26BP | tripartite motif containing 26B, pseudogene | 6 | 30238301 | 30242279 | Human |
1354336 | HLA-L | major histocompatibility complex, class I, L (pseudogene) | 6 | 30259562 | 30266951 | Human |
329339984 | LOC129389485 | MPRA-validated peak5750 silencer | 6 | 30266218 | 30266418 | Human |
1342994 | HCG18 | HLA complex group 18 | 6 | 30287397 | 30327156 | Human |
329340977 | LOC129389486 | MPRA-validated peak5752 silencer | 6 | 30311318 | 30311518 | Human |
155656191 | LOC127405710 | NANOG-H3K4me1 hESC enhancer GRCh37_chr6:30292740-30293383 | 6 | 30324963 | 30325606 | Human |
1345253 | TRIM39 | tripartite motif containing 39 | 6 | 30326469 | 30343729 | Human |
155229667 | LOC126859642 | BRD4-independent group 4 enhancer GRCh37_chr6:30296621-30297820 | 6 | 30328844 | 30330043 | Human |
5013861 | TRIM39-RPP21 | TRIM39-RPP21 readthrough | 6 | 30329311 | 30346858 | Human |
155229157 | LOC126859643 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:30308084-30309283 | 6 | 30340307 | 30341506 | Human |
1346051 | RPP21 | ribonuclease P/MRP subunit p21 | 6 | 30345156 | 30346857 | Human |
1347571 | HLA-N | major histocompatibility complex, class I, N (pseudogene) | 6 | 30351074 | 30352038 | Human |
155652036 | LOC127405711 | NANOG hESC enhancer GRCh37_chr6:30323175-30323676 | 6 | 30355398 | 30355899 | Human |
1345154 | UBQLN1P1 | ubiquilin 1 pseudogene 1 | 6 | 30358594 | 30364111 | Human |
329338276 | LOC129389487 | MPRA-validated peak5753 silencer | 6 | 30378419 | 30378619 | Human |
329337937 | LOC129661699 | ReSE screen-validated silencer GRCh37_chr6:30363628-30363824 | 6 | 30395851 | 30396047 | Human |
1344876 | MICC | MHC class I polypeptide-related sequence C (pseudogene) | 6 | 30414711 | 30416636 | Human |
38626191 | LOC105375012 | uncharacterized LOC105375012 | 6 | 30460825 | 30463603 | Human |
155649984 | LOC127405712 | H3K4me1 hESC enhancer GRCh37_chr6:30433693-30434436 | 6 | 30465916 | 30466659 | Human |
1353581 | TMPOP1 | thymopoietin pseudogene 1 | 6 | 30466225 | 30468871 | Human |
1349385 | SUCLA2P1 | SUCLA2 pseudogene 1 | 6 | 30468878 | 30470922 | Human |
155653285 | LOC127405713 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30443157-30443780 | 6 | 30475380 | 30476003 | Human |
1346292 | RANP1 | RAN pseudogene 1 | 6 | 30485885 | 30486976 | Human |
1353823 | HLA-E | major histocompatibility complex, class I, E | 6 | 30489509 | 30494194 | Human |
155651842 | LOC127405714 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30457579-30458127 | 6 | 30489802 | 30490350 | Human |
155662732 | LOC127405715 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30481847-30482624 | 6 | 30514070 | 30514847 | Human |
13210614 | LINC02569 | long intergenic non-protein coding RNA 2569 | 6 | 30516266 | 30519580 | Human |
155655536 | LOC127405716 | H3K4me1 hESC enhancer GRCh37_chr6:30485727-30486226 | 6 | 30517950 | 30518449 | Human |
1352530 | GNL1 | G protein nucleolar 1 (putative) | 6 | 30541381 | 30556489 | Human |
155647129 | LOC127405717 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30523544-30524109 | 6 | 30555767 | 30556332 | Human |
155647682 | LOC127405718 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30524110-30524674 | 6 | 30556333 | 30556897 | Human |
1343981 | PRR3 | proline rich 3 | 6 | 30556709 | 30563723 | Human |
155647998 | LOC127405719 | H3K27ac hESC enhancer GRCh37_chr6:30524675-30525239 | 6 | 30556898 | 30557462 | Human |
13208465 | ABCF1-DT | ABCF1 divergent transcript | 6 | 30563613 | 30571301 | Human |
155656786 | LOC127405720 | H3K27ac hESC enhancer GRCh37_chr6:30538839-30539400 | 6 | 30571062 | 30571623 | Human |
734018 | ABCF1 | ATP binding cassette subfamily F member 1 | 6 | 30571442 | 30591522 | Human |
2290241 | MIR877 | microRNA 877 | 6 | 30584332 | 30584417 | Human |
732967 | PPP1R10 | protein phosphatase 1 regulatory subunit 10 | 6 | 30600413 | 30617243 | Human |
155227863 | LOC126859644 | BRD4-independent group 4 enhancer GRCh37_chr6:30577096-30578295 | 6 | 30609319 | 30610518 | Human |
155651874 | LOC127405721 | H3K27ac hESC enhancer GRCh37_chr6:30585278-30585846 | 6 | 30617501 | 30618069 | Human |
1349132 | MRPS18B | mitochondrial ribosomal protein S18B | 6 | 30617840 | 30626392 | Human |
38667070 | LOC113174987 | Sharpr-MPRA regulatory region 13793 | 6 | 30626712 | 30627006 | Human |
1347627 | ATAT1 | alpha tubulin acetyltransferase 1 | 6 | 30626874 | 30646821 | Human |
1352168 | PTMAP1 | prothymosin alpha pseudogene 1 | 6 | 30633450 | 30635237 | Human |
1348259 | C6orf136 | chromosome 6 open reading frame 136 | 6 | 30647133 | 30653207 | Human |
1344132 | DHX16 | DEAH-box helicase 16 | 6 | 30653127 | 30673006 | Human |
155656383 | LOC127405722 | H3K4me1 hESC enhancer GRCh37_chr6:30638704-30639302 | 6 | 30670927 | 30671525 | Human |
155660655 | LOC127405723 | H3K27ac hESC enhancer GRCh37_chr6:30640498-30641094 | 6 | 30672721 | 30673317 | Human |
329342938 | LOC129661700 | ReSE screen-validated silencer GRCh37_chr6:30642736-30642875 | 6 | 30674959 | 30675098 | Human |
1319936 | PPP1R18 | protein phosphatase 1 regulatory subunit 18 | 6 | 30676389 | 30688391 | Human |
38611815 | LOC113174988 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30649761-30650650 | 6 | 30681984 | 30682873 | Human |
155658104 | LOC127405724 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30650651-30651540 | 6 | 30682874 | 30683763 | Human |
1352240 | NRM | nurim | 6 | 30688049 | 30691420 | Human |
1348113 | RPL7P4 | ribosomal protein L7 pseudogene 4 | 6 | 30696746 | 30697536 | Human |
1348817 | MDC1 | mediator of DNA damage checkpoint 1 | 6 | 30699807 | 30717281 | Human |
155650874 | LOC127405725 | H3K4me1 hESC enhancer GRCh37_chr6:30668297-30668798 | 6 | 30700520 | 30701021 | Human |
10399581 | MDC1-AS1 | MDC1 antisense RNA 1 | 6 | 30703067 | 30713184 | Human |
155650129 | LOC127405726 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30683707-30684454 | 6 | 30715930 | 30716677 | Human |
155652954 | LOC127405727 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30685203-30685950 | 6 | 30717426 | 30718173 | Human |
155648762 | LOC127405728 | H3K27ac hESC enhancer GRCh37_chr6:30687755-30688653 | 6 | 30719978 | 30720876 | Human |
1606428 | TUBB | tubulin beta class I | 6 | 30720352 | 30725422 | Human |
736684 | FLOT1 | flotillin 1 | 6 | 30727709 | 30742687 | Human |
155653983 | LOC127405729 | H3K4me1 hESC enhancer GRCh37_chr6:30698119-30698743 | 6 | 30730342 | 30730966 | Human |
155650408 | LOC127405730 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30709349-30710229 | 6 | 30741572 | 30742452 | Human |
13208497 | IER3-AS1 | IER3 antisense RNA 1 | 6 | 30742963 | 30743673 | Human |
1347080 | IER3 | immediate early response 3 | 6 | 30743199 | 30744547 | Human |
155646588 | LOC127405731 | H3K27ac hESC enhancer GRCh37_chr6:30711111-30711991 | 6 | 30743334 | 30744214 | Human |
10398852 | RN7SL353P | RNA, 7SL, cytoplasmic 353, pseudogene | 6 | 30751038 | 30751289 | Human |
150537064 | LOC123620079 | Sharpr-MPRA regulatory region 12821 | 6 | 30757552 | 30757846 | Human |
155661901 | LOC127405732 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30731545-30732332 | 6 | 30763768 | 30764555 | Human |
1346831 | HCG20 | HLA complex group 20 | 6 | 30766825 | 30792250 | Human |
155227730 | LOC126859645 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:30736863-30738062 | 6 | 30769086 | 30770285 | Human |
150537051 | LOC123620080 | Sharpr-MPRA regulatory region 6937 | 6 | 30779232 | 30779526 | Human |
329341870 | LOC129661701 | ReSE screen-validated silencer GRCh37_chr6:30756540-30756717 | 6 | 30788763 | 30788940 | Human |
38641606 | LOC116183057 | CRISPRi-validated cis-regulatory element chr6.1563 | 6 | 30793778 | 30793897 | Human |
401826861 | LOC132089380 | Neanderthal introgressed variant-containing enhancer experimental_91437 | 6 | 30803175 | 30803344 | Human |
1349170 | LINC00243 | long intergenic non-protein coding RNA 243 | 6 | 30812866 | 30830659 | Human |
38665331 | LOC113174989 | Sharpr-MPRA regulatory region 6414 | 6 | 30814292 | 30814586 | Human |
155662217 | LOC127405733 | H3K27ac hESC enhancer GRCh37_chr6:30795009-30795509 | 6 | 30827232 | 30827732 | Human |
126781825 | LOC121132676 | Sharpr-MPRA regulatory region 12192 | 6 | 30828532 | 30829605 | Human |
13208489 | LINC02570 | long intergenic non-protein coding RNA 2570 | 6 | 30839529 | 30848159 | Human |
329344140 | LOC129661702 | ReSE screen-validated silencer GRCh37_chr6:30808614-30808790 | 6 | 30840837 | 30841013 | Human |
150537083 | LOC123620081 | Sharpr-MPRA regulatory region 587 | 6 | 30844292 | 30844586 | Human |
155654182 | LOC127405734 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30814964-30815466 | 6 | 30847187 | 30847689 | Human |
38614108 | LOC114004399 | Sharpr-MPRA regulatory region 13207 | 6 | 30857552 | 30857846 | Human |
10400228 | RN7SKP186 | RN7SK pseudogene 186 | 6 | 30864250 | 30864493 | Human |
155650429 | LOC127405735 | NANOG hESC enhancer GRCh37_chr6:30845201-30845702 | 6 | 30877424 | 30877925 | Human |
155660121 | LOC127405736 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30848468-30849396 | 6 | 30880691 | 30881619 | Human |
735912 | DDR1 | discoidin domain receptor tyrosine kinase 1 | 6 | 30880970 | 30900156 | Human |
155661697 | LOC127405737 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30851831-30852604 | 6 | 30884054 | 30884827 | Human |
155650492 | LOC127405738 | H3K4me1 hESC enhancer GRCh37_chr6:30852674-30853181 | 6 | 30884897 | 30885404 | Human |
155646337 | LOC127405739 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30854197-30854703 | 6 | 30886420 | 30886926 | Human |
5134149 | MIR4640 | microRNA 4640 | 6 | 30890883 | 30890972 | Human |
1352501 | GTF2H4 | general transcription factor IIH subunit 4 | 6 | 30908207 | 30914106 | Human |
1346332 | VARS2 | valyl-tRNA synthetase 2, mitochondrial | 6 | 30914238 | 30926459 | Human |
155230343 | LOC126859646 | MED14-independent group 3 enhancer GRCh37_chr6:30889690-30890889 | 6 | 30921683 | 30923427 | Human |
1347220 | SFTA2 | surfactant associated 2 | 6 | 30931353 | 30932170 | Human |
151671563 | LOC124901299 | uncharacterized LOC124901299 | 6 | 30937041 | 30938906 | Human |
155659055 | LOC127405740 | H3K4me1 hESC enhancer GRCh37_chr6:30905665-30906166 | 6 | 30937888 | 30938389 | Human |
155648988 | LOC127405741 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:30908586-30909423 | 6 | 30940809 | 30941646 | Human |
1346376 | MUCL3 | mucin like 3 | 6 | 30940973 | 30954221 | Human |
1350067 | HCG21 | HLA complex group 21 | 6 | 30945979 | 30954862 | Human |
155653625 | LOC127405742 | H3K4me1 hESC enhancer GRCh37_chr6:30923489-30924169 | 6 | 30955712 | 30956392 | Human |
7241613 | NAPGP2 | N-ethylmaleimide-sensitive factor attachment protein, gamma pseudogene 2 | 6 | 30961401 | 30961978 | Human |
1606083 | MUC21 | mucin 21, cell surface associated | 6 | 30983718 | 30989903 | Human |
155228869 | LOC126859647 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:30954612-30955811 | 6 | 30986835 | 30988034 | Human |
155662008 | LOC127405743 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:30960303-30961066 | 6 | 30992526 | 30993289 | Human |
5453552 | MUC22 | mucin 22 | 6 | 31005952 | 31035402 | Human |
155660388 | LOC127405744 | H3K27ac hESC enhancer GRCh37_chr6:30997211-30997711 | 6 | 31029434 | 31029934 | Human |
150537069 | LOC123620082 | Sharpr-MPRA regulatory region 1306 | 6 | 31037772 | 31038066 | Human |
1353415 | HCG22 | HLA complex group 22 (non-protein coding) | 6 | 31053449 | 31059849 | Human |
155652963 | LOC127405745 | H3K4me1 hESC enhancer GRCh37_chr6:31021318-31021818 | 6 | 31053541 | 31054041 | Human |
155648981 | LOC127405746 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31037859-31038823 | 6 | 31070082 | 31071046 | Human |
155660090 | LOC127405747 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31038824-31039787 | 6 | 31071047 | 31072010 | Human |
155653023 | LOC127405748 | H3K4me1 hESC enhancer GRCh37_chr6:31047009-31047541 | 6 | 31079232 | 31079764 | Human |
10400777 | RNU6-1133P | RNA, U6 small nuclear 1133, pseudogene | 6 | 31083040 | 31083103 | Human |
155653184 | LOC127405749 | H3K27ac hESC enhancer GRCh37_chr6:31051567-31052066 | 6 | 31083790 | 31084289 | Human |
1348540 | C6orf15 | chromosome 6 open reading frame 15 | 6 | 31111223 | 31112575 | Human |
1343678 | PSORS1C1 | psoriasis susceptibility 1 candidate 1 | 6 | 31114800 | 31140092 | Human |
1353195 | CDSN | corneodesmosin | 6 | 31115087 | 31120446 | Human |
155657244 | LOC127405750 | H3K4me1 hESC enhancer GRCh37_chr6:31084517-31085386 | 6 | 31116740 | 31117609 | Human |
155660076 | LOC127405751 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31093168-31093768 | 6 | 31125391 | 31125991 | Human |
155652654 | LOC127405752 | H3K4me1 hESC enhancer GRCh37_chr6:31093769-31094369 | 6 | 31125992 | 31126592 | Human |
155651461 | LOC127405753 | H3K4me1 hESC enhancer GRCh37_chr6:31094370-31094969 | 6 | 31126593 | 31127192 | Human |
1349813 | PSORS1C2 | psoriasis susceptibility 1 candidate 2 | 6 | 31137534 | 31139066 | Human |
155657134 | LOC127405754 | H3K4me1 hESC enhancer GRCh37_chr6:31105363-31106343 | 6 | 31137586 | 31138566 | Human |
1345066 | POLR2LP1 | RNA polymerase II subunit L pseudogene 1 | 6 | 31140727 | 31140913 | Human |
1344859 | CCHCR1 | coiled-coil alpha-helical rod protein 1 | 6 | 31142439 | 31158197 | Human |
155649365 | LOC127405755 | OCT4 hESC enhancer GRCh37_chr6:31123471-31124086 | 6 | 31155694 | 31156309 | Human |
155652331 | LOC127405756 | H3K4me1 hESC enhancer GRCh37_chr6:31124820-31125320 | 6 | 31157043 | 31157543 | Human |
155656658 | LOC127405757 | H3K4me1 hESC enhancer GRCh37_chr6:31125321-31125821 | 6 | 31157544 | 31158044 | Human |
1345711 | TCF19 | transcription factor 19 | 6 | 31158589 | 31164215 | Human |
329341923 | LOC129661703 | ReSE screen-validated silencer GRCh37_chr6:31127045-31127228 | 6 | 31159268 | 31159451 | Human |
155649642 | LOC127405758 | OCT4-H3K4me1 hESC enhancer GRCh37_chr6:31128969-31129952 | 6 | 31161192 | 31162175 | Human |
155661887 | LOC127405759 | OCT4-H3K4me1 hESC enhancer GRCh37_chr6:31129953-31130936 | 6 | 31162176 | 31163159 | Human |
1350605 | POU5F1 | POU class 5 homeobox 1 | 6 | 31164337 | 31170682 | Human |
155653993 | LOC127405760 | OCT4-H3K4me1 hESC enhancer GRCh37_chr6:31132319-31132900 | 6 | 31164542 | 31165123 | Human |
155655678 | LOC127405761 | OCT4-H3K27ac hESC enhancer GRCh37_chr6:31135533-31136390 | 6 | 31167756 | 31168613 | Human |
155662180 | LOC127405762 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:31136391-31137248 | 6 | 31168614 | 31169471 | Human |
155649136 | LOC127405763 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr6:31137249-31138106 | 6 | 31169472 | 31170329 | Human |
38652815 | LOC108961161 | POU5F1 5' regulatory region | 6 | 31170330 | 31173761 | Human |
1353176 | PSORS1C3 | psoriasis susceptibility 1 candidate 3 | 6 | 31173735 | 31186317 | Human |
155658180 | LOC127405764 | OCT4-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31142488-31143384 | 6 | 31174711 | 31175607 | Human |
155649688 | LOC127405765 | OCT4 hESC enhancer GRCh37_chr6:31145628-31146222 | 6 | 31177851 | 31178445 | Human |
155657608 | LOC127405766 | OCT4 hESC enhancer GRCh37_chr6:31146755-31147256 | 6 | 31178978 | 31179479 | Human |
155658620 | LOC127405767 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31148363-31148906 | 6 | 31180586 | 31181129 | Human |
155657380 | LOC127405768 | OCT4-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31153427-31154016 | 6 | 31185650 | 31186239 | Human |
155651185 | LOC127405769 | OCT4-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31154017-31154604 | 6 | 31186240 | 31186827 | Human |
155652045 | LOC127405770 | OCT4 hESC enhancer GRCh37_chr6:31158168-31158669 | 6 | 31190391 | 31190892 | Human |
155649858 | LOC127405771 | OCT4-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31163380-31164262 | 6 | 31195603 | 31196485 | Human |
1353303 | HCG27 | HLA complex group 27 | 6 | 31197760 | 31203968 | Human |
155657913 | LOC127405772 | OCT4 hESC enhancer GRCh37_chr6:31166400-31167283 | 6 | 31198623 | 31199506 | Human |
155647985 | LOC127405773 | OCT4 hESC enhancer GRCh37_chr6:31167284-31168166 | 6 | 31199507 | 31200389 | Human |
155656995 | LOC127405774 | OCT4-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31169734-31170274 | 6 | 31201957 | 31202497 | Human |
155657516 | LOC127405775 | OCT4-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31170275-31170813 | 6 | 31202498 | 31203036 | Human |
155663305 | LOC127405776 | H3K27ac hESC enhancer GRCh37_chr6:31170972-31171692 | 6 | 31203195 | 31203915 | Human |
155653512 | LOC127405777 | OCT4-H3K27ac hESC enhancer GRCh37_chr6:31171693-31172412 | 6 | 31203916 | 31204635 | Human |
155653755 | LOC127405778 | OCT4-H3K27ac hESC enhancer GRCh37_chr6:31172413-31173132 | 6 | 31204636 | 31205355 | Human |
155649520 | LOC127405779 | OCT4-H3K27ac hESC enhancer GRCh37_chr6:31173133-31173851 | 6 | 31205356 | 31206074 | Human |
155652700 | LOC127405780 | OCT4 hESC enhancer GRCh37_chr6:31178749-31179743 | 6 | 31210972 | 31211966 | Human |
329339628 | LOC129661704 | ReSE screen-validated silencer GRCh37_chr6:31180245-31180430 | 6 | 31212468 | 31212653 | Human |
155659032 | LOC127405781 | OCT4 hESC enhancer GRCh37_chr6:31183567-31184468 | 6 | 31215790 | 31216691 | Human |
155653752 | LOC127405782 | OCT4 hESC enhancer GRCh37_chr6:31190777-31191278 | 6 | 31223000 | 31223501 | Human |
155651292 | LOC127405783 | OCT4 hESC enhancer GRCh37_chr6:31192075-31192697 | 6 | 31224298 | 31224920 | Human |
155654486 | LOC127405784 | OCT4 hESC enhancer GRCh37_chr6:31192791-31193386 | 6 | 31225014 | 31225609 | Human |
155659058 | LOC127405785 | OCT4 hESC enhancer GRCh37_chr6:31196240-31196741 | 6 | 31228463 | 31228964 | Human |
155650274 | LOC127405786 | OCT4 hESC enhancer GRCh37_chr6:31197314-31197823 | 6 | 31229537 | 31230046 | Human |
155656131 | LOC127405787 | OCT4 hESC enhancer GRCh37_chr6:31203152-31203653 | 6 | 31235375 | 31235876 | Human |
155647355 | LOC127405788 | OCT4 hESC enhancer GRCh37_chr6:31207427-31207928 | 6 | 31239650 | 31240151 | Human |
155649741 | LOC127405789 | NANOG-H3K27ac hESC enhancer GRCh37_chr6:31212376-31213125 | 6 | 31244599 | 31245348 | Human |
155656456 | LOC127405790 | OCT4 hESC enhancer GRCh37_chr6:31213660-31214161 | 6 | 31245883 | 31246384 | Human |
155657141 | LOC127405791 | OCT4 hESC enhancer GRCh37_chr6:31217950-31218451 | 6 | 31250173 | 31250674 | Human |
155663247 | LOC127405792 | OCT4 hESC enhancer GRCh37_chr6:31220759-31221378 | 6 | 31252982 | 31253601 | Human |
155650809 | LOC127405793 | OCT4 hESC enhancer GRCh37_chr6:31221379-31221998 | 6 | 31253602 | 31254221 | Human |
155646938 | LOC127405794 | OCT4 hESC enhancer GRCh37_chr6:31222367-31223043 | 6 | 31254590 | 31255266 | Human |
155652543 | LOC127405795 | OCT4 hESC enhancer GRCh37_chr6:31227633-31228239 | 6 | 31259856 | 31260462 | Human |
155648697 | LOC127405796 | OCT4 hESC enhancer GRCh37_chr6:31228743-31229244 | 6 | 31260966 | 31261467 | Human |
155657778 | LOC127405797 | OCT4 hESC enhancer GRCh37_chr6:31234264-31235207 | 6 | 31266487 | 31267430 | Human |
155657426 | LOC127405798 | OCT4 hESC enhancer GRCh37_chr6:31235343-31235902 | 6 | 31267566 | 31268125 | Human |
155652508 | LOC127405799 | OCT4 hESC enhancer GRCh37_chr6:31236021-31236522 | 6 | 31268244 | 31268745 | Human |
1343149 | HLA-C | major histocompatibility complex, class I, C | 6 | 31268749 | 31272092 | Human |
155654766 | LOC127405800 | OCT4 hESC enhancer GRCh37_chr6:31237308-31237809 | 6 | 31269531 | 31270032 | Human |
1350484 | USP8P1 | USP8 pseudogene 1 | 6 | 31275572 | 31279424 | Human |
155662574 | LOC127405801 | OCT4 hESC enhancer GRCh37_chr6:31246711-31247212 | 6 | 31278934 | 31279435 | Human |
155652988 | LOC127405802 | OCT4 hESC enhancer GRCh37_chr6:31247287-31248172 | 6 | 31279510 | 31280395 | Human |
1352938 | RPL3P2 | ribosomal protein L3 pseudogene 2 | 6 | 31280291 | 31281571 | Human |
155656998 | LOC127405803 | OCT4 hESC enhancer GRCh37_chr6:31248173-31249056 | 6 | 31280396 | 31281279 | Human |
155652024 | LOC127405804 | OCT4 hESC enhancer GRCh37_chr6:31250536-31251037 | 6 | 31282759 | 31283260 | Human |
155658902 | LOC127405805 | OCT4 hESC enhancer GRCh37_chr6:31251218-31252141 | 6 | 31283441 | 31284364 | Human |
1353645 | WASF5P | WASP family member 5, pseudogene | 6 | 31287501 | 31289115 | Human |
155661212 | LOC127405806 | OCT4 hESC enhancer GRCh37_chr6:31255707-31256557 | 6 | 31287930 | 31288780 | Human |
13208277 | LINC02571 | long intergenic non-protein coding RNA 2571 | 6 | 31293908 | 31301637 | Human |
38619036 | LOC112267902 | uncharacterized LOC112267902 | 6 | 31296826 | 31308594 | Human |
155229783 | LOC126859648 | MED14-independent group 3 enhancer GRCh37_chr6:31304266-31305465 | 6 | 31336489 | 31337688 | Human |
1352836 | HLA-B | major histocompatibility complex, class I, B | 6 | 31353875 | 31357179 | Human |
8551453 | MIR6891 | microRNA 6891 | 6 | 31355224 | 31355316 | Human |
155654587 | LOC127405807 | H3K4me1 hESC enhancer GRCh37_chr6:31324399-31325022 | 6 | 31356622 | 31357245 | Human |
1354176 | DHFRP2 | dihydrofolate reductase pseudogene 2 | 6 | 31363467 | 31366965 | Human |
10398834 | RNU6-283P | RNA, U6 small nuclear 283, pseudogene | 6 | 31370134 | 31370240 | Human |
150537078 | LOC123620083 | Sharpr-MPRA regulatory region 11702 | 6 | 31377652 | 31377946 | Human |
1347116 | FGFR3P1 | fibroblast growth factor receptor 3 pseudogene 1 | 6 | 31377717 | 31378028 | Human |
5134855 | ZDHHC20P2 | zinc finger DHHC-type containing 20 pseudogene 2 | 6 | 31380408 | 31380839 | Human |
1349267 | HLA-S | major histocompatibility complex, class I, S (pseudogene) | 6 | 31381569 | 31382487 | Human |
151670432 | LOC124901300 | uncharacterized LOC124901300 | 6 | 31385257 | 31387858 | Human |
13208475 | MICA-AS1 | MICA antisense RNA 1 | 6 | 31394289 | 31400470 | Human |
155648646 | LOC127405808 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31367562-31368428 | 6 | 31399785 | 31400651 | Human |
1345713 | MICA | MHC class I polypeptide-related sequence A | 6 | 31400711 | 31415315 | Human |
7758256 | LINC01149 | long intergenic non-protein coding RNA 1149 | 6 | 31441667 | 31446973 | Human |
1344404 | HLA-X | major histocompatibility complex, class I, X (pseudogene) | 6 | 31461846 | 31462490 | Human |
126781797 | LOC121132677 | BRD4-independent group 4 enhancer GRCh37_chr6:31430252-31431451 | 6 | 31462475 | 31463674 | Human |
1349217 | HCP5 | HLA complex P5 | 6 | 31463180 | 31465809 | Human |
1350954 | HCG26 | HLA complex group 26 | 6 | 31471229 | 31472408 | Human |
155662343 | LOC127405809 | H3K4me1 hESC enhancer GRCh37_chr6:31442899-31443399 | 6 | 31475122 | 31475622 | Human |
13208450 | MICB-DT | MICB divergent transcript | 6 | 31479918 | 31494794 | Human |
155652482 | LOC127405810 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31455304-31456014 | 6 | 31487527 | 31488237 | Human |
155657250 | LOC127405811 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31456015-31456724 | 6 | 31488238 | 31488947 | Human |
155654633 | LOC127405812 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31461392-31462273 | 6 | 31493615 | 31494496 | Human |
1354237 | MICB | MHC class I polypeptide-related sequence B | 6 | 31494918 | 31511124 | Human |
1345892 | PPIAP9 | peptidylprolyl isomerase A pseudogene 9 | 6 | 31518977 | 31520330 | Human |
1348057 | RPL15P4 | ribosomal protein L15 pseudogene 4 | 6 | 31528072 | 31528721 | Human |
1352481 | MCCD1 | mitochondrial coiled-coil domain 1 | 6 | 31528962 | 31530232 | Human |
5133074 | ATP6V1G2-DDX39B | ATP6V1G2-DDX39B readthrough (NMD candidate) | 6 | 31530219 | 31546848 | Human |
737407 | DDX39B | DExD-box helicase 39B | 6 | 31530226 | 31542003 | Human |
1602350 | SNORD117 | small nucleolar RNA, C/D box 117 | 6 | 31536374 | 31536449 | Human |
1602533 | SNORD84 | small nucleolar RNA, C/D box 84 | 6 | 31541101 | 31541178 | Human |
155230225 | LOC126859649 | MED14-independent group 3 enhancer GRCh37_chr6:31509210-31510409 | 6 | 31541433 | 31542660 | Human |
10400159 | DDX39B-AS1 | DDX39B antisense RNA 1 | 6 | 31542304 | 31543138 | Human |
1347481 | ATP6V1G2 | ATPase H+ transporting V1 subunit G2 | 6 | 31544444 | 31546742 | Human |
155658966 | LOC127405813 | H3K4me1 hESC enhancer GRCh37_chr6:31513919-31514418 | 6 | 31546142 | 31546641 | Human |
1351897 | NFKBIL1 | NFKB inhibitor like 1 | 6 | 31546851 | 31558829 | Human |
38645603 | LOC100287329 | uncharacterized LOC100287329 | 6 | 31559571 | 31572703 | Human |
1345394 | LTA | lymphotoxin alpha | 6 | 31560610 | 31574324 | Human |
1344192 | TNF | tumor necrosis factor | 6 | 31575565 | 31578336 | Human |
155230296 | LOC126859650 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:31545791-31546990 | 6 | 31578014 | 31579213 | Human |
1353964 | LTB | lymphotoxin beta | 6 | 31580558 | 31582425 | Human |
155650726 | LOC127405814 | H3K4me1 hESC enhancer GRCh37_chr6:31549801-31550555 | 6 | 31582024 | 31582778 | Human |
1350273 | LST1 | leukocyte specific transcript 1 | 6 | 31586277 | 31588909 | Human |
1353948 | NCR3 | natural cytotoxicity triggering receptor 3 | 6 | 31588895 | 31593006 | Human |
155657127 | LOC127405815 | H3K4me1 hESC enhancer GRCh37_chr6:31557557-31558057 | 6 | 31589780 | 31590280 | Human |
155647628 | LOC127405816 | H3K4me1 hESC enhancer GRCh37_chr6:31561069-31561989 | 6 | 31593292 | 31594212 | Human |
155656047 | LOC127405817 | H3K4me1 hESC enhancer GRCh37_chr6:31565006-31565506 | 6 | 31597229 | 31597729 | Human |
155647025 | LOC127405818 | H3K4me1 hESC enhancer GRCh37_chr6:31565507-31566007 | 6 | 31597730 | 31598230 | Human |
2946958 | UQCRHP1 | ubiquinol-cytochrome c reductase hinge protein pseudogene 1 | 6 | 31611083 | 31611356 | Human |
735562 | AIF1 | allograft inflammatory factor 1 | 6 | 31615234 | 31617015 | Human |
155660636 | LOC127405819 | H3K27ac hESC enhancer GRCh37_chr6:31583276-31583776 | 6 | 31615499 | 31615999 | Human |
155651817 | LOC127405820 | H3K27ac hESC enhancer GRCh37_chr6:31583777-31584277 | 6 | 31616000 | 31616500 | Human |
1350670 | PRRC2A | proline rich coiled-coil 2A | 6 | 31620715 | 31637771 | Human |
1602576 | SNORA38 | small nucleolar RNA, H/ACA box 38 | 6 | 31623079 | 31623210 | Human |
155655343 | LOC127405821 | H3K4me1 hESC enhancer GRCh37_chr6:31591608-31592555 | 6 | 31623831 | 31624778 | Human |
155660650 | LOC127405822 | H3K4me1 hESC enhancer GRCh37_chr6:31592556-31593502 | 6 | 31624779 | 31625725 | Human |
8551020 | MIR6832 | microRNA 6832 | 6 | 31633787 | 31633858 | Human |
329340169 | LOC129661705 | ReSE screen-validated silencer GRCh37_chr6:31602456-31602619 | 6 | 31634679 | 31634842 | Human |
733092 | BAG6 | BAG cochaperone 6 | 6 | 31639028 | 31652661 | Human |
155655166 | LOC127405823 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31619307-31619886 | 6 | 31651530 | 31652109 | Human |
155649253 | LOC127405824 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31619887-31620466 | 6 | 31652110 | 31652689 | Human |
1351807 | APOM | apolipoprotein M | 6 | 31652404 | 31658210 | Human |
155648805 | LOC127405825 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31620467-31621046 | 6 | 31652690 | 31653269 | Human |
1354435 | C6orf47 | chromosome 6 open reading frame 47 | 6 | 31658298 | 31660778 | Human |
150537081 | LOC123620084 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31627653-31628190 | 6 | 31659876 | 31660413 | Human |
155657421 | LOC127405826 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31628191-31628727 | 6 | 31660414 | 31660950 | Human |
1321766 | GPANK1 | G-patch domain and ankyrin repeats 1 | 6 | 31661228 | 31666283 | Human |
155649631 | LOC127405827 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31633065-31633659 | 6 | 31665288 | 31665882 | Human |
1347139 | CSNK2B | casein kinase 2 beta | 6 | 31666080 | 31670067 | Human |
1349012 | LY6G5B | lymphocyte antigen 6 family member G5B | 6 | 31669976 | 31673546 | Human |
1346509 | LY6G5C | lymphocyte antigen 6 family member G5C | 6 | 31676684 | 31681067 | Human |
329338469 | LOC129661706 | ReSE screen-validated silencer GRCh37_chr6:31647890-31648097 | 6 | 31680113 | 31680320 | Human |
38613300 | LOC105375019 | uncharacterized LOC105375019 | 6 | 31682852 | 31686850 | Human |
1351609 | ABHD16A | abhydrolase domain containing 16A, phospholipase | 6 | 31686955 | 31703324 | Human |
38649718 | LOC105375018 | uncharacterized LOC105375018 | 6 | 31689649 | 31691316 | Human |
5134148 | MIR4646 | microRNA 4646 | 6 | 31701029 | 31701091 | Human |
1342827 | LY6G6F | lymphocyte antigen 6 family member G6F | 6 | 31706866 | 31710679 | Human |
14995524 | LY6G6F-LY6G6D | LY6G6F-LY6G6D readthrough | 6 | 31706866 | 31717919 | Human |
1348643 | LY6G6E | lymphocyte antigen 6 family member G6E (pseudogene) | 6 | 31711976 | 31714065 | Human |
155662952 | LOC127405828 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31681075-31681858 | 6 | 31713298 | 31714081 | Human |
1354154 | LY6G6D | lymphocyte antigen 6 family member G6D | 6 | 31715348 | 31717919 | Human |
1344908 | LY6G6C | lymphocyte antigen 6 family member G6C | 6 | 31718648 | 31721746 | Human |
1354388 | MPIG6B | megakaryocyte and platelet inhibitory receptor G6b | 6 | 31720296 | 31726714 | Human |
1346413 | DDAH2 | DDAH family member 2, ADMA-independent | 6 | 31727040 | 31730263 | Human |
1353337 | CLIC1 | chloride intracellular channel 1 | 6 | 31730581 | 31737318 | Human |
38667387 | LOC113174991 | MED14-independent group 3 enhancer GRCh37_chr6:31701615-31702814 | 6 | 31733838 | 31735037 | Human |
155660175 | LOC127405829 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31704508-31705382 | 6 | 31736731 | 31737605 | Human |
38660035 | LOC105375020 | uncharacterized LOC105375020 | 6 | 31737421 | 31739935 | Human |
155646823 | LOC127405830 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31707224-31707854 | 6 | 31739447 | 31740077 | Human |
5133069 | MSH5-SAPCD1 | MSH5-SAPCD1 readthrough (NMD candidate) | 6 | 31739948 | 31764850 | Human |
1343663 | MSH5 | mutS homolog 5 | 6 | 31740005 | 31762676 | Human |
155653370 | LOC127405831 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31707855-31708486 | 6 | 31740078 | 31740709 | Human |
10399655 | RNU6-850P | RNA, U6 small nuclear 850, pseudogene | 6 | 31756951 | 31757053 | Human |
1352760 | SAPCD1 | suppressor APC domain containing 1 | 6 | 31762656 | 31764850 | Human |
155654374 | LOC127405832 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31731027-31731582 | 6 | 31763250 | 31763805 | Human |
9588831 | SAPCD1-AS1 | SAPCD1 antisense RNA 1 | 6 | 31764135 | 31765588 | Human |
1342662 | VWA7 | von Willebrand factor A domain containing 7 | 6 | 31765590 | 31777328 | Human |
126781790 | LOC121132678 | Sharpr-MPRA regulatory regions 3149 and 4553 | 6 | 31772872 | 31773186 | Human |
735744 | VARS1 | valyl-tRNA synthetase 1 | 6 | 31777518 | 31795752 | Human |
329343201 | LOC129661707 | ReSE screen-validated silencer GRCh37_chr6:31759127-31759287 | 6 | 31791350 | 31791510 | Human |
155229651 | LOC126859651 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:31759783-31760982 | 6 | 31792006 | 31793205 | Human |
155651858 | LOC127405833 | H3K27ac hESC enhancer GRCh37_chr6:31763127-31763981 | 6 | 31795350 | 31796204 | Human |
1350592 | LSM2 | LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated | 6 | 31797396 | 31806966 | Human |
1353078 | HSPA1L | heat shock protein family A (Hsp70) member 1 like | 6 | 31809619 | 31815283 | Human |
155754835 | LOC127882482 | H3K27ac hESC enhancer GRCh37_chr6:31782423-31783252 | 6 | 31814646 | 31815475 | Human |
38647160 | LOC107063610 | origin of replication in promoter of HSPA1A | 6 | 31815250 | 31815907 | Human |
1349475 | HSPA1A | heat shock protein family A (Hsp70) member 1A | 6 | 31815543 | 31817942 | Human |
155647912 | LOC127405834 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31783959-31784528 | 6 | 31816182 | 31816751 | Human |
155647952 | LOC127405835 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31784529-31785098 | 6 | 31816752 | 31817321 | Human |
155227329 | LOC126859652 | MED14-independent group 3 enhancer GRCh37_chr6:31789548-31790747 | 6 | 31821771 | 31822970 | Human |
155660892 | LOC127405836 | H3K27ac hESC enhancer GRCh37_chr6:31794443-31795254 | 6 | 31826666 | 31827477 | Human |
155651288 | LOC127405837 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31795278-31795907 | 6 | 31827501 | 31828130 | Human |
736398 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 6 | 31827738 | 31830254 | Human |
155652141 | LOC127405838 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31795908-31796536 | 6 | 31828131 | 31828759 | Human |
155651179 | LOC127405839 | H3K27ac hESC enhancer GRCh37_chr6:31801830-31802528 | 6 | 31834053 | 31834751 | Human |
1344247 | SNHG32 | small nucleolar RNA host gene 32 | 6 | 31834916 | 31839761 | Human |
1352935 | SNORD48 | small nucleolar RNA, C/D box 48 | 6 | 31835263 | 31835326 | Human |
1344796 | SNORD52 | small nucleolar RNA, C/D box 52 | 6 | 31837076 | 31837139 | Human |
735984 | NEU1 | neuraminidase 1 | 6 | 31857659 | 31862821 | Human |
155662165 | LOC127405840 | H3K27ac hESC enhancer GRCh37_chr6:31830779-31831404 | 6 | 31863002 | 31863627 | Human |
1349303 | SLC44A4 | solute carrier family 44 member 4 | 6 | 31863192 | 31878997 | Human |
155656460 | LOC127405841 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31831405-31832028 | 6 | 31863628 | 31864251 | Human |
155660814 | LOC127405842 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31832029-31832653 | 6 | 31864252 | 31864876 | Human |
155660371 | LOC127405843 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31838055-31838988 | 6 | 31870278 | 31871211 | Human |
38636852 | EHMT2-AS1 | EHMT2 and SLC44A4 antisense RNA 1 | 6 | 31877808 | 31884204 | Human |
1605700 | EHMT2 | euchromatic histone lysine methyltransferase 2 | 6 | 31879759 | 31897698 | Human |
155657314 | LOC127405844 | H3K4me1 hESC enhancer GRCh37_chr6:31864618-31865314 | 6 | 31896841 | 31897537 | Human |
155652648 | LOC127405845 | H3K27ac hESC enhancer GRCh37_chr6:31865398-31865992 | 6 | 31897621 | 31898215 | Human |
1353499 | C2 | complement C2 | 6 | 31897783 | 31945672 | Human |
1342499 | ZBTB12 | zinc finger and BTB domain containing 12 | 6 | 31899613 | 31902086 | Human |
8695014 | C2-AS1 | C2 antisense RNA 1 | 6 | 31934474 | 31941724 | Human |
1350557 | CFB | complement factor B | 6 | 31946095 | 31952084 | Human |
155662769 | LOC127405846 | H3K4me1 hESC enhancer GRCh37_chr6:31915103-31915602 | 6 | 31947326 | 31947825 | Human |
1344973 | NELFE | negative elongation factor complex member E | 6 | 31952087 | 31958971 | Human |
2312906 | MIR1236 | microRNA 1236 | 6 | 31956839 | 31956940 | Human |
1351044 | SKIC2 | SKI2 subunit of superkiller complex | 6 | 31959175 | 31969751 | Human |
155229269 | LOC126859653 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:31929542-31930741 | 6 | 31961765 | 31962964 | Human |
1348619 | DXO | decapping exoribonuclease | 6 | 31969815 | 31972138 | Human |
1347475 | WHR1 | winged helix repair factor 1 | 6 | 31971175 | 31981446 | Human |
155649792 | LOC127405847 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:31939702-31940412 | 6 | 31971925 | 31972635 | Human |
1350864 | C4A | complement C4A (Chido/Rodgers blood group) | 6 | 31982057 | 32002681 | Human |
1347734 | CYP21A1P | cytochrome P450 family 21 subfamily A member 1, pseudogene | 6 | 32005636 | 32008909 | Human |
38638800 | LOC108004539 | CYP21A1P recombination region | 6 | 32005826 | 32008652 | Human |
1343878 | TNXA | tenascin XA (pseudogene) | 6 | 32008420 | 32013023 | Human |
38633277 | LOC106780804 | tenascin XA (pseudogene) recombination region | 6 | 32008873 | 32013268 | Human |
1352725 | WHR1B | winged helix repair factor 1B (pseudogene) | 6 | 32013390 | 32014184 | Human |
1605129 | C4B | complement C4B (Chido/Rodgers blood group) | 6 | 32014795 | 32035418 | Human |
38658401 | LOC110631417 | CYP21A2 5' regulatory region | 6 | 32033425 | 32038438 | Human |
38669817 | LOC106780800 | CYP21A2 recombination region | 6 | 32037872 | 32041144 | Human |
1346271 | CYP21A2 | cytochrome P450 family 21 subfamily A member 2 | 6 | 32038415 | 32041644 | Human |
1345578 | TNXB | tenascin XB | 6 | 32041153 | 32109338 | Human |
38665552 | LOC106780803 | tenascin XB recombination region | 6 | 32041608 | 32046122 | Human |
329337944 | LOC129661708 | ReSE screen-validated silencer GRCh37_chr6:32013699-32013950 | 6 | 32045922 | 32046173 | Human |
155229305 | LOC126859654 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:32014364-32015563 | 6 | 32046587 | 32047786 | Human |
155659355 | LOC127405848 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32015753-32016386 | 6 | 32047976 | 32048609 | Human |
155656502 | LOC127405849 | H3K4me1 hESC enhancer GRCh37_chr6:32038327-32039327 | 6 | 32070550 | 32071550 | Human |
155648557 | LOC127405850 | H3K4me1 hESC enhancer GRCh37_chr6:32040222-32041078 | 6 | 32072445 | 32073301 | Human |
155648338 | LOC127405851 | H3K4me1 hESC enhancer GRCh37_chr6:32041114-32041614 | 6 | 32073337 | 32073837 | Human |
10413195 | RNA5SP206 | RNA, 5S ribosomal pseudogene 206 | 6 | 32078508 | 32078628 | Human |
155647750 | LOC127405852 | H3K4me1 hESC enhancer GRCh37_chr6:32049385-32049900 | 6 | 32081608 | 32082123 | Human |
1346168 | ATF6B | activating transcription factor 6 beta | 6 | 32115264 | 32128246 | Human |
150537085 | LOC123620085 | Sharpr-MPRA regulatory region 2290 | 6 | 32118892 | 32119186 | Human |
1353952 | FKBPL | FKBP prolyl isomerase like | 6 | 32128707 | 32130288 | Human |
38675312 | LOC116183058 | CRISPRi-validated cis-regulatory element chr6.1802 | 6 | 32131505 | 32131952 | Human |
1345386 | PRRT1 | proline rich transmembrane protein 1 | 6 | 32148363 | 32153083 | Human |
155650593 | LOC127405853 | H3K4me1 hESC enhancer GRCh37_chr6:32116858-32117395 | 6 | 32149081 | 32149618 | Human |
16570592 | AL662884.3 | novel transcript | 6 | 32152802 | 32154365 | Human |
731722 | PPT2 | palmitoyl-protein thioesterase 2 | 6 | 32153528 | 32163675 | Human |
7243718 | PPT2-EGFL8 | PPT2-EGFL8 readthrough (NMD candidate) | 6 | 32153999 | 32168285 | Human |
1347289 | EGFL8 | EGF like domain multiple 8 | 6 | 32164595 | 32168281 | Human |
155650231 | LOC127405854 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32134815-32135567 | 6 | 32167038 | 32167790 | Human |
1348475 | AGPAT1 | 1-acylglycerol-3-phosphate O-acyltransferase 1 | 6 | 32168212 | 32178108 | Human |
155227142 | LOC126859655 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr6:32137076-32138275 | 6 | 32169299 | 32170498 | Human |
8550681 | MIR6721 | microRNA 6721 | 6 | 32170030 | 32170116 | Human |
155657570 | LOC127405855 | H3K27ac hESC enhancer GRCh37_chr6:32145942-32146470 | 6 | 32178165 | 32178693 | Human |
1352556 | RNF5 | ring finger protein 5 | 6 | 32178405 | 32180793 | Human |
8550530 | MIR6833 | microRNA 6833 | 6 | 32179816 | 32179876 | Human |
737312 | AGER | advanced glycosylation end-product specific receptor | 6 | 32180969 | 32184253 | Human |
155653632 | LOC127405856 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32150105-32150623 | 6 | 32182328 | 32182846 | Human |
155649916 | LOC127405857 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32150624-32151141 | 6 | 32182847 | 32183364 | Human |
1350680 | PBX2 | PBX homeobox 2 | 6 | 32184733 | 32190202 | Human |
155660800 | LOC127405858 | H3K4me1 hESC enhancer GRCh37_chr6:32156057-32156613 | 6 | 32188280 | 32188836 | Human |
155650442 | LOC127405859 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32157766-32158334 | 6 | 32189989 | 32190557 | Human |
1343729 | GPSM3 | G protein signaling modulator 3 | 6 | 32190766 | 32195523 | Human |
329339298 | LOC129661709 | ReSE screen-validated silencer GRCh37_chr6:32158721-32158899 | 6 | 32190944 | 32191122 | Human |
1354309 | NOTCH4 | notch receptor 4 | 6 | 32194843 | 32224067 | Human |
155649491 | LOC127405860 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32163365-32164145 | 6 | 32195588 | 32196368 | Human |
155660957 | LOC127405861 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32164146-32164927 | 6 | 32196369 | 32197150 | Human |
155650594 | LOC127405862 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32164928-32165708 | 6 | 32197151 | 32197931 | Human |
155659679 | LOC127405863 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32222789-32223446 | 6 | 32255012 | 32255669 | Human |
13782242 | TSBP1-AS1 | TSBP1 and BTNL2 antisense RNA 1 | 6 | 32255173 | 32407730 | Human |
155650680 | LOC127405864 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr6:32223447-32224103 | 6 | 32255670 | 32256326 | Human |
329339727 | LOC129389488 | MPRA-validated peak5754 silencer | 6 | 32291638 | 32291838 | Human |
1346663 | TSBP1 | testis expressed basic protein 1 | 6 | 32292698 | 32371903 | Human |
1345278 | HNRNPA1P2 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 2 | 6 | 32325198 | 32326521 | Human |
10400638 | RNU6-603P | RNA, U6 small nuclear 603, pseudogene | 6 | 32352877 | 32352983 | Human |
329329690 | LOC129389489 | MPRA-validated peak5755 silencer | 6 | 32355058 | 32355258 | Human |
1348807 | HCG23 | HLA complex group 23 | 6 | 32390510 | 32393691 | Human |
1353557 | BTNL2 | butyrophilin like 2 | 6 | 32393339 | 32407181 | Human |
329341780 | LOC129661710 | ReSE screen-validated silencer GRCh37_chr6:32382003-32382278 | 6 | 32414226 | 32414501 | Human |
329338570 | LOC129661711 | ReSE screen-validated silencer GRCh37_chr6:32382475-32382623 | 6 | 32414698 | 32414846 | Human |
1344093 | HLA-DRA | major histocompatibility complex, class II, DR alpha | 6 | 32439887 | 32445046 | Human |
1345710 | HLA-DRB9 | major histocompatibility complex, class II, DR beta 9 (pseudogene) | 6 | 32459820 | 32460089 | Human |
155646779 | LOC127405865 | H3K4me1 hESC enhancer GRCh37_chr6:32427819-32428319 | 6 | 32460042 | 32460542 | Human |
329342096 | LOC129389490 | MPRA-validated peak5756 silencer | 6 | 32462638 | 32462838 | Human |
1350012 | HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 6 | 32517353 | 32530287 | Human |
155652013 | LOC127405866 | H3K4me1 hESC enhancer GRCh37_chr6:32515949-32516448 | 6 | 32548172 | 32548671 | Human |
10413565 | RNU1-61P | RNA, U1 small nuclear 61, pseudogene | 6 | 32549940 | 32550090 | Human |
1354106 | HLA-DRB6 | major histocompatibility complex, class II, DR beta 6 (pseudogene) | 6 | 32552713 | 32560002 | Human |
13208487 | RNU1-152P | RNA, U1 small nuclear 152, pseudogene | 6 | 32576277 | 32576423 | Human |
1349823 | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 | 6 | 32578775 | 32589848 | Human |
151675939 | HLA-DQA1-AS1 | HLA-DQA1 antisense RNA 1 | 6 | 32634991 | 32641310 | Human |
329819250 | LOC129996175 | ATAC-STARR-seq lymphoblastoid active region 24360 | 6 | 32637210 | 32637359 | Human |
1351810 | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 6 | 32637406 | 32655272 | Human |
155660476 | LOC127405867 | OCT4-NANOG hESC enhancer GRCh37_chr6:32623606-32624294 | 6 | 32655829 | 32656517 | Human |
1353906 | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 6 | 32659467 | 32666657 | Human |
10398884 | HLA-DQB1-AS1 | HLA-DQB1 antisense RNA 1 | 6 | 32659880 | 32660729 | Human |
155660968 | LOC127405868 | H3K4me1 hESC enhancer GRCh37_chr6:32632197-32632724 | 6 | 32664420 | 32664947 | Human |
1352145 | MTCO3P1 | MT-CO3 pseudogene 1 | 6 | 32706144 | 32706803 | Human |
156451435 | LOC128772278 | melanoma risk locus-associated MPRA allelic enhancer 6:32682862 | 6 | 32715013 | 32715157 | Human |
156451501 | LOC128772279 | melanoma risk locus-associated MPRA allelic enhancer 6:32685380 | 6 | 32717531 | 32717675 | Human |
16555229 | AL662789.1 | novel transcript | 6 | 32718019 | 32718827 | Human |
156451566 | LOC128772280 | melanoma risk locus-associated MPRA allelic enhancer 6:32698988 | 6 | 32731139 | 32731283 | Human |
1350485 | HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 6 | 32741391 | 32747198 | Human |
5133971 | MIR3135B | microRNA 3135b | 6 | 32749912 | 32749979 | Human |
1354401 | HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 6 | 32756098 | 32763532 | Human |
156451577 | LOC128772281 | melanoma risk locus-associated MPRA allelic enhancer 6:32746394 | 6 | 32778545 | 32778689 | Human |
242988347 | LOC128781587 | melanoma risk locus-associated MPRA allelic enhancers 6:32747727 and 6:32747786 | 6 | 32779878 | 32780081 | Human |
156451547 | LOC128772282 | melanoma risk locus-associated MPRA allelic enhancer 6:32748021 | 6 | 32780172 | 32780316 | Human |
156451429 | LOC128772283 | melanoma risk locus-associated MPRA allelic enhancer 6:32748137 | 6 | 32780288 | 32780432 | Human |
156451492 | LOC128772284 | melanoma risk locus-associated MPRA allelic enhancer 6:32749836 | 6 | 32781987 | 32782131 | Human |
156451465 | LOC128772285 | melanoma risk locus-associated MPRA allelic enhancer 6:32750346 | 6 | 32782497 | 32782641 | Human |
156451572 | LOC128772286 | melanoma risk locus-associated MPRA allelic enhancer 6:32751751 | 6 | 32783902 | 32784046 | Human |
156451499 | LOC128772287 | melanoma risk locus-associated MPRA allelic enhancer 6:32752130 | 6 | 32784281 | 32784425 | Human |
242979945 | LOC128781588 | melanoma risk locus-associated MPRA allelic enhancers 6:32752436, 6:32752477 and 6:32752546 | 6 | 32784587 | 32784841 | Human |
156451440 | LOC128772288 | melanoma risk locus-associated MPRA allelic enhancer 6:32752973 | 6 | 32785127 | 32785271 | Human |
156451533 | LOC128772289 | melanoma risk locus-associated MPRA allelic enhancer 6:32753654 | 6 | 32785805 | 32785949 | Human |
156451497 | LOC128772290 | melanoma risk locus-associated MPRA allelic enhancer 6:32754294 | 6 | 32786445 | 32786589 | Human |
156451502 | LOC128772291 | melanoma risk locus-associated MPRA allelic enhancer 6:32754458 | 6 | 32786609 | 32786753 | Human |
156451455 | LOC128772292 | melanoma risk locus-associated MPRA allelic enhancer 6:32754921 | 6 | 32787072 | 32787216 | Human |
156451600 | LOC128772293 | melanoma risk locus-associated MPRA allelic enhancer 6:32755087 | 6 | 32787238 | 32787382 | Human |
156451558 | LOC128772294 | melanoma risk locus-associated MPRA allelic enhancer 6:32756916 | 6 | 32789067 | 32789211 | Human |
156451454 | LOC128772295 | melanoma risk locus-associated MPRA allelic enhancer 6:32762528 | 6 | 32794679 | 32794823 | Human |
1346079 | HLA-DOB | major histocompatibility complex, class II, DO beta | 6 | 32812763 | 32817002 | Human |
1348865 | TAP2 | transporter 2, ATP binding cassette subfamily B member | 6 | 32821831 | 32838739 | Human |
38604177 | LOC107648851 | meiotic recombination hotspot TAP2 | 6 | 32835539 | 32837694 | Human |
731895 | PSMB8 | proteasome 20S subunit beta 8 | 6 | 32840717 | 32844679 | Human |
7247806 | PSMB8-AS1 | PSMB8 antisense RNA 1 (head to head) | 6 | 32844086 | 32846500 | Human |
736475 | TAP1 | transporter 1, ATP binding cassette subfamily B member | 6 | 32845209 | 32853704 | Human |
737219 | PSMB9 | proteasome 20S subunit beta 9 | 6 | 32854192 | 32859851 | Human |
1353440 | PPP1R2P1 | protein phosphatase 1 regulatory inhibitor subunit 2 pseudogene 1 | 6 | 32876478 | 32880074 | Human |
38650029 | LOC100294145 | uncharacterized LOC100294145 | 6 | 32894176 | 32903758 | Human |
1349791 | HLA-Z | major histocompatibility complex, class I, Z (pseudogene) | 6 | 32896402 | 32896489 | Human |
QTLs in Region (GRCh38)
597435294 | GWAS1531368_H | asthma QTL GWAS1531368 (human) | | 2e-10 | asthma | | 6 | 30010092 | 30010093 | Human |
597173136 | GWAS1269210_H | hephaestin-like protein 1 measurement QTL GWAS1269210 (human) | | 2e-19 | hephaestin-like protein 1 measurement | | 6 | 31942385 | 31942386 | Human |
597402514 | GWAS1498588_H | emphysema imaging measurement QTL GWAS1498588 (human) | | 0.000004 | emphysema imaging measurement | | 6 | 18575069 | 18575070 | Human |
597533584 | GWAS1629658_H | bone density QTL GWAS1629658 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 24729841 | 24729842 | Human |
407017548 | GWAS666524_H | Graves disease QTL GWAS666524 (human) | | 1e-13 | Graves disease | | 6 | 30569829 | 30569830 | Human |
597074822 | GWAS1170896_H | type 2 diabetes mellitus QTL GWAS1170896 (human) | | 1e-09 | type 2 diabetes mellitus | | 6 | 7290204 | 7290205 | Human |
597533581 | GWAS1629655_H | bone density QTL GWAS1629655 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 22559265 | 22559266 | Human |
597205896 | GWAS1301970_H | grip strength measurement QTL GWAS1301970 (human) | | 7e-12 | grip strength measurement | | 6 | 31624141 | 31624142 | Human |
597533580 | GWAS1629654_H | bone density QTL GWAS1629654 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 7897266 | 7897267 | Human |
597074823 | GWAS1170897_H | type 2 diabetes mellitus QTL GWAS1170897 (human) | | 2e-31 | type 2 diabetes mellitus | | 6 | 20661019 | 20661020 | Human |
597533583 | GWAS1629657_H | bone density QTL GWAS1629657 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 24725643 | 24725644 | Human |
597533582 | GWAS1629656_H | bone density QTL GWAS1629656 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 24538218 | 24538219 | Human |
597435272 | GWAS1531346_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1531346 (human) | | 2e-11 | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 31297358 | 31297359 | Human |
597205900 | GWAS1301974_H | grip strength measurement QTL GWAS1301974 (human) | | 1e-09 | grip strength measurement | | 6 | 32592994 | 32592995 | Human |
597271436 | GWAS1367510_H | response to lithium ion QTL GWAS1367510 (human) | | 0.000003 | response to lithium ion | | 6 | 16985077 | 16985078 | Human |
597238670 | GWAS1334744_H | neutrophil-to-lymphocyte ratio QTL GWAS1334744 (human) | | 8e-23 | neutrophil-to-lymphocyte ratio | | 6 | 24805820 | 24805821 | Human |
597107599 | GWAS1203673_H | Red cell distribution width QTL GWAS1203673 (human) | | 1e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16285830 | 16285831 | Human |
597599110 | GWAS1655970_H | HbA1c measurement QTL GWAS1655970 (human) | | 1e-13 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 32422220 | 32422221 | Human |
597107598 | GWAS1203672_H | Red cell distribution width QTL GWAS1203672 (human) | | 2e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16267244 | 16267245 | Human |
597140366 | GWAS1236440_H | X-11444-to-X-11470 ratio QTL GWAS1236440 (human) | | 1e-14 | X-11444-to-X-11470 ratio | | 6 | 31628105 | 31628106 | Human |
597369729 | GWAS1465803_H | hematocrit QTL GWAS1465803 (human) | | 3e-32 | hematocrit | hematocrit (CMO:0000037) | 6 | 7255417 | 7255418 | Human |
597599109 | GWAS1655969_H | HbA1c measurement QTL GWAS1655969 (human) | | 3e-21 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 25857692 | 25857693 | Human |
597304193 | GWAS1400267_H | body height QTL GWAS1400267 (human) | | 3e-40 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 28865850 | 28865851 | Human |
597238663 | GWAS1334737_H | eosinophil count QTL GWAS1334737 (human) | | 1e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 29592703 | 29592704 | Human |
597074824 | GWAS1170898_H | type 2 diabetes mellitus QTL GWAS1170898 (human) | | 6e-09 | type 2 diabetes mellitus | | 6 | 31168676 | 31168677 | Human |
597304250 | GWAS1400324_H | BMI-adjusted waist-hip ratio QTL GWAS1400324 (human) | | 6e-13 | body size trait (VT:0100005) | | 6 | 31870936 | 31870937 | Human |
597304251 | GWAS1400325_H | BMI-adjusted waist-hip ratio QTL GWAS1400325 (human) | | 3e-25 | body size trait (VT:0100005) | | 6 | 31872244 | 31872245 | Human |
597238712 | GWAS1334786_H | retinal vasculature measurement QTL GWAS1334786 (human) | | 0.000005 | retina blood vessel morphology trait (VT:0002792) | | 6 | 32643641 | 32643642 | Human |
597304249 | GWAS1400323_H | BMI-adjusted waist-hip ratio QTL GWAS1400323 (human) | | 5e-11 | body size trait (VT:0100005) | | 6 | 31901896 | 31901897 | Human |
597402559 | GWAS1498633_H | myocardial infarction QTL GWAS1498633 (human) | | 0.000002 | myocardial infarction | | 6 | 22609936 | 22609937 | Human |
597304254 | GWAS1400328_H | BMI-adjusted waist-hip ratio QTL GWAS1400328 (human) | | 2e-13 | body size trait (VT:0100005) | | 6 | 31954477 | 31954478 | Human |
597468088 | GWAS1564162_H | feeling nervous measurement QTL GWAS1564162 (human) | | 4e-10 | feeling nervous measurement | | 6 | 32390912 | 32390913 | Human |
597533624 | GWAS1629698_H | body height QTL GWAS1629698 (human) | | 1e-300 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 31276244 | 31276245 | Human |
597304255 | GWAS1400329_H | BMI-adjusted waist-hip ratio QTL GWAS1400329 (human) | | 4e-11 | body size trait (VT:0100005) | | 6 | 31914247 | 31914248 | Human |
597468089 | GWAS1564163_H | feeling nervous measurement QTL GWAS1564163 (human) | | 2e-10 | feeling nervous measurement | | 6 | 32691868 | 32691869 | Human |
597107633 | GWAS1203707_H | testosterone measurement QTL GWAS1203707 (human) | | 1e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 17416027 | 17416028 | Human |
597402557 | GWAS1498631_H | myocardial infarction QTL GWAS1498631 (human) | | 1e-08 | myocardial infarction | | 6 | 31276118 | 31276119 | Human |
597304252 | GWAS1400326_H | BMI-adjusted waist-hip ratio QTL GWAS1400326 (human) | | 6e-21 | body size trait (VT:0100005) | | 6 | 31870713 | 31870714 | Human |
597304253 | GWAS1400327_H | BMI-adjusted waist-hip ratio QTL GWAS1400327 (human) | | 1e-08 | body size trait (VT:0100005) | | 6 | 31872638 | 31872639 | Human |
597533623 | GWAS1629697_H | body height QTL GWAS1629697 (human) | | 1e-300 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 31138682 | 31138683 | Human |
597468086 | GWAS1564160_H | feeling nervous measurement QTL GWAS1564160 (human) | | 1e-08 | feeling nervous measurement | | 6 | 31352146 | 31352147 | Human |
597173170 | GWAS1269244_H | protein measurement QTL GWAS1269244 (human) | | 6e-37 | protein measurement | | 6 | 31967534 | 31967535 | Human |
597140412 | GWAS1236486_H | X-21410 measurement QTL GWAS1236486 (human) | | 3e-33 | X-21410 measurement | | 6 | 25826758 | 25826759 | Human |
597468087 | GWAS1564161_H | feeling nervous measurement QTL GWAS1564161 (human) | | 2e-13 | feeling nervous measurement | | 6 | 31729781 | 31729782 | Human |
597337009 | GWAS1433083_H | bullous pemphigoid, trait in response to hypoglycemic agent QTL GWAS1433083 (human) | | 0.000004 | bullous pemphigoid, trait in response to hypoglycemic agent | | 6 | 32415446 | 32415447 | Human |
597435319 | GWAS1531393_H | pulmonary tuberculosis QTL GWAS1531393 (human) | | 3e-23 | pulmonary tuberculosis | | 6 | 32657607 | 32657608 | Human |
597238709 | GWAS1334783_H | bone density QTL GWAS1334783 (human) | | 0.000001 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 7016826 | 7016827 | Human |
597140411 | GWAS1236485_H | X-21410 measurement QTL GWAS1236485 (human) | | 5e-32 | X-21410 measurement | | 6 | 25822135 | 25822136 | Human |
597238711 | GWAS1334785_H | retinal vasculature measurement QTL GWAS1334785 (human) | | 0.0000004 | retina blood vessel morphology trait (VT:0002792) | | 6 | 32523125 | 32523126 | Human |
597107623 | GWAS1203697_H | body height QTL GWAS1203697 (human) | | 2e-09 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 30696674 | 30696675 | Human |
597402536 | GWAS1498610_H | pallidum volume change measurement, age at assessment QTL GWAS1498610 (human) | | 0.000005 | pallidum volume change measurement, age at assessment | | 6 | 31383404 | 31383405 | Human |
597435307 | GWAS1531381_H | brain measurement QTL GWAS1531381 (human) | | 1e-18 | brain measurement | brain measurement (CMO:0000911) | 6 | 27553317 | 27553318 | Human |
597304227 | GWAS1400301_H | mean corpuscular hemoglobin QTL GWAS1400301 (human) | | 1e-32 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 15194877 | 15194878 | Human |
597599138 | GWAS1655998_H | serum alanine aminotransferase measurement QTL GWAS1655998 (human) | | 4e-20 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 32634020 | 32634021 | Human |
597304231 | GWAS1400305_H | level of endophilin-A3 in blood serum QTL GWAS1400305 (human) | | 7e-17 | level of endophilin-A3 in blood serum | | 6 | 32210103 | 32210104 | Human |
597304228 | GWAS1400302_H | mean corpuscular hemoglobin QTL GWAS1400302 (human) | | 3e-139 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16294491 | 16294492 | Human |
597599136 | GWAS1655996_H | serum alanine aminotransferase measurement QTL GWAS1655996 (human) | | 2e-13 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 20404189 | 20404190 | Human |
597599137 | GWAS1655997_H | serum alanine aminotransferase measurement QTL GWAS1655997 (human) | | 4e-21 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 31379427 | 31379428 | Human |
597173210 | GWAS1269284_H | protein measurement QTL GWAS1269284 (human) | | 2e-18 | protein measurement | | 6 | 24544247 | 24544248 | Human |
597173211 | GWAS1269285_H | protein measurement QTL GWAS1269285 (human) | | 3e-18 | protein measurement | | 6 | 24454085 | 24454086 | Human |
597173212 | GWAS1269286_H | protein measurement QTL GWAS1269286 (human) | | 2e-18 | protein measurement | | 6 | 24138912 | 24138913 | Human |
597173213 | GWAS1269287_H | protein measurement QTL GWAS1269287 (human) | | 6e-53 | protein measurement | | 6 | 24485949 | 24485950 | Human |
597369821 | GWAS1465895_H | body fat percentage QTL GWAS1465895 (human) | | 3e-10 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 6 | 31347871 | 31347872 | Human |
597173215 | GWAS1269289_H | protein measurement QTL GWAS1269289 (human) | | 6e-90 | protein measurement | | 6 | 24482276 | 24482277 | Human |
597435347 | GWAS1531421_H | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement QTL GWAS1531421 (human) | | 4e-08 | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 32446513 | 32446514 | Human |
597468108 | GWAS1564182_H | worry measurement QTL GWAS1564182 (human) | | 3e-12 | worry measurement | | 6 | 32658962 | 32658963 | Human |
597369802 | GWAS1465876_H | non-small cell lung carcinoma QTL GWAS1465876 (human) | | 5e-11 | non-small cell lung carcinoma | | 6 | 29908215 | 29908216 | Human |
597402575 | GWAS1498649_H | hair colour measurement QTL GWAS1498649 (human) | | 7e-09 | coat/hair pigmentation trait (VT:0010463) | coat/hair color measurement (CMO:0001808) | 6 | 22708314 | 22708315 | Human |
597468107 | GWAS1564181_H | worry measurement QTL GWAS1564181 (human) | | 3e-09 | worry measurement | | 6 | 11996817 | 11996818 | Human |
597140416 | GWAS1236490_H | X-15486 measurement QTL GWAS1236490 (human) | | 1e-43 | X-15486 measurement | | 6 | 25786765 | 25786766 | Human |
597074894 | GWAS1170968_H | asthma QTL GWAS1170968 (human) | | 2e-11 | asthma | | 6 | 31120368 | 31120369 | Human |
597042127 | GWAS1138201_H | fasting blood glucose measurement QTL GWAS1138201 (human) | | 0.000001 | fasting blood glucose measurement | blood glucose level (CMO:0000046) | 6 | 20686765 | 20686766 | Human |
597435334 | GWAS1531408_H | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1531408 (human) | | 4e-15 | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 29936214 | 29936215 | Human |
597173188 | GWAS1269262_H | protein measurement QTL GWAS1269262 (human) | | 3e-13 | protein measurement | | 6 | 31933131 | 31933132 | Human |
597042166 | GWAS1138240_H | fasting blood glucose measurement QTL GWAS1138240 (human) | | 3e-09 | fasting blood glucose measurement | blood glucose level (CMO:0000046) | 6 | 20686765 | 20686766 | Human |
597435388 | GWAS1531462_H | BMI-adjusted waist-hip ratio QTL GWAS1531462 (human) | | 2e-09 | body size trait (VT:0100005) | | 6 | 32465969 | 32465970 | Human |
597402618 | GWAS1498692_H | mean platelet volume QTL GWAS1498692 (human) | | 6e-11 | mean platelet volume | mean platelet volume (CMO:0001348) | 6 | 31452461 | 31452462 | Human |
597435389 | GWAS1531463_H | BMI-adjusted waist-hip ratio QTL GWAS1531463 (human) | | 2e-12 | body size trait (VT:0100005) | | 6 | 32639593 | 32639594 | Human |
597402617 | GWAS1498691_H | mean platelet volume QTL GWAS1498691 (human) | | 7e-17 | mean platelet volume | mean platelet volume (CMO:0001348) | 6 | 31423624 | 31423625 | Human |
597402616 | GWAS1498690_H | mean platelet volume QTL GWAS1498690 (human) | | 8e-72 | mean platelet volume | mean platelet volume (CMO:0001348) | 6 | 31432515 | 31432516 | Human |
597435391 | GWAS1531465_H | BMI-adjusted waist-hip ratio QTL GWAS1531465 (human) | | 5e-18 | body size trait (VT:0100005) | | 6 | 32446513 | 32446514 | Human |
597500921 | GWAS1596995_H | asthma QTL GWAS1596995 (human) | | 4e-08 | asthma | | 6 | 32660056 | 32660057 | Human |
597402611 | GWAS1498685_H | mean platelet volume QTL GWAS1498685 (human) | | 8e-10 | mean platelet volume | mean platelet volume (CMO:0001348) | 6 | 22904808 | 22904809 | Human |
597074940 | GWAS1171014_H | asthma QTL GWAS1171014 (human) | | 7e-08 | asthma | | 6 | 31120368 | 31120369 | Human |
597304310 | GWAS1400384_H | BMI-adjusted hip circumference QTL GWAS1400384 (human) | | 3e-15 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32421735 | 32421736 | Human |
597402614 | GWAS1498688_H | mean platelet volume QTL GWAS1498688 (human) | | 4e-17 | mean platelet volume | mean platelet volume (CMO:0001348) | 6 | 30756265 | 30756266 | Human |
597435377 | GWAS1531451_H | lymphoma QTL GWAS1531451 (human) | | 1e-16 | lymphoma | | 6 | 32658263 | 32658264 | Human |
597304311 | GWAS1400385_H | BMI-adjusted hip circumference QTL GWAS1400385 (human) | | 1e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32662082 | 32662083 | Human |
597402613 | GWAS1498687_H | mean platelet volume QTL GWAS1498687 (human) | | 3e-30 | mean platelet volume | mean platelet volume (CMO:0001348) | 6 | 29929352 | 29929353 | Human |
597304308 | GWAS1400382_H | BMI-adjusted hip circumference QTL GWAS1400382 (human) | | 3e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32400781 | 32400782 | Human |
597402612 | GWAS1498686_H | mean platelet volume QTL GWAS1498686 (human) | | 2e-33 | mean platelet volume | mean platelet volume (CMO:0001348) | 6 | 25296378 | 25296379 | Human |
597304309 | GWAS1400383_H | BMI-adjusted hip circumference QTL GWAS1400383 (human) | | 2e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32458206 | 32458207 | Human |
597369835 | GWAS1465909_H | hip circumference QTL GWAS1465909 (human) | | 5e-15 | hip circumference | hip circumference (CMO:0000014) | 6 | 26336344 | 26336345 | Human |
597468137 | GWAS1564211_H | BMI-adjusted waist-hip ratio QTL GWAS1564211 (human) | | 0.0000001 | body size trait (VT:0100005) | | 6 | 32413959 | 32413960 | Human |
597468139 | GWAS1564213_H | BMI-adjusted waist-hip ratio QTL GWAS1564213 (human) | | 2e-10 | body size trait (VT:0100005) | | 6 | 31880443 | 31880444 | Human |
597173216 | GWAS1269290_H | protein measurement QTL GWAS1269290 (human) | | 9e-50 | protein measurement | | 6 | 24470746 | 24470747 | Human |
407050303 | GWAS699279_H | HIV-1 infection, Susceptibility to viral and mycobacterial infections QTL GWAS699279 (human) | | 0.000002 | response to viral infection trait (VT:0010439) | | 6 | 11310186 | 11310187 | Human |
596976405 | GWAS1095924_H | Red cell distribution width QTL GWAS1095924 (human) | | 1e-09 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 25712268 | 25712269 | Human |
597074710 | GWAS1170784_H | trait in response to sulfasalazine, Drug-induced agranulocytosis QTL GWAS1170784 (human) | | 3e-08 | trait in response to sulfasalazine, Drug-induced agranulocytosis | | 6 | 31379201 | 31379202 | Human |
596976404 | GWAS1095923_H | Red cell distribution width QTL GWAS1095923 (human) | | 4e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16290617 | 16290620 | Human |
596976407 | GWAS1095926_H | Red cell distribution width QTL GWAS1095926 (human) | | 1e-10 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 26046337 | 26046338 | Human |
596976406 | GWAS1095925_H | Red cell distribution width QTL GWAS1095925 (human) | | 6e-16 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 25933704 | 25933705 | Human |
596976403 | GWAS1095922_H | Red cell distribution width QTL GWAS1095922 (human) | | 1e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16285830 | 16285831 | Human |
596976402 | GWAS1095921_H | Red cell distribution width QTL GWAS1095921 (human) | | 2e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16267244 | 16267245 | Human |
407214274 | GWAS863250_H | unipolar depression QTL GWAS863250 (human) | | 1e-16 | unipolar depression | | 6 | 27807896 | 27807897 | Human |
597173008 | GWAS1269082_H | C-C motif chemokine 1 measurement QTL GWAS1269082 (human) | | 1e-34 | C-C motif chemokine 1 measurement | | 6 | 31942385 | 31942386 | Human |
597140252 | GWAS1236326_H | X-19141 measurement QTL GWAS1236326 (human) | | 4e-17 | X-19141 measurement | | 6 | 25773581 | 25773582 | Human |
597140251 | GWAS1236325_H | X-19141 measurement QTL GWAS1236325 (human) | | 8e-68 | X-19141 measurement | | 6 | 25751092 | 25751093 | Human |
597107483 | GWAS1203557_H | testosterone measurement QTL GWAS1203557 (human) | | 7e-10 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 27528819 | 27528820 | Human |
596976409 | GWAS1095928_H | Red cell distribution width QTL GWAS1095928 (human) | | 8e-11 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 30143081 | 30143084 | Human |
597107482 | GWAS1203556_H | testosterone measurement QTL GWAS1203556 (human) | | 4e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 17416027 | 17416028 | Human |
596976408 | GWAS1095927_H | Red cell distribution width QTL GWAS1095927 (human) | | 9e-546 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 26104404 | 26104405 | Human |
597205768 | GWAS1301842_H | electrocardiography QTL GWAS1301842 (human) | | 2e-08 | electrocardiography | | 6 | 24980995 | 24980996 | Human |
597435149 | GWAS1531223_H | allergic rhinitis QTL GWAS1531223 (human) | | 2e-08 | allergic rhinitis | | 6 | 30037977 | 30037978 | Human |
597271309 | GWAS1367383_H | gremlin-1 measurement QTL GWAS1367383 (human) | | 1e-29 | gremlin-1 measurement | | 6 | 31946402 | 31946403 | Human |
597304077 | GWAS1400151_H | level of histone deacetylase complex subunit SAP30 in blood serum QTL GWAS1400151 (human) | | 1e-14 | level of histone deacetylase complex subunit SAP30 in blood serum | | 6 | 32084478 | 32084479 | Human |
597041935 | GWAS1138009_H | Parkinson disease QTL GWAS1138009 (human) | | 6e-12 | Parkinson disease | | 6 | 27771022 | 27771023 | Human |
597205764 | GWAS1301838_H | electrocardiography QTL GWAS1301838 (human) | | 5e-12 | electrocardiography | | 6 | 24980995 | 24980996 | Human |
597205765 | GWAS1301839_H | electrocardiography QTL GWAS1301839 (human) | | 1e-09 | electrocardiography | | 6 | 24980995 | 24980996 | Human |
597205766 | GWAS1301840_H | electrocardiography QTL GWAS1301840 (human) | | 1e-11 | electrocardiography | | 6 | 24980995 | 24980996 | Human |
597205767 | GWAS1301841_H | electrocardiography QTL GWAS1301841 (human) | | 9e-10 | electrocardiography | | 6 | 24980995 | 24980996 | Human |
597304127 | GWAS1400201_H | level of GATA zinc finger domain-containing protein 1 in blood serum QTL GWAS1400201 (human) | | 4e-22 | level of GATA zinc finger domain-containing protein 1 in blood serum | | 6 | 32133413 | 32133414 | Human |
407050468 | GWAS699444_H | cholesteryl ester 20:5 measurement QTL GWAS699444 (human) | | 0.000005 | blood lipid amount (VT:0003949) | | 6 | 20680633 | 20680634 | Human |
597467955 | GWAS1564029_H | breast carcinoma QTL GWAS1564029 (human) | | 2e-09 | mammary gland integrity trait (VT:0010552) | | 6 | 27307055 | 27307056 | Human |
597500719 | GWAS1596793_H | protein measurement QTL GWAS1596793 (human) | | 4e-39 | protein measurement | | 6 | 31979817 | 31979818 | Human |
597369640 | GWAS1465714_H | risk-taking behaviour QTL GWAS1465714 (human) | | 2e-11 | risk-taking behaviour | | 6 | 12009023 | 12009024 | Human |
597500718 | GWAS1596792_H | ferritin measurement QTL GWAS1596792 (human) | | 8e-20 | ferritin measurement | | 6 | 26123274 | 26123275 | Human |
597140259 | GWAS1236333_H | X-21364 measurement QTL GWAS1236333 (human) | | 3e-12 | X-21364 measurement | | 6 | 25867338 | 25867339 | Human |
597140258 | GWAS1236332_H | X-21364 measurement QTL GWAS1236332 (human) | | 1e-12 | X-21364 measurement | | 6 | 25769561 | 25769562 | Human |
597467940 | GWAS1564014_H | ferritin measurement QTL GWAS1564014 (human) | | 0.0000002 | ferritin measurement | | 6 | 26261299 | 26261300 | Human |
597467937 | GWAS1564011_H | serum iron measurement QTL GWAS1564011 (human) | | 1e-08 | serum iron measurement | | 6 | 25373818 | 25373819 | Human |
597467939 | GWAS1564013_H | serum iron measurement QTL GWAS1564013 (human) | | 4e-26 | serum iron measurement | | 6 | 26090951 | 26090952 | Human |
597369636 | GWAS1465710_H | risk-taking behaviour QTL GWAS1465710 (human) | | 1e-10 | risk-taking behaviour | | 6 | 32159700 | 32159701 | Human |
597304154 | GWAS1400228_H | neutrophil collagenase measurement QTL GWAS1400228 (human) | | 2e-81 | neutrophil collagenase measurement | | 6 | 31946402 | 31946403 | Human |
597205850 | GWAS1301924_H | neuroimaging measurement QTL GWAS1301924 (human) | | 8e-22 | neuroimaging measurement | | 6 | 26092913 | 26092914 | Human |
597238621 | GWAS1334695_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1334695 (human) | | 1e-08 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28272137 | 28272138 | Human |
597435225 | GWAS1531299_H | response to trastuzumab, left ventricular diastolic function measurement, trait in response to paclitaxel QTL GWAS1531299 (human) | | 0.000001 | response to trastuzumab, left ventricular diastolic function measurement, trait in response to paclitaxel | | 6 | 22957508 | 22957509 | Human |
597238620 | GWAS1334694_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1334694 (human) | | 2e-08 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28254038 | 28254039 | Human |
597369694 | GWAS1465768_H | white matter microstructure measurement QTL GWAS1465768 (human) | | 4e-10 | white matter microstructure measurement | | 6 | 29187972 | 29187973 | Human |
596976464 | GWAS1095983_H | Red cell distribution width QTL GWAS1095983 (human) | | 3e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 31451288 | 31451289 | Human |
596976477 | GWAS1095996_H | body height QTL GWAS1095996 (human) | | 2e-43 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 7801378 | 7801379 | Human |
597205844 | GWAS1301918_H | upper aerodigestive tract neoplasm QTL GWAS1301918 (human) | | 2e-10 | upper aerodigestive tract neoplasm | | 6 | 26740141 | 26740142 | Human |
597173076 | GWAS1269150_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1269150 (human) | | 1e-12 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 31340747 | 31340748 | Human |
597205845 | GWAS1301919_H | upper aerodigestive tract neoplasm QTL GWAS1301919 (human) | | 8e-11 | upper aerodigestive tract neoplasm | | 6 | 27174125 | 27174126 | Human |
597205846 | GWAS1301920_H | upper aerodigestive tract neoplasm QTL GWAS1301920 (human) | | 3e-11 | upper aerodigestive tract neoplasm | | 6 | 27916234 | 27916235 | Human |
597205847 | GWAS1301921_H | upper aerodigestive tract neoplasm QTL GWAS1301921 (human) | | 3e-12 | upper aerodigestive tract neoplasm | | 6 | 28233753 | 28233754 | Human |
597304141 | GWAS1400215_H | glomerular filtration rate QTL GWAS1400215 (human) | | 3e-20 | glomerular filtration rate | glomerular filtration rate (CMO:0000490) | 6 | 20428201 | 20428202 | Human |
597435207 | GWAS1531281_H | inosine measurement, cerebrospinal fluid biomarker measurement QTL GWAS1531281 (human) | | 2e-11 | inosine measurement, cerebrospinal fluid biomarker measurement | cerebrospinal fluid chemistry measurement (CMO:0001241) | 6 | 16269132 | 16269133 | Human |
597041992 | GWAS1138066_H | appendicular lean mass QTL GWAS1138066 (human) | | 3e-11 | appendicular lean mass | | 6 | 32584290 | 32584291 | Human |
597533565 | GWAS1629639_H | body height QTL GWAS1629639 (human) | | 5e-18 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 28069242 | 28069243 | Human |
597271416 | GWAS1367490_H | schizophrenia QTL GWAS1367490 (human) | | 0.000005 | schizophrenia | | 6 | 11553948 | 11553949 | Human |
597533564 | GWAS1629638_H | body height QTL GWAS1629638 (human) | | 8e-15 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 27334986 | 27334987 | Human |
406952099 | GWAS601075_H | eosinophil count QTL GWAS601075 (human) | | 0.0000002 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 28336792 | 28336793 | Human |
597599098 | GWAS1655958_H | HbA1c measurement QTL GWAS1655958 (human) | | 2e-14 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
597599099 | GWAS1655959_H | HbA1c measurement QTL GWAS1655959 (human) | | 3e-66 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 20680447 | 20680448 | Human |
597468025 | GWAS1564099_H | triglyceride measurement QTL GWAS1564099 (human) | | 0.000008 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 29867174 | 29867175 | Human |
597533563 | GWAS1629637_H | body height QTL GWAS1629637 (human) | | 7e-131 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 26183588 | 26183589 | Human |
597173118 | GWAS1269192_H | protein measurement QTL GWAS1269192 (human) | | 4e-13 | protein measurement | | 6 | 31965384 | 31965385 | Human |
597074801 | GWAS1170875_H | major depressive disorder QTL GWAS1170875 (human) | | 0.000002 | major depressive disorder | | 6 | 26121050 | 26121051 | Human |
597500791 | GWAS1596865_H | systolic blood pressure QTL GWAS1596865 (human) | | 0.0000004 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 31268274 | 31268275 | Human |
597205864 | GWAS1301938_H | wellbeing measurement QTL GWAS1301938 (human) | | 7e-21 | wellness/fitness trait (VT:1000152) | | 6 | 27332531 | 27332532 | Human |
597205865 | GWAS1301939_H | wellbeing measurement QTL GWAS1301939 (human) | | 1e-22 | wellness/fitness trait (VT:1000152) | | 6 | 27878966 | 27878967 | Human |
597205866 | GWAS1301940_H | wellbeing measurement QTL GWAS1301940 (human) | | 6e-21 | wellness/fitness trait (VT:1000152) | | 6 | 28381921 | 28381922 | Human |
597238635 | GWAS1334709_H | monocyte count QTL GWAS1334709 (human) | | 1e-34 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 31335498 | 31335499 | Human |
597140324 | GWAS1236398_H | 21-hydroxypregnenolone disulfate measurement QTL GWAS1236398 (human) | | 2e-18 | 21-hydroxypregnenolone disulfate measurement | | 6 | 25817561 | 25817562 | Human |
597205867 | GWAS1301941_H | wellbeing measurement QTL GWAS1301941 (human) | | 1e-18 | wellness/fitness trait (VT:1000152) | | 6 | 31111867 | 31111868 | Human |
597238634 | GWAS1334708_H | monocyte count QTL GWAS1334708 (human) | | 1e-35 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 32480822 | 32480823 | Human |
597369711 | GWAS1465785_H | insomnia measurement QTL GWAS1465785 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 6 | 30964446 | 30964447 | Human |
597205868 | GWAS1301942_H | wellbeing measurement QTL GWAS1301942 (human) | | 2e-12 | wellness/fitness trait (VT:1000152) | | 6 | 31135812 | 31135813 | Human |
597304175 | GWAS1400249_H | MHC class I polypeptide-related sequence A measurement QTL GWAS1400249 (human) | | 2e-100 | MHC class I polypeptide-related sequence A measurement | | 6 | 31410610 | 31410611 | Human |
597205869 | GWAS1301943_H | wellbeing measurement QTL GWAS1301943 (human) | | 4e-17 | wellness/fitness trait (VT:1000152) | | 6 | 32047051 | 32047052 | Human |
597402477 | GWAS1498551_H | pallidum volume change measurement, age at assessment QTL GWAS1498551 (human) | | 0.0000008 | pallidum volume change measurement, age at assessment | | 6 | 31394497 | 31394498 | Human |
597205870 | GWAS1301944_H | wellbeing measurement QTL GWAS1301944 (human) | | 1e-08 | wellness/fitness trait (VT:1000152) | | 6 | 32051735 | 32051736 | Human |
597074785 | GWAS1170859_H | cervical carcinoma QTL GWAS1170859 (human) | | 2e-13 | cervical carcinoma | | 6 | 31512891 | 31512892 | Human |
406919353 | GWAS568329_H | lean body mass QTL GWAS568329 (human) | | 0.0000005 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 19839184 | 19839185 | Human |
597238624 | GWAS1334698_H | monocyte count QTL GWAS1334698 (human) | | 2e-45 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 31347586 | 31347587 | Human |
597271394 | GWAS1367468_H | leprosy QTL GWAS1367468 (human) | | 0.000003 | leprosy | | 6 | 24538473 | 24538474 | Human |
597205860 | GWAS1301934_H | wellbeing measurement QTL GWAS1301934 (human) | | 4e-11 | wellness/fitness trait (VT:1000152) | | 6 | 11714917 | 11714918 | Human |
597205861 | GWAS1301935_H | wellbeing measurement QTL GWAS1301935 (human) | | 3e-08 | wellness/fitness trait (VT:1000152) | | 6 | 24281889 | 24281890 | Human |
597205862 | GWAS1301936_H | wellbeing measurement QTL GWAS1301936 (human) | | 6e-14 | wellness/fitness trait (VT:1000152) | | 6 | 25938539 | 25938540 | Human |
597238631 | GWAS1334705_H | monocyte count QTL GWAS1334705 (human) | | 2e-36 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 31256890 | 31256891 | Human |
597173094 | GWAS1269168_H | triglycerides in small VLDL measurement QTL GWAS1269168 (human) | | 6e-22 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 31271999 | 31272000 | Human |
597074792 | GWAS1170866_H | cervical carcinoma QTL GWAS1170866 (human) | | 6e-09 | cervical carcinoma | | 6 | 31572364 | 31572365 | Human |
597205863 | GWAS1301937_H | wellbeing measurement QTL GWAS1301937 (human) | | 5e-18 | wellness/fitness trait (VT:1000152) | | 6 | 26463346 | 26463347 | Human |
597074793 | GWAS1170867_H | trait in response to sulfasalazine, Drug-induced agranulocytosis QTL GWAS1170867 (human) | | 0.0000007 | trait in response to sulfasalazine, Drug-induced agranulocytosis | | 6 | 31910718 | 31910719 | Human |
597238421 | GWAS1334495_H | neutrophil count QTL GWAS1334495 (human) | | 9e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 26158765 | 26158766 | Human |
597238420 | GWAS1334494_H | neutrophil count QTL GWAS1334494 (human) | | 5e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7140598 | 7140599 | Human |
597271188 | GWAS1367262_H | systolic blood pressure QTL GWAS1367262 (human) | | 2e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 32170768 | 32170769 | Human |
597238423 | GWAS1334497_H | neutrophil count QTL GWAS1334497 (human) | | 8e-19 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 32668863 | 32668864 | Human |
597435020 | GWAS1531094_H | facial morphology measurement QTL GWAS1531094 (human) | | 1e-09 | facial morphology trait (VT:0003743) | | 6 | 23557094 | 23557095 | Human |
596976259 | GWAS1095778_H | Crohn's disease QTL GWAS1095778 (human) | | 7e-10 | intestine integrity trait (VT:0010554) | | 6 | 21385471 | 21385472 | Human |
596976258 | GWAS1095777_H | Crohn's disease QTL GWAS1095777 (human) | | 1e-08 | intestine integrity trait (VT:0010554) | | 6 | 14719265 | 14719266 | Human |
597271171 | GWAS1367245_H | type 2 diabetes mellitus QTL GWAS1367245 (human) | | 1e-11 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 20680447 | 20680448 | Human |
597238406 | GWAS1334480_H | monocyte count QTL GWAS1334480 (human) | | 1e-62 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 31976259 | 31976260 | Human |
597598908 | GWAS1655768_H | HbA1c measurement QTL GWAS1655768 (human) | | 4e-14 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 32465192 | 32465193 | Human |
597598906 | GWAS1655766_H | HbA1c measurement QTL GWAS1655766 (human) | | 6e-70 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 20680447 | 20680448 | Human |
597598907 | GWAS1655767_H | HbA1c measurement QTL GWAS1655767 (human) | | 3e-25 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 25917997 | 25917998 | Human |
597205693 | GWAS1301767_H | neuroimaging measurement QTL GWAS1301767 (human) | | 2e-17 | neuroimaging measurement | | 6 | 26092913 | 26092914 | Human |
597598905 | GWAS1655765_H | HbA1c measurement QTL GWAS1655765 (human) | | 1e-14 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 7231610 | 7231611 | Human |
597500599 | GWAS1596673_H | fat body mass QTL GWAS1596673 (human) | | 2e-14 | body fat mass (VT:0010482) | total body fat mass (CMO:0000305) | 6 | 27146032 | 27146033 | Human |
597271221 | GWAS1367295_H | natural cytotoxicity triggering receptor 3 measurement QTL GWAS1367295 (human) | | 9e-60 | natural cytotoxicity triggering receptor 3 measurement | | 6 | 31552649 | 31552650 | Human |
596976312 | GWAS1095831_H | Behcet's syndrome QTL GWAS1095831 (human) | | 5e-08 | Behcet's syndrome | | 6 | 32179380 | 32179381 | Human |
597271222 | GWAS1367296_H | natural cytotoxicity triggering receptor 3 measurement QTL GWAS1367296 (human) | | 3e-23 | natural cytotoxicity triggering receptor 3 measurement | | 6 | 31600692 | 31600693 | Human |
597435053 | GWAS1531127_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1531127 (human) | | 1e-08 | low density lipoprotein cholesterol measurement, phospholipid measurement | blood cholesterol level (CMO:0002280) | 6 | 29845118 | 29845119 | Human |
597435054 | GWAS1531128_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1531128 (human) | | 1e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 31363921 | 31363922 | Human |
597435055 | GWAS1531129_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1531129 (human) | | 1e-17 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 32633511 | 32633512 | Human |
597205677 | GWAS1301751_H | handedness QTL GWAS1301751 (human) | | 5e-09 | handedness | | 6 | 26599281 | 26599282 | Human |
597369518 | GWAS1465592_H | Modic type vertebral endplate changes QTL GWAS1465592 (human) | | 0.000003 | Modic type vertebral endplate changes | | 6 | 27487355 | 27487356 | Human |
597172911 | GWAS1268985_H | rhophilin-2 measurement QTL GWAS1268985 (human) | | 8e-24 | rhophilin-2 measurement | | 6 | 31967534 | 31967535 | Human |
597140141 | GWAS1236215_H | gout QTL GWAS1236215 (human) | | 1e-08 | gout | | 6 | 28321008 | 28321009 | Human |
597140140 | GWAS1236214_H | gout QTL GWAS1236214 (human) | | 4e-26 | gout | | 6 | 25812922 | 25812923 | Human |
597500579 | GWAS1596653_H | Alzheimer disease, polygenic risk score QTL GWAS1596653 (human) | | 9e-20 | Alzheimer disease, polygenic risk score | | 6 | 28783099 | 28783100 | Human |
597467868 | GWAS1563942_H | feeling nervous measurement QTL GWAS1563942 (human) | | 5e-08 | feeling nervous measurement | | 6 | 29292654 | 29292655 | Human |
597140180 | GWAS1236254_H | erythrocyte count QTL GWAS1236254 (human) | | 1e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 32602235 | 32602236 | Human |
597336798 | GWAS1432872_H | COVID-19 QTL GWAS1432872 (human) | | 0.00001 | COVID-19 | | 6 | 17920558 | 17920559 | Human |
597435096 | GWAS1531170_H | myocardial infarction QTL GWAS1531170 (human) | | 3e-20 | myocardial infarction | | 6 | 31352844 | 31352845 | Human |
597205726 | GWAS1301800_H | frontal fibrosing alopecia QTL GWAS1301800 (human) | | 0.000009 | frontal fibrosing alopecia | | 6 | 10220209 | 10220210 | Human |
597172958 | GWAS1269032_H | PR domain zinc finger protein 1 measurement QTL GWAS1269032 (human) | | 4e-22 | PR domain zinc finger protein 1 measurement | | 6 | 31966595 | 31966596 | Human |
597435099 | GWAS1531173_H | gut microbiome measurement QTL GWAS1531173 (human) | | 4e-09 | gut microbiome measurement | | 6 | 32660362 | 32660363 | Human |
597205712 | GWAS1301786_H | metabolic syndrome QTL GWAS1301786 (human) | | 1e-14 | metabolic syndrome | | 6 | 20693466 | 20693467 | Human |
597435093 | GWAS1531167_H | myocardial infarction QTL GWAS1531167 (human) | | 4e-63 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597140190 | GWAS1236264_H | erythrocyte count QTL GWAS1236264 (human) | | 3e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 29830005 | 29830006 | Human |
596976348 | GWAS1095867_H | body height QTL GWAS1095867 (human) | | 5e-102 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 31910718 | 31910719 | Human |
597172945 | GWAS1269019_H | tight junction protein ZO-1 measurement QTL GWAS1269019 (human) | | 3e-16 | tight junction protein ZO-1 measurement | | 6 | 31942385 | 31942386 | Human |
597140188 | GWAS1236262_H | erythrocyte count QTL GWAS1236262 (human) | | 1e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16295116 | 16295121 | Human |
597435095 | GWAS1531169_H | myocardial infarction QTL GWAS1531169 (human) | | 2e-08 | myocardial infarction | | 6 | 22598030 | 22598031 | Human |
597435086 | GWAS1531160_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1531160 (human) | | 2e-09 | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 32664436 | 32664437 | Human |
597467850 | GWAS1563924_H | worry measurement QTL GWAS1563924 (human) | | 4e-10 | worry measurement | | 6 | 31642752 | 31642753 | Human |
597074638 | GWAS1170712_H | neuroticism measurement QTL GWAS1170712 (human) | | 1e-09 | neuroticism measurement | | 6 | 29603064 | 29603065 | Human |
597435073 | GWAS1531147_H | eosinophil count QTL GWAS1531147 (human) | | 2e-40 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 31280901 | 31280902 | Human |
407083299 | GWAS732275_H | obsolete_red blood cell distribution width QTL GWAS732275 (human) | | 2e-13 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16267244 | 16267245 | Human |
597435132 | GWAS1531206_H | triglyceride measurement, phospholipid measurement QTL GWAS1531206 (human) | | 3e-10 | triglyceride measurement, phospholipid measurement | blood triglyceride level (CMO:0000118) | 6 | 31449965 | 31449966 | Human |
597238520 | GWAS1334594_H | type 2 diabetes mellitus QTL GWAS1334594 (human) | | 3e-11 | type 2 diabetes mellitus | | 6 | 20687890 | 20687891 | Human |
407083302 | GWAS732278_H | obsolete_red blood cell distribution width QTL GWAS732278 (human) | | 4e-13 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16290617 | 16290620 | Human |
407083301 | GWAS732277_H | obsolete_red blood cell distribution width QTL GWAS732277 (human) | | 1e-14 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16285830 | 16285831 | Human |
597041918 | GWAS1137992_H | cataract QTL GWAS1137992 (human) | | 3e-08 | cataract | | 6 | 32659383 | 32659384 | Human |
407083304 | GWAS732280_H | obsolete_red blood cell distribution width QTL GWAS732280 (human) | | 1e-11 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 6 | 18757083 | 18757084 | Human |
597205747 | GWAS1301821_H | grip strength measurement QTL GWAS1301821 (human) | | 9e-09 | grip strength measurement | | 6 | 32676776 | 32676777 | Human |
407083311 | GWAS732287_H | obsolete_red blood cell distribution width QTL GWAS732287 (human) | | 1e-09 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 25712268 | 25712269 | Human |
597402356 | GWAS1498430_H | Crohn's disease QTL GWAS1498430 (human) | | 2e-08 | intestine integrity trait (VT:0010554) | | 6 | 14719265 | 14719266 | Human |
597500653 | GWAS1596727_H | lean body mass QTL GWAS1596727 (human) | | 6e-14 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 28070396 | 28070397 | Human |
597205740 | GWAS1301814_H | grip strength measurement QTL GWAS1301814 (human) | | 6e-09 | grip strength measurement | | 6 | 32521902 | 32521903 | Human |
597172973 | GWAS1269047_H | protein measurement QTL GWAS1269047 (human) | | 1e-13 | protein measurement | | 6 | 31967534 | 31967535 | Human |
407050552 | GWAS699528_H | body mass index QTL GWAS699528 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 20694653 | 20694654 | Human |
597336806 | GWAS1432880_H | COVID-19 QTL GWAS1432880 (human) | | 0.000009 | COVID-19 | | 6 | 7466421 | 7466422 | Human |
597598746 | GWAS1655606_H | HbA1c measurement QTL GWAS1655606 (human) | | 3e-67 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 20680447 | 20680448 | Human |
597139985 | GWAS1236059_H | metabolite measurement QTL GWAS1236059 (human) | | 8e-11 | metabolite measurement | | 6 | 18345404 | 18345405 | Human |
597598745 | GWAS1655605_H | HbA1c measurement QTL GWAS1655605 (human) | | 6e-14 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
597369367 | GWAS1465441_H | autism spectrum disorder QTL GWAS1465441 (human) | | 0.000008 | autism spectrum disorder | | 6 | 23870547 | 23870548 | Human |
597172745 | GWAS1268819_H | peroxisome proliferator-activated receptor alpha measurement QTL GWAS1268819 (human) | | 2e-12 | peroxisome proliferator-activated receptor alpha measurement | | 6 | 13611846 | 13611847 | Human |
597533199 | GWAS1629273_H | level of Phosphatidylcholine (O-16:0_18:1) in blood serum QTL GWAS1629273 (human) | | 0.000004 | level of Phosphatidylcholine (O-16:0_18:1) in blood serum | | 6 | 31294392 | 31294393 | Human |
597041666 | GWAS1137740_H | advanced glycation end-product measurement QTL GWAS1137740 (human) | | 5e-12 | glycated serum protein amount (VT:0010677) | | 6 | 32183666 | 32183667 | Human |
597205505 | GWAS1301579_H | handedness QTL GWAS1301579 (human) | | 6e-25 | handedness | | 6 | 30720650 | 30720651 | Human |
597500420 | GWAS1596494_H | protein measurement QTL GWAS1596494 (human) | | 2e-27 | protein measurement | | 6 | 32007072 | 32007073 | Human |
597107214 | GWAS1203288_H | Immunosuppressant use measurement QTL GWAS1203288 (human) | | 2e-84 | Immunosuppressant use measurement | | 6 | 32599479 | 32599480 | Human |
597172796 | GWAS1268870_H | cytochrome b-c1 complex subunit 7 measurement QTL GWAS1268870 (human) | | 5e-22 | cytochrome b-c1 complex subunit 7 measurement | | 6 | 31966595 | 31966596 | Human |
597598777 | GWAS1655637_H | hemoglobin measurement QTL GWAS1655637 (human) | | 7e-282 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 26092913 | 26092914 | Human |
597205554 | GWAS1301628_H | asthma QTL GWAS1301628 (human) | | 0.0000004 | asthma | | 6 | 32725465 | 32725466 | Human |
597041725 | GWAS1137799_H | interleukin 16 measurement QTL GWAS1137799 (human) | | 6e-09 | interleukin 16 measurement | | 6 | 32405408 | 32405409 | Human |
597467697 | GWAS1563771_H | interleukin-6 measurement QTL GWAS1563771 (human) | | 0.000003 | interleukin-6 measurement | blood interleukin-6 level (CMO:0001926) | 6 | 21890181 | 21890182 | Human |
407017967 | GWAS666943_H | hepatitis B virus infection QTL GWAS666943 (human) | | 4e-37 | hepatitis B virus infection | | 6 | 32702478 | 32702479 | Human |
597500467 | GWAS1596541_H | B-cell lymphoma 6 protein measurement QTL GWAS1596541 (human) | | 2e-15 | B-cell lymphoma 6 protein measurement | | 6 | 31943161 | 31943162 | Human |
597303848 | GWAS1399922_H | complement C4b measurement QTL GWAS1399922 (human) | | 1e-15 | complement C4b measurement | | 6 | 32078498 | 32078499 | Human |
596976161 | GWAS1095680_H | Red cell distribution width QTL GWAS1095680 (human) | | 2e-135 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 26098246 | 26098247 | Human |
597598758 | GWAS1655618_H | HbA1c measurement QTL GWAS1655618 (human) | | 7e-14 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 32465192 | 32465193 | Human |
597172768 | GWAS1268842_H | protein measurement QTL GWAS1268842 (human) | | 8e-18 | protein measurement | | 6 | 32612840 | 32612841 | Human |
597303843 | GWAS1399917_H | level of spermatogenesis-associated protein 20 in blood serum QTL GWAS1399917 (human) | | 7e-21 | level of spermatogenesis-associated protein 20 in blood serum | | 6 | 31110449 | 31110450 | Human |
597598756 | GWAS1655616_H | HbA1c measurement QTL GWAS1655616 (human) | | 2e-30 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 26098246 | 26098247 | Human |
597598757 | GWAS1655617_H | HbA1c measurement QTL GWAS1655617 (human) | | 4e-11 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 26883139 | 26883140 | Human |
597303844 | GWAS1399918_H | level of spermatogenesis-associated protein 20 in blood serum QTL GWAS1399918 (human) | | 3e-34 | level of spermatogenesis-associated protein 20 in blood serum | | 6 | 32238948 | 32238949 | Human |
597500509 | GWAS1596583_H | soluble transferrin receptor measurement QTL GWAS1596583 (human) | | 8e-33 | soluble transferrin receptor measurement | | 6 | 25957198 | 25957199 | Human |
597271129 | GWAS1367203_H | BMI-adjusted hip circumference QTL GWAS1367203 (human) | | 3e-15 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 26699004 | 26699005 | Human |
597402203 | GWAS1498277_H | health study participation QTL GWAS1498277 (human) | | 4e-09 | health study participation | | 6 | 30320506 | 30320507 | Human |
597271128 | GWAS1367202_H | BMI-adjusted hip circumference QTL GWAS1367202 (human) | | 4e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 26197818 | 26197819 | Human |
597271131 | GWAS1367205_H | BMI-adjusted hip circumference QTL GWAS1367205 (human) | | 4e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 28358758 | 28358759 | Human |
597205595 | GWAS1301669_H | electrocardiography QTL GWAS1301669 (human) | | 3e-09 | electrocardiography | | 6 | 18387461 | 18387462 | Human |
597271130 | GWAS1367204_H | BMI-adjusted hip circumference QTL GWAS1367204 (human) | | 6e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 26739219 | 26739220 | Human |
597205596 | GWAS1301670_H | electrocardiography QTL GWAS1301670 (human) | | 2e-08 | electrocardiography | | 6 | 18387461 | 18387462 | Human |
597271133 | GWAS1367207_H | BMI-adjusted hip circumference QTL GWAS1367207 (human) | | 7e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 29378449 | 29378450 | Human |
597205597 | GWAS1301671_H | electrocardiography QTL GWAS1301671 (human) | | 1e-08 | electrocardiography | | 6 | 18387461 | 18387462 | Human |
597369438 | GWAS1465512_H | parental longevity QTL GWAS1465512 (human) | | 0.0000001 | total life span (VT:0001661) | | 6 | 26337828 | 26337829 | Human |
597271132 | GWAS1367206_H | BMI-adjusted hip circumference QTL GWAS1367206 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 28769196 | 28769197 | Human |
597336668 | GWAS1432742_H | COVID-19 QTL GWAS1432742 (human) | | 0.000008 | COVID-19 | | 6 | 18853436 | 18853437 | Human |
597271135 | GWAS1367209_H | BMI-adjusted hip circumference QTL GWAS1367209 (human) | | 3e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 30796697 | 30796700 | Human |
597271134 | GWAS1367208_H | BMI-adjusted hip circumference QTL GWAS1367208 (human) | | 3e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 29387371 | 29387372 | Human |
597369425 | GWAS1465499_H | asthma QTL GWAS1465499 (human) | | 1e-09 | asthma | | 6 | 31570500 | 31570501 | Human |
597140057 | GWAS1236131_H | DHEA-S-to-4-androsten-3beta,17beta-diol disulfate 2 ratio QTL GWAS1236131 (human) | | 1e-26 | DHEA-S-to-4-androsten-3beta,17beta-diol disulfate 2 ratio | | 6 | 25818360 | 25818361 | Human |
597369418 | GWAS1465492_H | asthma, major depressive disorder QTL GWAS1465492 (human) | | 3e-08 | asthma, major depressive disorder | | 6 | 27303811 | 27303812 | Human |
597434957 | GWAS1531031_H | BMI-adjusted waist-hip ratio QTL GWAS1531031 (human) | | 0.000002 | body size trait (VT:0100005) | | 6 | 31466589 | 31466590 | Human |
597369417 | GWAS1465491_H | asthma, major depressive disorder QTL GWAS1465491 (human) | | 1e-09 | Inguinal hernia | | 6 | 27882936 | 27882937 | Human |
597434958 | GWAS1531032_H | BMI-adjusted waist-hip ratio QTL GWAS1531032 (human) | | 0.000009 | body size trait (VT:0100005) | | 6 | 32255481 | 32255482 | Human |
597369416 | GWAS1465490_H | asthma, major depressive disorder QTL GWAS1465490 (human) | | 4e-10 | asthma, major depressive disorder | | 6 | 29257248 | 29257249 | Human |
407050640 | GWAS699616_H | reticulocyte measurement QTL GWAS699616 (human) | | 3e-33 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 31554892 | 31554893 | Human |
597434959 | GWAS1531033_H | BMI-adjusted waist-hip ratio QTL GWAS1531033 (human) | | 6e-08 | body size trait (VT:0100005) | | 6 | 32377912 | 32377913 | Human |
597172815 | GWAS1268889_H | cystatin-8 measurement QTL GWAS1268889 (human) | | 2e-12 | cystatin-8 measurement | | 6 | 31942385 | 31942386 | Human |
597369420 | GWAS1465494_H | asthma QTL GWAS1465494 (human) | | 3e-17 | asthma | | 6 | 32639135 | 32639136 | Human |
597369415 | GWAS1465489_H | asthma, major depressive disorder QTL GWAS1465489 (human) | | 2e-11 | asthma, major depressive disorder | | 6 | 28728995 | 28728996 | Human |
597598842 | GWAS1655702_H | hemoglobin measurement QTL GWAS1655702 (human) | | 6e-33 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7195451 | 7195452 | Human |
597467768 | GWAS1563842_H | type 1 diabetes mellitus QTL GWAS1563842 (human) | | 3e-08 | type 1 diabetes mellitus | | 6 | 26423332 | 26423333 | Human |
597369471 | GWAS1465545_H | wheat allergic reaction QTL GWAS1465545 (human) | | 1e-26 | wheat allergic reaction | | 6 | 32623176 | 32623177 | Human |
597467769 | GWAS1563843_H | type 1 diabetes mellitus QTL GWAS1563843 (human) | | 2e-232 | type 1 diabetes mellitus | | 6 | 32660056 | 32660057 | Human |
597238384 | GWAS1334458_H | major depressive disorder QTL GWAS1334458 (human) | | 8e-09 | major depressive disorder | | 6 | 28398374 | 28398375 | Human |
597467766 | GWAS1563840_H | keratinocyte carcinoma QTL GWAS1563840 (human) | | 4e-16 | keratinocyte carcinoma | | 6 | 22057337 | 22057338 | Human |
597467762 | GWAS1563836_H | keratinocyte carcinoma QTL GWAS1563836 (human) | | 4e-13 | keratinocyte carcinoma | | 6 | 31441506 | 31441507 | Human |
596976228 | GWAS1095747_H | cardiovascular disease QTL GWAS1095747 (human) | | 3e-08 | cardiovascular disease | | 6 | 22513685 | 22513686 | Human |
597238383 | GWAS1334457_H | major depressive disorder QTL GWAS1334457 (human) | | 3e-11 | major depressive disorder | | 6 | 28294909 | 28294910 | Human |
597434980 | GWAS1531054_H | breast carcinoma QTL GWAS1531054 (human) | | 0.000008 | mammary gland integrity trait (VT:0010552) | | 6 | 30793795 | 30793796 | Human |
597271136 | GWAS1367210_H | BMI-adjusted hip circumference QTL GWAS1367210 (human) | | 1e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 30936495 | 30936496 | Human |
597369447 | GWAS1465521_H | short-term memory QTL GWAS1465521 (human) | | 0.000002 | short-term memory | | 6 | 8282300 | 8282301 | Human |
597533084 | GWAS1629158_H | Parkinson disease QTL GWAS1629158 (human) | | 5e-08 | Parkinson disease | | 6 | 26660427 | 26660428 | Human |
597467549 | GWAS1563623_H | basal cell carcinoma QTL GWAS1563623 (human) | | 8e-23 | basal cell carcinoma | | 6 | 32616594 | 32616595 | Human |
597205402 | GWAS1301476_H | podoconiosis QTL GWAS1301476 (human) | | 5e-09 | podoconiosis | | 6 | 32727298 | 32727299 | Human |
597205392 | GWAS1301466_H | daytime rest measurement QTL GWAS1301466 (human) | | 3e-18 | sleep behavior trait (VT:0001501) | | 6 | 28231986 | 28231987 | Human |
406985290 | GWAS634266_H | triglyceride measurement, alcohol consumption measurement QTL GWAS634266 (human) | | 1e-18 | response to alcohol trait (VT:0010489) | ethanol drink intake rate (CMO:0001407) | 6 | 31872244 | 31872245 | Human |
597467543 | GWAS1563617_H | basal cell carcinoma QTL GWAS1563617 (human) | | 5e-20 | basal cell carcinoma | | 6 | 22057337 | 22057338 | Human |
597139865 | GWAS1235939_H | total cholesterol measurement QTL GWAS1235939 (human) | | 4e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16126703 | 16126704 | Human |
597336458 | GWAS1432532_H | COVID-19 QTL GWAS1432532 (human) | | 0.000006 | COVID-19 | | 6 | 19208246 | 19208247 | Human |
407083603 | GWAS732579_H | obsolete_red blood cell distribution width QTL GWAS732579 (human) | | 1e-10 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 26046337 | 26046338 | Human |
407083602 | GWAS732578_H | obsolete_red blood cell distribution width QTL GWAS732578 (human) | | 6e-16 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 25933704 | 25933705 | Human |
597434765 | GWAS1530839_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1530839 (human) | | 8e-12 | very low density lipoprotein cholesterol measurement, phospholipid measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 31468255 | 31468256 | Human |
597434766 | GWAS1530840_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1530840 (human) | | 1e-22 | very low density lipoprotein cholesterol measurement, phospholipid measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 32633511 | 32633512 | Human |
597369230 | GWAS1465304_H | brain volume measurement QTL GWAS1465304 (human) | | 8e-09 | brain volume measurement | brain morphological measurement (CMO:0000136) | 6 | 7684834 | 7684835 | Human |
407083606 | GWAS732582_H | obsolete_red blood cell distribution width QTL GWAS732582 (human) | | 9e-546 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 26104404 | 26104405 | Human |
597074307 | GWAS1170381_H | sarcoidosis QTL GWAS1170381 (human) | | 4e-66 | sarcoidosis | | 6 | 32128224 | 32128225 | Human |
597270927 | GWAS1367001_H | BMI-adjusted hip circumference QTL GWAS1367001 (human) | | 5e-23 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 26159128 | 26159129 | Human |
597074304 | GWAS1170378_H | sarcoidosis QTL GWAS1170378 (human) | | 5e-36 | sarcoidosis | | 6 | 32638107 | 32638108 | Human |
597270926 | GWAS1367000_H | BMI-adjusted hip circumference QTL GWAS1367000 (human) | | 1e-21 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 19839184 | 19839185 | Human |
597172623 | GWAS1268697_H | body mass index QTL GWAS1268697 (human) | | 1e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 26159128 | 26159129 | Human |
597139840 | GWAS1235914_H | leukocyte count QTL GWAS1235914 (human) | | 4e-08 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 6 | 31354106 | 31354107 | Human |
597074305 | GWAS1170379_H | sarcoidosis QTL GWAS1170379 (human) | | 4e-11 | sarcoidosis | | 6 | 32812947 | 32812948 | Human |
597369219 | GWAS1465293_H | hemoglobin measurement QTL GWAS1465293 (human) | | 5e-14 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 12288189 | 12288190 | Human |
597369221 | GWAS1465295_H | hemoglobin measurement QTL GWAS1465295 (human) | | 2e-580 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 26123274 | 26123275 | Human |
407083613 | GWAS732589_H | obsolete_red blood cell distribution width QTL GWAS732589 (human) | | 9e-26 | obsolete_red blood cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 31437843 | 31437844 | Human |
597369220 | GWAS1465294_H | hemoglobin measurement QTL GWAS1465294 (human) | | 6e-20 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 22136033 | 22136034 | Human |
597074358 | GWAS1170432_H | type 2 diabetes mellitus QTL GWAS1170432 (human) | | 2e-56 | type 2 diabetes mellitus | | 6 | 20661019 | 20661020 | Human |
406919777 | GWAS568753_H | lymphocyte count QTL GWAS568753 (human) | | 6e-72 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 31572779 | 31572780 | Human |
597074359 | GWAS1170433_H | type 2 diabetes mellitus QTL GWAS1170433 (human) | | 4e-12 | type 2 diabetes mellitus | | 6 | 31168676 | 31168677 | Human |
597074357 | GWAS1170431_H | type 2 diabetes mellitus QTL GWAS1170431 (human) | | 2e-08 | type 2 diabetes mellitus | | 6 | 7290204 | 7290205 | Human |
597238206 | GWAS1334280_H | neutrophil count QTL GWAS1334280 (human) | | 1e-24 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31022242 | 31022243 | Human |
597434803 | GWAS1530877_H | chylomicron measurement, very low density lipoprotein cholesterol measurement QTL GWAS1530877 (human) | | 8e-11 | chylomicron measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 31468255 | 31468256 | Human |
597238187 | GWAS1334261_H | major depressive disorder QTL GWAS1334261 (human) | | 1e-08 | major depressive disorder | | 6 | 26365451 | 26365452 | Human |
597467567 | GWAS1563641_H | Alzheimer disease QTL GWAS1563641 (human) | | 0.000001 | Alzheimer disease | | 6 | 23378723 | 23378724 | Human |
597238189 | GWAS1334263_H | major depressive disorder QTL GWAS1334263 (human) | | 5e-09 | major depressive disorder | | 6 | 27442643 | 27442644 | Human |
597336495 | GWAS1432569_H | susceptibility to common cold measurement QTL GWAS1432569 (human) | | 0.000003 | susceptibility to common cold measurement | | 6 | 18149914 | 18149915 | Human |
597238188 | GWAS1334262_H | major depressive disorder QTL GWAS1334262 (human) | | 1e-09 | major depressive disorder | | 6 | 27190254 | 27190255 | Human |
597238190 | GWAS1334264_H | major depressive disorder QTL GWAS1334264 (human) | | 9e-09 | major depressive disorder | | 6 | 27867657 | 27867658 | Human |
597500327 | GWAS1596401_H | waist-hip ratio QTL GWAS1596401 (human) | | 1e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 7217284 | 7217285 | Human |
597336480 | GWAS1432554_H | phosphatidylcholine diacyl C42:5 measurement QTL GWAS1432554 (human) | | 7e-19 | lipid metabolism trait (VT:0010633) | | 6 | 11005609 | 11005610 | Human |
597336481 | GWAS1432555_H | phosphatidylcholine diacyl C42:6 measurement QTL GWAS1432555 (human) | | 2e-13 | lipid metabolism trait (VT:0010633) | | 6 | 11005609 | 11005610 | Human |
406887038 | GWAS536014_H | reticulocyte count QTL GWAS536014 (human) | | 1e-26 | reticulocyte count | total reticulocyte count (CMO:0003020) | 6 | 30289159 | 30289160 | Human |
597271001 | GWAS1367075_H | BMI-adjusted hip circumference QTL GWAS1367075 (human) | | 1e-28 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31596390 | 31596391 | Human |
597172696 | GWAS1268770_H | regulator of G-protein signaling 8 measurement QTL GWAS1268770 (human) | | 6e-35 | protein measurement | | 6 | 31966595 | 31966596 | Human |
597271003 | GWAS1367077_H | BMI-adjusted hip circumference QTL GWAS1367077 (human) | | 8e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31663054 | 31663055 | Human |
597271002 | GWAS1367076_H | BMI-adjusted hip circumference QTL GWAS1367076 (human) | | 4e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31758911 | 31758912 | Human |
597238236 | GWAS1334310_H | neutrophil-to-lymphocyte ratio QTL GWAS1334310 (human) | | 1e-12 | neutrophil-to-lymphocyte ratio | | 6 | 30414391 | 30414392 | Human |
597271004 | GWAS1367078_H | BMI-adjusted hip circumference QTL GWAS1367078 (human) | | 2e-15 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31618684 | 31618685 | Human |
597369299 | GWAS1465373_H | high density lipoprotein cholesterol measurement QTL GWAS1465373 (human) | | 4e-19 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 28021474 | 28021475 | Human |
597303762 | GWAS1399836_H | BMI-adjusted hip circumference QTL GWAS1399836 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31795067 | 31795068 | Human |
597172688 | GWAS1268762_H | regulator of G-protein signaling 19 measurement QTL GWAS1268762 (human) | | 3e-23 | regulator of G-protein signaling 19 measurement | | 6 | 31968902 | 31968903 | Human |
597402066 | GWAS1498140_H | childhood aggressive behaviour measurement QTL GWAS1498140 (human) | | 0.000002 | childhood aggressive behaviour measurement | | 6 | 28929137 | 28929138 | Human |
597303763 | GWAS1399837_H | BMI-adjusted hip circumference QTL GWAS1399837 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31778771 | 31778772 | Human |
597303760 | GWAS1399834_H | BMI-adjusted hip circumference QTL GWAS1399834 (human) | | 8e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32312814 | 32312815 | Human |
597303761 | GWAS1399835_H | BMI-adjusted hip circumference QTL GWAS1399835 (human) | | 4e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31873232 | 31873233 | Human |
597303766 | GWAS1399840_H | BMI-adjusted hip circumference QTL GWAS1399840 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31926167 | 31926168 | Human |
597303764 | GWAS1399838_H | BMI-adjusted hip circumference QTL GWAS1399838 (human) | | 2e-20 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31874113 | 31874114 | Human |
597303765 | GWAS1399839_H | BMI-adjusted hip circumference QTL GWAS1399839 (human) | | 2e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31870713 | 31870714 | Human |
597369291 | GWAS1465365_H | apolipoprotein B measurement QTL GWAS1465365 (human) | | 2e-08 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 31109462 | 31109463 | Human |
597500366 | GWAS1596440_H | protein measurement QTL GWAS1596440 (human) | | 1e-43 | protein measurement | | 6 | 31979817 | 31979818 | Human |
597303756 | GWAS1399830_H | level of calsequestrin-1 in blood serum QTL GWAS1399830 (human) | | 5e-14 | level of calsequestrin-1 in blood serum | | 6 | 31875082 | 31875083 | Human |
597303757 | GWAS1399831_H | level of cyclic AMP-responsive element-binding protein 3-like protein 4 in blood serum QTL GWAS1399831 (human) | | 3e-14 | level of cyclic AMP-responsive element-binding protein 3-like protein 4 in blood serum | | 6 | 31382067 | 31382068 | Human |
597172673 | GWAS1268747_H | hemoglobin measurement QTL GWAS1268747 (human) | | 2e-46 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 27973609 | 27973610 | Human |
597172674 | GWAS1268748_H | hemoglobin measurement QTL GWAS1268748 (human) | | 3e-43 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 26500335 | 26500336 | Human |
597238211 | GWAS1334285_H | neutrophil count QTL GWAS1334285 (human) | | 8e-20 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 27399042 | 27399043 | Human |
597172675 | GWAS1268749_H | hemoglobin measurement QTL GWAS1268749 (human) | | 2e-43 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 28360288 | 28360289 | Human |
597238213 | GWAS1334287_H | neutrophil count QTL GWAS1334287 (human) | | 1e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31772677 | 31772678 | Human |
597369286 | GWAS1465360_H | pulse pressure measurement QTL GWAS1465360 (human) | | 1e-23 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 32168770 | 32168771 | Human |
597369285 | GWAS1465359_H | pulse pressure measurement QTL GWAS1465359 (human) | | 4e-20 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 26132842 | 26132843 | Human |
597434877 | GWAS1530951_H | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement QTL GWAS1530951 (human) | | 4e-08 | blood lipid amount (VT:0003949) | blood lipid measurement (CMO:0000050) | 6 | 29845118 | 29845119 | Human |
597139957 | GWAS1236031_H | N-acetylhistidine measurement QTL GWAS1236031 (human) | | 1e-13 | N-acetylhistidine measurement | | 6 | 25817561 | 25817562 | Human |
597434878 | GWAS1530952_H | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement QTL GWAS1530952 (human) | | 7e-11 | blood lipid amount (VT:0003949) | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 31363921 | 31363922 | Human |
597434879 | GWAS1530953_H | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement QTL GWAS1530953 (human) | | 4e-26 | blood lipid amount (VT:0003949) | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 32633511 | 32633512 | Human |
597500408 | GWAS1596482_H | neuronal pentraxin-1 measurement QTL GWAS1596482 (human) | | 1e-45 | neuronal pentraxin-1 measurement | | 6 | 29945358 | 29945359 | Human |
597500411 | GWAS1596485_H | neurexophilin-1 measurement QTL GWAS1596485 (human) | | 2e-23 | neurexophilin-1 measurement | | 6 | 31937551 | 31937552 | Human |
597336560 | GWAS1432634_H | dyslexia QTL GWAS1432634 (human) | | 4e-08 | dyslexia | | 6 | 17009359 | 17009360 | Human |
597434864 | GWAS1530938_H | BMI-adjusted waist-hip ratio QTL GWAS1530938 (human) | | 1e-09 | body size trait (VT:0100005) | | 6 | 32384839 | 32384840 | Human |
597434860 | GWAS1530934_H | BMI-adjusted waist-hip ratio QTL GWAS1530934 (human) | | 2e-13 | body size trait (VT:0100005) | | 6 | 32244917 | 32244918 | Human |
597434861 | GWAS1530935_H | BMI-adjusted waist-hip ratio QTL GWAS1530935 (human) | | 5e-24 | body size trait (VT:0100005) | | 6 | 32255481 | 32255482 | Human |
597467630 | GWAS1563704_H | basal cell carcinoma QTL GWAS1563704 (human) | | 3e-08 | basal cell carcinoma | | 6 | 22056694 | 22056695 | Human |
597434862 | GWAS1530936_H | BMI-adjusted waist-hip ratio QTL GWAS1530936 (human) | | 3e-08 | body size trait (VT:0100005) | | 6 | 32369373 | 32369389 | Human |
597434863 | GWAS1530937_H | BMI-adjusted waist-hip ratio QTL GWAS1530937 (human) | | 4e-17 | body size trait (VT:0100005) | | 6 | 32373576 | 32373577 | Human |
597434858 | GWAS1530932_H | BMI-adjusted waist-hip ratio QTL GWAS1530932 (human) | | 1e-09 | body size trait (VT:0100005) | | 6 | 31883457 | 31883458 | Human |
407018036 | GWAS667012_H | response to vaccine QTL GWAS667012 (human) | | 1e-17 | response to vaccine | | 6 | 31903079 | 31903080 | Human |
597402092 | GWAS1498166_H | schizophrenia QTL GWAS1498166 (human) | | 7e-09 | schizophrenia | | 6 | 25170440 | 25170441 | Human |
597500394 | GWAS1596468_H | right ventricular ejection fraction measurement QTL GWAS1596468 (human) | | 2e-09 | right ventricular ejection fraction measurement | | 6 | 31345013 | 31345014 | Human |
597467627 | GWAS1563701_H | basal cell carcinoma QTL GWAS1563701 (human) | | 1e-08 | basal cell carcinoma | | 6 | 31857135 | 31857136 | Human |
597434859 | GWAS1530933_H | BMI-adjusted waist-hip ratio QTL GWAS1530933 (human) | | 3e-08 | body size trait (VT:0100005) | | 6 | 32192179 | 32192180 | Human |
597205474 | GWAS1301548_H | neuroimaging measurement QTL GWAS1301548 (human) | | 1e-26 | neuroimaging measurement | | 6 | 26092913 | 26092914 | Human |
597434854 | GWAS1530928_H | triglyceride measurement, very low density lipoprotein cholesterol measurement QTL GWAS1530928 (human) | | 4e-18 | triglyceride measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 31297358 | 31297359 | Human |
597369317 | GWAS1465391_H | intelligence QTL GWAS1465391 (human) | | 5e-09 | intelligence | | 6 | 30255651 | 30255652 | Human |
597369115 | GWAS1465189_H | Uveal Melanoma QTL GWAS1465189 (human) | | 0.000003 | Uveal Melanoma | | 6 | 7080590 | 7080591 | Human |
597172504 | GWAS1268578_H | hemoglobin measurement QTL GWAS1268578 (human) | | 1e-75 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 25488355 | 25488356 | Human |
597106966 | GWAS1203040_H | cancer QTL GWAS1203040 (human) | | 2e-14 | cancer | | 6 | 31346329 | 31346330 | Human |
597598492 | GWAS1655352_H | body height QTL GWAS1655352 (human) | | 8e-300 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 7723729 | 7723730 | Human |
597238044 | GWAS1334118_H | neutrophil-to-lymphocyte ratio QTL GWAS1334118 (human) | | 9e-34 | neutrophil-to-lymphocyte ratio | | 6 | 31572779 | 31572780 | Human |
597500187 | GWAS1596261_H | high density lipoprotein cholesterol measurement QTL GWAS1596261 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 28628203 | 28628204 | Human |
597238047 | GWAS1334121_H | neutrophil-to-lymphocyte ratio QTL GWAS1334121 (human) | | 8e-26 | neutrophil-to-lymphocyte ratio | | 6 | 32656110 | 32656111 | Human |
597238032 | GWAS1334106_H | lymphocyte:monocyte ratio QTL GWAS1334106 (human) | | 2e-41 | leukocyte quantity (VT:0000217) | | 6 | 31260408 | 31260409 | Human |
597434645 | GWAS1530719_H | Antithrombotic agent use measurement QTL GWAS1530719 (human) | | 2e-16 | Antithrombotic agent use measurement | | 6 | 31365142 | 31365143 | Human |
597467414 | GWAS1563488_H | body height QTL GWAS1563488 (human) | | 0.000005 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 26103868 | 26103869 | Human |
597172499 | GWAS1268573_H | hemoglobin measurement QTL GWAS1268573 (human) | | 4e-169 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 25917997 | 25917998 | Human |
597205268 | GWAS1301342_H | neuroimaging measurement QTL GWAS1301342 (human) | | 4e-47 | neuroimaging measurement | | 6 | 26092913 | 26092914 | Human |
597369110 | GWAS1465184_H | Uveal Melanoma QTL GWAS1465184 (human) | | 0.000002 | Uveal Melanoma | | 6 | 7080590 | 7080591 | Human |
597172502 | GWAS1268576_H | hemoglobin measurement QTL GWAS1268576 (human) | | 2e-82 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 25640972 | 25640973 | Human |
597303562 | GWAS1399636_H | BMI-adjusted hip circumference QTL GWAS1399636 (human) | | 2e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31596390 | 31596391 | Human |
597303563 | GWAS1399637_H | BMI-adjusted hip circumference QTL GWAS1399637 (human) | | 1e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32212369 | 32212370 | Human |
597303560 | GWAS1399634_H | BMI-adjusted hip circumference QTL GWAS1399634 (human) | | 1e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31557671 | 31557672 | Human |
596975879 | GWAS1095398_H | rheumatoid arthritis QTL GWAS1095398 (human) | | 2e-11 | rheumatoid arthritis | | 6 | 32227599 | 32227600 | Human |
597238026 | GWAS1334100_H | lymphocyte:monocyte ratio QTL GWAS1334100 (human) | | 2e-47 | leukocyte quantity (VT:0000217) | | 6 | 31572779 | 31572780 | Human |
597303561 | GWAS1399635_H | BMI-adjusted hip circumference QTL GWAS1399635 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31572980 | 31572981 | Human |
597205260 | GWAS1301334_H | rheumatoid arthritis QTL GWAS1301334 (human) | | 1e-11 | rheumatoid arthritis | | 6 | 14106966 | 14106967 | Human |
597369101 | GWAS1465175_H | heel bone mineral density QTL GWAS1465175 (human) | | 2e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 10052356 | 10052357 | Human |
597303564 | GWAS1399638_H | BMI-adjusted hip circumference QTL GWAS1399638 (human) | | 8e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31605179 | 31605180 | Human |
597303565 | GWAS1399639_H | BMI-adjusted hip circumference QTL GWAS1399639 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31627710 | 31627711 | Human |
597172495 | GWAS1268569_H | hemoglobin measurement QTL GWAS1268569 (human) | | 4e-19 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 32420498 | 32420499 | Human |
597303554 | GWAS1399628_H | body height QTL GWAS1399628 (human) | | 2e-195 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 19839184 | 19839185 | Human |
597270785 | GWAS1366859_H | BMI-adjusted hip circumference QTL GWAS1366859 (human) | | 3e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31523354 | 31523355 | Human |
407050971 | GWAS699947_H | rheumatoid arthritis QTL GWAS699947 (human) | | 2e-58 | rheumatoid arthritis | | 6 | 32703326 | 32703327 | Human |
597270784 | GWAS1366858_H | BMI-adjusted hip circumference QTL GWAS1366858 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31551876 | 31551877 | Human |
597369090 | GWAS1465164_H | parental longevity QTL GWAS1465164 (human) | | 0.0000007 | total life span (VT:0001661) | | 6 | 31660956 | 31660957 | Human |
596975884 | GWAS1095403_H | rheumatoid arthritis QTL GWAS1095403 (human) | | 4e-08 | rheumatoid arthritis | | 6 | 32412901 | 32412902 | Human |
597270787 | GWAS1366861_H | BMI-adjusted hip circumference QTL GWAS1366861 (human) | | 8e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31524676 | 31524677 | Human |
597270786 | GWAS1366860_H | BMI-adjusted hip circumference QTL GWAS1366860 (human) | | 1e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31515359 | 31515360 | Human |
596975881 | GWAS1095400_H | rheumatoid arthritis QTL GWAS1095400 (human) | | 9e-11 | rheumatoid arthritis | | 6 | 32687953 | 32687954 | Human |
597303559 | GWAS1399633_H | BMI-adjusted hip circumference QTL GWAS1399633 (human) | | 4e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31521867 | 31521868 | Human |
597270788 | GWAS1366862_H | BMI-adjusted hip circumference QTL GWAS1366862 (human) | | 1e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31557671 | 31557672 | Human |
596975880 | GWAS1095399_H | rheumatoid arthritis QTL GWAS1095399 (human) | | 4e-11 | rheumatoid arthritis | | 6 | 31637422 | 31637423 | Human |
597238020 | GWAS1334094_H | neutrophil count QTL GWAS1334094 (human) | | 1e-25 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 32742444 | 32742445 | Human |
597238023 | GWAS1334097_H | lymphocyte:monocyte ratio QTL GWAS1334097 (human) | | 3e-52 | leukocyte quantity (VT:0000217) | | 6 | 31262216 | 31262217 | Human |
596975883 | GWAS1095402_H | rheumatoid arthritis QTL GWAS1095402 (human) | | 5e-09 | rheumatoid arthritis | | 6 | 31487417 | 31487418 | Human |
596975882 | GWAS1095401_H | rheumatoid arthritis QTL GWAS1095401 (human) | | 2e-10 | rheumatoid arthritis | | 6 | 32232370 | 32232371 | Human |
597598524 | GWAS1655384_H | body height QTL GWAS1655384 (human) | | 2e-143 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 7723729 | 7723730 | Human |
597270843 | GWAS1366917_H | taste liking measurement QTL GWAS1366917 (human) | | 7e-09 | taste liking measurement | | 6 | 25853293 | 25853294 | Human |
597598525 | GWAS1655385_H | body height QTL GWAS1655385 (human) | | 1e-216 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 26206946 | 26206947 | Human |
597434672 | GWAS1530746_H | cerebrospinal fluid biomarker measurement, xanthosine measurement QTL GWAS1530746 (human) | | 8e-20 | cerebrospinal fluid biomarker measurement, xanthosine measurement | cerebrospinal fluid chemistry measurement (CMO:0001241) | 6 | 16275611 | 16275612 | Human |
597074232 | GWAS1170306_H | major depressive disorder QTL GWAS1170306 (human) | | 0.000003 | major depressive disorder | | 6 | 10818696 | 10818697 | Human |
597106980 | GWAS1203054_H | body height QTL GWAS1203054 (human) | | 0.000006 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 7695740 | 7695741 | Human |
597369123 | GWAS1465197_H | dentures QTL GWAS1465197 (human) | | 4e-26 | dentures | | 6 | 26336468 | 26336469 | Human |
597434658 | GWAS1530732_H | HWESASXX measurement QTL GWAS1530732 (human) | | 0.000006 | HWESASXX measurement | | 6 | 7214266 | 7214267 | Human |
407182075 | GWAS831051_H | blood protein measurement QTL GWAS831051 (human) | | 2e-17 | blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 31366700 | 31366701 | Human |
597369178 | GWAS1465252_H | white matter microstructure measurement QTL GWAS1465252 (human) | | 2e-11 | white matter microstructure measurement | | 6 | 29187972 | 29187973 | Human |
597172571 | GWAS1268645_H | cysteine and glycine-rich protein 2 measurement QTL GWAS1268645 (human) | | 2e-12 | cysteine and glycine-rich protein 2 measurement | | 6 | 31947367 | 31947368 | Human |
597107027 | GWAS1203101_H | fibroblast growth factor 23 measurement QTL GWAS1203101 (human) | | 2e-08 | fibroblast growth factor 23 measurement | | 6 | 32653236 | 32653237 | Human |
597107039 | GWAS1203113_H | systemic lupus erythematosus QTL GWAS1203113 (human) | | 2e-19 | systemic lupus erythematosus | | 6 | 28442366 | 28442367 | Human |
597107038 | GWAS1203112_H | systemic lupus erythematosus QTL GWAS1203112 (human) | | 8e-11 | systemic lupus erythematosus | | 6 | 25928148 | 25928149 | Human |
406919820 | GWAS568796_H | birth weight QTL GWAS568796 (human) | | 3e-25 | birth weight | neonatal body weight (CMO:0002079) | 6 | 20687890 | 20687891 | Human |
597467474 | GWAS1563548_H | breast carcinoma QTL GWAS1563548 (human) | | 0.0000003 | mammary gland integrity trait (VT:0010552) | | 6 | 21905495 | 21905496 | Human |
597041478 | GWAS1137552_H | appendicular lean mass QTL GWAS1137552 (human) | | 2e-12 | appendicular lean mass | | 6 | 31874113 | 31874114 | Human |
406887057 | GWAS536033_H | pulse pressure measurement QTL GWAS536033 (human) | | 8e-19 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 31575254 | 31575255 | Human |
597467464 | GWAS1563538_H | breast carcinoma QTL GWAS1563538 (human) | | 8e-09 | mammary gland integrity trait (VT:0010552) | | 6 | 28594470 | 28594471 | Human |
597303630 | GWAS1399704_H | level of stromal cell-derived factor 2 in blood serum QTL GWAS1399704 (human) | | 5e-18 | level of stromal cell-derived factor 2 in blood serum | | 6 | 31358633 | 31358634 | Human |
597467466 | GWAS1563540_H | breast carcinoma QTL GWAS1563540 (human) | | 9e-10 | mammary gland integrity trait (VT:0010552) | | 6 | 26993501 | 26993502 | Human |
597467467 | GWAS1563541_H | breast carcinoma QTL GWAS1563541 (human) | | 3e-09 | mammary gland integrity trait (VT:0010552) | | 6 | 28106103 | 28106104 | Human |
597107023 | GWAS1203097_H | remission, hepatitis C virus infection QTL GWAS1203097 (human) | | 1e-11 | remission, hepatitis C virus infection | | 6 | 32694503 | 32694504 | Human |
406985368 | GWAS634344_H | triglyceride measurement, alcohol consumption measurement QTL GWAS634344 (human) | | 8e-14 | response to alcohol trait (VT:0010489) | ethanol drink intake rate (CMO:0001407) | 6 | 31872244 | 31872245 | Human |
597467462 | GWAS1563536_H | inflammatory bowel disease QTL GWAS1563536 (human) | | 2e-31 | inflammatory bowel disease | | 6 | 32644620 | 32644621 | Human |
597107019 | GWAS1203093_H | remission, hepatitis C virus infection QTL GWAS1203093 (human) | | 2e-12 | remission, hepatitis C virus infection | | 6 | 32693516 | 32693517 | Human |
406887073 | GWAS536049_H | unipolar depression QTL GWAS536049 (human) | | 4e-12 | unipolar depression | | 6 | 28515140 | 28515141 | Human |
596975991 | GWAS1095510_H | Behcet's syndrome QTL GWAS1095510 (human) | | 5e-09 | Behcet's syndrome | | 6 | 31361146 | 31361147 | Human |
597401976 | GWAS1498050_H | corneal topography QTL GWAS1498050 (human) | | 2e-08 | corneal topography | | 6 | 22064410 | 22064411 | Human |
596975990 | GWAS1095509_H | Behcet's syndrome QTL GWAS1095509 (human) | | 6e-10 | Behcet's syndrome | | 6 | 31036146 | 31036147 | Human |
597500281 | GWAS1596355_H | alpha fetoprotein measurement QTL GWAS1596355 (human) | | 2e-09 | blood alpha-fetoprotein amount (VT:0010776) | | 6 | 28591470 | 28591471 | Human |
597434744 | GWAS1530818_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1530818 (human) | | 3e-12 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 32697338 | 32697339 | Human |
597401981 | GWAS1498055_H | corneal topography QTL GWAS1498055 (human) | | 0.000003 | corneal topography | | 6 | 10028593 | 10028594 | Human |
597074302 | GWAS1170376_H | sarcoidosis QTL GWAS1170376 (human) | | 1e-33 | sarcoidosis | | 6 | 32334605 | 32334606 | Human |
597074303 | GWAS1170377_H | sarcoidosis QTL GWAS1170377 (human) | | 3e-33 | sarcoidosis | | 6 | 32440720 | 32440721 | Human |
597434743 | GWAS1530817_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1530817 (human) | | 2e-11 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 31415353 | 31415354 | Human |
597074301 | GWAS1170375_H | sarcoidosis QTL GWAS1170375 (human) | | 3e-33 | sarcoidosis | | 6 | 32128224 | 32128225 | Human |
597369207 | GWAS1465281_H | white matter microstructure measurement QTL GWAS1465281 (human) | | 9e-09 | white matter microstructure measurement | | 6 | 29187972 | 29187973 | Human |
407050930 | GWAS699906_H | hypothyroidism QTL GWAS699906 (human) | | 0.0000005 | hypothyroidism | | 6 | 32695854 | 32695855 | Human |
597336424 | GWAS1432498_H | dyslexia QTL GWAS1432498 (human) | | 0.0000006 | dyslexia | | 6 | 19071080 | 19071081 | Human |
597139821 | GWAS1235895_H | migraine disorder, type 2 diabetes mellitus QTL GWAS1235895 (human) | | 1e-08 | migraine disorder, type 2 diabetes mellitus | | 6 | 7204195 | 7204196 | Human |
597598560 | GWAS1655420_H | hemoglobin measurement QTL GWAS1655420 (human) | | 2e-18 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 25857692 | 25857693 | Human |
597336216 | GWAS1432290_H | COVID-19 QTL GWAS1432290 (human) | | 0.00001 | COVID-19 | | 6 | 19208246 | 19208247 | Human |
407018304 | GWAS667280_H | docosapentaenoic acid measurement QTL GWAS667280 (human) | | 0.0000005 | docosapentaenoic acid measurement | blood free fatty acids level (CMO:0000117) | 6 | 32103240 | 32103241 | Human |
597172365 | GWAS1268439_H | poly(A) RNA polymerase, mitochondrial measurement QTL GWAS1268439 (human) | | 1e-12 | poly(A) RNA polymerase, mitochondrial measurement | | 6 | 31965384 | 31965385 | Human |
597598341 | GWAS1655201_H | mean corpuscular hemoglobin concentration QTL GWAS1655201 (human) | | 2e-16 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 10723216 | 10723217 | Human |
597074058 | GWAS1170132_H | response to lithium ion QTL GWAS1170132 (human) | | 0.000002 | response to lithium ion | | 6 | 32218468 | 32218469 | Human |
597074103 | GWAS1170177_H | asthma QTL GWAS1170177 (human) | | 3e-10 | asthma | | 6 | 31504943 | 31504944 | Human |
597106868 | GWAS1202942_H | remission, hepatitis C virus infection QTL GWAS1202942 (human) | | 0.0000005 | remission, hepatitis C virus infection | | 6 | 32484810 | 32484811 | Human |
597401779 | GWAS1497853_H | schizophrenia QTL GWAS1497853 (human) | | 0.000007 | schizophrenia | | 6 | 29696112 | 29696113 | Human |
597500084 | GWAS1596158_H | ER membrane protein complex subunit 4 measurement QTL GWAS1596158 (human) | | 7e-31 | ER membrane protein complex subunit 4 measurement | | 6 | 31951126 | 31951127 | Human |
597434551 | GWAS1530625_H | Inguinal hernia QTL GWAS1530625 (human) | | 8e-11 | Inguinal hernia | | 6 | 28865366 | 28865367 | Human |
597139643 | GWAS1235717_H | hemoglobin measurement QTL GWAS1235717 (human) | | 2e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16295116 | 16295121 | Human |
597205173 | GWAS1301247_H | type 2 diabetes mellitus QTL GWAS1301247 (human) | | 1e-13 | Drugs used in diabetes use measurement | | 6 | 7231610 | 7231611 | Human |
597205174 | GWAS1301248_H | type 2 diabetes mellitus QTL GWAS1301248 (human) | | 2e-10 | type 2 diabetes mellitus | | 6 | 31161839 | 31161840 | Human |
406985586 | GWAS634562_H | von Willebrand factor measurement QTL GWAS634562 (human) | | 1e-08 | von Willebrand factor measurement | | 6 | 31939051 | 31939052 | Human |
597467308 | GWAS1563382_H | glomerular filtration rate QTL GWAS1563382 (human) | | 7e-17 | glomerular filtration rate | glomerular filtration rate (CMO:0000490) | 6 | 32192179 | 32192180 | Human |
406985594 | GWAS634570_H | von Willebrand factor measurement QTL GWAS634570 (human) | | 3e-08 | von Willebrand factor measurement | | 6 | 31973852 | 31973853 | Human |
597106861 | GWAS1202935_H | body height QTL GWAS1202935 (human) | | 0.000002 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 7708398 | 7708399 | Human |
597074091 | GWAS1170165_H | asthma QTL GWAS1170165 (human) | | 5e-09 | asthma | | 6 | 28744470 | 28744471 | Human |
597139669 | GWAS1235743_H | neuroimaging measurement QTL GWAS1235743 (human) | | 3e-19 | neuroimaging measurement | | 6 | 7112586 | 7112587 | Human |
597434584 | GWAS1530658_H | BMI-adjusted waist-hip ratio QTL GWAS1530658 (human) | | 4e-10 | body size trait (VT:0100005) | | 6 | 31819186 | 31819187 | Human |
597434585 | GWAS1530659_H | BMI-adjusted waist-hip ratio QTL GWAS1530659 (human) | | 3e-08 | body size trait (VT:0100005) | | 6 | 31883692 | 31883693 | Human |
597467348 | GWAS1563422_H | decreased fine motor function QTL GWAS1563422 (human) | | 0.000001 | decreased fine motor function | | 6 | 30805537 | 30805538 | Human |
406985482 | GWAS634458_H | von Willebrand factor measurement QTL GWAS634458 (human) | | 3e-08 | von Willebrand factor measurement | | 6 | 31958071 | 31958072 | Human |
597434581 | GWAS1530655_H | BMI-adjusted waist-hip ratio QTL GWAS1530655 (human) | | 4e-08 | body size trait (VT:0100005) | | 6 | 31620093 | 31620094 | Human |
597434582 | GWAS1530656_H | BMI-adjusted waist-hip ratio QTL GWAS1530656 (human) | | 5e-11 | body size trait (VT:0100005) | | 6 | 31635814 | 31635815 | Human |
597434576 | GWAS1530650_H | BMI-adjusted waist-hip ratio QTL GWAS1530650 (human) | | 6e-11 | body size trait (VT:0100005) | | 6 | 31474954 | 31474955 | Human |
406985486 | GWAS634462_H | von Willebrand factor measurement QTL GWAS634462 (human) | | 1e-08 | von Willebrand factor measurement | | 6 | 31973852 | 31973853 | Human |
597434577 | GWAS1530651_H | BMI-adjusted waist-hip ratio QTL GWAS1530651 (human) | | 4e-10 | body size trait (VT:0100005) | | 6 | 31493266 | 31493267 | Human |
597434578 | GWAS1530652_H | BMI-adjusted waist-hip ratio QTL GWAS1530652 (human) | | 1e-08 | body size trait (VT:0100005) | | 6 | 31494828 | 31494829 | Human |
597434579 | GWAS1530653_H | BMI-adjusted waist-hip ratio QTL GWAS1530653 (human) | | 1e-12 | body size trait (VT:0100005) | | 6 | 31570712 | 31570713 | Human |
597434574 | GWAS1530648_H | BMI-adjusted waist-hip ratio QTL GWAS1530648 (human) | | 1e-13 | body size trait (VT:0100005) | | 6 | 31465781 | 31465782 | Human |
407018256 | GWAS667232_H | hepatitis B virus infection QTL GWAS667232 (human) | | 6e-28 | hepatitis B virus infection | | 6 | 32762235 | 32762236 | Human |
597434575 | GWAS1530649_H | BMI-adjusted waist-hip ratio QTL GWAS1530649 (human) | | 4e-14 | body size trait (VT:0100005) | | 6 | 31463022 | 31463023 | Human |
407018257 | GWAS667233_H | age at menopause QTL GWAS667233 (human) | | 2e-16 | age at menopause | | 6 | 31635190 | 31635191 | Human |
597369029 | GWAS1465103_H | autism spectrum disorder QTL GWAS1465103 (human) | | 0.0000004 | autism spectrum disorder | | 6 | 11731766 | 11731767 | Human |
597270777 | GWAS1366851_H | BMI-adjusted hip circumference QTL GWAS1366851 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31978837 | 31978838 | Human |
597336314 | GWAS1432388_H | Acute tubulointerstitial nephritis QTL GWAS1432388 (human) | | 3e-39 | Acute tubulointerstitial nephritis | | 6 | 32642660 | 32642661 | Human |
597238009 | GWAS1334083_H | neutrophil count QTL GWAS1334083 (human) | | 1e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 32837530 | 32837531 | Human |
597270776 | GWAS1366850_H | BMI-adjusted hip circumference QTL GWAS1366850 (human) | | 3e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32092689 | 32092690 | Human |
597401849 | GWAS1497923_H | anti-tetanus toxoid IgG measurement, response to vaccine QTL GWAS1497923 (human) | | 1e-09 | anti-tetanus toxoid IgG measurement, response to vaccine | | 6 | 31481245 | 31481246 | Human |
597270779 | GWAS1366853_H | BMI-adjusted hip circumference QTL GWAS1366853 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31511868 | 31511869 | Human |
597270778 | GWAS1366852_H | BMI-adjusted hip circumference QTL GWAS1366852 (human) | | 1e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32042955 | 32042956 | Human |
597369080 | GWAS1465154_H | asthma, major depressive disorder QTL GWAS1465154 (human) | | 3e-13 | asthma, major depressive disorder | | 6 | 32660651 | 32660652 | Human |
597270781 | GWAS1366855_H | BMI-adjusted hip circumference QTL GWAS1366855 (human) | | 1e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31498510 | 31498511 | Human |
597270780 | GWAS1366854_H | BMI-adjusted hip circumference QTL GWAS1366854 (human) | | 8e-16 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31527842 | 31527843 | Human |
407018279 | GWAS667255_H | age-related macular degeneration QTL GWAS667255 (human) | | 2e-23 | age-related macular degeneration | | 6 | 31936027 | 31936028 | Human |
597270783 | GWAS1366857_H | BMI-adjusted hip circumference QTL GWAS1366857 (human) | | 1e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31507878 | 31507879 | Human |
597270782 | GWAS1366856_H | BMI-adjusted hip circumference QTL GWAS1366856 (human) | | 2e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31501814 | 31501815 | Human |
597238001 | GWAS1334075_H | lymphocyte count QTL GWAS1334075 (human) | | 6e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 31256890 | 31256891 | Human |
597598455 | GWAS1655315_H | body height QTL GWAS1655315 (human) | | 2e-11 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 19839184 | 19839185 | Human |
597270773 | GWAS1366847_H | type 2 diabetes mellitus QTL GWAS1366847 (human) | | 5e-136 | type 2 diabetes mellitus | | 6 | 20680447 | 20680448 | Human |
597270772 | GWAS1366846_H | type 2 diabetes mellitus QTL GWAS1366846 (human) | | 1e-08 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597270775 | GWAS1366849_H | BMI-adjusted hip circumference QTL GWAS1366849 (human) | | 9e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32058086 | 32058087 | Human |
407083820 | GWAS732796_H | stroke QTL GWAS732796 (human) | | 0.0000001 | stroke | | 6 | 24740561 | 24740562 | Human |
406952750 | GWAS601726_H | eosinophil count QTL GWAS601726 (human) | | 4e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 28336792 | 28336793 | Human |
597270774 | GWAS1366848_H | BMI-adjusted hip circumference QTL GWAS1366848 (human) | | 9e-16 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 32057055 | 32057056 | Human |
597237995 | GWAS1334069_H | lymphocyte count QTL GWAS1334069 (human) | | 2e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 7144958 | 7144959 | Human |
597172458 | GWAS1268532_H | triglyceride measurement, phospholipid measurement QTL GWAS1268532 (human) | | 8e-18 | triglyceride measurement, phospholipid measurement | blood triglyceride level (CMO:0000118) | 6 | 31271999 | 31272000 | Human |
597237994 | GWAS1334068_H | lymphocyte count QTL GWAS1334068 (human) | | 8e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 24806110 | 24806111 | Human |
597074145 | GWAS1170219_H | asthma QTL GWAS1170219 (human) | | 1e-18 | asthma | | 6 | 32408196 | 32408197 | Human |
406887226 | GWAS536202_H | neuroblastoma, cutaneous melanoma QTL GWAS536202 (human) | | 0.000002 | neuroblastoma, cutaneous melanoma | | 6 | 32625367 | 32625368 | Human |
597237989 | GWAS1334063_H | lymphocyte count QTL GWAS1334063 (human) | | 3e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 29519505 | 29519506 | Human |
407214907 | GWAS863883_H | unipolar depression QTL GWAS863883 (human) | | 1e-09 | unipolar depression | | 6 | 32609856 | 32609857 | Human |
407214906 | GWAS863882_H | unipolar depression QTL GWAS863882 (human) | | 1e-09 | unipolar depression | | 6 | 26974367 | 26974368 | Human |
597172248 | GWAS1268322_H | intelligence QTL GWAS1268322 (human) | | 4e-08 | intelligence | | 6 | 19102055 | 19102056 | Human |
406920129 | GWAS569105_H | intelligence QTL GWAS569105 (human) | | 0.0000006 | intelligence | | 6 | 29677772 | 29677773 | Human |
597336093 | GWAS1432167_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432167 (human) | | 0.0000007 | S-warfarin to R-warfarin ratio measurement | | 6 | 19007171 | 19007172 | Human |
597139485 | GWAS1235559_H | leukocyte count QTL GWAS1235559 (human) | | 4e-08 | body size trait (VT:0100005) | white blood cell count (CMO:0000027) | 6 | 7220146 | 7220147 | Human |
597598226 | GWAS1655086_H | mean corpuscular hemoglobin concentration QTL GWAS1655086 (human) | | 5e-89 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 26090951 | 26090952 | Human |
597172232 | GWAS1268306_H | smoking initiation QTL GWAS1268306 (human) | | 3e-10 | smoking initiation | | 6 | 21160216 | 21160217 | Human |
597172233 | GWAS1268307_H | smoking initiation QTL GWAS1268307 (human) | | 6e-37 | smoking initiation | | 6 | 26171022 | 26171023 | Human |
597270536 | GWAS1366610_H | BMI-adjusted hip circumference QTL GWAS1366610 (human) | | 5e-15 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31962664 | 31962665 | Human |
597499909 | GWAS1595983_H | inflammatory bowel disease QTL GWAS1595983 (human) | | 2e-09 | inflammatory bowel disease | | 6 | 32660372 | 32660373 | Human |
597499908 | GWAS1595982_H | inflammatory bowel disease QTL GWAS1595982 (human) | | 1e-12 | inflammatory bowel disease | | 6 | 29976407 | 29976408 | Human |
597270531 | GWAS1366605_H | BMI-adjusted hip circumference QTL GWAS1366605 (human) | | 4e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31607123 | 31607124 | Human |
597270530 | GWAS1366604_H | BMI-adjusted hip circumference QTL GWAS1366604 (human) | | 1e-15 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31914363 | 31914364 | Human |
597172228 | GWAS1268302_H | smoking initiation QTL GWAS1268302 (human) | | 4e-12 | smoking initiation | | 6 | 17012781 | 17012782 | Human |
597270533 | GWAS1366607_H | BMI-adjusted hip circumference QTL GWAS1366607 (human) | | 5e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31615378 | 31615379 | Human |
597172229 | GWAS1268303_H | smoking initiation QTL GWAS1268303 (human) | | 3e-12 | smoking initiation | | 6 | 17013198 | 17013199 | Human |
597270532 | GWAS1366606_H | BMI-adjusted hip circumference QTL GWAS1366606 (human) | | 6e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31609322 | 31609323 | Human |
597172230 | GWAS1268304_H | smoking initiation QTL GWAS1268304 (human) | | 4e-11 | smoking initiation | | 6 | 18834425 | 18834426 | Human |
597270535 | GWAS1366609_H | BMI-adjusted hip circumference QTL GWAS1366609 (human) | | 2e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31976259 | 31976260 | Human |
597172231 | GWAS1268305_H | smoking initiation QTL GWAS1268305 (human) | | 2e-20 | smoking initiation | | 6 | 19030499 | 19030500 | Human |
597270534 | GWAS1366608_H | BMI-adjusted hip circumference QTL GWAS1366608 (human) | | 2e-23 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 31954477 | 31954478 | Human |
597237821 | GWAS1333895_H | neutrophil-to-lymphocyte ratio QTL GWAS1333895 (human) | | 9e-15 | neutrophil-to-lymphocyte ratio | | 6 | 30916423 | 30916424 | Human |
597467188 | GWAS1563262_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS1563262 (human) | | 1e-08 | body size trait (VT:0100005) | | 6 | 32413959 | 32413960 | Human |
597303349 | GWAS1399423_H | interleukin-36 alpha measurement QTL GWAS1399423 (human) | | 8e-23 | interleukin-36 alpha measurement | | 6 | 32133413 | 32133414 | Human |
406985709 | GWAS634685_H | risk-taking behaviour QTL GWAS634685 (human) | | 2e-09 | risk-taking behaviour | | 6 | 32480784 | 32480785 | Human |
597336105 | GWAS1432179_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432179 (human) | | 0.000006 | S-warfarin to R-warfarin ratio measurement | | 6 | 18266261 | 18266262 | Human |
597237802 | GWAS1333876_H | neutrophil count QTL GWAS1333876 (human) | | 3e-36 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31572779 | 31572780 | Human |
597237805 | GWAS1333879_H | neutrophil count QTL GWAS1333879 (human) | | 2e-31 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 32772634 | 32772635 | Human |
597106723 | GWAS1202797_H | cerebral white matter volume change measurement, age at assessment QTL GWAS1202797 (human) | | 0.000001 | cerebral white matter volume change measurement, age at assessment | | 6 | 32792668 | 32792669 | Human |
597237804 | GWAS1333878_H | neutrophil count QTL GWAS1333878 (human) | | 2e-33 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 30393581 | 30393582 | Human |
597237795 | GWAS1333869_H | lymphocyte count QTL GWAS1333869 (human) | | 1e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 30993156 | 30993157 | Human |
597106733 | GWAS1202807_H | cervical carcinoma QTL GWAS1202807 (human) | | 6e-13 | cervical carcinoma | | 6 | 31021915 | 31021916 | Human |
597532707 | GWAS1628781_H | cardiovascular measurement QTL GWAS1628781 (human) | | 1e-08 | cardiovascular measurement | cardiovascular measurement (CMO:0000001) | 6 | 31260501 | 31260502 | Human |
597139496 | GWAS1235570_H | neuroimaging measurement QTL GWAS1235570 (human) | | 2e-21 | neuroimaging measurement | | 6 | 29581876 | 29581877 | Human |
597434461 | GWAS1530535_H | type 2 diabetes mellitus QTL GWAS1530535 (human) | | 7e-20 | type 2 diabetes mellitus | | 6 | 31197002 | 31197003 | Human |
597434462 | GWAS1530536_H | type 2 diabetes mellitus QTL GWAS1530536 (human) | | 1e-09 | type 2 diabetes mellitus | | 6 | 32700254 | 32700255 | Human |
597172317 | GWAS1268391_H | hemoglobin measurement QTL GWAS1268391 (human) | | 2e-40 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 28468891 | 28468892 | Human |
406985604 | GWAS634580_H | low density lipoprotein cholesterol measurement, alcohol drinking QTL GWAS634580 (human) | | 4e-12 | low density lipoprotein cholesterol measurement, alcohol drinking | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 31872244 | 31872245 | Human |
597172319 | GWAS1268393_H | hemoglobin measurement QTL GWAS1268393 (human) | | 2e-36 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 29542853 | 29542854 | Human |
407051145 | GWAS700121_H | sphingomyelin 22:0 measurement QTL GWAS700121 (human) | | 0.000008 | blood phospholipid amount (VT:0006084) | | 6 | 12371479 | 12371480 | Human |
597270601 | GWAS1366675_H | taste liking measurement QTL GWAS1366675 (human) | | 4e-09 | taste liking measurement | | 6 | 27326794 | 27326795 | Human |
597598280 | GWAS1655140_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1655140 (human) | | 7e-17 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 6 | 13525133 | 13525134 | Human |
597467211 | GWAS1563285_H | interleukin 10 measurement QTL GWAS1563285 (human) | | 0.000006 | interleukin 10 measurement | | 6 | 26242129 | 26242130 | Human |
597598281 | GWAS1655141_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1655141 (human) | | 2e-32 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 6 | 32634153 | 32634154 | Human |
597205058 | GWAS1301132_H | neuroimaging measurement QTL GWAS1301132 (human) | | 5e-47 | neuroimaging measurement | | 6 | 26092913 | 26092914 | Human |
597073996 | GWAS1170070_H | asthma QTL GWAS1170070 (human) | | 0.0000006 | asthma | | 6 | 28744470 | 28744471 | Human |
597041229 | GWAS1137303_H | low density lipoprotein cholesterol measurement QTL GWAS1137303 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 11856023 | 11856026 | Human |
597073997 | GWAS1170071_H | asthma QTL GWAS1170071 (human) | | 9e-12 | asthma | | 6 | 31504943 | 31504944 | Human |
597237830 | GWAS1333904_H | neutrophil-to-lymphocyte ratio QTL GWAS1333904 (human) | | 4e-13 | neutrophil-to-lymphocyte ratio | | 6 | 32243540 | 32243541 | Human |
597368955 | GWAS1465029_H | apolipoprotein B measurement QTL GWAS1465029 (human) | | 8e-09 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 29786616 | 29786617 | Human |
597106800 | GWAS1202874_H | cancer QTL GWAS1202874 (human) | | 2e-10 | cancer | | 6 | 31045574 | 31045575 | Human |
597237874 | GWAS1333948_H | leprosy QTL GWAS1333948 (human) | | 4e-50 | leprosy | | 6 | 32606899 | 32606900 | Human |
597139579 | GWAS1235653_H | N-acetylphenylalanine measurement QTL GWAS1235653 (human) | | 5e-31 | N-acetylphenylalanine measurement | | 6 | 25817561 | 25817562 | Human |
597303413 | GWAS1399487_H | apolipoprotein M measurement QTL GWAS1399487 (human) | | 8e-18 | apolipoprotein M measurement | | 6 | 31637501 | 31637502 | Human |
597106808 | GWAS1202882_H | cytokine measurement QTL GWAS1202882 (human) | | 0.000003 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 32714625 | 32714626 | Human |
597434476 | GWAS1530550_H | angina pectoris QTL GWAS1530550 (human) | | 6e-11 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597434478 | GWAS1530552_H | angina pectoris QTL GWAS1530552 (human) | | 3e-12 | angina pectoris | | 6 | 31477737 | 31477738 | Human |
597139556 | GWAS1235630_H | age of onset of colorectal cancer QTL GWAS1235630 (human) | | 4e-13 | age of onset of colorectal cancer | | 6 | 27901014 | 27901015 | Human |
597401711 | GWAS1497785_H | ubiquitin-conjugating enzyme E2 G2 measurement QTL GWAS1497785 (human) | | 2e-12 | ubiquitin-conjugating enzyme E2 G2 measurement | | 6 | 32227555 | 32227556 | Human |
597434474 | GWAS1530548_H | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1530548 (human) | | 2e-12 | blood lipid amount (VT:0003949) | blood lipid measurement (CMO:0000050) | 6 | 31468255 | 31468256 | Human |
597434475 | GWAS1530549_H | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1530549 (human) | | 1e-08 | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 32610856 | 32610857 | Human |
597467236 | GWAS1563310_H | breast carcinoma QTL GWAS1563310 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 6 | 30473526 | 30473527 | Human |
406887353 | GWAS536329_H | susceptibility to cold sores measurement QTL GWAS536329 (human) | | 0.0000003 | susceptibility to cold sores measurement | | 6 | 30262744 | 30262747 | Human |
597172323 | GWAS1268397_H | hemoglobin measurement QTL GWAS1268397 (human) | | 8e-25 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 25769121 | 25769122 | Human |
597467235 | GWAS1563309_H | breast carcinoma QTL GWAS1563309 (human) | | 5e-09 | mammary gland integrity trait (VT:0010552) | | 6 | 29280372 | 29280373 | Human |
597270630 | GWAS1366704_H | pulse pressure measurement QTL GWAS1366704 (human) | | 4e-22 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 31644063 | 31644064 | Human |
597469087 | GWAS1565161_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565161 (human) | | 0.000002 | age at diagnosis, type 1 diabetes mellitus | | 6 | 29058810 | 29058811 | Human |
597436314 | GWAS1532388_H | BMI-adjusted waist circumference, physical activity measurement QTL GWAS1532388 (human) | | 5e-08 | body size trait (VT:0100005) | voluntary body movement measurement (CMO:0000954) | 6 | 26200449 | 26200450 | Human |
597370768 | GWAS1466842_H | drug-induced liver injury QTL GWAS1466842 (human) | | 2e-10 | drug-induced liver injury | | 6 | 29860883 | 29860884 | Human |
597436306 | GWAS1532380_H | serine measurement QTL GWAS1532380 (human) | | 0.000009 | serine measurement | blood amino acid measurement (CMO:0003730) | 6 | 25277191 | 25277192 | Human |
597174152 | GWAS1270226_H | cholesteryl esters to total lipids in very large HDL percentage QTL GWAS1270226 (human) | | 1e-10 | blood lipid amount (VT:0003949) | | 6 | 25715429 | 25715430 | Human |
597469069 | GWAS1565143_H | lung carcinoma QTL GWAS1565143 (human) | | 9e-09 | lung carcinoma | | 6 | 26476825 | 26476826 | Human |
406985814 | GWAS634790_H | mean corpuscular hemoglobin concentration QTL GWAS634790 (human) | | 6e-15 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 8002426 | 8002427 | Human |
597469064 | GWAS1565138_H | lung carcinoma QTL GWAS1565138 (human) | | 2e-09 | lung carcinoma | | 6 | 31448099 | 31448100 | Human |
406985815 | GWAS634791_H | mean corpuscular hemoglobin concentration QTL GWAS634791 (human) | | 1e-186 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597141378 | GWAS1237452_H | etiocholanolone glucuronide measurement QTL GWAS1237452 (human) | | 4e-11 | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | | 6 | 25818527 | 25818528 | Human |
597469065 | GWAS1565139_H | lung carcinoma QTL GWAS1565139 (human) | | 3e-10 | lung carcinoma | | 6 | 30356199 | 30356201 | Human |
597305228 | GWAS1401302_H | glomerular filtration rate QTL GWAS1401302 (human) | | 7e-35 | glomerular filtration rate | glomerular filtration rate (CMO:0000490) | 6 | 7120224 | 7120225 | Human |
597469067 | GWAS1565141_H | lung carcinoma QTL GWAS1565141 (human) | | 1e-09 | lung carcinoma | | 6 | 29865214 | 29865215 | Human |
406985819 | GWAS634795_H | mean corpuscular hemoglobin concentration QTL GWAS634795 (human) | | 5e-656 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 26049696 | 26049697 | Human |
406985817 | GWAS634793_H | mean corpuscular hemoglobin concentration QTL GWAS634793 (human) | | 1e-10 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 20585242 | 20585243 | Human |
597141384 | GWAS1237458_H | ferulic acid 4-sulfate measurement QTL GWAS1237458 (human) | | 7e-224 | ferulic acid 4-sulfate measurement | | 6 | 25794203 | 25794204 | Human |
597043126 | GWAS1139200_H | hemoglobin measurement QTL GWAS1139200 (human) | | 7e-52 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 27807896 | 27807897 | Human |
597338043 | GWAS1434117_H | duodenal ulcer QTL GWAS1434117 (human) | | 5e-09 | duodenal ulcer | | 6 | 26162451 | 26162452 | Human |
597403582 | GWAS1499656_H | schizophrenia QTL GWAS1499656 (human) | | 6e-19 | schizophrenia | | 6 | 32668221 | 32668222 | Human |
597043134 | GWAS1139208_H | hemoglobin measurement QTL GWAS1139208 (human) | | 3e-15 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 27457406 | 27457407 | Human |
597043135 | GWAS1139209_H | hemoglobin measurement QTL GWAS1139209 (human) | | 1e-24 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 32837530 | 32837531 | Human |
597043133 | GWAS1139207_H | hemoglobin measurement QTL GWAS1139207 (human) | | 2e-146 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 25914573 | 25914574 | Human |
407084142 | GWAS733118_H | response to anti-thyroid drug, Drug-induced agranulocytosis QTL GWAS733118 (human) | | 2e-09 | response to anti-thyroid drug, Drug-induced agranulocytosis | | 6 | 31356759 | 31356760 | Human |
597239734 | GWAS1335808_H | blood protein measurement QTL GWAS1335808 (human) | | 9e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 32617103 | 32617104 | Human |
407084147 | GWAS733123_H | response to xenobiotic stimulus, Drug-induced agranulocytosis QTL GWAS733123 (human) | | 2e-15 | response to xenobiotic stimulus, Drug-induced agranulocytosis | | 6 | 31409863 | 31409864 | Human |
597206952 | GWAS1303026_H | depressive symptom measurement QTL GWAS1303026 (human) | | 4e-11 | ulcerative colitis | | 6 | 32108722 | 32108723 | Human |
597272493 | GWAS1368567_H | low density lipoprotein cholesterol measurement QTL GWAS1368567 (human) | | 2e-76 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597075874 | GWAS1171948_H | leukocyte count QTL GWAS1171948 (human) | | 4e-54 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 6 | 32459228 | 32459229 | Human |
597469096 | GWAS1565170_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565170 (human) | | 6e-11 | age at diagnosis, type 1 diabetes mellitus | | 6 | 32615624 | 32615625 | Human |
597272492 | GWAS1368566_H | low density lipoprotein cholesterol measurement QTL GWAS1368566 (human) | | 2e-13 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 11850521 | 11850522 | Human |
597272494 | GWAS1368568_H | low density lipoprotein cholesterol measurement QTL GWAS1368568 (human) | | 1e-71 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 26092913 | 26092914 | Human |
407084148 | GWAS733124_H | response to xenobiotic stimulus, Drug-induced agranulocytosis QTL GWAS733124 (human) | | 9e-13 | response to xenobiotic stimulus, Drug-induced agranulocytosis | | 6 | 31359883 | 31359884 | Human |
597469092 | GWAS1565166_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565166 (human) | | 0.000002 | age at diagnosis, type 1 diabetes mellitus | | 6 | 31110838 | 31110839 | Human |
597501860 | GWAS1597934_H | fish consumption measurement QTL GWAS1597934 (human) | | 2e-08 | fish consumption measurement | | 6 | 16753143 | 16753146 | Human |
597469093 | GWAS1565167_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565167 (human) | | 1e-14 | age at diagnosis, type 1 diabetes mellitus | | 6 | 31173705 | 31173706 | Human |
597469094 | GWAS1565168_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565168 (human) | | 0.0000003 | age at diagnosis, type 1 diabetes mellitus | | 6 | 31280657 | 31280658 | Human |
597436327 | GWAS1532401_H | psoriasis QTL GWAS1532401 (human) | | 5e-723 | psoriasis | | 6 | 31298313 | 31298314 | Human |
597469095 | GWAS1565169_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565169 (human) | | 2e-11 | age at diagnosis, type 1 diabetes mellitus | | 6 | 31449679 | 31449680 | Human |
597469088 | GWAS1565162_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565162 (human) | | 0.0000008 | age at diagnosis, type 1 diabetes mellitus | | 6 | 29931850 | 29931851 | Human |
597075882 | GWAS1171956_H | leukocyte count QTL GWAS1171956 (human) | | 2e-46 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 6 | 31378876 | 31378877 | Human |
597206949 | GWAS1303023_H | depressive symptom measurement QTL GWAS1303023 (human) | | 7e-21 | depressive symptom measurement | | 6 | 28381921 | 28381922 | Human |
597469089 | GWAS1565163_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565163 (human) | | 2e-09 | age at diagnosis, type 1 diabetes mellitus | | 6 | 29946109 | 29946110 | Human |
597469090 | GWAS1565164_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565164 (human) | | 0.000001 | age at diagnosis, type 1 diabetes mellitus | | 6 | 30345252 | 30345253 | Human |
597206950 | GWAS1303024_H | depressive symptom measurement QTL GWAS1303024 (human) | | 1e-11 | wellness/fitness trait (VT:1000152) | | 6 | 31508681 | 31508682 | Human |
597469091 | GWAS1565165_H | age at diagnosis, type 1 diabetes mellitus QTL GWAS1565165 (human) | | 0.0000003 | age at diagnosis, type 1 diabetes mellitus | | 6 | 30954755 | 30954756 | Human |
597206951 | GWAS1303025_H | depressive symptom measurement QTL GWAS1303025 (human) | | 1e-14 | wellness/fitness trait (VT:1000152) | | 6 | 32061428 | 32061429 | Human |
596977622 | GWAS1097141_H | body height QTL GWAS1097141 (human) | | 2e-195 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 19839184 | 19839185 | Human |
597501913 | GWAS1597987_H | diet measurement QTL GWAS1597987 (human) | | 4e-20 | diet measurement | food intake measurement (CMO:0000772) | 6 | 31347852 | 31347853 | Human |
597239775 | GWAS1335849_H | monocyte count QTL GWAS1335849 (human) | | 3e-27 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 31770631 | 31770632 | Human |
597206993 | GWAS1303067_H | major depressive disorder QTL GWAS1303067 (human) | | 0.0000007 | major depressive disorder | | 6 | 24274224 | 24274225 | Human |
597206994 | GWAS1303068_H | major depressive disorder QTL GWAS1303068 (human) | | 0.0000006 | major depressive disorder | | 6 | 25710343 | 25710344 | Human |
597206995 | GWAS1303069_H | major depressive disorder QTL GWAS1303069 (human) | | 6e-09 | major depressive disorder | | 6 | 26408323 | 26408324 | Human |
597239765 | GWAS1335839_H | monocyte count QTL GWAS1335839 (human) | | 1e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 27399042 | 27399043 | Human |
407051279 | GWAS700255_H | Graves disease QTL GWAS700255 (human) | | 4e-51 | Graves disease | | 6 | 31090401 | 31090402 | Human |
597338069 | GWAS1434143_H | angiopoietin-1 receptor measurement QTL GWAS1434143 (human) | | 4e-09 | angiopoietin-1 receptor measurement | | 6 | 31356934 | 31356935 | Human |
597600206 | GWAS1657066_H | blood bicarbonate measurement QTL GWAS1657066 (human) | | 2e-15 | blood bicarbonate measurement | | 6 | 31446464 | 31446465 | Human |
597043143 | GWAS1139217_H | body fat distribution QTL GWAS1139217 (human) | | 1e-38 | body fat distribution | body fat morphological measurement (CMO:0000089) | 6 | 19839184 | 19839185 | Human |
597600205 | GWAS1657065_H | blood bicarbonate measurement QTL GWAS1657065 (human) | | 3e-23 | blood bicarbonate measurement | | 6 | 9547303 | 9547304 | Human |
407051280 | GWAS700256_H | Graves disease QTL GWAS700256 (human) | | 7e-33 | Graves disease | | 6 | 32696074 | 32696075 | Human |
597239757 | GWAS1335831_H | lymphocyte count QTL GWAS1335831 (human) | | 1e-20 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 32714887 | 32714888 | Human |
597043136 | GWAS1139210_H | hemoglobin measurement QTL GWAS1139210 (human) | | 6e-27 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 28904669 | 28904670 | Human |
597239759 | GWAS1335833_H | lymphocyte count QTL GWAS1335833 (human) | | 5e-26 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 30916423 | 30916424 | Human |
597239749 | GWAS1335823_H | lymphocyte count QTL GWAS1335823 (human) | | 2e-23 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 27658852 | 27658853 | Human |
597239748 | GWAS1335822_H | lymphocyte count QTL GWAS1335822 (human) | | 4e-24 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 32586668 | 32586669 | Human |
597141495 | GWAS1237569_H | androsterone sulfate measurement QTL GWAS1237569 (human) | | 8e-26 | androsterone sulfate measurement | | 6 | 25818527 | 25818528 | Human |
597534717 | GWAS1630791_H | body height QTL GWAS1630791 (human) | | 1e-278 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 26288975 | 26288976 | Human |
597534716 | GWAS1630790_H | body height QTL GWAS1630790 (human) | | 1e-300 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 26267527 | 26267528 | Human |
597534719 | GWAS1630793_H | body height QTL GWAS1630793 (human) | | 1e-156 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 28611694 | 28611695 | Human |
597534718 | GWAS1630792_H | body height QTL GWAS1630792 (human) | | 3e-128 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 26550391 | 26550392 | Human |
597534715 | GWAS1630789_H | body height QTL GWAS1630789 (human) | | 1e-300 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 26255223 | 26255224 | Human |
597043199 | GWAS1139273_H | hemoglobin measurement QTL GWAS1139273 (human) | | 2e-19 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 31274306 | 31274307 | Human |
597403633 | GWAS1499707_H | severe cutaneous adverse reaction, trait in response to carbamazepine QTL GWAS1499707 (human) | | 2e-12 | severe cutaneous adverse reaction, trait in response to carbamazepine | | 6 | 29963568 | 29963569 | Human |
597600242 | GWAS1657102_H | basophil measurement QTL GWAS1657102 (human) | | 7e-27 | basophil measurement | | 6 | 22340162 | 22340163 | Human |
597600243 | GWAS1657103_H | basophil measurement QTL GWAS1657103 (human) | | 5e-31 | basophil measurement | | 6 | 31411527 | 31411528 | Human |
597239796 | GWAS1335870_H | eosinophil count QTL GWAS1335870 (human) | | 6e-103 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 32619436 | 32619437 | Human |
597600241 | GWAS1657101_H | basophil measurement QTL GWAS1657101 (human) | | 1e-19 | basophil measurement | | 6 | 7143371 | 7143372 | Human |
597239784 | GWAS1335858_H | basophil count QTL GWAS1335858 (human) | | 7e-19 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 30394030 | 30394031 | Human |
597239787 | GWAS1335861_H | basophil count QTL GWAS1335861 (human) | | 1e-08 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 31356785 | 31356786 | Human |
597600236 | GWAS1657096_H | basophil measurement QTL GWAS1657096 (human) | | 4e-16 | basophil measurement | | 6 | 31415134 | 31415135 | Human |
596977639 | GWAS1097158_H | body height QTL GWAS1097158 (human) | | 1e-82 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 31596390 | 31596391 | Human |
406887476 | GWAS536452_H | tonsillectomy risk measurement QTL GWAS536452 (human) | | 1e-08 | tonsillectomy risk measurement | | 6 | 30273759 | 30273760 | Human |
597600235 | GWAS1657095_H | basophil measurement QTL GWAS1657095 (human) | | 1e-11 | basophil measurement | | 6 | 7143371 | 7143372 | Human |
597338083 | GWAS1434157_H | sexual dimorphism measurement QTL GWAS1434157 (human) | | 2e-25 | sexual dimorphism measurement | | 6 | 26159128 | 26159129 | Human |
597239776 | GWAS1335850_H | monocyte count QTL GWAS1335850 (human) | | 8e-27 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 31358305 | 31358306 | Human |
597272547 | GWAS1368621_H | total cholesterol measurement QTL GWAS1368621 (human) | | 1e-35 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 31910718 | 31910719 | Human |
597337882 | GWAS1433956_H | systolic blood pressure QTL GWAS1433956 (human) | | 5e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20661019 | 20661020 | Human |
597239577 | GWAS1335651_H | basophil count QTL GWAS1335651 (human) | | 4e-37 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 31572779 | 31572780 | Human |
597272345 | GWAS1368419_H | diastolic blood pressure QTL GWAS1368419 (human) | | 4e-18 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 32212119 | 32212120 | Human |
597337883 | GWAS1433957_H | systolic blood pressure QTL GWAS1433957 (human) | | 4e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20679478 | 20679479 | Human |
596977428 | GWAS1096947_H | Red cell distribution width QTL GWAS1096947 (human) | | 2e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 25933704 | 25933705 | Human |
597337880 | GWAS1433954_H | systolic blood pressure QTL GWAS1433954 (human) | | 3e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20657634 | 20657635 | Human |
597239579 | GWAS1335653_H | basophil count QTL GWAS1335653 (human) | | 9e-36 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 31302580 | 31302581 | Human |
597337881 | GWAS1433955_H | systolic blood pressure QTL GWAS1433955 (human) | | 3e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20660803 | 20660804 | Human |
597272346 | GWAS1368420_H | diastolic blood pressure QTL GWAS1368420 (human) | | 6e-18 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 29677836 | 29677837 | Human |
597468953 | GWAS1565027_H | telomere length QTL GWAS1565027 (human) | | 3e-17 | telomere length | | 6 | 31815431 | 31815432 | Human |
597370654 | GWAS1466728_H | schizophrenia QTL GWAS1466728 (human) | | 7e-08 | schizophrenia | | 6 | 32634492 | 32634493 | Human |
597337884 | GWAS1433958_H | systolic blood pressure QTL GWAS1433958 (human) | | 3e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20687890 | 20687891 | Human |
597370653 | GWAS1466727_H | schizophrenia QTL GWAS1466727 (human) | | 1e-08 | schizophrenia | | 6 | 27176104 | 27176105 | Human |
597337885 | GWAS1433959_H | systolic blood pressure QTL GWAS1433959 (human) | | 4e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20694653 | 20694654 | Human |
597075743 | GWAS1171817_H | insulin response measurement QTL GWAS1171817 (human) | | 2e-10 | insulin response measurement | | 6 | 20664850 | 20664851 | Human |
597075740 | GWAS1171814_H | insulin measurement QTL GWAS1171814 (human) | | 6e-08 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 6 | 20664850 | 20664851 | Human |
597239571 | GWAS1335645_H | basophil count QTL GWAS1335645 (human) | | 2e-76 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 31274397 | 31274398 | Human |
597337878 | GWAS1433952_H | systolic blood pressure QTL GWAS1433952 (human) | | 3e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20652486 | 20652487 | Human |
597239573 | GWAS1335647_H | basophil count QTL GWAS1335647 (human) | | 1e-58 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 32082290 | 32082291 | Human |
597337879 | GWAS1433953_H | systolic blood pressure QTL GWAS1433953 (human) | | 5e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20657333 | 20657334 | Human |
597600019 | GWAS1656879_H | rheumatoid arthritis, hypothyroidism QTL GWAS1656879 (human) | | 2e-11 | rheumatoid arthritis, hypothyroidism | | 6 | 30270373 | 30270374 | Human |
597239572 | GWAS1335646_H | basophil count QTL GWAS1335646 (human) | | 5e-70 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 32480352 | 32480353 | Human |
597337876 | GWAS1433950_H | systolic blood pressure QTL GWAS1433950 (human) | | 8e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12296022 | 12296023 | Human |
597239575 | GWAS1335649_H | basophil count QTL GWAS1335649 (human) | | 4e-55 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 31343434 | 31343435 | Human |
597337877 | GWAS1433951_H | systolic blood pressure QTL GWAS1433951 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 16321561 | 16321562 | Human |
597239574 | GWAS1335648_H | neutrophil count QTL GWAS1335648 (human) | | 4e-08 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31256890 | 31256891 | Human |
597239560 | GWAS1335634_H | neutrophil count QTL GWAS1335634 (human) | | 4e-80 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31343434 | 31343435 | Human |
597239563 | GWAS1335637_H | neutrophil count QTL GWAS1335637 (human) | | 5e-63 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31302628 | 31302629 | Human |
406985942 | GWAS634918_H | triglyceride measurement QTL GWAS634918 (human) | | 0.000004 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 31872244 | 31872245 | Human |
597108481 | GWAS1204555_H | urate measurement QTL GWAS1204555 (human) | | 4e-126 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 25809488 | 25809489 | Human |
597206799 | GWAS1302873_H | pulmonary alveolar proteinosis QTL GWAS1302873 (human) | | 2e-12 | pulmonary alveolar proteinosis | | 6 | 32485493 | 32485494 | Human |
597272321 | GWAS1368395_H | total cholesterol measurement QTL GWAS1368395 (human) | | 9e-55 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 25917997 | 25917998 | Human |
597272323 | GWAS1368397_H | total cholesterol measurement QTL GWAS1368397 (human) | | 7e-24 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 30106070 | 30106071 | Human |
597239555 | GWAS1335629_H | lymphocyte count QTL GWAS1335629 (human) | | 6e-25 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 30108087 | 30108088 | Human |
597272322 | GWAS1368396_H | total cholesterol measurement QTL GWAS1368396 (human) | | 3e-21 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 27099878 | 27099879 | Human |
597239554 | GWAS1335628_H | lymphocyte count QTL GWAS1335628 (human) | | 4e-35 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 32761281 | 32761282 | Human |
597239556 | GWAS1335630_H | neutrophil count QTL GWAS1335630 (human) | | 4e-109 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31274397 | 31274398 | Human |
597042952 | GWAS1139026_H | gestational blood glucose measurement, fetal genotype effect measurement, Glycosuria QTL GWAS1139026 (human) | | 3e-08 | gestational blood glucose measurement, fetal genotype effect measurement, Glycosuria | | 6 | 29387440 | 29387441 | Human |
597239558 | GWAS1335632_H | neutrophil count QTL GWAS1335632 (human) | | 5e-83 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 32082290 | 32082291 | Human |
597501757 | GWAS1597831_H | mitral valve annular diameter QTL GWAS1597831 (human) | | 6e-10 | mitral valve morphology trait (VT:0000033) | | 6 | 22606797 | 22606798 | Human |
597403442 | GWAS1499516_H | myocardial infarction QTL GWAS1499516 (human) | | 1e-27 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597108542 | GWAS1204616_H | urate measurement QTL GWAS1204616 (human) | | 8e-08 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 32623102 | 32623103 | Human |
406887665 | GWAS536641_H | parental longevity QTL GWAS536641 (human) | | 0.0000003 | total life span (VT:0001661) | | 6 | 31219298 | 31219299 | Human |
597337899 | GWAS1433973_H | MHC class I polypeptide-related sequence A measurement QTL GWAS1433973 (human) | | 3e-11 | MHC class I polypeptide-related sequence A measurement | | 6 | 31605800 | 31605801 | Human |
597239594 | GWAS1335668_H | lymphocyte:monocyte ratio QTL GWAS1335668 (human) | | 1e-09 | leukocyte quantity (VT:0000217) | | 6 | 31256890 | 31256891 | Human |
597337902 | GWAS1433976_H | MHC class I polypeptide-related sequence A measurement QTL GWAS1433976 (human) | | 3e-10 | MHC class I polypeptide-related sequence A measurement | | 6 | 29678388 | 29678389 | Human |
597337903 | GWAS1433977_H | MHC class I polypeptide-related sequence A measurement QTL GWAS1433977 (human) | | 6e-29 | MHC class I polypeptide-related sequence A measurement | | 6 | 31410016 | 31410017 | Human |
597337900 | GWAS1433974_H | MHC class I polypeptide-related sequence A measurement QTL GWAS1433974 (human) | | 4e-11 | MHC class I polypeptide-related sequence A measurement | | 6 | 32241468 | 32241469 | Human |
597337901 | GWAS1433975_H | MHC class I polypeptide-related sequence A measurement QTL GWAS1433975 (human) | | 2e-09 | MHC class I polypeptide-related sequence A measurement | | 6 | 29388810 | 29388811 | Human |
597600039 | GWAS1656899_H | blood bicarbonate measurement QTL GWAS1656899 (human) | | 1e-15 | blood bicarbonate measurement | | 6 | 31204374 | 31204375 | Human |
597174050 | GWAS1270124_H | alcohol consumption measurement QTL GWAS1270124 (human) | | 4e-13 | response to alcohol trait (VT:0010489) | ethanol drink intake rate (CMO:0001407) | 6 | 16714386 | 16714387 | Human |
597272355 | GWAS1368429_H | diastolic blood pressure QTL GWAS1368429 (human) | | 3e-22 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 32702531 | 32702532 | Human |
597239586 | GWAS1335660_H | basophil count QTL GWAS1335660 (human) | | 1e-22 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 32717603 | 32717604 | Human |
597600033 | GWAS1656893_H | blood bicarbonate measurement QTL GWAS1656893 (human) | | 4e-20 | blood bicarbonate measurement | | 6 | 9559401 | 9559402 | Human |
597272358 | GWAS1368432_H | diastolic blood pressure QTL GWAS1368432 (human) | | 3e-21 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 32231367 | 32231368 | Human |
597337947 | GWAS1434021_H | hypertension QTL GWAS1434021 (human) | | 0.000004 | hypertension | | 6 | 20657634 | 20657635 | Human |
407084162 | GWAS733138_H | eosinophil percentage of leukocytes QTL GWAS733138 (human) | | 7e-35 | eosinophil percentage of leukocytes | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 31359924 | 31359925 | Human |
597337944 | GWAS1434018_H | hypertension QTL GWAS1434018 (human) | | 0.000004 | hypertension | | 6 | 20687890 | 20687891 | Human |
597370713 | GWAS1466787_H | response to antineoplastic agent QTL GWAS1466787 (human) | | 0.000006 | response to antineoplastic agent | | 6 | 31440488 | 31440489 | Human |
597469016 | GWAS1565090_H | neutrophil count QTL GWAS1565090 (human) | | 3e-23 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31280655 | 31280656 | Human |
597469015 | GWAS1565089_H | neutrophil count QTL GWAS1565089 (human) | | 6e-25 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 31272944 | 31272945 | Human |
597337942 | GWAS1434016_H | hypertension QTL GWAS1434016 (human) | | 0.000009 | hypertension | | 6 | 20661019 | 20661020 | Human |
597534545 | GWAS1630619_H | bone density QTL GWAS1630619 (human) | | 1e-176 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 32379040 | 32379041 | Human |
597337943 | GWAS1434017_H | hypertension QTL GWAS1434017 (human) | | 0.000002 | hypertension | | 6 | 20679478 | 20679479 | Human |
597469009 | GWAS1565083_H | Hepatic fibrosis QTL GWAS1565083 (human) | | 0.0000001 | Hepatic fibrosis | | 6 | 23993395 | 23993396 | Human |
597534544 | GWAS1630618_H | bone density QTL GWAS1630618 (human) | | 4e-177 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 6 | 32380015 | 32380016 | Human |
597337941 | GWAS1434015_H | hypertension QTL GWAS1434015 (human) | | 0.000005 | hypertension | | 6 | 20660803 | 20660804 | Human |
597141315 | GWAS1237389_H | andro steroid monosulfate C19H28O6S (1) measurement QTL GWAS1237389 (human) | | 5e-53 | andro steroid monosulfate C19H28O6S (1) measurement | | 6 | 25824581 | 25824582 | Human |
597075789 | GWAS1171863_H | insulin sensitivity measurement, insulin response measurement QTL GWAS1171863 (human) | | 0.0000001 | insulin sensitivity measurement, insulin response measurement | calculated blood insulin level (CMO:0000353) | 6 | 20664850 | 20664851 | Human |
597501760 | GWAS1597834_H | mitral valve annular diameter QTL GWAS1597834 (human) | | 1e-09 | mitral valve morphology trait (VT:0000033) | | 6 | 22606797 | 22606798 | Human |
597436284 | GWAS1532358_H | lipid measurement QTL GWAS1532358 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 11200924 | 11200925 | Human |
597600122 | GWAS1656982_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656982 (human) | | 2e-21 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 32854409 | 32854410 | Human |
597600120 | GWAS1656980_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656980 (human) | | 4e-22 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 29999761 | 29999762 | Human |
597600121 | GWAS1656981_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656981 (human) | | 1e-21 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 30338776 | 30338777 | Human |
597206896 | GWAS1302970_H | urate measurement QTL GWAS1302970 (human) | | 1e-08 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 20682391 | 20682392 | Human |
597600118 | GWAS1656978_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656978 (human) | | 4e-33 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 31379674 | 31379675 | Human |
597043071 | GWAS1139145_H | hemoglobin measurement QTL GWAS1139145 (human) | | 2e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 27310241 | 27310242 | Human |
597600119 | GWAS1656979_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656979 (human) | | 8e-32 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 32588684 | 32588685 | Human |
597501815 | GWAS1597889_H | rheumatoid arthritis QTL GWAS1597889 (human) | | 0.000001 | rheumatoid arthritis | | 6 | 23924793 | 23924794 | Human |
597305200 | GWAS1401274_H | metabolite measurement QTL GWAS1401274 (human) | | 2e-26 | metabolite measurement | | 6 | 25801091 | 25801092 | Human |
597600116 | GWAS1656976_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656976 (human) | | 3e-23 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 32142202 | 32142203 | Human |
597600117 | GWAS1656977_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656977 (human) | | 3e-23 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 30941684 | 30941685 | Human |
597469040 | GWAS1565114_H | neutrophil count QTL GWAS1565114 (human) | | 8e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 22079256 | 22079257 | Human |
597600110 | GWAS1656970_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656970 (human) | | 1e-23 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 32203511 | 32203512 | Human |
597600108 | GWAS1656968_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656968 (human) | | 1e-25 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 31486629 | 31486630 | Human |
597141348 | GWAS1237422_H | chronic obstructive pulmonary disease QTL GWAS1237422 (human) | | 2e-09 | lung integrity trait (VT:0010906) | | 6 | 17898894 | 17898895 | Human |
597469039 | GWAS1565113_H | neutrophil count QTL GWAS1565113 (human) | | 6e-22 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 21382534 | 21382535 | Human |
597600109 | GWAS1656969_H | rheumatoid arthritis, chronic interstitial cystitis QTL GWAS1656969 (human) | | 1e-24 | rheumatoid arthritis, chronic interstitial cystitis | | 6 | 32446696 | 32446697 | Human |
597436265 | GWAS1532339_H | angina pectoris QTL GWAS1532339 (human) | | 4e-08 | angina pectoris | | 6 | 25282949 | 25282950 | Human |
597600107 | GWAS1656967_H | chronic interstitial cystitis, Autoimmune Hepatitis QTL GWAS1656967 (human) | | 9e-09 | chronic interstitial cystitis, Autoimmune Hepatitis | | 6 | 32674248 | 32674249 | Human |
597174126 | GWAS1270200_H | C-type lectin domain family 4 member D measurement QTL GWAS1270200 (human) | | 2e-25 | C-type lectin domain family 4 member D measurement | | 6 | 31960529 | 31960530 | Human |
597403491 | GWAS1499565_H | coronary artery disease QTL GWAS1499565 (human) | | 1e-08 | coronary artery disease | | 6 | 12934070 | 12934071 | Human |
406985912 | GWAS634888_H | body fat percentage QTL GWAS634888 (human) | | 0.000003 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 6 | 31628105 | 31628106 | Human |
597436263 | GWAS1532337_H | angina pectoris QTL GWAS1532337 (human) | | 3e-30 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
406985916 | GWAS634892_H | von Willebrand factor measurement QTL GWAS634892 (human) | | 3e-08 | von Willebrand factor measurement | | 6 | 31939051 | 31939052 | Human |
597042838 | GWAS1138912_H | erythrocyte count QTL GWAS1138912 (human) | | 4e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 20504620 | 20504621 | Human |
597042839 | GWAS1138913_H | appendicular lean mass QTL GWAS1138913 (human) | | 4e-13 | appendicular lean mass | | 6 | 32421768 | 32421769 | Human |
597042836 | GWAS1138910_H | erythrocyte count QTL GWAS1138910 (human) | | 3e-28 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15173989 | 15173990 | Human |
597436062 | GWAS1532136_H | hip circumference QTL GWAS1532136 (human) | | 0.000004 | hip circumference | hip circumference (CMO:0000014) | 6 | 27287459 | 27287460 | Human |
597468830 | GWAS1564904_H | protein measurement QTL GWAS1564904 (human) | | 3e-08 | protein measurement | | 6 | 31059792 | 31059793 | Human |
597042837 | GWAS1138911_H | erythrocyte count QTL GWAS1138911 (human) | | 2e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16280956 | 16280957 | Human |
597042834 | GWAS1138908_H | erythrocyte count QTL GWAS1138908 (human) | | 5e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 9547364 | 9547365 | Human |
597370527 | GWAS1466601_H | intelligence QTL GWAS1466601 (human) | | 6e-08 | intelligence | | 6 | 29850949 | 29850950 | Human |
597042835 | GWAS1138909_H | erythrocyte count QTL GWAS1138909 (human) | | 3e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 12294629 | 12294630 | Human |
597272220 | GWAS1368294_H | interleukin-17F measurement QTL GWAS1368294 (human) | | 6e-17 | interleukin-17F measurement | | 6 | 31927842 | 31927843 | Human |
597042832 | GWAS1138906_H | erythrocyte count QTL GWAS1138906 (human) | | 8e-10 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7098023 | 7098024 | Human |
597042833 | GWAS1138907_H | erythrocyte count QTL GWAS1138907 (human) | | 7e-31 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7232156 | 7232157 | Human |
597075601 | GWAS1171675_H | Testicular Germ Cell Tumor QTL GWAS1171675 (human) | | 0.000006 | Testicular Germ Cell Tumor | | 6 | 31121204 | 31121205 | Human |
597403283 | GWAS1499357_H | schizophrenia QTL GWAS1499357 (human) | | 4e-11 | schizophrenia | | 6 | 26947221 | 26947222 | Human |
597403282 | GWAS1499356_H | schizophrenia QTL GWAS1499356 (human) | | 4e-15 | schizophrenia | | 6 | 25371141 | 25371142 | Human |
596977311 | GWAS1096830_H | body height QTL GWAS1096830 (human) | | 3e-40 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 28865850 | 28865851 | Human |
597304982 | GWAS1401056_H | total blood protein measurement QTL GWAS1401056 (human) | | 1e-14 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 7231610 | 7231611 | Human |
597173908 | GWAS1269982_H | ascending aortic diameter QTL GWAS1269982 (human) | | 8e-14 | ascending aortic diameter | | 6 | 12295754 | 12295755 | Human |
597468818 | GWAS1564892_H | self reported educational attainment QTL GWAS1564892 (human) | | 8e-18 | self reported educational attainment | | 6 | 14721666 | 14721667 | Human |
597173896 | GWAS1269970_H | intelligence QTL GWAS1269970 (human) | | 9e-11 | intelligence | | 6 | 26582901 | 26582902 | Human |
407379291 | GWAS1028267_H | base metabolic rate measurement QTL GWAS1028267 (human) | | 1e-09 | energy metabolism trait (VT:0010637) | | 6 | 28254038 | 28254039 | Human |
597436043 | GWAS1532117_H | BMI-adjusted waist circumference, physical activity measurement QTL GWAS1532117 (human) | | 0.000004 | body size trait (VT:0100005) | voluntary body movement measurement (CMO:0000954) | 6 | 26200449 | 26200450 | Human |
597173889 | GWAS1269963_H | intelligence QTL GWAS1269963 (human) | | 3e-12 | intelligence | | 6 | 26663250 | 26663251 | Human |
597403264 | GWAS1499338_H | low density lipoprotein cholesterol measurement QTL GWAS1499338 (human) | | 2e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
597173893 | GWAS1269967_H | intelligence QTL GWAS1269967 (human) | | 6e-12 | intelligence | | 6 | 28184805 | 28184806 | Human |
596977334 | GWAS1096853_H | body height QTL GWAS1096853 (human) | | 6e-15 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 22056694 | 22056695 | Human |
597436089 | GWAS1532163_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1532163 (human) | | 1e-12 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 31468255 | 31468256 | Human |
597305023 | GWAS1401097_H | level of ferritin, mitochondrial in blood serum QTL GWAS1401097 (human) | | 7e-33 | level of ferritin, mitochondrial in blood serum | | 6 | 31875082 | 31875083 | Human |
597305021 | GWAS1401095_H | protein measurement QTL GWAS1401095 (human) | | 3e-17 | protein measurement | | 6 | 32133413 | 32133414 | Human |
597272240 | GWAS1368314_H | complement factor B measurement QTL GWAS1368314 (human) | | 1e-31 | complement factor B measurement | | 6 | 31946247 | 31946248 | Human |
597370539 | GWAS1466613_H | mean corpuscular hemoglobin concentration QTL GWAS1466613 (human) | | 6e-26 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 21722685 | 21722686 | Human |
406986099 | GWAS635075_H | triacylglycerol 58:12 measurement QTL GWAS635075 (human) | | 0.000003 | blood triglyceride amount (VT:0002644) | | 6 | 20366349 | 20366350 | Human |
597305003 | GWAS1401077_H | glomerular filtration rate QTL GWAS1401077 (human) | | 6e-35 | glomerular filtration rate | glomerular filtration rate (CMO:0000490) | 6 | 31867387 | 31867388 | Human |
597337772 | GWAS1433846_H | hypertension QTL GWAS1433846 (human) | | 0.000008 | hypertension | | 6 | 20657333 | 20657334 | Human |
597370540 | GWAS1466614_H | mean corpuscular hemoglobin concentration QTL GWAS1466614 (human) | | 4e-356 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 25367966 | 25367967 | Human |
597173922 | GWAS1269996_H | protein measurement QTL GWAS1269996 (human) | | 4e-25 | protein measurement | | 6 | 31967534 | 31967535 | Human |
597370528 | GWAS1466602_H | intelligence QTL GWAS1466602 (human) | | 6e-08 | intelligence | | 6 | 30964067 | 30964068 | Human |
597173924 | GWAS1269998_H | desmoglein-1 measurement QTL GWAS1269998 (human) | | 8e-41 | desmoglein-1 measurement | | 6 | 31979309 | 31979310 | Human |
406985987 | GWAS634963_H | intelligence QTL GWAS634963 (human) | | 2e-09 | intelligence | | 6 | 30796116 | 30796117 | Human |
597436120 | GWAS1532194_H | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement QTL GWAS1532194 (human) | | 2e-11 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 6 | 26340644 | 26340645 | Human |
597436121 | GWAS1532195_H | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement QTL GWAS1532195 (human) | | 2e-14 | blood lipid amount (VT:0003949) | blood very low density lipoprotein cholesterol level (CMO:0000648) | 6 | 29935853 | 29935854 | Human |
406985991 | GWAS634967_H | atrophic macular degeneration QTL GWAS634967 (human) | | 0.000001 | atrophic macular degeneration | | 6 | 31936027 | 31936028 | Human |
597042908 | GWAS1138982_H | appendicular lean mass QTL GWAS1138982 (human) | | 1e-09 | appendicular lean mass | | 6 | 31318282 | 31318283 | Human |
406986007 | GWAS634983_H | wet macular degeneration QTL GWAS634983 (human) | | 2e-08 | wet macular degeneration | | 6 | 31936027 | 31936028 | Human |
597305027 | GWAS1401101_H | level of T-cell surface protein tactile in blood serum QTL GWAS1401101 (human) | | 3e-29 | level of T-cell surface protein tactile in blood serum | | 6 | 32084478 | 32084479 | Human |
597239545 | GWAS1335619_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335619 (human) | | 2e-09 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28333322 | 28333323 | Human |
597075703 | GWAS1171777_H | insulin response measurement QTL GWAS1171777 (human) | | 4e-10 | insulin response measurement | | 6 | 20664850 | 20664851 | Human |
597239544 | GWAS1335618_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335618 (human) | | 2e-08 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28169721 | 28169722 | Human |
597075700 | GWAS1171774_H | insulin measurement QTL GWAS1171774 (human) | | 8e-09 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 6 | 20664850 | 20664851 | Human |
597239547 | GWAS1335621_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335621 (human) | | 1e-10 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28329086 | 28329087 | Human |
597239546 | GWAS1335620_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335620 (human) | | 7e-11 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28331910 | 28331911 | Human |
597239549 | GWAS1335623_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335623 (human) | | 2e-10 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28328098 | 28328099 | Human |
597239548 | GWAS1335622_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335622 (human) | | 1e-10 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28328873 | 28328874 | Human |
597305084 | GWAS1401158_H | cortical surface area measurement QTL GWAS1401158 (human) | | 9e-18 | cerebral cortex morphology trait (VT:0000788) | tibia-fibula cortical bone total cross-sectional area (CMO:0001721) | 6 | 7120224 | 7120225 | Human |
597239550 | GWAS1335624_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335624 (human) | | 8e-11 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28321008 | 28321009 | Human |
597534453 | GWAS1630527_H | body height QTL GWAS1630527 (human) | | 3e-15 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 6958873 | 6958874 | Human |
597239539 | GWAS1335613_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335613 (human) | | 2e-08 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28322551 | 28322552 | Human |
597239541 | GWAS1335615_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335615 (human) | | 1e-08 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28270281 | 28270282 | Human |
597239540 | GWAS1335614_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335614 (human) | | 1e-08 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28304196 | 28304197 | Human |
597239543 | GWAS1335617_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335617 (human) | | 4e-11 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28294909 | 28294910 | Human |
597599984 | GWAS1656844_H | smoking initiation QTL GWAS1656844 (human) | | 7e-35 | smoking initiation | | 6 | 30262884 | 30262885 | Human |
597075705 | GWAS1171779_H | disposition index measurement QTL GWAS1171779 (human) | | 0.0000003 | disposition index measurement | whole body insulin sensitivity index (CMO:0003001) | 6 | 20664850 | 20664851 | Human |
597239542 | GWAS1335616_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335616 (human) | | 6e-09 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28283207 | 28283208 | Human |
597108453 | GWAS1204527_H | HMG CoA reductase inhibitor use measurement QTL GWAS1204527 (human) | | 4e-10 | HMG CoA reductase inhibitor use measurement | | 6 | 16131066 | 16131067 | Human |
406920501 | GWAS569477_H | celiac disease QTL GWAS569477 (human) | | 5e-21 | celiac disease | | 6 | 32240547 | 32240548 | Human |
597436139 | GWAS1532213_H | brain measurement QTL GWAS1532213 (human) | | 1e-59 | brain measurement | brain measurement (CMO:0000911) | 6 | 8730721 | 8730722 | Human |
407018810 | GWAS667786_H | body height QTL GWAS667786 (human) | | 8e-29 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 31412752 | 31412753 | Human |
597075690 | GWAS1171764_H | heel bone mineral density QTL GWAS1171764 (human) | | 3e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7231610 | 7231611 | Human |
597534433 | GWAS1630507_H | body height QTL GWAS1630507 (human) | | 1e-84 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 22100138 | 22100139 | Human |
407018814 | GWAS667790_H | systolic blood pressure QTL GWAS667790 (human) | | 2e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 31648589 | 31648590 | Human |
597534432 | GWAS1630506_H | body height QTL GWAS1630506 (human) | | 3e-109 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 22055902 | 22055903 | Human |
597534239 | GWAS1630313_H | body height QTL GWAS1630313 (human) | | 0.000004 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 22141825 | 22141826 | Human |
597534238 | GWAS1630312_H | body height QTL GWAS1630312 (human) | | 3e-08 | body height (VT:0001253) | body height (CMO:0000106) | 6 | 7886672 | 7886673 | Human |
597075472 | GWAS1171546_H | body mass index QTL GWAS1171546 (human) | | 4e-29 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 20675561 | 20675562 | Human |
597239327 | GWAS1335401_H | anxiety, stress-related disorder, major depressive disorder QTL GWAS1335401 (human) | | 2e-08 | anxiety, stress-related disorder, major depressive disorder | | 6 | 28225324 | 28225325 | Human |
597141008 | GWAS1237082_H | X-19141 measurement QTL GWAS1237082 (human) | | 2e-114 | X-19141 measurement | | 6 | 25817561 | 25817562 | Human |
597435931 | GWAS1532005_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1532005 (human) | | 5e-10 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 29978172 | 29978173 | Human |
597304855 | GWAS1400929_H | erythrocyte count QTL GWAS1400929 (human) | | 1e-19 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15176027 | 15176028 | Human |
597599763 | GWAS1656623_H | mean corpuscular hemoglobin concentration QTL GWAS1656623 (human) | | 5e-22 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 26090951 | 26090952 | Human |
597435921 | GWAS1531995_H | gut microbiome measurement QTL GWAS1531995 (human) | | 2e-08 | gut microbiome measurement | | 6 | 31394210 | 31394211 | Human |
597108249 | GWAS1204323_H | cocaine dependence QTL GWAS1204323 (human) | | 0.000003 | cocaine dependence | | 6 | 27333733 | 27333734 | Human |
597304853 | GWAS1400927_H | erythrocyte count QTL GWAS1400927 (human) | | 5e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 12294629 | 12294630 | Human |
597403147 | GWAS1499221_H | corneal topography QTL GWAS1499221 (human) | | 5e-37 | corneal topography | | 6 | 22064410 | 22064411 | Human |
597468682 | GWAS1564756_H | neutrophil count QTL GWAS1564756 (human) | | 5e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 29955471 | 29955472 | Human |
597403148 | GWAS1499222_H | corneal topography QTL GWAS1499222 (human) | | 4e-35 | corneal topography | | 6 | 10028593 | 10028594 | Human |
597468678 | GWAS1564752_H | obsessive-compulsive symptom measurement QTL GWAS1564752 (human) | | 0.000009 | anxiety-related behavior trait (VT:0010716) | | 6 | 8180053 | 8180054 | Human |
597141004 | GWAS1237078_H | X-17690 measurement QTL GWAS1237078 (human) | | 1e-25 | X-17690 measurement | | 6 | 25829405 | 25829406 | Human |
597403136 | GWAS1499210_H | mean reticulocyte volume QTL GWAS1499210 (human) | | 3e-71 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 6 | 31652357 | 31652358 | Human |
597599744 | GWAS1656604_H | mean corpuscular hemoglobin concentration QTL GWAS1656604 (human) | | 2e-56 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 26090951 | 26090952 | Human |
597337658 | GWAS1433732_H | systolic blood pressure QTL GWAS1433732 (human) | | 6e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 20660803 | 20660804 | Human |
|